DID_id,src_nm,src_id,drug_raw_name,cas_cas_no,cas_pt,cas_source,cas_match,chebi_pt,chebi_id,chebi_cas_no,chebi_match,chebi_syn,chebi_syn_match,chebi_match_aid,chemid_pt,chemid_display_name,chemid_id,chemi_match,chemid_syn,chemid_syn_match,chemid_match_aid,ctd_pt,ctd_mesh_id,ctd_cas_no,ctd_match,ctd_syn,ctd_syn_match,ctd_match_aid,umls_pt,umls_cui,umls_match,umls_syn,umls_syn_match,umls_match_aid,umls_sem_typ1,umls_sem_typ2,umls_sem_typ3,umls_sem_typ4,ind_raw,ind_agg,_ind_search,ind_raw_value,ind_raw_target,ind_raw_match,ind_umls_entry_term_match,ind_umls_entry_term,ind_umls_pt,und_umls_cuii,ind_umls_term_typ,ind_umls_pheno_flg,ind_umls_sem_typ1,ind_umls_sem_typ2,ind_umls_sem_typ3,ind_umls_sem_typ4,ind_umls_in_term_match,ind_umls_in_term,ind_umls_in_pt,ind_umls_in_cui,ind_umls_in_term_typ,ind_umls_in_sem_typ1,ind_umls_in_sem_typ2,ind_umls_in_sem_typ3,ind_umls_in_sem_typ4
1_000001,NDFRT,C0016157,Fish Oils,8016-13-5,Fish oil,ChemID+,<syn per source>,,,,,,,,Fish oil,,8016-13-5,syn plural/singular,Fish oils,exact,,Fish Oils,D005395,,exact,,,,Fish Oils,C0016157,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,may_prevent,,#VALUE!,Arrhythmia,Arrhythmia,Y,exact (CUI-based),arrhythmia,Cardiac Arrhythmia,C0003811,S,Y,B2.2.1.2_Pathologic Function,,,,,,,,,,,,
1_000002,NDFRT,C0016157,Fish Oils,8016-13-5,Fish oil,ChemID+,<syn per source>,,,,,,,,Fish oil,,8016-13-5,syn plural/singular,Fish oils,exact,,Fish Oils,D005395,,exact,,,,Fish Oils,C0016157,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,may_treat,,#VALUE!,"Arthritis, Rheumatoid","Arthritis, Rheumatoid",Y,exact (CUI-based),"arthritis, rheumatoid",Rheumatoid Arthritis,C0003873,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_000003,NDFRT,C0016157,Fish Oils,8016-13-5,Fish oil,ChemID+,<syn per source>,,,,,,,,Fish oil,,8016-13-5,syn plural/singular,Fish oils,exact,,Fish Oils,D005395,,exact,,,,Fish Oils,C0016157,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,may_treat,,#VALUE!,"Fatigue Syndrome, Chronic","Fatigue Syndrome, Chronic",Y,exact (CUI-based),"fatigue syndrome, chronic",Chronic Fatigue Syndrome,C0015674,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_000004,NDFRT,C0016157,Fish Oils,8016-13-5,Fish oil,ChemID+,<syn per source>,,,,,,,,Fish oil,,8016-13-5,syn plural/singular,Fish oils,exact,,Fish Oils,D005395,,exact,,,,Fish Oils,C0016157,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,may_treat,,#VALUE!,Hyperlipidemia,Hyperlipidemia,Y,exact (CUI-based),Hyperlipidemia,Hyperlipidemia,C0020473,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_000005,NDFRT,C0016157,Fish Oils,8016-13-5,Fish oil,ChemID+,<syn per source>,,,,,,,,Fish oil,,8016-13-5,syn plural/singular,Fish oils,exact,,Fish Oils,D005395,,exact,,,,Fish Oils,C0016157,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,may_treat,,#VALUE!,Hypertension,Hypertension,Y,exact (CUI-based),hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_000006,MeSH_PA,D015718,Fibrin Tissue Adhesive,103170-82-7,Fibrin Tissue Adhesive,ChemID+,exact,,,,,,,,Fibrin Tissue Adhesive,,103170-82-7,exact,,,,,,,,,,,Fibrin Tissue Adhesive,C0016004,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.2_Biomedical or Dental Material,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Coagulants,Coagulants,Y,quasi syn therclass-to-disease,Clotting Decreased,Clotting Decreased,C0549625,P,Y,A2.2_Finding,,,,exact (CUI-based),Coagulants,Coagulants,C0009117,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000007,MeSH_PA,D015718,Fibrin Tissue Adhesive,103170-82-7,Fibrin Tissue Adhesive,ChemID+,exact,,,,,,,,Fibrin Tissue Adhesive,,103170-82-7,exact,,,,,,,,,,,Fibrin Tissue Adhesive,C0016004,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.2_Biomedical or Dental Material,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000008,MeSH_PA,D015718,Fibrin Tissue Adhesive,103170-82-7,Fibrin Tissue Adhesive,ChemID+,exact,,,,,,,,Fibrin Tissue Adhesive,,103170-82-7,exact,,,,,,,,,,,Fibrin Tissue Adhesive,C0016004,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.2_Biomedical or Dental Material,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,static,,#VALUE!,Hemostatics,Hemostatics,Y,quasi syn therclass-to-disease,Hemorrhage,Hemorrhage,C0019080,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),hemostatics,Hemostatic Agents,C0019120,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000009,MeSH_PA,D015718,Fibrin Tissue Adhesive,103170-82-7,Fibrin Tissue Adhesive,ChemID+,exact,,,,,,,,Fibrin Tissue Adhesive,,103170-82-7,exact,,,,,,,,,,,Fibrin Tissue Adhesive,C0016004,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.2_Biomedical or Dental Material,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Surgical Fixation Devices,Surgical Fixation Devices,Y,exact (CUI-based),Surgical Fixation Devices,Surgical Fixation Devices,C1721086,P,,A1.3.1_Medical Device,,,,,,,,,,,,
1_000010,MeSH_PA,D015718,Fibrin Tissue Adhesive,103170-82-7,Fibrin Tissue Adhesive,ChemID+,exact,,,,,,,,Fibrin Tissue Adhesive,,103170-82-7,exact,,,,,,,,,,,Fibrin Tissue Adhesive,C0016004,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.2_Biomedical or Dental Material,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Tissue Adhesives,Tissue Adhesives,Y,quasi syn therclass-to-disease,Tissue Damage,Tissue Damage,C0010957,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Tissue Adhesives,Tissue Adhesives,C0040277,P,A1.4.1.1.2_Biomedical or Dental Material,,,
1_000011,ChEBI,,organochlorine insecticide,,,,,organochlorine insecticide,25705,,exact,,,,,,,,,,,,,,,,,,Organochlorine Insecticide,C0021579,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,cide,,#VALUE!,insecticide,insecticide,Y,quasi syn therclass-to-disease,Infestation By Insect,Infestation By Insect,C0277344,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,insecticide,Insecticides,C0021576,S,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000012,ChEBI,,organochlorine pesticide,,,,,organochlorine pesticide,38656,,exact,,,,,,,,,,,,,,,,,,Organochlorine Pesticide,C0392143,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,pesticide,pesticide,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact 1,pesticide,Pesticides,C0031253,S,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000013,MeSH_PA,C546060,hydrated silica gel-based toothpaste,112926-00-8,Hydrated silica,ChemID+,NT app,,,,,,,,Hydrated silica,,112926-00-8,NT app,,,,hydrated silica gel-based toothpaste,C546060,,exact,,,,Hydrated Silica Gel-Based Toothpaste,C2974024,exact,,,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,#VALUE!,Cosmetics,Cosmetics,Y,exact (CUI-based),Cosmetics,Cosmetics,C0010164,P,,A1.3_Manufactured Object,,,,,,,,,,,,
1_000014,MeSH_PA,C546060,hydrated silica gel-based toothpaste,112926-00-8,Hydrated silica,ChemID+,NT app,,,,,,,,Hydrated silica,,112926-00-8,NT app,,,,hydrated silica gel-based toothpaste,C546060,,exact,,,,Hydrated Silica Gel-Based Toothpaste,C2974024,exact,,,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,#VALUE!,Dentifrices,Dentifrices,Y,quasi syn therclass-to-disease,Tooth Diseases,Tooth Diseases,C0040435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dentifrices,Dentifrices,C0011427,P,A1.4.1.1.2_Biomedical or Dental Material,,,
1_000015,MeSH_PA,D019422,Dietary Sucrose,,,,,,,,,,,,Dietary Sucrose,,D019422000,exact,,,,Dietary Sucrose,D019422,,exact,,,,Dietary Sucrose,C0376597,exact,,,,A1.4.1.2.1.8_Carbohydrate,A1.4.3_Food,,,,,#VALUE!,Flavoring Agents,Flavoring Agents,Y,quasi syn therclass-to-function,Flavor Perception,Flavor Perception,C0699771,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),flavoring agents,Flavoring,C0475332,S,A1.4_Substance,,,
1_000016,MeSH_PA,D019422,Dietary Sucrose,,,,,,,,,,,,Dietary Sucrose,,D019422000,exact,,,,Dietary Sucrose,D019422,,exact,,,,Dietary Sucrose,C0376597,exact,,,,A1.4.1.2.1.8_Carbohydrate,A1.4.3_Food,,,,,#VALUE!,Food Additives,Food Additives,Y,exact (CUI-based),Food Additives,Food Additives,C0016453,P,,A1.4.3_Food,,,,,,,,,,,,
1_000017,MeSH_PA,D019422,Dietary Sucrose,,,,,,,,,,,,Dietary Sucrose,,D019422000,exact,,,,Dietary Sucrose,D019422,,exact,,,,Dietary Sucrose,C0376597,exact,,,,A1.4.1.2.1.8_Carbohydrate,A1.4.3_Food,,,,,#VALUE!,Sweetening Agents,Sweetening Agents,Y,quasi syn therclass-to-function,Sweet Taste Perception,Sweet Taste Perception,C1154613,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Sweetening Agents,Sweetening Agents,C0038998,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_000018,MeSH_PA,C003438,thiazolidine-4-carboxylic acid,444-27-9,Timonacic,ChemID+,<syn per source>,thioproline,64564,444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,Timonacic,Timonacic [INN],444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,thiazolidine-4-carboxylic acid,C003438,444-27-9,exact,,,,Thiazolidine-4-Carboxylic Acid,C0076425,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Antidotes,Antidotes,Y,quasi syn therclass-to-disease,Poisoning,Poisoning,C0032343,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Antidotes,Antidotes,C0003295,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000019,MeSH_PA,C003438,thiazolidine-4-carboxylic acid,444-27-9,Timonacic,ChemID+,<syn per source>,thioproline,64564,444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,Timonacic,Timonacic [INN],444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,thiazolidine-4-carboxylic acid,C003438,444-27-9,exact,,,,Thiazolidine-4-Carboxylic Acid,C0076425,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000020,MeSH_PA,C003438,thiazolidine-4-carboxylic acid,444-27-9,Timonacic,ChemID+,<syn per source>,thioproline,64564,444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,Timonacic,Timonacic [INN],444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,thiazolidine-4-carboxylic acid,C003438,444-27-9,exact,,,,Thiazolidine-4-Carboxylic Acid,C0076425,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000021,MeSH_PA,C003438,thiazolidine-4-carboxylic acid,444-27-9,Timonacic,ChemID+,<syn per source>,thioproline,64564,444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,Timonacic,Timonacic [INN],444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,thiazolidine-4-carboxylic acid,C003438,444-27-9,exact,,,,Thiazolidine-4-Carboxylic Acid,C0076425,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000022,MeSH_PA,C003438,thiazolidine-4-carboxylic acid,444-27-9,Timonacic,ChemID+,<syn per source>,thioproline,64564,444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,Timonacic,Timonacic [INN],444-27-9,<syn per source>,Thiazolidine-4-carboxylic acid,exact,,thiazolidine-4-carboxylic acid,C003438,444-27-9,exact,,,,Thiazolidine-4-Carboxylic Acid,C0076425,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000023,MeSH_PA,C002041,"1,5-difluoro-2,4-dinitrobenzene",327-92-4,"1,5-Difluoro-2,4-dinitrobenzene",ChemID+,exact,,,,,,,,"1,5-Difluoro-2,4-dinitrobenzene",,327-92-4,exact,,,,"1,5-difluoro-2,4-dinitrobenzene",C002041,327-92-4,exact,,,,"1,5-Difluoro-2,4-Dinitrobenzene",C0044034,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000024,MeSH_PA,C002041,"1,5-difluoro-2,4-dinitrobenzene",327-92-4,"1,5-Difluoro-2,4-dinitrobenzene",ChemID+,exact,,,,,,,,"1,5-Difluoro-2,4-dinitrobenzene",,327-92-4,exact,,,,"1,5-difluoro-2,4-dinitrobenzene",C002041,327-92-4,exact,,,,"1,5-Difluoro-2,4-Dinitrobenzene",C0044034,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000025,MeSH_PA,C017367,1-hexylcarbamoyl-5-fluorouracil,61422-45-5,Carmofur,ChemID+,<syn per source>,,,,,,,,Carmofur,Carmofur [INN:JAN],61422-45-5,<syn per source>,1-Hexylcarbamoyl-5-fluorouracil,exact,,1-hexylcarbamoyl-5-fluorouracil,C017367,61422-45-5,exact,,,,1-Hexylcarbamoyl-5-Fluorouracil,C0044401,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000026,MeSH_PA,C014211,"2,3,7,8-tetrachlorodibenzofuran",51207-31-9,"2,3,7,8-Tetrachlorodibenzofuran",ChemID+,exact,"2,3,7,8-Tetrachlorodibenzofuran",81507,,exact,,,,"2,3,7,8-Tetrachlorodibenzofuran",,51207-31-9,exact,,,,"2,3,7,8-tetrachlorodibenzofuran",C014211,51207-31-9,exact,,,,"2,3,7,8-Tetrachlorodibenzofuran",C0045334,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Environmental Pollutants,Environmental Pollutants,Y,quasi syn therclass-to-function,Pollutant Interaction,Pollutant Interaction,C0597263,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Environmental Pollutants,Environmental Pollutants,C0014417,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000027,MeSH_PA,C027717,"2,3-naphthalenedicarboxaldehyde",7149-49-7,"2,3-Naphthalenedicarboxaldehyde",ChemID+,exact,,,,,,,,"2,3-Naphthalenedicarboxaldehyde",,7149-49-7,exact,,,,"2,3-naphthalenedicarboxaldehyde",C027717,7149-49-7,exact,,,,"2,3-Naphthalenedicarboxaldehyde",C0045407,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000028,MeSH_PA,C029262,"2,3-piperidinedicarboxylic acid",46026-75-9,"2,3-Piperidinedicarboxylic acid",ChemID+,exact,,,,,,,,"2,3-Piperidinedicarboxylic acid",,46026-75-9,exact,,,,"2,3-piperidinedicarboxylic acid",C029262,46026-75-9,exact,,,,"2,3-Piperidinedicarboxylic Acid",C0045412,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000029,MeSH_PA,C029262,"2,3-piperidinedicarboxylic acid",46026-75-9,"2,3-Piperidinedicarboxylic acid",ChemID+,exact,,,,,,,,"2,3-Piperidinedicarboxylic acid",,46026-75-9,exact,,,,"2,3-piperidinedicarboxylic acid",C029262,46026-75-9,exact,,,,"2,3-Piperidinedicarboxylic Acid",C0045412,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000030,MeSH_PA,C029262,"2,3-piperidinedicarboxylic acid",46026-75-9,"2,3-Piperidinedicarboxylic acid",ChemID+,exact,,,,,,,,"2,3-Piperidinedicarboxylic acid",,46026-75-9,exact,,,,"2,3-piperidinedicarboxylic acid",C029262,46026-75-9,exact,,,,"2,3-Piperidinedicarboxylic Acid",C0045412,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000031,MeSH_PA,C029262,"2,3-piperidinedicarboxylic acid",46026-75-9,"2,3-Piperidinedicarboxylic acid",ChemID+,exact,,,,,,,,"2,3-Piperidinedicarboxylic acid",,46026-75-9,exact,,,,"2,3-piperidinedicarboxylic acid",C029262,46026-75-9,exact,,,,"2,3-Piperidinedicarboxylic Acid",C0045412,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000032,MeSH_PA,C029262,"2,3-piperidinedicarboxylic acid",46026-75-9,"2,3-Piperidinedicarboxylic acid",ChemID+,exact,,,,,,,,"2,3-Piperidinedicarboxylic acid",,46026-75-9,exact,,,,"2,3-piperidinedicarboxylic acid",C029262,46026-75-9,exact,,,,"2,3-Piperidinedicarboxylic Acid",C0045412,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000033,MeSH_PA,C012729,2-amino-4-phosphonobutyric acid,6323-99-5,2-Amino-4-phosphonobutyric acid,ChemID+,exact,,,,,,,,2-Amino-4-phosphonobutyric acid,,6323-99-5,exact,,,,2-amino-4-phosphonobutyric acid,C012729,6323-99-5,exact,,,,2-Amino-4-Phosphonobutyric Acid,C0045845,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000034,MeSH_PA,C012729,2-amino-4-phosphonobutyric acid,6323-99-5,2-Amino-4-phosphonobutyric acid,ChemID+,exact,,,,,,,,2-Amino-4-phosphonobutyric acid,,6323-99-5,exact,,,,2-amino-4-phosphonobutyric acid,C012729,6323-99-5,exact,,,,2-Amino-4-Phosphonobutyric Acid,C0045845,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000035,MeSH_PA,C012729,2-amino-4-phosphonobutyric acid,6323-99-5,2-Amino-4-phosphonobutyric acid,ChemID+,exact,,,,,,,,2-Amino-4-phosphonobutyric acid,,6323-99-5,exact,,,,2-amino-4-phosphonobutyric acid,C012729,6323-99-5,exact,,,,2-Amino-4-Phosphonobutyric Acid,C0045845,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000036,MeSH_PA,C012729,2-amino-4-phosphonobutyric acid,6323-99-5,2-Amino-4-phosphonobutyric acid,ChemID+,exact,,,,,,,,2-Amino-4-phosphonobutyric acid,,6323-99-5,exact,,,,2-amino-4-phosphonobutyric acid,C012729,6323-99-5,exact,,,,2-Amino-4-Phosphonobutyric Acid,C0045845,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,23,Excitatory Amino Acid Agonists,Excitatory Amino Acid Agonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agonists,Excitatory Amino Acid Agonists,C0242909,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000037,MeSH_PA,C012729,2-amino-4-phosphonobutyric acid,6323-99-5,2-Amino-4-phosphonobutyric acid,ChemID+,exact,,,,,,,,2-Amino-4-phosphonobutyric acid,,6323-99-5,exact,,,,2-amino-4-phosphonobutyric acid,C012729,6323-99-5,exact,,,,2-Amino-4-Phosphonobutyric Acid,C0045845,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000038,MeSH_PA,C107349,2-chloro-5-hydroxyphenylglycine,,,,,,,,,,,,2-Chloro-5-hydroxyphenylglycine,,C107349000,exact,,,,2-chloro-5-hydroxyphenylglycine,C107349,,exact,,,,2-Chloro-5-Hydroxyphenylglycine,C0664038,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000039,MeSH_PA,C107349,2-chloro-5-hydroxyphenylglycine,,,,,,,,,,,,2-Chloro-5-hydroxyphenylglycine,,C107349000,exact,,,,2-chloro-5-hydroxyphenylglycine,C107349,,exact,,,,2-Chloro-5-Hydroxyphenylglycine,C0664038,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,23,Excitatory Amino Acid Agonists,Excitatory Amino Acid Agonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agonists,Excitatory Amino Acid Agonists,C0242909,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000040,MeSH_PA,C107349,2-chloro-5-hydroxyphenylglycine,,,,,,,,,,,,2-Chloro-5-hydroxyphenylglycine,,C107349000,exact,,,,2-chloro-5-hydroxyphenylglycine,C107349,,exact,,,,2-Chloro-5-Hydroxyphenylglycine,C0664038,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000041,MeSH_PA,C056034,2'-methyl-2'-deoxyidenecytidine,119804-96-5,2'-Methyl-2'-deoxyidenecytidine,ChemID+,exact,,,,,,,,2'-Methyl-2'-deoxyidenecytidine,,119804-96-5,exact,,,,2'-methyl-2'-deoxyidenecytidine,C056034,119804-96-5,exact,,,,2'-Methyl-2'-Deoxyidenecytidine,C0045176,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000042,MeSH_PA,C056034,2'-methyl-2'-deoxyidenecytidine,119804-96-5,2'-Methyl-2'-deoxyidenecytidine,ChemID+,exact,,,,,,,,2'-Methyl-2'-deoxyidenecytidine,,119804-96-5,exact,,,,2'-methyl-2'-deoxyidenecytidine,C056034,119804-96-5,exact,,,,2'-Methyl-2'-Deoxyidenecytidine,C0045176,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000043,MeSH_PA,C056034,2'-methyl-2'-deoxyidenecytidine,119804-96-5,2'-Methyl-2'-deoxyidenecytidine,ChemID+,exact,,,,,,,,2'-Methyl-2'-deoxyidenecytidine,,119804-96-5,exact,,,,2'-methyl-2'-deoxyidenecytidine,C056034,119804-96-5,exact,,,,2'-Methyl-2'-Deoxyidenecytidine,C0045176,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000044,MeSH_PA,C056034,2'-methyl-2'-deoxyidenecytidine,119804-96-5,2'-Methyl-2'-deoxyidenecytidine,ChemID+,exact,,,,,,,,2'-Methyl-2'-deoxyidenecytidine,,119804-96-5,exact,,,,2'-methyl-2'-deoxyidenecytidine,C056034,119804-96-5,exact,,,,2'-Methyl-2'-Deoxyidenecytidine,C0045176,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000045,MeSH_PA,C008658,2-nitro-5-thiocyanobenzoic acid,30211-77-9,2-Nitro-5-thiocyanobenzoic acid,ChemID+,exact,,,,,,,,2-Nitro-5-thiocyanobenzoic acid,,30211-77-9,exact,,,,2-nitro-5-thiocyanobenzoic acid,C008658,30211-77-9,exact,,,,2-Nitro-5-Thiocyanobenzoic Acid,C0046431,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000046,MeSH_PA,C008658,2-nitro-5-thiocyanobenzoic acid,30211-77-9,2-Nitro-5-thiocyanobenzoic acid,ChemID+,exact,,,,,,,,2-Nitro-5-thiocyanobenzoic acid,,30211-77-9,exact,,,,2-nitro-5-thiocyanobenzoic acid,C008658,30211-77-9,exact,,,,2-Nitro-5-Thiocyanobenzoic Acid,C0046431,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000047,MeSH_PA,C023035,"3,4,5,3',4'-pentachlorobiphenyl",57465-28-8,"3,4,5,3',4'-Pentachlorobiphenyl",ChemID+,exact,"3,3',4,4',5-pentachlorobiphenyl",34317,57465-28-8,<syn per source>,"3,4,5,3',4'-Pentachlorobiphenyl",exact,,"3,4,5,3',4'-Pentachlorobiphenyl",,57465-28-8,exact,,,,"3,4,5,3',4'-pentachlorobiphenyl",C023035,57465-28-8,exact,,,,"3,4,5,3',4'-Pentachlorobiphenyl",C0046929,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Estrogen Antagonists,Estrogen Antagonists,Y,quasi syn therclass-to-function,Estrogen Receptor Activity,Estrogen Receptor Activity,C1148776,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Estrogen Antagonists,Estrogen Antagonists,C0014930,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000048,MeSH_PA,C023035,"3,4,5,3',4'-pentachlorobiphenyl",57465-28-8,"3,4,5,3',4'-Pentachlorobiphenyl",ChemID+,exact,"3,3',4,4',5-pentachlorobiphenyl",34317,57465-28-8,<syn per source>,"3,4,5,3',4'-Pentachlorobiphenyl",exact,,"3,4,5,3',4'-Pentachlorobiphenyl",,57465-28-8,exact,,,,"3,4,5,3',4'-pentachlorobiphenyl",C023035,57465-28-8,exact,,,,"3,4,5,3',4'-Pentachlorobiphenyl",C0046929,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,modulator,,#VALUE!,Estrogen Receptor Modulators,Estrogen Receptor Modulators,Y,quasi syn therclass-to-function,Estrogen Receptor Activity,Estrogen Receptor Activity,C1148776,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Estrogen Receptor Modulators,Estrogen Receptor Modulators,C0752229,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000049,MeSH_PA,C023035,"3,4,5,3',4'-pentachlorobiphenyl",57465-28-8,"3,4,5,3',4'-Pentachlorobiphenyl",ChemID+,exact,"3,3',4,4',5-pentachlorobiphenyl",34317,57465-28-8,<syn per source>,"3,4,5,3',4'-Pentachlorobiphenyl",exact,,"3,4,5,3',4'-Pentachlorobiphenyl",,57465-28-8,exact,,,,"3,4,5,3',4'-pentachlorobiphenyl",C023035,57465-28-8,exact,,,,"3,4,5,3',4'-Pentachlorobiphenyl",C0046929,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000050,MeSH_PA,C023035,"3,4,5,3',4'-pentachlorobiphenyl",57465-28-8,"3,4,5,3',4'-Pentachlorobiphenyl",ChemID+,exact,"3,3',4,4',5-pentachlorobiphenyl",34317,57465-28-8,<syn per source>,"3,4,5,3',4'-Pentachlorobiphenyl",exact,,"3,4,5,3',4'-Pentachlorobiphenyl",,57465-28-8,exact,,,,"3,4,5,3',4'-pentachlorobiphenyl",C023035,57465-28-8,exact,,,,"3,4,5,3',4'-Pentachlorobiphenyl",C0046929,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000051,MeSH_PA,C053450,4-des-dimethylaminotetracycline,2444-65-7,4-Des-dimethylaminotetracycline,ChemID+,exact,,,,,,,,4-Des-dimethylaminotetracycline,,2444-65-7,exact,,,,4-des-dimethylaminotetracycline,C053450,2444-65-7,exact,,,,4-Des-Dimethylaminotetracycline,C0048233,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000052,MeSH_PA,C053450,4-des-dimethylaminotetracycline,2444-65-7,4-Des-dimethylaminotetracycline,ChemID+,exact,,,,,,,,4-Des-dimethylaminotetracycline,,2444-65-7,exact,,,,4-des-dimethylaminotetracycline,C053450,2444-65-7,exact,,,,4-Des-Dimethylaminotetracycline,C0048233,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000053,MeSH_PA,C030360,5-(2-iodovinyl)-2'-deoxyuridine,87727-68-2,5-(2-Iodovinyl)-2'-deoxyuridine,ChemID+,exact,,,,,,,,5-(2-Iodovinyl)-2'-deoxyuridine,,87727-68-2,exact,,,,5-(2-iodovinyl)-2'-deoxyuridine,C030360,87727-68-2,exact,,,,5-(2-Iodovinyl)-2'-Deoxyuridine,C0048983,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000054,MeSH_PA,C030360,5-(2-iodovinyl)-2'-deoxyuridine,87727-68-2,5-(2-Iodovinyl)-2'-deoxyuridine,ChemID+,exact,,,,,,,,5-(2-Iodovinyl)-2'-deoxyuridine,,87727-68-2,exact,,,,5-(2-iodovinyl)-2'-deoxyuridine,C030360,87727-68-2,exact,,,,5-(2-Iodovinyl)-2'-Deoxyuridine,C0048983,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000055,MeSH_PA,C018080,5-hydroxymethyl-2'-deoxyuridine,5116-24-5,5-Hydroxymethyl-2'-deoxyuridine,ChemID+,exact,5-hydroxymethyl-2'-deoxyuridine,61288,5116-24-5,exact,,,,5-Hydroxymethyl-2'-deoxyuridine,,5116-24-5,exact,,,,5-hydroxymethyl-2'-deoxyuridine,C018080,5116-24-5,exact,,,,5-Hydroxymethyl-2'-Deoxyuridine,C0049238,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000056,MeSH_PA,C044612,6-methoxy-2-naphthylacetic acid,23981-47-7,6-Methoxy-2-naphthylacetic acid,ChemID+,exact,(6-methoxy-2-naphthyl)acetic acid,35628,23981-47-7,<syn per source>,6-Methoxy-2-naphthylacetic acid,exact,,6-Methoxy-2-naphthylacetic acid,,23981-47-7,exact,,,,6-methoxy-2-naphthylacetic acid,C044612,23981-47-7,exact,,,,6-Methoxy-2-Naphthylacetic Acid,C0049640,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000057,MeSH_PA,C033118,acetyl tert-butyl dimethylindan,13171-00-1,acetyl tert-butyl dimethylindan,CTD,exact,,,,,,,,"1H-Indene, 6-(1,1-dimethylethyl)-2,3-dihydro-1,1-dimethyl-",,3605-31-0,NT salt/deriv/analog/df + <syn per source>,"6-(tert-Butyl)-1,1-dimethylindan",NT salt/deriv/analog/df,,acetyl tert-butyl dimethylindan,C033118,13171-00-1,exact,,,,Acetyl Tert-Butyl Dimethylindan,C0377472,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Cosmetics,Cosmetics,Y,exact (CUI-based),Cosmetics,Cosmetics,C0010164,P,,A1.3_Manufactured Object,,,,,,,,,,,,
1_000058,MeSH_PA,C033118,acetyl tert-butyl dimethylindan,13171-00-1,acetyl tert-butyl dimethylindan,CTD,exact,,,,,,,,"1H-Indene, 6-(1,1-dimethylethyl)-2,3-dihydro-1,1-dimethyl-",,3605-31-0,NT salt/deriv/analog/df + <syn per source>,"6-(tert-Butyl)-1,1-dimethylindan",NT salt/deriv/analog/df,,acetyl tert-butyl dimethylindan,C033118,13171-00-1,exact,,,,Acetyl Tert-Butyl Dimethylindan,C0377472,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Perfume,Perfume,Y,exact (CUI-based),Perfume,Perfume,C0031000,P,,A1.3_Manufactured Object,,,,,,,,,,,,
1_000059,MeSH_PA,C063261,acetylleucyl-leucyl-norleucinal,110044-82-1,Acetylleucyl-leucyl-norleucinal,ChemID+,exact,acetylleucyl-leucyl-norleucinal,2423,110044-82-1,exact,,,,Acetylleucyl-leucyl-norleucinal,,110044-82-1,exact,,,,acetylleucyl-leucyl-norleucinal,C063261,110044-82-1,exact,,,,Acetylleucyl-Leucyl-Norleucinal,C0081446,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000060,MeSH_PA,C063261,acetylleucyl-leucyl-norleucinal,110044-82-1,Acetylleucyl-leucyl-norleucinal,ChemID+,exact,acetylleucyl-leucyl-norleucinal,2423,110044-82-1,exact,,,,Acetylleucyl-leucyl-norleucinal,,110044-82-1,exact,,,,acetylleucyl-leucyl-norleucinal,C063261,110044-82-1,exact,,,,Acetylleucyl-Leucyl-Norleucinal,C0081446,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000061,MeSH_PA,C063261,acetylleucyl-leucyl-norleucinal,110044-82-1,Acetylleucyl-leucyl-norleucinal,ChemID+,exact,acetylleucyl-leucyl-norleucinal,2423,110044-82-1,exact,,,,Acetylleucyl-leucyl-norleucinal,,110044-82-1,exact,,,,acetylleucyl-leucyl-norleucinal,C063261,110044-82-1,exact,,,,Acetylleucyl-Leucyl-Norleucinal,C0081446,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000062,MeSH_PA,C021630,"bis(3,5-dibromosalicyl)fumarate",71337-53-6,"Bis(3,5-dibromosalicyl)fumarate",ChemID+,exact,,,,,,,,"Bis(3,5-dibromosalicyl)fumarate",,71337-53-6,exact,,,,"bis(3,5-dibromosalicyl)fumarate",C021630,71337-53-6,exact,,,,"Bis(3,5-Dibromosalicyl)Fumarate",C0053698,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000063,MeSH_PA,C021630,"bis(3,5-dibromosalicyl)fumarate",71337-53-6,"Bis(3,5-dibromosalicyl)fumarate",ChemID+,exact,,,,,,,,"Bis(3,5-dibromosalicyl)fumarate",,71337-53-6,exact,,,,"bis(3,5-dibromosalicyl)fumarate",C021630,71337-53-6,exact,,,,"Bis(3,5-Dibromosalicyl)Fumarate",C0053698,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000064,MeSH_PA,C020743,hydrochlorothiazide-triamterene,14124-50-6,Hydrochlorothiazide mixture with Triamterene,ChemID+,<syn per source>,,,,,,,,Hydrochlorothiazide mixture with Triamterene,,14124-50-6,syn +/- superfluous words,Hydrochlorothiazide-triamterene,exact,,hydrochlorothiazide-triamterene,C020743,14124-50-6,exact,,,,Hydrochlorothiazide-Triamterene,C0813211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000065,MeSH_PA,C020743,hydrochlorothiazide-triamterene,14124-50-6,Hydrochlorothiazide mixture with Triamterene,ChemID+,<syn per source>,,,,,,,,Hydrochlorothiazide mixture with Triamterene,,14124-50-6,syn +/- superfluous words,Hydrochlorothiazide-triamterene,exact,,hydrochlorothiazide-triamterene,C020743,14124-50-6,exact,,,,Hydrochlorothiazide-Triamterene,C0813211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000066,MeSH_PA,C020972,pyrrolidine dithiocarbamic acid,25769-03-3,Pyrrolidine dithiocarbamic acid,ChemID+,exact,pyrrolidine dithiocarbamate,78782,25769-03-3,quasi syn acid/-ate,Pyrrolidine dithiocarbamic acid,exact,,Pyrrolidine dithiocarbamic acid,,25769-03-3,exact,,,,pyrrolidine dithiocarbamic acid,C020972,25769-03-3,exact,,,,Pyrrolidine Dithiocarbamic Acid,C0072781,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000067,MeSH_PA,C020972,pyrrolidine dithiocarbamic acid,25769-03-3,Pyrrolidine dithiocarbamic acid,ChemID+,exact,pyrrolidine dithiocarbamate,78782,25769-03-3,quasi syn acid/-ate,Pyrrolidine dithiocarbamic acid,exact,,Pyrrolidine dithiocarbamic acid,,25769-03-3,exact,,,,pyrrolidine dithiocarbamic acid,C020972,25769-03-3,exact,,,,Pyrrolidine Dithiocarbamic Acid,C0072781,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000068,MeSH_PA,D026423,S-Nitroso-N-Acetylpenicillamine,79032-48-7,S-Nitroso-N-acetylpenicillamine,ChemID+,exact,S-nitroso-N-acetyl-D-penicillamine,77702,79032-48-7,<syn per source>,S-nitroso-N-acetylpenicillamine,exact,,S-Nitroso-N-acetylpenicillamine,,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,D026423,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,C0073894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000069,MeSH_PA,D026423,S-Nitroso-N-Acetylpenicillamine,79032-48-7,S-Nitroso-N-acetylpenicillamine,ChemID+,exact,S-nitroso-N-acetyl-D-penicillamine,77702,79032-48-7,<syn per source>,S-nitroso-N-acetylpenicillamine,exact,,S-Nitroso-N-acetylpenicillamine,,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,D026423,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,C0073894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000070,MeSH_PA,D026423,S-Nitroso-N-Acetylpenicillamine,79032-48-7,S-Nitroso-N-acetylpenicillamine,ChemID+,exact,S-nitroso-N-acetyl-D-penicillamine,77702,79032-48-7,<syn per source>,S-nitroso-N-acetylpenicillamine,exact,,S-Nitroso-N-acetylpenicillamine,,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,D026423,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,C0073894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Nitric Oxide Donors,Nitric Oxide Donors,Y,quasi syn therclass-to-function,Nitric Oxide Metabolic Process,Nitric Oxide Metabolic Process,C1158468,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nitric Oxide Donors,Nitric Oxide Donors,C0600437,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000071,MeSH_PA,D026423,S-Nitroso-N-Acetylpenicillamine,79032-48-7,S-Nitroso-N-acetylpenicillamine,ChemID+,exact,S-nitroso-N-acetyl-D-penicillamine,77702,79032-48-7,<syn per source>,S-nitroso-N-acetylpenicillamine,exact,,S-Nitroso-N-acetylpenicillamine,,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,D026423,79032-48-7,exact,,,,S-Nitroso-N-Acetylpenicillamine,C0073894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,causes,,#VALUE!,Vasodilator Agents,Vasodilator Agents,Y,quasi syn therclass-to-function,Vasodilation,Vasodilation,C0042401,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Vasodilator Agents,Vasodilator Agents,C0042402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000072,MeSH_PA,C062078,1-(carboxymethylthio)tetradecane,2921-20-2,1-(Carboxymethylthio)tetradecane,ChemID+,exact,,,,,,,,1-(Carboxymethylthio)tetradecane,,2921-20-2,exact,,,,1-(carboxymethylthio)tetradecane,C062078,2921-20-2,exact,,,,1-(Carboxymethylthio)Tetradecane,C0044232,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000073,MeSH_PA,C062078,1-(carboxymethylthio)tetradecane,2921-20-2,1-(Carboxymethylthio)tetradecane,ChemID+,exact,,,,,,,,1-(Carboxymethylthio)tetradecane,,2921-20-2,exact,,,,1-(carboxymethylthio)tetradecane,C062078,2921-20-2,exact,,,,1-(Carboxymethylthio)Tetradecane,C0044232,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Free Radical Scavengers,Free Radical Scavengers,Y,quasi syn therclass-to-function,Free Radical Scavenging [Moa],Free Radical Scavenging [Moa],C1517315,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Free Radical Scavengers,Free Radical Scavengers,C0079381,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_000074,MeSH_PA,C062078,1-(carboxymethylthio)tetradecane,2921-20-2,1-(Carboxymethylthio)tetradecane,ChemID+,exact,,,,,,,,1-(Carboxymethylthio)tetradecane,,2921-20-2,exact,,,,1-(carboxymethylthio)tetradecane,C062078,2921-20-2,exact,,,,1-(Carboxymethylthio)Tetradecane,C0044232,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000075,MeSH_PA,C027132,1-anilino-8-naphthalenesulfonate,82-76-8,1-Anilino-8-naphthalenesulfonate,ChemID+,exact,8-anilinonaphthalene-1-sulfonic acid,39708,82-76-8,<syn per source>,1-Anilino-8-naphthalenesulfonate,exact,,1-Anilino-8-naphthalenesulfonate,,82-76-8,exact,,,,1-anilino-8-naphthalenesulfonate,C027132,82-76-8,exact,,,,1-Anilino-8-Naphthalenesulfonate,C0044291,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000076,MeSH_PA,C027132,1-anilino-8-naphthalenesulfonate,82-76-8,1-Anilino-8-naphthalenesulfonate,ChemID+,exact,8-anilinonaphthalene-1-sulfonic acid,39708,82-76-8,<syn per source>,1-Anilino-8-naphthalenesulfonate,exact,,1-Anilino-8-naphthalenesulfonate,,82-76-8,exact,,,,1-anilino-8-naphthalenesulfonate,C027132,82-76-8,exact,,,,1-Anilino-8-Naphthalenesulfonate,C0044291,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000077,MeSH_PA,C027132,1-anilino-8-naphthalenesulfonate,82-76-8,1-Anilino-8-naphthalenesulfonate,ChemID+,exact,8-anilinonaphthalene-1-sulfonic acid,39708,82-76-8,<syn per source>,1-Anilino-8-naphthalenesulfonate,exact,,1-Anilino-8-naphthalenesulfonate,,82-76-8,exact,,,,1-anilino-8-naphthalenesulfonate,C027132,82-76-8,exact,,,,1-Anilino-8-Naphthalenesulfonate,C0044291,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000078,MeSH_PA,C027132,1-anilino-8-naphthalenesulfonate,82-76-8,1-Anilino-8-naphthalenesulfonate,ChemID+,exact,8-anilinonaphthalene-1-sulfonic acid,39708,82-76-8,<syn per source>,1-Anilino-8-naphthalenesulfonate,exact,,1-Anilino-8-naphthalenesulfonate,,82-76-8,exact,,,,1-anilino-8-naphthalenesulfonate,C027132,82-76-8,exact,,,,1-Anilino-8-Naphthalenesulfonate,C0044291,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000079,ChEBI,,"1-O-acetyl-4R,6S-britannilactone",,,,,"1-O-acetyl-4R,6S-britannilactone",65365,,exact,,,,,,,,,,,"1-O-acetyl-4R,6S-britannilactone",C492707,,exact,,,,"1-O-Acetyl-4R,6S-Britannilactone",C1528245,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits, inhibitor,nitric oxide synthase inhibitor,nitric oxide synthase inhibitor,Y,quasi syn therclass-to-function,Nitric Oxide Synthase Activity,Nitric Oxide Synthase Activity,C1151471,P,Y,B2.2.1.1.4_Molecular Function,,,,exact 1,Nitric Oxide Synthase Inhibitor,Nitric Oxide Synthase Inhibitor,C1373060,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000080,MeSH_PA,C103723,2-(2-benzofuranyl)-2-imidazoline,72583-92-7,2-(2-Benzofuranyl)-2-imidazoline,ChemID+,exact,,,,,,,,2-(2-Benzofuranyl)-2-imidazoline,,72583-92-7,exact,,,,2-(2-benzofuranyl)-2-imidazoline,C103723,72583-92-7,exact,,,,2-(2-Benzofuranyl)-2-Imidazoline,C0534468,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000081,MeSH_PA,C103723,2-(2-benzofuranyl)-2-imidazoline,72583-92-7,2-(2-Benzofuranyl)-2-imidazoline,ChemID+,exact,,,,,,,,2-(2-Benzofuranyl)-2-imidazoline,,72583-92-7,exact,,,,2-(2-benzofuranyl)-2-imidazoline,C103723,72583-92-7,exact,,,,2-(2-Benzofuranyl)-2-Imidazoline,C0534468,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000082,ChEBI,,2-(methyldithio)pyridine-N-oxide,,,,,2-(methyldithio)pyridine-N-oxide,66373,,exact,,,,,,,,,,,2-(methyldithio)pyridine-N-oxide,C548574,,exact,,,,2-(Methyldithio)Pyridine-N-Oxide,C2933174,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,antibacterial agent,antibacterial agent,Y,quasi syn therclass-to-disease,Bacterial Infections,Bacterial Infections,C0004623,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,antibacterial agent,Anti-Bacterial Agents,C0279516,S,A1.4.1.1.1.1_Antibiotic,,,
1_000083,MeSH_PA,C003943,"2,5-dimethoxy-4-bromoamphetamine",64638-07-9,Brolamfetamine,ChemID+,<syn per source>,,,,,,,,Brolamfetamine,Brolamfetamine [INN],64638-07-9,<syn per source>,"2,5-Dimethoxy-4-bromoamphetamine",exact,,"2,5-dimethoxy-4-bromoamphetamine",C003943,32156-26-6,exact,,,,"2,5-Dimethoxy-4-Bromoamphetamine",C0045561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000084,MeSH_PA,C003943,"2,5-dimethoxy-4-bromoamphetamine",64638-07-9,Brolamfetamine,ChemID+,<syn per source>,,,,,,,,Brolamfetamine,Brolamfetamine [INN],64638-07-9,<syn per source>,"2,5-Dimethoxy-4-bromoamphetamine",exact,,"2,5-dimethoxy-4-bromoamphetamine",C003943,32156-26-6,exact,,,,"2,5-Dimethoxy-4-Bromoamphetamine",C0045561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hallucinogens,Hallucinogens,Y,quasi syn therclass-to-function,Perception,Perception,C0030971,P,Y,B2.2.1.1.1.1_Mental Process,,,,exact (CUI-based),Hallucinogens,Hallucinogens,C0018533,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_000085,MeSH_PA,C003943,"2,5-dimethoxy-4-bromoamphetamine",64638-07-9,Brolamfetamine,ChemID+,<syn per source>,,,,,,,,Brolamfetamine,Brolamfetamine [INN],64638-07-9,<syn per source>,"2,5-Dimethoxy-4-bromoamphetamine",exact,,"2,5-dimethoxy-4-bromoamphetamine",C003943,32156-26-6,exact,,,,"2,5-Dimethoxy-4-Bromoamphetamine",C0045561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000086,MeSH_PA,C003943,"2,5-dimethoxy-4-bromoamphetamine",64638-07-9,Brolamfetamine,ChemID+,<syn per source>,,,,,,,,Brolamfetamine,Brolamfetamine [INN],64638-07-9,<syn per source>,"2,5-Dimethoxy-4-bromoamphetamine",exact,,"2,5-dimethoxy-4-bromoamphetamine",C003943,32156-26-6,exact,,,,"2,5-Dimethoxy-4-Bromoamphetamine",C0045561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000087,MeSH_PA,C003943,"2,5-dimethoxy-4-bromoamphetamine",64638-07-9,Brolamfetamine,ChemID+,<syn per source>,,,,,,,,Brolamfetamine,Brolamfetamine [INN],64638-07-9,<syn per source>,"2,5-Dimethoxy-4-bromoamphetamine",exact,,"2,5-dimethoxy-4-bromoamphetamine",C003943,32156-26-6,exact,,,,"2,5-Dimethoxy-4-Bromoamphetamine",C0045561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000088,MeSH_PA,C003943,"2,5-dimethoxy-4-bromoamphetamine",64638-07-9,Brolamfetamine,ChemID+,<syn per source>,,,,,,,,Brolamfetamine,Brolamfetamine [INN],64638-07-9,<syn per source>,"2,5-Dimethoxy-4-bromoamphetamine",exact,,"2,5-dimethoxy-4-bromoamphetamine",C003943,32156-26-6,exact,,,,"2,5-Dimethoxy-4-Bromoamphetamine",C0045561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,20,Serotonin Receptor Agonists,Serotonin Receptor Agonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),serotonin receptor agonists,Serotonin Agonists,C0162757,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000089,MeSH_PA,C035005,"3,3'-dihexadecylindocarbocyanine",,,,,,,,,,,,,,,,,,,"3,3'-dihexadecylindocarbocyanine",C035005,,exact,,,,"3,3'-Dihexadecylindocarbocyanine",C0046893,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000090,MeSH_PA,C035005,"3,3'-dihexadecylindocarbocyanine",,,,,,,,,,,,,,,,,,,"3,3'-dihexadecylindocarbocyanine",C035005,,exact,,,,"3,3'-Dihexadecylindocarbocyanine",C0046893,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000091,MeSH_PA,C035005,"3,3'-dihexadecylindocarbocyanine",,,,,,,,,,,,,,,,,,,"3,3'-dihexadecylindocarbocyanine",C035005,,exact,,,,"3,3'-Dihexadecylindocarbocyanine",C0046893,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000092,MeSH_PA,C035005,"3,3'-dihexadecylindocarbocyanine",,,,,,,,,,,,,,,,,,,"3,3'-dihexadecylindocarbocyanine",C035005,,exact,,,,"3,3'-Dihexadecylindocarbocyanine",C0046893,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000093,MeSH_PA,C024286,"3,3'-dioctadecylindocarbocyanine",40957-95-7,"3,3'-Dioctadecylindocarbocyanine",ChemID+,exact,dilC18(3)(1+),52818,40957-95-7,<syn per source>,"3,3'-Dioctadecylindocarbocyanine",exact,,"3,3'-Dioctadecylindocarbocyanine",,40957-95-7,exact,,,,"3,3'-dioctadecylindocarbocyanine",C024286,40957-95-7,exact,,,,"3,3'-Dioctadecylindocarbocyanine",C0046899,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000094,MeSH_PA,C024286,"3,3'-dioctadecylindocarbocyanine",40957-95-7,"3,3'-Dioctadecylindocarbocyanine",ChemID+,exact,dilC18(3)(1+),52818,40957-95-7,<syn per source>,"3,3'-Dioctadecylindocarbocyanine",exact,,"3,3'-Dioctadecylindocarbocyanine",,40957-95-7,exact,,,,"3,3'-dioctadecylindocarbocyanine",C024286,40957-95-7,exact,,,,"3,3'-Dioctadecylindocarbocyanine",C0046899,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000095,MeSH_PA,C024286,"3,3'-dioctadecylindocarbocyanine",40957-95-7,"3,3'-Dioctadecylindocarbocyanine",ChemID+,exact,dilC18(3)(1+),52818,40957-95-7,<syn per source>,"3,3'-Dioctadecylindocarbocyanine",exact,,"3,3'-Dioctadecylindocarbocyanine",,40957-95-7,exact,,,,"3,3'-dioctadecylindocarbocyanine",C024286,40957-95-7,exact,,,,"3,3'-Dioctadecylindocarbocyanine",C0046899,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000096,MeSH_PA,C024286,"3,3'-dioctadecylindocarbocyanine",40957-95-7,"3,3'-Dioctadecylindocarbocyanine",ChemID+,exact,dilC18(3)(1+),52818,40957-95-7,<syn per source>,"3,3'-Dioctadecylindocarbocyanine",exact,,"3,3'-Dioctadecylindocarbocyanine",,40957-95-7,exact,,,,"3,3'-dioctadecylindocarbocyanine",C024286,40957-95-7,exact,,,,"3,3'-Dioctadecylindocarbocyanine",C0046899,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000097,MeSH_PA,C024286,"3,3'-dioctadecylindocarbocyanine",40957-95-7,"3,3'-Dioctadecylindocarbocyanine",ChemID+,exact,dilC18(3)(1+),52818,40957-95-7,<syn per source>,"3,3'-Dioctadecylindocarbocyanine",exact,,"3,3'-Dioctadecylindocarbocyanine",,40957-95-7,exact,,,,"3,3'-dioctadecylindocarbocyanine",C024286,40957-95-7,exact,,,,"3,3'-Dioctadecylindocarbocyanine",C0046899,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000098,MeSH_PA,C057837,"3,7-dimethyl-1-propargylxanthine",14114-46-6,"3,7-Dimethyl-1-propargylxanthine",ChemID+,exact,,,,,,,,"3,7-Dimethyl-1-propargylxanthine",,14114-46-6,exact,,,,"3,7-dimethyl-1-propargylxanthine",C057837,14114-46-6,exact,,,,"3,7-Dimethyl-1-Propargylxanthine",C0165153,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Adenosine A2 Receptor Antagonists,Adenosine A2 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,G-Protein Coupled Adenosine Receptor Activity,G-Protein Coupled Adenosine Receptor Activity,C1152761,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Adenosine A2 Receptor Antagonists,Adenosine A2 Receptor Antagonists,C2936570,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000099,MeSH_PA,C057837,"3,7-dimethyl-1-propargylxanthine",14114-46-6,"3,7-Dimethyl-1-propargylxanthine",ChemID+,exact,,,,,,,,"3,7-Dimethyl-1-propargylxanthine",,14114-46-6,exact,,,,"3,7-dimethyl-1-propargylxanthine",C057837,14114-46-6,exact,,,,"3,7-Dimethyl-1-Propargylxanthine",C0165153,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000100,MeSH_PA,C057837,"3,7-dimethyl-1-propargylxanthine",14114-46-6,"3,7-Dimethyl-1-propargylxanthine",ChemID+,exact,,,,,,,,"3,7-Dimethyl-1-propargylxanthine",,14114-46-6,exact,,,,"3,7-dimethyl-1-propargylxanthine",C057837,14114-46-6,exact,,,,"3,7-Dimethyl-1-Propargylxanthine",C0165153,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000101,MeSH_PA,C057837,"3,7-dimethyl-1-propargylxanthine",14114-46-6,"3,7-Dimethyl-1-propargylxanthine",ChemID+,exact,,,,,,,,"3,7-Dimethyl-1-propargylxanthine",,14114-46-6,exact,,,,"3,7-dimethyl-1-propargylxanthine",C057837,14114-46-6,exact,,,,"3,7-Dimethyl-1-Propargylxanthine",C0165153,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000102,MeSH_PA,C057837,"3,7-dimethyl-1-propargylxanthine",14114-46-6,"3,7-Dimethyl-1-propargylxanthine",ChemID+,exact,,,,,,,,"3,7-Dimethyl-1-propargylxanthine",,14114-46-6,exact,,,,"3,7-dimethyl-1-propargylxanthine",C057837,14114-46-6,exact,,,,"3,7-Dimethyl-1-Propargylxanthine",C0165153,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000103,MeSH_PA,C004420,"4-aminopyrazolo(3,4-d)pyrimidine",23771-52-0,"4-Aminopyrazolo(3,4-d)pyrimidine",ChemID+,exact,,,,,,,,"4-Aminopyrazolo(3,4-d)pyrimidine",,23771-52-0,exact,,,,"4-aminopyrazolo(3,4-d)pyrimidine",C004420,2380-63-4,exact,,,,"4-Aminopyrazolo(3,4-D)Pyrimidine",C0048058,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anticholesteremic Agents,Anticholesteremic Agents,Y,quasi syn therclass-to-disease,Hypercholesterolemia,Hypercholesterolemia,C0020443,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anticholesteremic Agents,Anticholesteremic Agents,C0003277,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000104,MeSH_PA,C004420,"4-aminopyrazolo(3,4-d)pyrimidine",23771-52-0,"4-Aminopyrazolo(3,4-d)pyrimidine",ChemID+,exact,,,,,,,,"4-Aminopyrazolo(3,4-d)pyrimidine",,23771-52-0,exact,,,,"4-aminopyrazolo(3,4-d)pyrimidine",C004420,2380-63-4,exact,,,,"4-Aminopyrazolo(3,4-D)Pyrimidine",C0048058,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000105,MeSH_PA,C004420,"4-aminopyrazolo(3,4-d)pyrimidine",23771-52-0,"4-Aminopyrazolo(3,4-d)pyrimidine",ChemID+,exact,,,,,,,,"4-Aminopyrazolo(3,4-d)pyrimidine",,23771-52-0,exact,,,,"4-aminopyrazolo(3,4-d)pyrimidine",C004420,2380-63-4,exact,,,,"4-Aminopyrazolo(3,4-D)Pyrimidine",C0048058,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antimetabolites,Antimetabolites,Y,quasi syn therclass-to-function,Metabolism,Metabolism,C0025519,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Antimetabolites,Antimetabolites,C0003376,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000106,MeSH_PA,C004420,"4-aminopyrazolo(3,4-d)pyrimidine",23771-52-0,"4-Aminopyrazolo(3,4-d)pyrimidine",ChemID+,exact,,,,,,,,"4-Aminopyrazolo(3,4-d)pyrimidine",,23771-52-0,exact,,,,"4-aminopyrazolo(3,4-d)pyrimidine",C004420,2380-63-4,exact,,,,"4-Aminopyrazolo(3,4-D)Pyrimidine",C0048058,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000107,MeSH_PA,C004420,"4-aminopyrazolo(3,4-d)pyrimidine",23771-52-0,"4-Aminopyrazolo(3,4-d)pyrimidine",ChemID+,exact,,,,,,,,"4-Aminopyrazolo(3,4-d)pyrimidine",,23771-52-0,exact,,,,"4-aminopyrazolo(3,4-d)pyrimidine",C004420,2380-63-4,exact,,,,"4-Aminopyrazolo(3,4-D)Pyrimidine",C0048058,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiprotozoal Agents,Antiprotozoal Agents,Y,quasi syn therclass-to-disease,Protozoan Infections,Protozoan Infections,C0033740,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiprotozoal Agents,Antiprotozoal Agents,C0003416,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000108,MeSH_PA,C004420,"4-aminopyrazolo(3,4-d)pyrimidine",23771-52-0,"4-Aminopyrazolo(3,4-d)pyrimidine",ChemID+,exact,,,,,,,,"4-Aminopyrazolo(3,4-d)pyrimidine",,23771-52-0,exact,,,,"4-aminopyrazolo(3,4-d)pyrimidine",C004420,2380-63-4,exact,,,,"4-Aminopyrazolo(3,4-D)Pyrimidine",C0048058,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,hypo,,#VALUE!,Hypolipidemic Agents,Hypolipidemic Agents,Y,quasi syn therclass-to-disease,Hyperlipidemia,Hyperlipidemia,C0020473,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypolipidemic Agents,Hypolipidemic Agents,C0086440,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000109,MeSH_PA,C004420,"4-aminopyrazolo(3,4-d)pyrimidine",23771-52-0,"4-Aminopyrazolo(3,4-d)pyrimidine",ChemID+,exact,,,,,,,,"4-Aminopyrazolo(3,4-d)pyrimidine",,23771-52-0,exact,,,,"4-aminopyrazolo(3,4-d)pyrimidine",C004420,2380-63-4,exact,,,,"4-Aminopyrazolo(3,4-D)Pyrimidine",C0048058,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,regulating,,#VALUE!,Lipid Regulating Agents,Lipid Regulating Agents,Y,quasi syn therclass-to-function,Lipid Metabolism,Lipid Metabolism,C0598783,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipid Regulating Agents,Lipid Regulating Agents,C2936244,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000110,MeSH_PA,C078245,4-carboxy-3-hydroxyphenylglycine,134052-66-7,4-Carboxy-3-hydroxyphenylglycine,ChemID+,exact,,,,,,,,4-Carboxy-3-hydroxyphenylglycine,,134052-66-7,exact,,,,,,,,,,,4-Carboxy-3-Hydroxyphenylglycine,C0210574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000111,MeSH_PA,C078245,4-carboxy-3-hydroxyphenylglycine,134052-66-7,4-Carboxy-3-hydroxyphenylglycine,ChemID+,exact,,,,,,,,4-Carboxy-3-hydroxyphenylglycine,,134052-66-7,exact,,,,,,,,,,,4-Carboxy-3-Hydroxyphenylglycine,C0210574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000112,MeSH_PA,C078245,4-carboxy-3-hydroxyphenylglycine,134052-66-7,4-Carboxy-3-hydroxyphenylglycine,ChemID+,exact,,,,,,,,4-Carboxy-3-hydroxyphenylglycine,,134052-66-7,exact,,,,,,,,,,,4-Carboxy-3-Hydroxyphenylglycine,C0210574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000113,MeSH_PA,C002910,4-hydroxymercuribenzenesulfonate,17781-34-9,4-Hydroxymercuribenzenesulfonate,ChemID+,exact,,,,,,,,4-Hydroxymercuribenzenesulfonate,,17781-34-9,exact,,,,4-hydroxymercuribenzenesulfonate,C002910,17781-34-9,exact,,,,4-Hydroxymercuribenzenesulfonate,C0048362,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000114,MeSH_PA,C002910,4-hydroxymercuribenzenesulfonate,17781-34-9,4-Hydroxymercuribenzenesulfonate,ChemID+,exact,,,,,,,,4-Hydroxymercuribenzenesulfonate,,17781-34-9,exact,,,,4-hydroxymercuribenzenesulfonate,C002910,17781-34-9,exact,,,,4-Hydroxymercuribenzenesulfonate,C0048362,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Oxidants,Oxidants,Y,quasi syn therclass-to-function,Oxidation,Oxidation,C0030011,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Oxidants,Oxidants,C0085403,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_000115,MeSH_PA,C034888,4-methylumbelliferyl glucuronide,6160-80-1,4-Methylumbelliferyl glucuronide,ChemID+,exact,,,,,,,,4-Methylumbelliferyl glucuronide,,6160-80-1,exact,,,,4-methylumbelliferyl glucuronide,C034888,6160-80-1,exact,,,,4-Methylumbelliferyl Glucuronide,C0048514,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000116,MeSH_PA,C034888,4-methylumbelliferyl glucuronide,6160-80-1,4-Methylumbelliferyl glucuronide,ChemID+,exact,,,,,,,,4-Methylumbelliferyl glucuronide,,6160-80-1,exact,,,,4-methylumbelliferyl glucuronide,C034888,6160-80-1,exact,,,,4-Methylumbelliferyl Glucuronide,C0048514,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000117,MeSH_PA,C034888,4-methylumbelliferyl glucuronide,6160-80-1,4-Methylumbelliferyl glucuronide,ChemID+,exact,,,,,,,,4-Methylumbelliferyl glucuronide,,6160-80-1,exact,,,,4-methylumbelliferyl glucuronide,C034888,6160-80-1,exact,,,,4-Methylumbelliferyl Glucuronide,C0048514,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000118,MeSH_PA,C034888,4-methylumbelliferyl glucuronide,6160-80-1,4-Methylumbelliferyl glucuronide,ChemID+,exact,,,,,,,,4-Methylumbelliferyl glucuronide,,6160-80-1,exact,,,,4-methylumbelliferyl glucuronide,C034888,6160-80-1,exact,,,,4-Methylumbelliferyl Glucuronide,C0048514,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000119,MeSH_PA,C576317,"5-imino-1,2,4-thiadiazole VP1.14",,,,,,,,,,,,,,,,,,,"5-imino-1,2,4-thiadiazole VP1.14",C576317,,exact,,,,"5-Imino-1,2,4-Thiadiazole Vp1.14",C3501088,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000120,MeSH_PA,C576317,"5-imino-1,2,4-thiadiazole VP1.14",,,,,,,,,,,,,,,,,,,"5-imino-1,2,4-thiadiazole VP1.14",C576317,,exact,,,,"5-Imino-1,2,4-Thiadiazole Vp1.14",C3501088,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000121,MeSH_PA,C576317,"5-imino-1,2,4-thiadiazole VP1.14",,,,,,,,,,,,,,,,,,,"5-imino-1,2,4-thiadiazole VP1.14",C576317,,exact,,,,"5-Imino-1,2,4-Thiadiazole Vp1.14",C3501088,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000122,MeSH_PA,D015127,"9,10-Dimethyl-1,2-benzanthracene",57-97-6,"7,12-Dimethylbenz(a)anthracene",ChemID+,<syn per source>,"7,12-dimethyltetraphene",254496,57-97-6,<syn per source>,"9,10-Dimethyl-1,2-benzanthracene",exact,,"7,12-Dimethylbenz(a)anthracene",,57-97-6,<syn per source>,"9,10-Dimethyl-1,2-benzanthracene",exact,,"9,10-Dimethyl-1,2-benzanthracene",D015127,57-97-6,exact,,,,"9,10-Dimethyl-1,2-Benzanthracene",C0000677,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000123,MeSH_PA,D015127,"9,10-Dimethyl-1,2-benzanthracene",57-97-6,"7,12-Dimethylbenz(a)anthracene",ChemID+,<syn per source>,"7,12-dimethyltetraphene",254496,57-97-6,<syn per source>,"9,10-Dimethyl-1,2-benzanthracene",exact,,"7,12-Dimethylbenz(a)anthracene",,57-97-6,<syn per source>,"9,10-Dimethyl-1,2-benzanthracene",exact,,"9,10-Dimethyl-1,2-benzanthracene",D015127,57-97-6,exact,,,,"9,10-Dimethyl-1,2-Benzanthracene",C0000677,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000124,MeSH_PA,C011658,"androsta-1,4,6-triene-3,17-dione",633-35-2,"Androsta-1,4,6-triene-3,17-dione",ChemID+,exact,,,,,,,,"Androsta-1,4,6-triene-3,17-dione",,633-35-2,exact,,,,"androsta-1,4,6-triene-3,17-dione",C011658,633-35-2,exact,,,,"Androsta-1,4,6-Triene-3,17-Dione",C0051825,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000125,MeSH_PA,C108637,aspartyl-glutamyl-valyl-aspartal,,,,,,,,,,,,Aspartyl-glutamyl-valyl-aspartal,,C108637000,exact,,,,aspartyl-glutamyl-valyl-aspartal,C108637,,exact,,,,Aspartyl-Glutamyl-Valyl-Aspartal,C0666879,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000126,MeSH_PA,C108637,aspartyl-glutamyl-valyl-aspartal,,,,,,,,,,,,Aspartyl-glutamyl-valyl-aspartal,,C108637000,exact,,,,aspartyl-glutamyl-valyl-aspartal,C108637,,exact,,,,Aspartyl-Glutamyl-Valyl-Aspartal,C0666879,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000127,MeSH_PA,C108637,aspartyl-glutamyl-valyl-aspartal,,,,,,,,,,,,Aspartyl-glutamyl-valyl-aspartal,,C108637000,exact,,,,aspartyl-glutamyl-valyl-aspartal,C108637,,exact,,,,Aspartyl-Glutamyl-Valyl-Aspartal,C0666879,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000128,MeSH_PA,C007471,dimethyl dithiobispropionimidate,59012-54-3,Dimethyl dithiobispropionimidate,ChemID+,exact,,,,,,,,Dimethyl dithiobispropionimidate,,59012-54-3,exact,,,,dimethyl dithiobispropionimidate,C007471,59012-54-3,exact,,,,Dimethyl Dithiobispropionimidate,C0058216,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000129,MeSH_PA,C007471,dimethyl dithiobispropionimidate,59012-54-3,Dimethyl dithiobispropionimidate,ChemID+,exact,,,,,,,,Dimethyl dithiobispropionimidate,,59012-54-3,exact,,,,dimethyl dithiobispropionimidate,C007471,59012-54-3,exact,,,,Dimethyl Dithiobispropionimidate,C0058216,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000130,USAN_TC,,indium In 111 capromab pendetide,,,,,,,,,,,,,,,,,,,,,,,,,,Indium^111^ Capromab Pendetide,C2959379,syn,indium in 111 capromab pendetide,exact,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.2_Inorganic Chemical,,,,#VALUE!,radioactive agent,radioactive agent,Y,exact 1,Radioactive Agent,Radioactive Agent,C0279165,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000131,ChEBI,,"methyl 3,5-di-O-caffeoyl quinate",,,,,"methyl 3,5-di-O-caffeoyl quinate",66708,,exact,,,,,,,,,,,"3,4-di-O-caffeoylquinic acid",C478100,,NT salt/deriv/analog/df,"methyl 3,5-di-O-caffeoyl quinate",exact,,"Methyl 3,5-Di-O-Caffeoyl Quinate",C1871591,exact,,,,A1.4.1.2.1_Organic Chemical,,,,protective,,#VALUE!,hepatoprotective agent,hepatoprotective agent,Y,quasi syn therclass-to-disease,Liver Damage,Liver Damage,C0151763,P,Y,B2.2.1.2_Pathologic Function,,,,exact 1,Hepatoprotective Agent,Hepatoprotective Agent,C1512412,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000132,MeSH_PA,C014659,methyl(acetoxymethyl)nitrosamine,56856-83-8,Methyl(acetoxymethyl)nitrosamine,ChemID+,exact,,,,,,,,Methyl(acetoxymethyl)nitrosamine,,56856-83-8,exact,,,,methyl(acetoxymethyl)nitrosamine,C014659,56856-83-8,exact,,,,Methyl(Acetoxymethyl)Nitrosamine,C0066293,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000133,MeSH_PA,C014659,methyl(acetoxymethyl)nitrosamine,56856-83-8,Methyl(acetoxymethyl)nitrosamine,ChemID+,exact,,,,,,,,Methyl(acetoxymethyl)nitrosamine,,56856-83-8,exact,,,,methyl(acetoxymethyl)nitrosamine,C014659,56856-83-8,exact,,,,Methyl(Acetoxymethyl)Nitrosamine,C0066293,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000134,MeSH_PA,C004845,"N,N'-diphenyl-4-phenylenediamine",74-31-7,"p-Phenylenediamine, N,N'-diphenyl-",ChemID+,<syn per source>,,,,,,,,"p-Phenylenediamine, N,N'-diphenyl-",,74-31-7,syn word order,"N,N'-Diphenyl-4-phenylenediamine",exact,,"N,N'-diphenyl-4-phenylenediamine",C004845,74-31-7,exact,,,,"N,N'-Diphenyl-4-Phenylenediamine",C0067309,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000135,MeSH_PA,C004845,"N,N'-diphenyl-4-phenylenediamine",74-31-7,"p-Phenylenediamine, N,N'-diphenyl-",ChemID+,<syn per source>,,,,,,,,"p-Phenylenediamine, N,N'-diphenyl-",,74-31-7,syn word order,"N,N'-Diphenyl-4-phenylenediamine",exact,,"N,N'-diphenyl-4-phenylenediamine",C004845,74-31-7,exact,,,,"N,N'-Diphenyl-4-Phenylenediamine",C0067309,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000136,MeSH_PA,C014130,"N-nitroso-2,6-dimethylmorpholine",1456-28-6,"N-Nitroso-2,6-dimethylmorpholine",ChemID+,exact,,,,,,,,"N-Nitroso-2,6-dimethylmorpholine",,1456-28-6,exact,,,,"N-nitroso-2,6-dimethylmorpholine",C014130,1456-28-6,exact,,,,"N-Nitroso-2,6-Dimethylmorpholine",C0068183,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000137,MeSH_PA,C014130,"N-nitroso-2,6-dimethylmorpholine",1456-28-6,"N-Nitroso-2,6-dimethylmorpholine",ChemID+,exact,,,,,,,,"N-Nitroso-2,6-dimethylmorpholine",,1456-28-6,exact,,,,"N-nitroso-2,6-dimethylmorpholine",C014130,1456-28-6,exact,,,,"N-Nitroso-2,6-Dimethylmorpholine",C0068183,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000138,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Angiogenesis Inhibitors,Angiogenesis Inhibitors,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Inhibitors,Angiogenesis Inhibitors,C0596087,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000139,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulating agent,,#VALUE!,Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,C1257849,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000140,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000141,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000142,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dermatologic Agents,Dermatologic Agents,Y,quasi syn therclass-to-disease,Dermatologic Disorders,Dermatologic Disorders,C0037274,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dermatologic Agents,Dermatologic Agents,C0011625,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000143,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000144,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Growth Inhibitors,Growth Inhibitors,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Inhibitors,Growth Inhibitors,C0018282,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000145,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000146,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Photosensitizing Agents,Photosensitizing Agents,Y,quasi syn therclass-to-function,Photosensitizing Effect,Photosensitizing Effect,C3179153,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Photosensitizing Agents,Photosensitizing Agents,C0162713,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000147,MeSH_PA,C021096,tetra(4-N-methylpyridyl)porphine,38673-65-3,Tetra(4-N-methylpyridyl)porphine,ChemID+,exact,meso-tetrakis(N-methyl-4-pyridyl)porphine(4+),37447,38673-65-3,<syn per source>,tetra(4-N-methylpyridyl)porphine,exact,,Tetra(4-N-methylpyridyl)porphine,,38673-65-3,exact,,,,tetra(4-N-methylpyridyl)porphine,C021096,38673-65-3,exact,,,,Tetra(4-N-Methylpyridyl)Porphine,C0076211,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,Y,quasi syn therclass-to-function,Radiation-Sensitizing Effect,Radiation-Sensitizing Effect,C3179280,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,C0034541,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000148,MeSH_PA,C046498,tricyclodecane-9-yl-xanthogenate,83373-60-8,Tricyclodecane-9-yl-xanthogenate,ChemID+,exact,,,,,,,,Tricyclodecane-9-yl-xanthogenate,,83373-60-8,exact,,,,tricyclodecane-9-yl-xanthogenate,C046498,83373-60-8,exact,,,,Tricyclodecane-9-Yl-Xanthogenate,C0146692,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000149,MeSH_PA,C046498,tricyclodecane-9-yl-xanthogenate,83373-60-8,Tricyclodecane-9-yl-xanthogenate,ChemID+,exact,,,,,,,,Tricyclodecane-9-yl-xanthogenate,,83373-60-8,exact,,,,tricyclodecane-9-yl-xanthogenate,C046498,83373-60-8,exact,,,,Tricyclodecane-9-Yl-Xanthogenate,C0146692,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000150,MeSH_PA,C046498,tricyclodecane-9-yl-xanthogenate,83373-60-8,Tricyclodecane-9-yl-xanthogenate,ChemID+,exact,,,,,,,,Tricyclodecane-9-yl-xanthogenate,,83373-60-8,exact,,,,tricyclodecane-9-yl-xanthogenate,C046498,83373-60-8,exact,,,,Tricyclodecane-9-Yl-Xanthogenate,C0146692,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000151,MeSH_PA,C046498,tricyclodecane-9-yl-xanthogenate,83373-60-8,Tricyclodecane-9-yl-xanthogenate,ChemID+,exact,,,,,,,,Tricyclodecane-9-yl-xanthogenate,,83373-60-8,exact,,,,tricyclodecane-9-yl-xanthogenate,C046498,83373-60-8,exact,,,,Tricyclodecane-9-Yl-Xanthogenate,C0146692,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000152,MeSH_PA,C046498,tricyclodecane-9-yl-xanthogenate,83373-60-8,Tricyclodecane-9-yl-xanthogenate,ChemID+,exact,,,,,,,,Tricyclodecane-9-yl-xanthogenate,,83373-60-8,exact,,,,tricyclodecane-9-yl-xanthogenate,C046498,83373-60-8,exact,,,,Tricyclodecane-9-Yl-Xanthogenate,C0146692,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000153,MeSH_PA,C046498,tricyclodecane-9-yl-xanthogenate,83373-60-8,Tricyclodecane-9-yl-xanthogenate,ChemID+,exact,,,,,,,,Tricyclodecane-9-yl-xanthogenate,,83373-60-8,exact,,,,tricyclodecane-9-yl-xanthogenate,C046498,83373-60-8,exact,,,,Tricyclodecane-9-Yl-Xanthogenate,C0146692,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,C0031638,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000154,MeSH_PA,C046498,tricyclodecane-9-yl-xanthogenate,83373-60-8,Tricyclodecane-9-yl-xanthogenate,ChemID+,exact,,,,,,,,Tricyclodecane-9-yl-xanthogenate,,83373-60-8,exact,,,,tricyclodecane-9-yl-xanthogenate,C046498,83373-60-8,exact,,,,Tricyclodecane-9-Yl-Xanthogenate,C0146692,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000155,MeSH_PA,C035261,(alpha-carboxycyclopropyl)glycine,22255-17-0,(alpha-Carboxycyclopropyl)glycine,ChemID+,exact,,,,,,,,(alpha-Carboxycyclopropyl)glycine,,22255-17-0,exact,,,,,,,,,,,(Alpha-Carboxycyclopropyl)Glycine,C0043629,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000156,MeSH_PA,C035261,(alpha-carboxycyclopropyl)glycine,22255-17-0,(alpha-Carboxycyclopropyl)glycine,ChemID+,exact,,,,,,,,(alpha-Carboxycyclopropyl)glycine,,22255-17-0,exact,,,,,,,,,,,(Alpha-Carboxycyclopropyl)Glycine,C0043629,exact,,,,A1.4.1.2.1_Organic Chemical,,,,agonist,agonist,23,Excitatory Amino Acid Agonists,Excitatory Amino Acid Agonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agonists,Excitatory Amino Acid Agonists,C0242909,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000157,MeSH_PA,C035261,(alpha-carboxycyclopropyl)glycine,22255-17-0,(alpha-Carboxycyclopropyl)glycine,ChemID+,exact,,,,,,,,(alpha-Carboxycyclopropyl)glycine,,22255-17-0,exact,,,,,,,,,,,(Alpha-Carboxycyclopropyl)Glycine,C0043629,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000158,MeSH_PA,C033472,"10,10'-dimethyl-9,9'-biacridinium",2315-97-1,"10,10'-dimethyl-9,9'-biacridinium nitrate",ChemID+,<syn per source>,,,,,,,,"10,10'-dimethyl-9,9'-biacridinium nitrate",,2315-97-1,BT of salt/deriv/analog/df,"10,10'-dimethyl-9,9'-biacridinium",exact,,"10,10'-dimethyl-9,9'-biacridinium",C033472,2315-97-1,exact,,,,"10,10'-Dimethyl-9,9'-Biacridinium",C0044638,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000159,MeSH_PA,C033472,"10,10'-dimethyl-9,9'-biacridinium",2315-97-1,"10,10'-dimethyl-9,9'-biacridinium nitrate",ChemID+,<syn per source>,,,,,,,,"10,10'-dimethyl-9,9'-biacridinium nitrate",,2315-97-1,BT of salt/deriv/analog/df,"10,10'-dimethyl-9,9'-biacridinium",exact,,"10,10'-dimethyl-9,9'-biacridinium",C033472,2315-97-1,exact,,,,"10,10'-Dimethyl-9,9'-Biacridinium",C0044638,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000160,MeSH_PA,C036361,"1-amino-1,3-dicarboxycyclopentane",111900-32-4,"1-Amino-1,3-dicarboxycyclopentane",ChemID+,exact,,,,,,,,"1-Amino-1,3-dicarboxycyclopentane",,111900-32-4,exact,,,,"1-amino-1,3-dicarboxycyclopentane",C036361,111900-32-4,exact,,,,"1-Amino-1,3-Dicarboxycyclopentane",C0044270,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000161,MeSH_PA,C036361,"1-amino-1,3-dicarboxycyclopentane",111900-32-4,"1-Amino-1,3-dicarboxycyclopentane",ChemID+,exact,,,,,,,,"1-Amino-1,3-dicarboxycyclopentane",,111900-32-4,exact,,,,"1-amino-1,3-dicarboxycyclopentane",C036361,111900-32-4,exact,,,,"1-Amino-1,3-Dicarboxycyclopentane",C0044270,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000162,MeSH_PA,C036361,"1-amino-1,3-dicarboxycyclopentane",111900-32-4,"1-Amino-1,3-dicarboxycyclopentane",ChemID+,exact,,,,,,,,"1-Amino-1,3-dicarboxycyclopentane",,111900-32-4,exact,,,,"1-amino-1,3-dicarboxycyclopentane",C036361,111900-32-4,exact,,,,"1-Amino-1,3-Dicarboxycyclopentane",C0044270,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000163,MeSH_PA,D015085,"2,4,5-Trichlorophenoxyacetic Acid",93-76-5,"2,4,5-T",ChemID+,<syn per source>,"(2,4,5-trichlorophenoxy)acetic acid",27903,93-76-5,<syn per source>,"2,4,5-Trichlorophenoxyacetic acid",exact,,"2,4,5-T","2,4,5-T [BSI:ISO]",93-76-5,syn abbr,"2,4,5-Trichlorophenoxyacetic acid",exact,,"2,4,5-Trichlorophenoxyacetic Acid",D015085,93-76-5,exact,,,,"2,4,5-Trichlorophenoxyacetic Acid",C0000215,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,cide,,#VALUE!,Herbicides,Herbicides,Y,quasi syn therclass-to-function,Plant Development,Plant Development,C0597252,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Herbicides,Herbicides,C0019236,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000164,MeSH_PA,D015085,"2,4,5-Trichlorophenoxyacetic Acid",93-76-5,"2,4,5-T",ChemID+,<syn per source>,"(2,4,5-trichlorophenoxy)acetic acid",27903,93-76-5,<syn per source>,"2,4,5-Trichlorophenoxyacetic acid",exact,,"2,4,5-T","2,4,5-T [BSI:ISO]",93-76-5,syn abbr,"2,4,5-Trichlorophenoxyacetic acid",exact,,"2,4,5-Trichlorophenoxyacetic Acid",D015085,93-76-5,exact,,,,"2,4,5-Trichlorophenoxyacetic Acid",C0000215,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Pesticides,Pesticides,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Pesticides,Pesticides,C0031253,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000165,MeSH_PA,C000211,2-amino-3-phosphonopropionic acid,5652-28-8,2-Amino-3-phosphonopropionic acid,ChemID+,exact,,,,,,,,2-Amino-3-phosphonopropionic acid,,5652-28-8,exact,,,,,,,,,,,2-Amino-3-Phosphonopropionic Acid,C0045829,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000166,MeSH_PA,C000211,2-amino-3-phosphonopropionic acid,5652-28-8,2-Amino-3-phosphonopropionic acid,ChemID+,exact,,,,,,,,2-Amino-3-phosphonopropionic acid,,5652-28-8,exact,,,,,,,,,,,2-Amino-3-Phosphonopropionic Acid,C0045829,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000167,MeSH_PA,C000211,2-amino-3-phosphonopropionic acid,5652-28-8,2-Amino-3-phosphonopropionic acid,ChemID+,exact,,,,,,,,2-Amino-3-phosphonopropionic acid,,5652-28-8,exact,,,,,,,,,,,2-Amino-3-Phosphonopropionic Acid,C0045829,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000168,MeSH_PA,C031231,2-amino-7-phosphonoheptanoic acid,85797-13-3,2-Amino-7-phosphonoheptanoic acid,ChemID+,exact,,,,,,,,2-Amino-7-phosphonoheptanoic acid,,85797-13-3,exact,,,,,,,,,,,2-Amino-7-Phosphonoheptanoic Acid,C0045862,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,A1.4.1.2.1_Organic Chemical,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000169,MeSH_PA,C031231,2-amino-7-phosphonoheptanoic acid,85797-13-3,2-Amino-7-phosphonoheptanoic acid,ChemID+,exact,,,,,,,,2-Amino-7-phosphonoheptanoic acid,,85797-13-3,exact,,,,,,,,,,,2-Amino-7-Phosphonoheptanoic Acid,C0045862,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000170,MeSH_PA,C031231,2-amino-7-phosphonoheptanoic acid,85797-13-3,2-Amino-7-phosphonoheptanoic acid,ChemID+,exact,,,,,,,,2-Amino-7-phosphonoheptanoic acid,,85797-13-3,exact,,,,,,,,,,,2-Amino-7-Phosphonoheptanoic Acid,C0045862,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000171,MeSH_PA,C031231,2-amino-7-phosphonoheptanoic acid,85797-13-3,2-Amino-7-phosphonoheptanoic acid,ChemID+,exact,,,,,,,,2-Amino-7-phosphonoheptanoic acid,,85797-13-3,exact,,,,,,,,,,,2-Amino-7-Phosphonoheptanoic Acid,C0045862,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,A1.4.1.2.1_Organic Chemical,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000172,MeSH_PA,C031231,2-amino-7-phosphonoheptanoic acid,85797-13-3,2-Amino-7-phosphonoheptanoic acid,ChemID+,exact,,,,,,,,2-Amino-7-phosphonoheptanoic acid,,85797-13-3,exact,,,,,,,,,,,2-Amino-7-Phosphonoheptanoic Acid,C0045862,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000173,MeSH_PA,C076145,3-(1-deoxyribofuranosyl)benzamide,138385-29-2,3-(1-Deoxyribofuranosyl)benzamide,ChemID+,exact,,,,,,,,3-(1-Deoxyribofuranosyl)benzamide,,138385-29-2,exact,,,,3-(1-deoxyribofuranosyl)benzamide,C076145,138385-29-2,exact,,,,3-(1-Deoxyribofuranosyl)Benzamide,C0653231,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000174,MeSH_PA,C007392,"3,3'-dihexyl-2,2'-oxacarbocyanine",54501-79-0,"3,3'-Dihexyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dihexyl-2,2'-oxacarbocyanine",,54501-79-0,exact,,,,"3,3'-dihexyl-2,2'-oxacarbocyanine",C007392,54501-79-0,exact,,,,"3,3'-Dihexyl-2,2'-Oxacarbocyanine",C0995156,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000175,MeSH_PA,C007392,"3,3'-dihexyl-2,2'-oxacarbocyanine",54501-79-0,"3,3'-Dihexyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dihexyl-2,2'-oxacarbocyanine",,54501-79-0,exact,,,,"3,3'-dihexyl-2,2'-oxacarbocyanine",C007392,54501-79-0,exact,,,,"3,3'-Dihexyl-2,2'-Oxacarbocyanine",C0995156,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000176,MeSH_PA,C007392,"3,3'-dihexyl-2,2'-oxacarbocyanine",54501-79-0,"3,3'-Dihexyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dihexyl-2,2'-oxacarbocyanine",,54501-79-0,exact,,,,"3,3'-dihexyl-2,2'-oxacarbocyanine",C007392,54501-79-0,exact,,,,"3,3'-Dihexyl-2,2'-Oxacarbocyanine",C0995156,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000177,MeSH_PA,C007392,"3,3'-dihexyl-2,2'-oxacarbocyanine",54501-79-0,"3,3'-Dihexyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dihexyl-2,2'-oxacarbocyanine",,54501-79-0,exact,,,,"3,3'-dihexyl-2,2'-oxacarbocyanine",C007392,54501-79-0,exact,,,,"3,3'-Dihexyl-2,2'-Oxacarbocyanine",C0995156,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000178,MeSH_PA,C035419,"3,4-dihydroxybenzohydroxamic acid",69839-83-4,"3,4-Dihydroxybenzohydroxamic acid",ChemID+,exact,,,,,,,,"3,4-Dihydroxybenzohydroxamic acid",,69839-83-4,exact,,,,"3,4-dihydroxybenzohydroxamic acid",C035419,69839-83-4,exact,,,,"3,4-Dihydroxybenzohydroxamic Acid",C0094556,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000179,MeSH_PA,C035419,"3,4-dihydroxybenzohydroxamic acid",69839-83-4,"3,4-Dihydroxybenzohydroxamic acid",ChemID+,exact,,,,,,,,"3,4-Dihydroxybenzohydroxamic acid",,69839-83-4,exact,,,,"3,4-dihydroxybenzohydroxamic acid",C035419,69839-83-4,exact,,,,"3,4-Dihydroxybenzohydroxamic Acid",C0094556,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000180,ChEBI,,3-methylflavone-8-carboxylic acid,3468-01-7,3-Methylflavone-8-carboxylic acid,ChemID+,exact,3-methylflavone-8-carboxylic acid,61237,3468-01-7,exact,,,,3-Methylflavone-8-carboxylic acid,,3468-01-7,exact,,,,3-methylflavone-8-carboxylic acid,C011504,3468-01-7,exact,,,,3-Methylflavone-8-Carboxylic Acid,C0047591,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits, inhibitor,phosphodiesterase inhibitor,phosphodiesterase inhibitor,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact 1,phosphodiesterase inhibitor,Phosphodiesterase Inhibitors,C0031638,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000181,MeSH_PA,C052562,4-(acetylamino)benzeneacetic acid,18699-02-0,Actarit,ChemID+,<syn per source>,,,,,,,,Actarit,Actarit [INN:JAN],18699-02-0,<syn per source>,4-(Acetylamino)benzeneacetic acid,exact,,4-(acetylamino)benzeneacetic acid,C052562,18699-02-0,exact,,,,4-(Acetylamino)Benzeneacetic Acid,C0096557,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000182,ChEBI,,"4-methyl-5-pentylbenzene-1,3-diol",,,,,"4-methyl-5-pentylbenzene-1,3-diol",61089,,exact,,,,,,,,,,,"4-methyl-5-pentylbenzene-1,3-diol",C511448,,exact,,,,"4-Methyl-5-Pentylbenzene-1,3-Diol",C1722937,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antineoplastic agent,antineoplastic agent,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact 1,antineoplastic agent,Antineoplastic Agents,C0003392,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000183,MeSH_PA,D019830,Adenosine-5'-(N-ethylcarboxamide),35920-39-9,Adenosine-5'-(N-ethylcarboxamide),ChemID+,exact,N-ethyl-5'-carboxamidoadenosine,73284,35920-39-9,<syn per source>,Adenosine-5'-(N-ethylcarboxamide),exact,,Adenosine-5'-(N-ethylcarboxamide),,35920-39-9,exact,,,,Adenosine-5'-(N-ethylcarboxamide),D019830,35920-39-9,exact,,,,Adenosine-5'-(N-Ethylcarboxamide),C0050789,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000184,MeSH_PA,D019830,Adenosine-5'-(N-ethylcarboxamide),35920-39-9,Adenosine-5'-(N-ethylcarboxamide),ChemID+,exact,N-ethyl-5'-carboxamidoadenosine,73284,35920-39-9,<syn per source>,Adenosine-5'-(N-ethylcarboxamide),exact,,Adenosine-5'-(N-ethylcarboxamide),,35920-39-9,exact,,,,Adenosine-5'-(N-ethylcarboxamide),D019830,35920-39-9,exact,,,,Adenosine-5'-(N-Ethylcarboxamide),C0050789,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000185,MeSH_PA,D019830,Adenosine-5'-(N-ethylcarboxamide),35920-39-9,Adenosine-5'-(N-ethylcarboxamide),ChemID+,exact,N-ethyl-5'-carboxamidoadenosine,73284,35920-39-9,<syn per source>,Adenosine-5'-(N-ethylcarboxamide),exact,,Adenosine-5'-(N-ethylcarboxamide),,35920-39-9,exact,,,,Adenosine-5'-(N-ethylcarboxamide),D019830,35920-39-9,exact,,,,Adenosine-5'-(N-Ethylcarboxamide),C0050789,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,causes,,#VALUE!,Vasodilator Agents,Vasodilator Agents,Y,quasi syn therclass-to-function,Vasodilation,Vasodilation,C0042401,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Vasodilator Agents,Vasodilator Agents,C0042402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000186,MeSH_PA,C561029,arachidonoyl-2 chloroethanolamine,,,,,,,,,,,,,,,,,,,arachidonoyl-2 chloroethanolamine,C561029,,exact,,,,Arachidonoyl-2 Chloroethanolamine,C3254041,exact,,,,A1.4.1.2.1.9_Lipid,,,,agonist,agonist,22,Cannabinoid Receptor Agonists,Cannabinoid Receptor Agonists,Y,quasi syn therclass-to-function,Cannabinoid Receptor Activity,Cannabinoid Receptor Activity,C1152747,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cannabinoid Receptor Agonists,Cannabinoid Receptor Agonists,C2927148,P,B2.2.1.1.4_Molecular Function,,,
1_000187,MeSH_PA,C561029,arachidonoyl-2 chloroethanolamine,,,,,,,,,,,,,,,,,,,arachidonoyl-2 chloroethanolamine,C561029,,exact,,,,Arachidonoyl-2 Chloroethanolamine,C3254041,exact,,,,A1.4.1.2.1.9_Lipid,,,,modulator,,#VALUE!,Cannabinoid Receptor Modulators,Cannabinoid Receptor Modulators,Y,quasi syn therclass-to-function,Cannabinoid Receptor Activity,Cannabinoid Receptor Activity,C1152747,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cannabinoid Receptor Modulators,Cannabinoid Receptor Modulators,C3494475,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000188,MeSH_PA,C561029,arachidonoyl-2 chloroethanolamine,,,,,,,,,,,,,,,,,,,arachidonoyl-2 chloroethanolamine,C561029,,exact,,,,Arachidonoyl-2 Chloroethanolamine,C3254041,exact,,,,A1.4.1.2.1.9_Lipid,,,,,,#VALUE!,Hormones,Hormones,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormones,Hormones,C0019932,P,A1.4.1.1.3.2_Hormone,,,
1_000189,MeSH_PA,C561029,arachidonoyl-2 chloroethanolamine,,,,,,,,,,,,,,,,,,,arachidonoyl-2 chloroethanolamine,C561029,,exact,,,,Arachidonoyl-2 Chloroethanolamine,C3254041,exact,,,,A1.4.1.2.1.9_Lipid,,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000190,MeSH_PA,C561029,arachidonoyl-2 chloroethanolamine,,,,,,,,,,,,,,,,,,,arachidonoyl-2 chloroethanolamine,C561029,,exact,,,,Arachidonoyl-2 Chloroethanolamine,C3254041,exact,,,,A1.4.1.2.1.9_Lipid,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000191,MeSH_PA,C011870,beta-(5-hydroxy-2-pyridyl)alanine,943-82-8,beta-(5-Hydroxy-2-pyridyl)alanine,ChemID+,exact,,,,,,,,beta-(5-Hydroxy-2-pyridyl)alanine,,943-82-8,exact,,,,,,,,,,,Beta-(5-Hydroxy-2-Pyridyl)Alanine,C0053370,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",C0003236,P,A1.4.1.1.1.1_Antibiotic,,,
1_000192,MeSH_PA,C011870,beta-(5-hydroxy-2-pyridyl)alanine,943-82-8,beta-(5-Hydroxy-2-pyridyl)alanine,ChemID+,exact,,,,,,,,beta-(5-Hydroxy-2-pyridyl)alanine,,943-82-8,exact,,,,,,,,,,,Beta-(5-Hydroxy-2-Pyridyl)Alanine,C0053370,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000193,MeSH_PA,C006853,butyl(3-carboxypropyl)nitrosamine,38252-74-3,Butyl(3-carboxypropyl)nitrosamine,ChemID+,exact,,,,,,,,Butyl(3-carboxypropyl)nitrosamine,,38252-74-3,exact,,,,butyl(3-carboxypropyl)nitrosamine,C006853,38252-74-3,exact,,,,Butyl(3-Carboxypropyl)Nitrosamine,C0054285,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000194,MeSH_PA,C006853,butyl(3-carboxypropyl)nitrosamine,38252-74-3,Butyl(3-carboxypropyl)nitrosamine,ChemID+,exact,,,,,,,,Butyl(3-carboxypropyl)nitrosamine,,38252-74-3,exact,,,,butyl(3-carboxypropyl)nitrosamine,C006853,38252-74-3,exact,,,,Butyl(3-Carboxypropyl)Nitrosamine,C0054285,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000195,MeSH_PA,D004246,Dimethylphenylpiperazinium Iodide,54-77-3,Dimethylphenylpiperazinium Iodide,ChemID+,exact,"1,1-dimethyl-4-phenylpiperazinium iodide",4290,54-77-3,<syn per source>,Dimethylphenylpiperazinium iodide,exact,,Dimethylphenylpiperazinium Iodide,,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,D004246,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,C0012847,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000196,MeSH_PA,D004246,Dimethylphenylpiperazinium Iodide,54-77-3,Dimethylphenylpiperazinium Iodide,ChemID+,exact,"1,1-dimethyl-4-phenylpiperazinium iodide",4290,54-77-3,<syn per source>,Dimethylphenylpiperazinium iodide,exact,,Dimethylphenylpiperazinium Iodide,,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,D004246,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,C0012847,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000197,MeSH_PA,D004246,Dimethylphenylpiperazinium Iodide,54-77-3,Dimethylphenylpiperazinium Iodide,ChemID+,exact,"1,1-dimethyl-4-phenylpiperazinium iodide",4290,54-77-3,<syn per source>,Dimethylphenylpiperazinium iodide,exact,,Dimethylphenylpiperazinium Iodide,,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,D004246,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,C0012847,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,13,Cholinergic Agonists,Cholinergic Agonists,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agonists,Cholinergic Agonists,C0242894,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000198,MeSH_PA,D004246,Dimethylphenylpiperazinium Iodide,54-77-3,Dimethylphenylpiperazinium Iodide,ChemID+,exact,"1,1-dimethyl-4-phenylpiperazinium iodide",4290,54-77-3,<syn per source>,Dimethylphenylpiperazinium iodide,exact,,Dimethylphenylpiperazinium Iodide,,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,D004246,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,C0012847,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Ganglionic Stimulants,Ganglionic Stimulants,Y,exact (CUI-based),Ganglionic Stimulants,Ganglionic Stimulants,C0017078,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000199,MeSH_PA,D004246,Dimethylphenylpiperazinium Iodide,54-77-3,Dimethylphenylpiperazinium Iodide,ChemID+,exact,"1,1-dimethyl-4-phenylpiperazinium iodide",4290,54-77-3,<syn per source>,Dimethylphenylpiperazinium iodide,exact,,Dimethylphenylpiperazinium Iodide,,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,D004246,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,C0012847,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000200,MeSH_PA,D004246,Dimethylphenylpiperazinium Iodide,54-77-3,Dimethylphenylpiperazinium Iodide,ChemID+,exact,"1,1-dimethyl-4-phenylpiperazinium iodide",4290,54-77-3,<syn per source>,Dimethylphenylpiperazinium iodide,exact,,Dimethylphenylpiperazinium Iodide,,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,D004246,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,C0012847,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,11,Nicotinic Agonists,Nicotinic Agonists,Y,quasi syn therclass-to-function,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,C1148665,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nicotinic Agonists,Nicotinic Agonists,C0242948,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000201,MeSH_PA,D004246,Dimethylphenylpiperazinium Iodide,54-77-3,Dimethylphenylpiperazinium Iodide,ChemID+,exact,"1,1-dimethyl-4-phenylpiperazinium iodide",4290,54-77-3,<syn per source>,Dimethylphenylpiperazinium iodide,exact,,Dimethylphenylpiperazinium Iodide,,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,D004246,54-77-3,exact,,,,Dimethylphenylpiperazinium Iodide,C0012847,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000202,ChEBI,,"diphenylmethane-4,4'-diisocyanate",101-68-8,"4,4'-Diphenylmethane diisocyanate",ChemID+,<syn per source>,"diphenylmethane-4,4'-diisocyanate",53218,101-68-8,exact,,,,"4,4'-Diphenylmethane diisocyanate",,101-68-8,<syn per source>,"Diphenylmethane-4,4'-diisocyanate",exact,,"4,4'-diphenylmethane diisocyanate",C005969,101-68-8,<syn per source>,"diphenylmethane-4,4'-diisocyanate",exact,,"4,4'-Diphenylmethane Diisocyanate",C0047822,syn word order,"diphenylmethane-4,4'-diisocyanate",exact,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,allergenic agent,allergenic agent,Y,quasi syn therclass-to-function,Allergic Reaction,Allergic Reaction,C1527304,P,Y,B2.2.1.2_Pathologic Function,,,,quasi syn,Allergens,Allergens,C0002092,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000203,MeSH_PA,C011240,dithiobis(succinimidylpropionate),57757-57-0,Dithiobis(succinimidylpropionate),ChemID+,exact,,,,,,,,Dithiobis(succinimidylpropionate),,57757-57-0,exact,,,,dithiobis(succinimidylpropionate),C011240,57757-57-0,exact,,,,Dithiobis(Succinimidylpropionate),C0058494,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000204,MeSH_PA,C011240,dithiobis(succinimidylpropionate),57757-57-0,Dithiobis(succinimidylpropionate),ChemID+,exact,,,,,,,,Dithiobis(succinimidylpropionate),,57757-57-0,exact,,,,dithiobis(succinimidylpropionate),C011240,57757-57-0,exact,,,,Dithiobis(Succinimidylpropionate),C0058494,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000205,MeSH_PA,C058306,"N(1),N(14)-bis(ethyl)homospermine",119422-08-1,"N(1),N(14)-Bis(ethyl)homospermine",ChemID+,exact,,,,,,,,"N(1),N(14)-Bis(ethyl)homospermine",,119422-08-1,exact,,,,"N(1),N(14)-bis(ethyl)homospermine",C058306,119422-08-1,exact,,,,"N(1),N(14)-Bis(Ethyl)Homospermine",C0067118,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000206,MeSH_PA,C058306,"N(1),N(14)-bis(ethyl)homospermine",119422-08-1,"N(1),N(14)-Bis(ethyl)homospermine",ChemID+,exact,,,,,,,,"N(1),N(14)-Bis(ethyl)homospermine",,119422-08-1,exact,,,,"N(1),N(14)-bis(ethyl)homospermine",C058306,119422-08-1,exact,,,,"N(1),N(14)-Bis(Ethyl)Homospermine",C0067118,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000207,MeSH_PA,C058306,"N(1),N(14)-bis(ethyl)homospermine",119422-08-1,"N(1),N(14)-Bis(ethyl)homospermine",ChemID+,exact,,,,,,,,"N(1),N(14)-Bis(ethyl)homospermine",,119422-08-1,exact,,,,"N(1),N(14)-bis(ethyl)homospermine",C058306,119422-08-1,exact,,,,"N(1),N(14)-Bis(Ethyl)Homospermine",C0067118,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000208,MeSH_PA,C058306,"N(1),N(14)-bis(ethyl)homospermine",119422-08-1,"N(1),N(14)-Bis(ethyl)homospermine",ChemID+,exact,,,,,,,,"N(1),N(14)-Bis(ethyl)homospermine",,119422-08-1,exact,,,,"N(1),N(14)-bis(ethyl)homospermine",C058306,119422-08-1,exact,,,,"N(1),N(14)-Bis(Ethyl)Homospermine",C0067118,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,Y,quasi syn therclass-to-function,Radiation-Sensitizing Effect,Radiation-Sensitizing Effect,C3179280,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,C0034541,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000209,MeSH_PA,C007352,"N-(3,5-dichlorophenyl)succinimide",24096-53-5,"N-(3,5-Dichlorophenyl)succinimide",ChemID+,exact,"N-(3,5-Dichlorophenyl)succinimide",7087,,exact,,,,"N-(3,5-Dichlorophenyl)succinimide",,24096-53-5,exact,,,,"N-(3,5-dichlorophenyl)succinimide",C007352,24096-53-5,exact,,,,"N-(3,5-Dichlorophenyl)Succinimide",C0067483,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,cide,,#VALUE!,"Fungicides, Industrial","Fungicides, Industrial",Y,quasi syn therclass-to-disease,fungal infections,Mycoses,C0026946,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),"fungicides, industrial",Industrial Fungicide,C0392419,S,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000210,MeSH_PA,C007352,"N-(3,5-dichlorophenyl)succinimide",24096-53-5,"N-(3,5-Dichlorophenyl)succinimide",ChemID+,exact,"N-(3,5-Dichlorophenyl)succinimide",7087,,exact,,,,"N-(3,5-Dichlorophenyl)succinimide",,24096-53-5,exact,,,,"N-(3,5-dichlorophenyl)succinimide",C007352,24096-53-5,exact,,,,"N-(3,5-Dichlorophenyl)Succinimide",C0067483,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Pesticides,Pesticides,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Pesticides,Pesticides,C0031253,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000211,MeSH_PA,C069861,N-acetylleucyl-leucyl-methioninal,110115-07-6,N-Acetylleucyl-leucyl-methioninal,ChemID+,exact,N-Acetylleucyl-leucyl-methioninal,7209,,exact,,,,N-Acetylleucyl-leucyl-methioninal,,110115-07-6,exact,,,,N-acetylleucyl-leucyl-methioninal,C069861,110115-07-6,exact,,,,N-Acetylleucyl-Leucyl-Methioninal,C0130753,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000212,MeSH_PA,C069861,N-acetylleucyl-leucyl-methioninal,110115-07-6,N-Acetylleucyl-leucyl-methioninal,ChemID+,exact,N-Acetylleucyl-leucyl-methioninal,7209,,exact,,,,N-Acetylleucyl-leucyl-methioninal,,110115-07-6,exact,,,,N-acetylleucyl-leucyl-methioninal,C069861,110115-07-6,exact,,,,N-Acetylleucyl-Leucyl-Methioninal,C0130753,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000213,MeSH_PA,C069861,N-acetylleucyl-leucyl-methioninal,110115-07-6,N-Acetylleucyl-leucyl-methioninal,ChemID+,exact,N-Acetylleucyl-leucyl-methioninal,7209,,exact,,,,N-Acetylleucyl-leucyl-methioninal,,110115-07-6,exact,,,,N-acetylleucyl-leucyl-methioninal,C069861,110115-07-6,exact,,,,N-Acetylleucyl-Leucyl-Methioninal,C0130753,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000214,MeSH_PA,C048763,N-benzylglucamine dithiocarbamate,110771-92-1,N-Benzylglucamine dithiocarbamate,ChemID+,exact,,,,,,,,N-Benzylglucamine dithiocarbamate,,110771-92-1,exact,,,,N-benzylglucamine dithiocarbamate,C048763,110771-92-1,exact,,,,N-Benzylglucamine Dithiocarbamate,C0067834,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000215,MeSH_PA,C023845,N-ethyl-N-hydroxyethylnitrosamine,13147-25-6,N-Ethyl-N-hydroxyethylnitrosamine,ChemID+,exact,,,,,,,,N-Ethyl-N-hydroxyethylnitrosamine,,13147-25-6,exact,,,,N-ethyl-N-hydroxyethylnitrosamine,C023845,13147-25-6,exact,,,,N-Ethyl-N-Hydroxyethylnitrosamine,C0067957,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000216,MeSH_PA,C023845,N-ethyl-N-hydroxyethylnitrosamine,13147-25-6,N-Ethyl-N-hydroxyethylnitrosamine,ChemID+,exact,,,,,,,,N-Ethyl-N-hydroxyethylnitrosamine,,13147-25-6,exact,,,,N-ethyl-N-hydroxyethylnitrosamine,C023845,13147-25-6,exact,,,,N-Ethyl-N-Hydroxyethylnitrosamine,C0067957,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000217,MeSH_PA,C083486,"pyrrolidine-2,4-dicarboxylic acid",99319-03-6,"Pyrrolidine-2,4-dicarboxylic acid",ChemID+,exact,,,,,,,,"Pyrrolidine-2,4-dicarboxylic acid",,99319-03-6,exact,,,,"pyrrolidine-2,4-dicarboxylic acid",C083486,99319-03-6,exact,,,,"Pyrrolidine-2,4-Dicarboxylic Acid",C0247402,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000218,MeSH_PA,C083486,"pyrrolidine-2,4-dicarboxylic acid",99319-03-6,"Pyrrolidine-2,4-dicarboxylic acid",ChemID+,exact,,,,,,,,"Pyrrolidine-2,4-dicarboxylic acid",,99319-03-6,exact,,,,"pyrrolidine-2,4-dicarboxylic acid",C083486,99319-03-6,exact,,,,"Pyrrolidine-2,4-Dicarboxylic Acid",C0247402,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Neurotransmitter Uptake Inhibitors,Neurotransmitter Uptake Inhibitors,Y,quasi syn therclass-to-function,Neurotransmitter Uptake,Neurotransmitter Uptake,C0598962,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Uptake Inhibitors,Neurotransmitter Uptake Inhibitors,C0040724,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000219,MeSH_PA,C068543,"1,2-diethyl-3-hydroxypyridin-4-one",115900-75-9,"1,2-Diethyl-3-hydroxypyridin-4-one",ChemID+,exact,,,,,,,,"1,2-Diethyl-3-hydroxypyridin-4-one",,115900-75-9,exact,,,,"1,2-diethyl-3-hydroxypyridin-4-one",C068543,115900-75-9,exact,,,,"1,2-Diethyl-3-Hydroxypyridin-4-One",C0088045,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000220,MeSH_PA,C068543,"1,2-diethyl-3-hydroxypyridin-4-one",115900-75-9,"1,2-Diethyl-3-hydroxypyridin-4-one",ChemID+,exact,,,,,,,,"1,2-Diethyl-3-hydroxypyridin-4-one",,115900-75-9,exact,,,,"1,2-diethyl-3-hydroxypyridin-4-one",C068543,115900-75-9,exact,,,,"1,2-Diethyl-3-Hydroxypyridin-4-One",C0088045,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Iron Chelating Agents,Iron Chelating Agents,Y,quasi syn therclass-to-function,iron chelating activity,Iron Chelating Activity [Moa],C2757050,S,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Iron Chelating Agents,Iron Chelating Agents,C0022086,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,
1_000221,MeSH_PA,C051360,"1,3-dipropyl-8-cyclopentylxanthine",102146-07-6,PD 116948,ChemID+,<syn per source>,DPCPX,73282,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,PD 116948,,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,"1,3-dipropyl-8-cyclopentylxanthine",C051360,102146-07-6,exact,,,,"1,3-Dipropyl-8-Cyclopentylxanthine",C0088321,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adenosine A1 Receptor Antagonists,Adenosine A1 Receptor Antagonists,Y,quasi syn therclass-to-function,"A1 Adenosine Receptor Activity, G-Protein Coupled","A1 Adenosine Receptor Activity, G-Protein Coupled",C1152762,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Adenosine A1 Receptor Antagonists,Adenosine A1 Receptor Antagonists,C2936569,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000222,MeSH_PA,C051360,"1,3-dipropyl-8-cyclopentylxanthine",102146-07-6,PD 116948,ChemID+,<syn per source>,DPCPX,73282,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,PD 116948,,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,"1,3-dipropyl-8-cyclopentylxanthine",C051360,102146-07-6,exact,,,,"1,3-Dipropyl-8-Cyclopentylxanthine",C0088321,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000223,MeSH_PA,C051360,"1,3-dipropyl-8-cyclopentylxanthine",102146-07-6,PD 116948,ChemID+,<syn per source>,DPCPX,73282,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,PD 116948,,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,"1,3-dipropyl-8-cyclopentylxanthine",C051360,102146-07-6,exact,,,,"1,3-Dipropyl-8-Cyclopentylxanthine",C0088321,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000224,MeSH_PA,C051360,"1,3-dipropyl-8-cyclopentylxanthine",102146-07-6,PD 116948,ChemID+,<syn per source>,DPCPX,73282,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,PD 116948,,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,"1,3-dipropyl-8-cyclopentylxanthine",C051360,102146-07-6,exact,,,,"1,3-Dipropyl-8-Cyclopentylxanthine",C0088321,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000225,MeSH_PA,C051360,"1,3-dipropyl-8-cyclopentylxanthine",102146-07-6,PD 116948,ChemID+,<syn per source>,DPCPX,73282,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,PD 116948,,102146-07-6,<syn per source>,"1,3-Dipropyl-8-cyclopentylxanthine",exact,,"1,3-dipropyl-8-cyclopentylxanthine",C051360,102146-07-6,exact,,,,"1,3-Dipropyl-8-Cyclopentylxanthine",C0088321,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000226,MeSH_PA,C095756,"1-aminoindan-1,5-dicarboxylic acid",168560-79-0,"1-Aminoindan-1,5-dicarboxylic acid",ChemID+,exact,,,,,,,,"1-Aminoindan-1,5-dicarboxylic acid",,168560-79-0,exact,,,,"1-aminoindan-1,5-dicarboxylic acid",C095756,,exact,,,,"1-Aminoindan-1,5-Dicarboxylic Acid",C0381784,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000227,MeSH_PA,C095756,"1-aminoindan-1,5-dicarboxylic acid",168560-79-0,"1-Aminoindan-1,5-dicarboxylic acid",ChemID+,exact,,,,,,,,"1-Aminoindan-1,5-dicarboxylic acid",,168560-79-0,exact,,,,"1-aminoindan-1,5-dicarboxylic acid",C095756,,exact,,,,"1-Aminoindan-1,5-Dicarboxylic Acid",C0381784,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000228,MeSH_PA,C095756,"1-aminoindan-1,5-dicarboxylic acid",168560-79-0,"1-Aminoindan-1,5-dicarboxylic acid",ChemID+,exact,,,,,,,,"1-Aminoindan-1,5-dicarboxylic acid",,168560-79-0,exact,,,,"1-aminoindan-1,5-dicarboxylic acid",C095756,,exact,,,,"1-Aminoindan-1,5-Dicarboxylic Acid",C0381784,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000229,ChEBI,,2-methyl-6-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,<syn per source>,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,exact,,,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,<syn per source>,2-Methyl-6-(phenylethynyl)pyridine,exact,,6-methyl-2-(phenylethynyl)pyridine,C121465,,<syn per source>,2-methyl-6-(phenylethynyl)pyridine,exact,,2-Methyl-6-(Phenylethynyl)Pyridine,C0909109,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,lytic,,#VALUE!,anxiolytic drug,anxiolytic drug,Y,quasi syn therclass-to-disease,Anxiety,Anxiety,C0003467,P,Y,B2.2.1.1.1.1_Mental Process,,,,quasi syn,anxiolytic,Anti-Anxiety Agents,C0040616,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000230,ChEBI,,2-methyl-6-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,<syn per source>,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,exact,,,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,<syn per source>,2-Methyl-6-(phenylethynyl)pyridine,exact,,6-methyl-2-(phenylethynyl)pyridine,C121465,,<syn per source>,2-methyl-6-(phenylethynyl)pyridine,exact,,2-Methyl-6-(Phenylethynyl)Pyridine,C0909109,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,metabotropic glutamate receptor antagonist,metabotropic glutamate receptor antagonist,Y,comp/NT + quasi syn therclass-to-function,Glutamate Receptor Activity,Glutamate Receptor Activity,C1152799,P,Y,B2.2.1.1.4_Molecular Function,,,,compound >1 term,metabotropic glutamate receptors,"Receptors, Metabotropic Glutamate",C0206529,S,A1.4.1.1.3.6_Receptor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,
1_000231,MeSH_PA,C018528,"3,3'-dipentyl-2,2'-oxacarbocyanine",60031-82-5,"3,3'-Dipentyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dipentyl-2,2'-oxacarbocyanine",,60031-82-5,exact,,,,"3,3'-dipentyl-2,2'-oxacarbocyanine",C018528,60031-82-5,exact,,,,"3,3'-Dipentyl-2,2'-Oxacarbocyanine",C0046900,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000232,MeSH_PA,C018528,"3,3'-dipentyl-2,2'-oxacarbocyanine",60031-82-5,"3,3'-Dipentyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dipentyl-2,2'-oxacarbocyanine",,60031-82-5,exact,,,,"3,3'-dipentyl-2,2'-oxacarbocyanine",C018528,60031-82-5,exact,,,,"3,3'-Dipentyl-2,2'-Oxacarbocyanine",C0046900,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000233,MeSH_PA,C018528,"3,3'-dipentyl-2,2'-oxacarbocyanine",60031-82-5,"3,3'-Dipentyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dipentyl-2,2'-oxacarbocyanine",,60031-82-5,exact,,,,"3,3'-dipentyl-2,2'-oxacarbocyanine",C018528,60031-82-5,exact,,,,"3,3'-Dipentyl-2,2'-Oxacarbocyanine",C0046900,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000234,MeSH_PA,C018528,"3,3'-dipentyl-2,2'-oxacarbocyanine",60031-82-5,"3,3'-Dipentyl-2,2'-oxacarbocyanine",ChemID+,exact,,,,,,,,"3,3'-Dipentyl-2,2'-oxacarbocyanine",,60031-82-5,exact,,,,"3,3'-dipentyl-2,2'-oxacarbocyanine",C018528,60031-82-5,exact,,,,"3,3'-Dipentyl-2,2'-Oxacarbocyanine",C0046900,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000235,MeSH_PA,C004805,5'-guanylylmethylenebisphosphonate,13912-93-1,5'-Guanylylmethylenebisphosphonate,ChemID+,exact,,,,,,,,5'-Guanylylmethylenebisphosphonate,,13912-93-1,exact,,,,5'-guanylylmethylenebisphosphonate,C004805,13912-93-1,exact,,,,5'-Guanylylmethylenebisphosphonate,C0048815,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000236,MeSH_PA,C004805,5'-guanylylmethylenebisphosphonate,13912-93-1,5'-Guanylylmethylenebisphosphonate,ChemID+,exact,,,,,,,,5'-Guanylylmethylenebisphosphonate,,13912-93-1,exact,,,,5'-guanylylmethylenebisphosphonate,C004805,13912-93-1,exact,,,,5'-Guanylylmethylenebisphosphonate,C0048815,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000237,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Anxiety Agents,Anti-Anxiety Agents,Y,quasi syn therclass-to-disease,Anxiety,Anxiety,C0003467,P,Y,B2.2.1.1.1.1_Mental Process,,,,exact (CUI-based),Anti-Anxiety Agents,Anti-Anxiety Agents,C0040616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000238,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000239,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000240,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000241,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000242,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000243,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000244,MeSH_PA,C121465,6-methyl-2-(phenylethynyl)pyridine,219911-35-0,6-Methyl-2-(phenylethynyl)pyridine,ChemID+,exact,2-methyl-6-(phenylethynyl)pyridine,64159,219911-35-0,syn word order,6-Methyl-2-(phenylethynyl)pyridine,exact,,6-Methyl-2-(phenylethynyl)pyridine,,219911-35-0,exact,,,,6-methyl-2-(phenylethynyl)pyridine,C121465,,exact,,,,6-Methyl-2-(Phenylethynyl)Pyridine,C0909108,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Tranquilizing Agents,Tranquilizing Agents,Y,quasi syn therclass-to-function,Tranquilizing Effect,Tranquilizing Effect,C3179402,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Tranquilizing Agents,Tranquilizing Agents,C0040614,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000245,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,Y,quasi syn therclass-to-disease,Cardiac Arrhythmia,Cardiac Arrhythmia,C0003811,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,C0003195,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000246,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000247,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000248,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000249,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000250,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000251,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000252,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000253,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000254,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000255,MeSH_PA,C009820,6-methyl-2-ethyl-3-hydroxypyridine,2364-75-2,Emoxipine,ChemID+,<syn per source>,,,,,,,,Emoxipine,,2364-75-2,<syn per source>,6-Methyl-2-ethyl-3-hydroxypyridine,exact,,6-methyl-2-ethyl-3-hydroxypyridine,C009820,2364-75-2,exact,,,,6-Methyl-2-Ethyl-3-Hydroxypyridine,C0049648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Protective Agents,Radiation-Protective Agents,Y,quasi syn therclass-to-function,Radiation-Protective Effect,Radiation-Protective Effect,C3179279,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Protective Agents,Radiation-Protective Agents,C0034540,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000256,MeSH_PA,C053907,"8-cyclopentyl-1,3-dimethylxanthine",35873-49-5,"8-Cyclopentyl-1,3-dimethylxanthine",ChemID+,exact,,,,,,,,"8-Cyclopentyl-1,3-dimethylxanthine",,35873-49-5,exact,,,,"8-cyclopentyl-1,3-dimethylxanthine",C053907,35873-49-5,exact,,,,"8-Cyclopentyl-1,3-Dimethylxanthine",C0050068,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000257,MeSH_PA,C053907,"8-cyclopentyl-1,3-dimethylxanthine",35873-49-5,"8-Cyclopentyl-1,3-dimethylxanthine",ChemID+,exact,,,,,,,,"8-Cyclopentyl-1,3-dimethylxanthine",,35873-49-5,exact,,,,"8-cyclopentyl-1,3-dimethylxanthine",C053907,35873-49-5,exact,,,,"8-Cyclopentyl-1,3-Dimethylxanthine",C0050068,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000258,MeSH_PA,C053907,"8-cyclopentyl-1,3-dimethylxanthine",35873-49-5,"8-Cyclopentyl-1,3-dimethylxanthine",ChemID+,exact,,,,,,,,"8-Cyclopentyl-1,3-dimethylxanthine",,35873-49-5,exact,,,,"8-cyclopentyl-1,3-dimethylxanthine",C053907,35873-49-5,exact,,,,"8-Cyclopentyl-1,3-Dimethylxanthine",C0050068,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000259,MeSH_PA,C053907,"8-cyclopentyl-1,3-dimethylxanthine",35873-49-5,"8-Cyclopentyl-1,3-dimethylxanthine",ChemID+,exact,,,,,,,,"8-Cyclopentyl-1,3-dimethylxanthine",,35873-49-5,exact,,,,"8-cyclopentyl-1,3-dimethylxanthine",C053907,35873-49-5,exact,,,,"8-Cyclopentyl-1,3-Dimethylxanthine",C0050068,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000260,MeSH_PA,C010847,9-amino-6-chloro-2-methoxyacridine,3548-09-2,9-Amino-6-chloro-2-methoxyacridine,ChemID+,exact,,,,,,,,9-Amino-6-chloro-2-methoxyacridine,,3548-09-2,exact,,,,9-amino-6-chloro-2-methoxyacridine,C010847,3548-09-2,exact,,,,9-Amino-6-Chloro-2-Methoxyacridine,C0050195,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000261,MeSH_PA,C010847,9-amino-6-chloro-2-methoxyacridine,3548-09-2,9-Amino-6-chloro-2-methoxyacridine,ChemID+,exact,,,,,,,,9-Amino-6-chloro-2-methoxyacridine,,3548-09-2,exact,,,,9-amino-6-chloro-2-methoxyacridine,C010847,3548-09-2,exact,,,,9-Amino-6-Chloro-2-Methoxyacridine,C0050195,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000262,MeSH_PA,C010847,9-amino-6-chloro-2-methoxyacridine,3548-09-2,9-Amino-6-chloro-2-methoxyacridine,ChemID+,exact,,,,,,,,9-Amino-6-chloro-2-methoxyacridine,,3548-09-2,exact,,,,9-amino-6-chloro-2-methoxyacridine,C010847,3548-09-2,exact,,,,9-Amino-6-Chloro-2-Methoxyacridine,C0050195,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000263,MeSH_PA,C010847,9-amino-6-chloro-2-methoxyacridine,3548-09-2,9-Amino-6-chloro-2-methoxyacridine,ChemID+,exact,,,,,,,,9-Amino-6-chloro-2-methoxyacridine,,3548-09-2,exact,,,,9-amino-6-chloro-2-methoxyacridine,C010847,3548-09-2,exact,,,,9-Amino-6-Chloro-2-Methoxyacridine,C0050195,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Intercalating Agents,Intercalating Agents,Y,exact (CUI-based),Intercalating Agents,Intercalating Agents,C0021717,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000264,MeSH_PA,C010847,9-amino-6-chloro-2-methoxyacridine,3548-09-2,9-Amino-6-chloro-2-methoxyacridine,ChemID+,exact,,,,,,,,9-Amino-6-chloro-2-methoxyacridine,,3548-09-2,exact,,,,9-amino-6-chloro-2-methoxyacridine,C010847,3548-09-2,exact,,,,9-Amino-6-Chloro-2-Methoxyacridine,C0050195,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000265,ChEBI,,alpha-cyano-4-hydroxycinnamic acid,28166-41-8,alpha-Cyano-4-hydroxycinnamate,ChemID+,quasi syn acid/-ate,alpha-cyano-4-hydroxycinnamic acid,64340,28166-41-8,exact,,,,alpha-Cyano-4-hydroxycinnamate,,28166-41-8,quasi syn acid/-ate,,,,alpha-cyano-4-hydroxycinnamate,C007175,28166-41-8,quasi syn acid/-ate,alpha-cyano-4-hydroxycinnamic acid,exact,,Alpha-Cyano-4-Hydroxycinnamic Acid,C0102508,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,MALDI matrix material,MALDI matrix material,Y,quasi syn,maldi,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",C0282597,S,,B1.3.1.1_Laboratory Procedure,,,,,,,,,,,,
1_000266,MeSH_PA,C087229,diethylamine dinitric oxide adduct,92818-79-6,Diethylamine dinitric oxide adduct,ChemID+,exact,,,,,,,,Diethylamine dinitric oxide adduct,,92818-79-6,exact,,,,diethylamine dinitric oxide adduct,C087229,92818-79-6,exact,,,,Diethylamine Dinitric Oxide Adduct,C0254718,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000267,MeSH_PA,C087229,diethylamine dinitric oxide adduct,92818-79-6,Diethylamine dinitric oxide adduct,ChemID+,exact,,,,,,,,Diethylamine dinitric oxide adduct,,92818-79-6,exact,,,,diethylamine dinitric oxide adduct,C087229,92818-79-6,exact,,,,Diethylamine Dinitric Oxide Adduct,C0254718,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Nitric Oxide Donors,Nitric Oxide Donors,Y,quasi syn therclass-to-function,Nitric Oxide Metabolic Process,Nitric Oxide Metabolic Process,C1158468,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nitric Oxide Donors,Nitric Oxide Donors,C0600437,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000268,MeSH_PA,C093171,methanethiosulfonate ethylammonium,44059-82-7,Methanethiosulfonate,ChemID+,NT salt/deriv/analog/df,,,,,,,,Methanethiosulfonate,,44059-82-7,NT salt/deriv/analog/df,,,,methanethiosulfonate ethylammonium,C093171,,exact,,,,Methanethiosulfonate Ethylammonium,C0296679,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000269,MeSH_PA,C042989,n-octyl-beta-D-thioglucopyranoside,85618-21-9,N-Octyl-beta-D-thioglucopyranoside,ChemID+,exact,,,,,,,,N-Octyl-beta-D-thioglucopyranoside,,85618-21-9,exact,,,,n-octyl-beta-D-thioglucopyranoside,C042989,85618-21-9,exact,,,,N-Octyl-Beta-D-Thioglucopyranoside,C0068248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.8_Carbohydrate,,,,,#VALUE!,Detergents,Detergents,Y,exact (CUI-based),Detergents,Detergents,C0011740,P,,A1.4.1.1_Chemical Viewed Functionally,,,,,,,,,,,,
1_000270,MeSH_PA,C042989,n-octyl-beta-D-thioglucopyranoside,85618-21-9,N-Octyl-beta-D-thioglucopyranoside,ChemID+,exact,,,,,,,,N-Octyl-beta-D-thioglucopyranoside,,85618-21-9,exact,,,,n-octyl-beta-D-thioglucopyranoside,C042989,85618-21-9,exact,,,,N-Octyl-Beta-D-Thioglucopyranoside,C0068248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.8_Carbohydrate,,,,,#VALUE!,Surface-Active Agents,Surface-Active Agents,Y,exact (CUI-based),Surface-Active Agents,Surface-Active Agents,C0038888,P,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,,,,,,,
1_000271,MeSH_PA,C015516,succinyl-trialanine-4-nitroanilide,52299-14-6,Succinyl-trialanine-4-nitroanilide,ChemID+,exact,,,,,,,,Succinyl-trialanine-4-nitroanilide,,52299-14-6,exact,,,,succinyl-trialanine-4-nitroanilide,C015516,52299-14-6,exact,,,,Succinyl-Trialanine-4-Nitroanilide,C0075451,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Chromogenic Compounds,Chromogenic Compounds,Y,exact (CUI-based),Chromogenic Compounds,Chromogenic Compounds,C0008583,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000272,MeSH_PA,C015516,succinyl-trialanine-4-nitroanilide,52299-14-6,Succinyl-trialanine-4-nitroanilide,ChemID+,exact,,,,,,,,Succinyl-trialanine-4-nitroanilide,,52299-14-6,exact,,,,succinyl-trialanine-4-nitroanilide,C015516,52299-14-6,exact,,,,Succinyl-Trialanine-4-Nitroanilide,C0075451,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000273,MeSH_PA,C015516,succinyl-trialanine-4-nitroanilide,52299-14-6,Succinyl-trialanine-4-nitroanilide,ChemID+,exact,,,,,,,,Succinyl-trialanine-4-nitroanilide,,52299-14-6,exact,,,,succinyl-trialanine-4-nitroanilide,C015516,52299-14-6,exact,,,,Succinyl-Trialanine-4-Nitroanilide,C0075451,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000274,MeSH_PA,C037476,tert-butylbicyclophosphorothionate,70636-86-1,tert-Butylbicyclophosphorothionate,ChemID+,exact,,,,,,,,tert-Butylbicyclophosphorothionate,,70636-86-1,exact,,,,tert-butylbicyclophosphorothionate,C037476,70636-86-1,exact,,,,Tert-Butylbicyclophosphorothionate,C0076147,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000275,MeSH_PA,C037476,tert-butylbicyclophosphorothionate,70636-86-1,tert-Butylbicyclophosphorothionate,ChemID+,exact,,,,,,,,tert-Butylbicyclophosphorothionate,,70636-86-1,exact,,,,tert-butylbicyclophosphorothionate,C037476,70636-86-1,exact,,,,Tert-Butylbicyclophosphorothionate,C0076147,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Stimulants,Central Nervous System Stimulants,Y,quasi syn therclass-to-function,central nervous system stimulation,Central Nervous System Stimulation [Pe],C2917138,S,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Central Nervous System Stimulants,Central Nervous System Stimulants,C0002763,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000276,MeSH_PA,C037476,tert-butylbicyclophosphorothionate,70636-86-1,tert-Butylbicyclophosphorothionate,ChemID+,exact,,,,,,,,tert-Butylbicyclophosphorothionate,,70636-86-1,exact,,,,tert-butylbicyclophosphorothionate,C037476,70636-86-1,exact,,,,Tert-Butylbicyclophosphorothionate,C0076147,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Convulsants,Convulsants,Y,quasi syn therclass-to-function,Convulsant Effect,Convulsant Effect,C3179492,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Convulsants,Convulsants,C0009950,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_000277,MeSH_PA,C018788,valyl-leucyl-lysine 4-nitroanilide,63589-93-5,Valyl-leucyl-lysine 4-nitroanilide,ChemID+,exact,,,,,,,,Valyl-leucyl-lysine 4-nitroanilide,,63589-93-5,exact,,,,valyl-leucyl-lysine 4-nitroanilide,C018788,63589-93-5,exact,,,,Valyl-Leucyl-Lysine 4-Nitroanilide,C0148143,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Chromogenic Compounds,Chromogenic Compounds,Y,exact (CUI-based),Chromogenic Compounds,Chromogenic Compounds,C0008583,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000278,MeSH_PA,C018788,valyl-leucyl-lysine 4-nitroanilide,63589-93-5,Valyl-leucyl-lysine 4-nitroanilide,ChemID+,exact,,,,,,,,Valyl-leucyl-lysine 4-nitroanilide,,63589-93-5,exact,,,,valyl-leucyl-lysine 4-nitroanilide,C018788,63589-93-5,exact,,,,Valyl-Leucyl-Lysine 4-Nitroanilide,C0148143,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000279,MeSH_PA,C018788,valyl-leucyl-lysine 4-nitroanilide,63589-93-5,Valyl-leucyl-lysine 4-nitroanilide,ChemID+,exact,,,,,,,,Valyl-leucyl-lysine 4-nitroanilide,,63589-93-5,exact,,,,valyl-leucyl-lysine 4-nitroanilide,C018788,63589-93-5,exact,,,,Valyl-Leucyl-Lysine 4-Nitroanilide,C0148143,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000280,MeSH_PA,C054007,1-(9-fluorenyl)methyl chloroformate,28920-43-6,1-(9-Fluorenyl)methyl chloroformate,ChemID+,exact,,,,,,,,1-(9-Fluorenyl)methyl chloroformate,,28920-43-6,exact,,,,1-(9-fluorenyl)methyl chloroformate,C054007,28920-43-6,exact,,,,1-(9-Fluorenyl)Methyl Chloroformate,C0044226,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000281,MeSH_PA,C007606,"1,2-epoxy-3-(p-nitrophenoxy)propane",5255-75-4,"1,2-Epoxy-3-(p-nitrophenoxy)propane",ChemID+,exact,"1,2-epoxy-3-(4-nitrophenoxy)propane",508,5255-75-4,<syn per source>,"1,2-Epoxy-3-(p-Nitrophenoxy)propane",exact,,"1,2-Epoxy-3-(p-nitrophenoxy)propane",,5255-75-4,exact,,,,"1,2-epoxy-3-(p-nitrophenoxy)propane",C007606,5255-75-4,exact,,,,"1,2-Epoxy-3-(P-Nitrophenoxy)Propane",C0043858,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000282,MeSH_PA,C007606,"1,2-epoxy-3-(p-nitrophenoxy)propane",5255-75-4,"1,2-Epoxy-3-(p-nitrophenoxy)propane",ChemID+,exact,"1,2-epoxy-3-(4-nitrophenoxy)propane",508,5255-75-4,<syn per source>,"1,2-Epoxy-3-(p-Nitrophenoxy)propane",exact,,"1,2-Epoxy-3-(p-nitrophenoxy)propane",,5255-75-4,exact,,,,"1,2-epoxy-3-(p-nitrophenoxy)propane",C007606,5255-75-4,exact,,,,"1,2-Epoxy-3-(P-Nitrophenoxy)Propane",C0043858,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000283,MeSH_PA,C007606,"1,2-epoxy-3-(p-nitrophenoxy)propane",5255-75-4,"1,2-Epoxy-3-(p-nitrophenoxy)propane",ChemID+,exact,"1,2-epoxy-3-(4-nitrophenoxy)propane",508,5255-75-4,<syn per source>,"1,2-Epoxy-3-(p-Nitrophenoxy)propane",exact,,"1,2-Epoxy-3-(p-nitrophenoxy)propane",,5255-75-4,exact,,,,"1,2-epoxy-3-(p-nitrophenoxy)propane",C007606,5255-75-4,exact,,,,"1,2-Epoxy-3-(P-Nitrophenoxy)Propane",C0043858,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000284,MeSH_PA,C082313,"2-(2,3-dicarboxycyclopropyl)glycine",147782-19-2,"2-(2,3-Dicarboxycyclopropyl)glycine",ChemID+,exact,,,,,,,,"2-(2,3-Dicarboxycyclopropyl)glycine",,147782-19-2,exact,,,,"2-(2,3-dicarboxycyclopropyl)glycine",C082313,147782-19-2,exact,,,,"2-(2,3-Dicarboxycyclopropyl)Glycine",C0218405,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000285,MeSH_PA,C082313,"2-(2,3-dicarboxycyclopropyl)glycine",147782-19-2,"2-(2,3-Dicarboxycyclopropyl)glycine",ChemID+,exact,,,,,,,,"2-(2,3-Dicarboxycyclopropyl)glycine",,147782-19-2,exact,,,,"2-(2,3-dicarboxycyclopropyl)glycine",C082313,147782-19-2,exact,,,,"2-(2,3-Dicarboxycyclopropyl)Glycine",C0218405,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000286,MeSH_PA,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",1675-54-3,Bisphenol A diglycidyl ether,ChemID+,<syn per source>,,,,,,,,Bisphenol A diglycidyl ether,,1675-54-3,<syn per source>,"2,2-Bis(4-glycidyloxyphenyl)propane",exact,,"2,2-bis(4-glycidyloxyphenyl)propane",C019273,1675-54-3,exact,,,,"2,2-Bis(4-Glycidyloxyphenyl)Propane",C0045287,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000287,MeSH_PA,C019273,"2,2-bis(4-glycidyloxyphenyl)propane",1675-54-3,Bisphenol A diglycidyl ether,ChemID+,<syn per source>,,,,,,,,Bisphenol A diglycidyl ether,,1675-54-3,<syn per source>,"2,2-Bis(4-glycidyloxyphenyl)propane",exact,,"2,2-bis(4-glycidyloxyphenyl)propane",C019273,1675-54-3,exact,,,,"2,2-Bis(4-Glycidyloxyphenyl)Propane",C0045287,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000288,MeSH_PA,C030911,2-nitro-7-methoxynaphtho(2-1b)furan,75965-74-1,2-nitro-7-methoxynaphtho(2-1b)furan,ChemID+,exact,,,,,,,,2-nitro-7-methoxynaphtho(2-1b)furan,,75965-74-1,exact,,,,2-nitro-7-methoxynaphtho(2-1b)furan,C030911,75965-74-1,exact,,,,2-Nitro-7-Methoxynaphtho(2-1B)Furan,C0093504,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000289,MeSH_PA,C030911,2-nitro-7-methoxynaphtho(2-1b)furan,75965-74-1,2-nitro-7-methoxynaphtho(2-1b)furan,ChemID+,exact,,,,,,,,2-nitro-7-methoxynaphtho(2-1b)furan,,75965-74-1,exact,,,,2-nitro-7-methoxynaphtho(2-1b)furan,C030911,75965-74-1,exact,,,,2-Nitro-7-Methoxynaphtho(2-1B)Furan,C0093504,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000290,MeSH_PA,C030911,2-nitro-7-methoxynaphtho(2-1b)furan,75965-74-1,2-nitro-7-methoxynaphtho(2-1b)furan,ChemID+,exact,,,,,,,,2-nitro-7-methoxynaphtho(2-1b)furan,,75965-74-1,exact,,,,2-nitro-7-methoxynaphtho(2-1b)furan,C030911,75965-74-1,exact,,,,2-Nitro-7-Methoxynaphtho(2-1B)Furan,C0093504,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000291,MeSH_PA,C030911,2-nitro-7-methoxynaphtho(2-1b)furan,75965-74-1,2-nitro-7-methoxynaphtho(2-1b)furan,ChemID+,exact,,,,,,,,2-nitro-7-methoxynaphtho(2-1b)furan,,75965-74-1,exact,,,,2-nitro-7-methoxynaphtho(2-1b)furan,C030911,75965-74-1,exact,,,,2-Nitro-7-Methoxynaphtho(2-1B)Furan,C0093504,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000292,MeSH_PA,C003390,"3,3',4',5-tetrachlorosalicylanilide",1154-59-2,"3,3',4',5-Tetrachlorosalicylanilide",ChemID+,exact,"3,3',4',5-tetrachlorosalicylanilide",188648,1154-59-2,exact,,,,"3,3',4',5-Tetrachlorosalicylanilide",,1154-59-2,exact,,,,"3,3',4',5-tetrachlorosalicylanilide",C003390,1154-59-2,exact,,,,"3,3',4',5-Tetrachlorosalicylanilide",C0046874,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000293,MeSH_PA,C013919,5'-deoxy-5'-S-isobutylthioadenosine,35899-54-8,5'-Deoxy-5'-S-isobutylthioadenosine,ChemID+,exact,,,,,,,,5'-Deoxy-5'-S-isobutylthioadenosine,,35899-54-8,exact,,,,5'-deoxy-5'-S-isobutylthioadenosine,C013919,35899-54-8,exact,,,,5'-Deoxy-5'-S-Isobutylthioadenosine,C0048806,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000294,MeSH_PA,C013919,5'-deoxy-5'-S-isobutylthioadenosine,35899-54-8,5'-Deoxy-5'-S-isobutylthioadenosine,ChemID+,exact,,,,,,,,5'-Deoxy-5'-S-isobutylthioadenosine,,35899-54-8,exact,,,,5'-deoxy-5'-S-isobutylthioadenosine,C013919,35899-54-8,exact,,,,5'-Deoxy-5'-S-Isobutylthioadenosine,C0048806,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antimalarials,Antimalarials,Y,quasi syn therclass-to-disease,Malaria,Malaria,C0024530,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antimalarials,Antimalarials,C0003374,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000295,MeSH_PA,C013919,5'-deoxy-5'-S-isobutylthioadenosine,35899-54-8,5'-Deoxy-5'-S-isobutylthioadenosine,ChemID+,exact,,,,,,,,5'-Deoxy-5'-S-isobutylthioadenosine,,35899-54-8,exact,,,,5'-deoxy-5'-S-isobutylthioadenosine,C013919,35899-54-8,exact,,,,5'-Deoxy-5'-S-Isobutylthioadenosine,C0048806,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000296,MeSH_PA,C013919,5'-deoxy-5'-S-isobutylthioadenosine,35899-54-8,5'-Deoxy-5'-S-isobutylthioadenosine,ChemID+,exact,,,,,,,,5'-Deoxy-5'-S-isobutylthioadenosine,,35899-54-8,exact,,,,5'-deoxy-5'-S-isobutylthioadenosine,C013919,35899-54-8,exact,,,,5'-Deoxy-5'-S-Isobutylthioadenosine,C0048806,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000297,MeSH_PA,C013919,5'-deoxy-5'-S-isobutylthioadenosine,35899-54-8,5'-Deoxy-5'-S-isobutylthioadenosine,ChemID+,exact,,,,,,,,5'-Deoxy-5'-S-isobutylthioadenosine,,35899-54-8,exact,,,,5'-deoxy-5'-S-isobutylthioadenosine,C013919,35899-54-8,exact,,,,5'-Deoxy-5'-S-Isobutylthioadenosine,C0048806,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiprotozoal Agents,Antiprotozoal Agents,Y,quasi syn therclass-to-disease,Protozoan Infections,Protozoan Infections,C0033740,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiprotozoal Agents,Antiprotozoal Agents,C0003416,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000298,ChEBI,,"5-methoxy-N,N-diisopropyltryptamine",4021-34-5,"5-Methoxy-N,N-diisopropyltryptamine",ChemID+,exact,"5-methoxy-N,N-diisopropyltryptamine",48282,4021-34-5,exact,,,,"5-Methoxy-N,N-diisopropyltryptamine",,4021-34-5,exact,,,,"5-methoxy-N,N-diisopropyltryptamine",C033696,4021-34-5,exact,,,,"5-Methoxy-N,N-Diisopropyltryptamine",C0615748,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,hallucinogen,hallucinogen,Y,quasi syn therclass-to-function,Perception,Perception,C0030971,P,Y,B2.2.1.1.1.1_Mental Process,,,,exact 1,hallucinogen,Hallucinogens,C0018533,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_000299,ChEBI,,"6'',7''-dihydro-5',5'''-dicapsaicin",,,,,"6'',7''-dihydro-5',5'''-dicapsaicin",65771,,exact,,,,,,,,,,,"6'',7''-dihydro-5',5'''-dicapsaicin",C479844,,exact,,,,"6'',7''-Dihydro-5',5'''-Dicapsaicin",C1432926,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antioxidant,antioxidant,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact 1,antioxidant,Antioxidants,C0003402,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000300,MeSH_PA,C079694,alpha-methyl-4-carboxyphenylglycine,146669-29-6,alpha-Methyl-4-carboxyphenylglycine,ChemID+,exact,(S)-alpha-methyl-4-carboxyphenylglycine,43876,,BT of isomer,(+)-alpha-methyl-4-carboxyphenylglycine,BT of isomer,,alpha-Methyl-4-carboxyphenylglycine,,146669-29-6,exact,,,,alpha-methyl-4-carboxyphenylglycine,C079694,146669-29-6,exact,,,,Alpha-Methyl-4-Carboxyphenylglycine,C0213389,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000301,MeSH_PA,C079694,alpha-methyl-4-carboxyphenylglycine,146669-29-6,alpha-Methyl-4-carboxyphenylglycine,ChemID+,exact,(S)-alpha-methyl-4-carboxyphenylglycine,43876,,BT of isomer,(+)-alpha-methyl-4-carboxyphenylglycine,BT of isomer,,alpha-Methyl-4-carboxyphenylglycine,,146669-29-6,exact,,,,alpha-methyl-4-carboxyphenylglycine,C079694,146669-29-6,exact,,,,Alpha-Methyl-4-Carboxyphenylglycine,C0213389,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000302,MeSH_PA,C079694,alpha-methyl-4-carboxyphenylglycine,146669-29-6,alpha-Methyl-4-carboxyphenylglycine,ChemID+,exact,(S)-alpha-methyl-4-carboxyphenylglycine,43876,,BT of isomer,(+)-alpha-methyl-4-carboxyphenylglycine,BT of isomer,,alpha-Methyl-4-carboxyphenylglycine,,146669-29-6,exact,,,,alpha-methyl-4-carboxyphenylglycine,C079694,146669-29-6,exact,,,,Alpha-Methyl-4-Carboxyphenylglycine,C0213389,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000303,ChEBI,,alpha-methylene gamma-butyrolactone,547-65-9,alpha-Methylene butyrolactone,ChemID+,<syn per source> no\W,alpha-methylene gamma-butyrolactone,104120,547-65-9,exact,,,,alpha-Methylene butyrolactone,,547-65-9,<syn per source>,alpha-Methylene-gamma-butyrolactone,syn no\W,,alpha-methylene gamma-butyrolactone,C014096,547-65-9,exact,,,,Alpha-Methylene Gamma-Butyrolactone,C0051414,exact,,,,A1.4.1.1.3.5_Immunologic Factor,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,anti-ulcer drug,anti-ulcer drug,Y,quasi syn therclass-to-disease,Ulcer,Ulcer,C0041582,P,Y,B2.2.1.2_Pathologic Function,,,,syn plural/sing,anti-ulcer drugs,Anti-Ulcer Agent,C0003216,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000304,ChEBI,,alpha-methylene gamma-butyrolactone,547-65-9,alpha-Methylene butyrolactone,ChemID+,<syn per source> no\W,alpha-methylene gamma-butyrolactone,104120,547-65-9,exact,,,,alpha-Methylene butyrolactone,,547-65-9,<syn per source>,alpha-Methylene-gamma-butyrolactone,syn no\W,,alpha-methylene gamma-butyrolactone,C014096,547-65-9,exact,,,,Alpha-Methylene Gamma-Butyrolactone,C0051414,exact,,,,A1.4.1.1.3.5_Immunologic Factor,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,gastrointestinal drug,gastrointestinal drug,Y,quasi syn therclass-to-disease,Gastrointestinal Diseases,Gastrointestinal Diseases,C0017178,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,gastrointestinal drug,Gastrointestinal Agents,C0017173,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000305,MeSH_PA,C014096,alpha-methylene gamma-butyrolactone,547-65-9,alpha-Methylene butyrolactone,ChemID+,<syn per source> no\W,alpha-methylene gamma-butyrolactone,104120,547-65-9,exact,,,,alpha-Methylene butyrolactone,,547-65-9,<syn per source>,alpha-Methylene-gamma-butyrolactone,syn no\W,,alpha-methylene gamma-butyrolactone,C014096,547-65-9,exact,,,,Alpha-Methylene Gamma-Butyrolactone,C0051414,exact,,,,A1.4.1.1.3.5_Immunologic Factor,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Ulcer Agents,Anti-Ulcer Agents,Y,quasi syn therclass-to-disease,Ulcer,Ulcer,C0041582,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),anti-ulcer agents,Anti-Ulcer Agent,C0003216,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000306,MeSH_PA,C014096,alpha-methylene gamma-butyrolactone,547-65-9,alpha-Methylene butyrolactone,ChemID+,<syn per source> no\W,alpha-methylene gamma-butyrolactone,104120,547-65-9,exact,,,,alpha-Methylene butyrolactone,,547-65-9,<syn per source>,alpha-Methylene-gamma-butyrolactone,syn no\W,,alpha-methylene gamma-butyrolactone,C014096,547-65-9,exact,,,,Alpha-Methylene Gamma-Butyrolactone,C0051414,exact,,,,A1.4.1.1.3.5_Immunologic Factor,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Gastrointestinal Agents,Gastrointestinal Agents,Y,quasi syn therclass-to-disease,Gastrointestinal Diseases,Gastrointestinal Diseases,C0017178,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Gastrointestinal Agents,Gastrointestinal Agents,C0017173,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000307,MeSH_PA,C017272,dodecyloctaethyleneglycol monoether,3055-98-9,Dodecyloctaethyleneglycol monoether,ChemID+,exact,octaethyleneglycol monododecyl ether,41527,3055-98-9,<syn per source>,dodecyloctaethyleneglycol monoether,exact,,Dodecyloctaethyleneglycol monoether,,3055-98-9,exact,,,,dodecyloctaethyleneglycol monoether,C017272,3055-98-9,exact,,,,Dodecyloctaethyleneglycol Monoether,C0058642,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Detergents,Detergents,Y,exact (CUI-based),Detergents,Detergents,C0011740,P,,A1.4.1.1_Chemical Viewed Functionally,,,,,,,,,,,,
1_000308,MeSH_PA,C017272,dodecyloctaethyleneglycol monoether,3055-98-9,Dodecyloctaethyleneglycol monoether,ChemID+,exact,octaethyleneglycol monododecyl ether,41527,3055-98-9,<syn per source>,dodecyloctaethyleneglycol monoether,exact,,Dodecyloctaethyleneglycol monoether,,3055-98-9,exact,,,,dodecyloctaethyleneglycol monoether,C017272,3055-98-9,exact,,,,Dodecyloctaethyleneglycol Monoether,C0058642,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Surface-Active Agents,Surface-Active Agents,Y,exact (CUI-based),Surface-Active Agents,Surface-Active Agents,C0038888,P,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,,,,,,,
1_000309,MeSH_PA,C029534,hydroxysuccinimidyl-4-azidobenzoate,53053-08-0,Hydroxysuccinimidyl-4-azidobenzoate,ChemID+,exact,,,,,,,,Hydroxysuccinimidyl-4-azidobenzoate,,53053-08-0,exact,,,,hydroxysuccinimidyl-4-azidobenzoate,C029534,53053-08-0,exact,,,,Hydroxysuccinimidyl-4-Azidobenzoate,C0063196,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000310,MeSH_PA,C029534,hydroxysuccinimidyl-4-azidobenzoate,53053-08-0,Hydroxysuccinimidyl-4-azidobenzoate,ChemID+,exact,,,,,,,,Hydroxysuccinimidyl-4-azidobenzoate,,53053-08-0,exact,,,,hydroxysuccinimidyl-4-azidobenzoate,C029534,53053-08-0,exact,,,,Hydroxysuccinimidyl-4-Azidobenzoate,C0063196,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000311,MeSH_PA,C029534,hydroxysuccinimidyl-4-azidobenzoate,53053-08-0,Hydroxysuccinimidyl-4-azidobenzoate,ChemID+,exact,,,,,,,,Hydroxysuccinimidyl-4-azidobenzoate,,53053-08-0,exact,,,,hydroxysuccinimidyl-4-azidobenzoate,C029534,53053-08-0,exact,,,,Hydroxysuccinimidyl-4-Azidobenzoate,C0063196,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000312,MeSH_PA,C104810,methyl arachidonylfluorophosphonate,,,,,,,,,,,,Methyl arachidonylfluorophosphonate,,C104810000,exact,,,,methyl arachidonylfluorophosphonate,C104810,,exact,,,,Methyl Arachidonylfluorophosphonate,C0536663,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000313,MeSH_PA,C010854,N-(1-anilinonaphthalyl)-4-maleimide,50539-45-2,N-(1-Anilinonaphthalyl)-4-maleimide,ChemID+,exact,,,,,,,,N-(1-Anilinonaphthalyl)-4-maleimide,,50539-45-2,exact,,,,N-(1-anilinonaphthalyl)-4-maleimide,C010854,50539-45-2,exact,,,,N-(1-Anilinonaphthalyl)-4-Maleimide,C0067419,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000314,MeSH_PA,C047235,N-(1-methyl-2-phenylethyl)adenosine,20125-40-0,N-(1-Methyl-2-phenylethyl)adenosine,ChemID+,exact,,,,,,,,N-(1-Methyl-2-phenylethyl)adenosine,,20125-40-0,exact,,,,N-(1-methyl-2-phenylethyl)adenosine,C047235,20125-40-0,exact,,,,N-(1-Methyl-2-Phenylethyl)Adenosine,C0067427,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000315,MeSH_PA,C047235,N-(1-methyl-2-phenylethyl)adenosine,20125-40-0,N-(1-Methyl-2-phenylethyl)adenosine,ChemID+,exact,,,,,,,,N-(1-Methyl-2-phenylethyl)adenosine,,20125-40-0,exact,,,,N-(1-methyl-2-phenylethyl)adenosine,C047235,20125-40-0,exact,,,,N-(1-Methyl-2-Phenylethyl)Adenosine,C0067427,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000316,MeSH_PA,C047235,N-(1-methyl-2-phenylethyl)adenosine,20125-40-0,N-(1-Methyl-2-phenylethyl)adenosine,ChemID+,exact,,,,,,,,N-(1-Methyl-2-phenylethyl)adenosine,,20125-40-0,exact,,,,N-(1-methyl-2-phenylethyl)adenosine,C047235,20125-40-0,exact,,,,N-(1-Methyl-2-Phenylethyl)Adenosine,C0067427,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000317,MeSH_PA,C047235,N-(1-methyl-2-phenylethyl)adenosine,20125-40-0,N-(1-Methyl-2-phenylethyl)adenosine,ChemID+,exact,,,,,,,,N-(1-Methyl-2-phenylethyl)adenosine,,20125-40-0,exact,,,,N-(1-methyl-2-phenylethyl)adenosine,C047235,20125-40-0,exact,,,,N-(1-Methyl-2-Phenylethyl)Adenosine,C0067427,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000318,MeSH_PA,C047235,N-(1-methyl-2-phenylethyl)adenosine,20125-40-0,N-(1-Methyl-2-phenylethyl)adenosine,ChemID+,exact,,,,,,,,N-(1-Methyl-2-phenylethyl)adenosine,,20125-40-0,exact,,,,N-(1-methyl-2-phenylethyl)adenosine,C047235,20125-40-0,exact,,,,N-(1-Methyl-2-Phenylethyl)Adenosine,C0067427,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,causes,,#VALUE!,Vasodilator Agents,Vasodilator Agents,Y,quasi syn therclass-to-function,Vasodilation,Vasodilation,C0042401,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Vasodilator Agents,Vasodilator Agents,C0042402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000319,MeSH_PA,C066515,O-(chloroacetylcarbamoyl)fumagillol,129298-91-5,O-Chloroacetylcarbamoylfumagillol,ChemID+,<syn per source>,,,,,,,,O-Chloroacetylcarbamoylfumagillol,,129298-91-5,syn no\W,O-(Chloroacetylcarbamoyl)fumagillol,exact,,O-(chloroacetylcarbamoyl)fumagillol,C066515,129298-91-5,exact,,,,O-(Chloroacetylcarbamoyl)Fumagillol,C0081489,exact,,,,A1.4.1.1.1.1_Antibiotic,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Angiogenesis Inhibitors,Angiogenesis Inhibitors,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Inhibitors,Angiogenesis Inhibitors,C0596087,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000320,MeSH_PA,C066515,O-(chloroacetylcarbamoyl)fumagillol,129298-91-5,O-Chloroacetylcarbamoylfumagillol,ChemID+,<syn per source>,,,,,,,,O-Chloroacetylcarbamoylfumagillol,,129298-91-5,syn no\W,O-(Chloroacetylcarbamoyl)fumagillol,exact,,O-(chloroacetylcarbamoyl)fumagillol,C066515,129298-91-5,exact,,,,O-(Chloroacetylcarbamoyl)Fumagillol,C0081489,exact,,,,A1.4.1.1.1.1_Antibiotic,A1.4.1.2.1_Organic Chemical,,,modulating agent,,#VALUE!,Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,C1257849,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000321,MeSH_PA,C066515,O-(chloroacetylcarbamoyl)fumagillol,129298-91-5,O-Chloroacetylcarbamoylfumagillol,ChemID+,<syn per source>,,,,,,,,O-Chloroacetylcarbamoylfumagillol,,129298-91-5,syn no\W,O-(Chloroacetylcarbamoyl)fumagillol,exact,,O-(chloroacetylcarbamoyl)fumagillol,C066515,129298-91-5,exact,,,,O-(Chloroacetylcarbamoyl)Fumagillol,C0081489,exact,,,,A1.4.1.1.1.1_Antibiotic,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",C0003236,P,A1.4.1.1.1.1_Antibiotic,,,
1_000322,MeSH_PA,C066515,O-(chloroacetylcarbamoyl)fumagillol,129298-91-5,O-Chloroacetylcarbamoylfumagillol,ChemID+,<syn per source>,,,,,,,,O-Chloroacetylcarbamoylfumagillol,,129298-91-5,syn no\W,O-(Chloroacetylcarbamoyl)fumagillol,exact,,O-(chloroacetylcarbamoyl)fumagillol,C066515,129298-91-5,exact,,,,O-(Chloroacetylcarbamoyl)Fumagillol,C0081489,exact,,,,A1.4.1.1.1.1_Antibiotic,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000323,MeSH_PA,C066515,O-(chloroacetylcarbamoyl)fumagillol,129298-91-5,O-Chloroacetylcarbamoylfumagillol,ChemID+,<syn per source>,,,,,,,,O-Chloroacetylcarbamoylfumagillol,,129298-91-5,syn no\W,O-(Chloroacetylcarbamoyl)fumagillol,exact,,O-(chloroacetylcarbamoyl)fumagillol,C066515,129298-91-5,exact,,,,O-(Chloroacetylcarbamoyl)Fumagillol,C0081489,exact,,,,A1.4.1.1.1.1_Antibiotic,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Growth Inhibitors,Growth Inhibitors,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Inhibitors,Growth Inhibitors,C0018282,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000324,MeSH_PA,C066515,O-(chloroacetylcarbamoyl)fumagillol,129298-91-5,O-Chloroacetylcarbamoylfumagillol,ChemID+,<syn per source>,,,,,,,,O-Chloroacetylcarbamoylfumagillol,,129298-91-5,syn no\W,O-(Chloroacetylcarbamoyl)fumagillol,exact,,O-(chloroacetylcarbamoyl)fumagillol,C066515,129298-91-5,exact,,,,O-(Chloroacetylcarbamoyl)Fumagillol,C0081489,exact,,,,A1.4.1.1.1.1_Antibiotic,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000325,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000326,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000327,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000328,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000329,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000330,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Diuretics,Diuretics,Y,quasi syn therclass-to-function,Diuresis,Diuresis,C0012797,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Diuretics,Diuretics,C0012798,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000331,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Natriuretic Agents,Natriuretic Agents,Y,quasi syn therclass-to-function,Natriuresis,Natriuresis,C0027477,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Natriuretic Agents,Natriuretic Agents,C1258001,P,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,
1_000332,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000333,MeSH_PA,C013753,2-aminomethyl-4-t-butyl-6-iodophenol,58456-91-0,2-Aminomethyl-4-t-butyl-6-iodophenol,ChemID+,exact,,,,,,,,2-Aminomethyl-4-t-butyl-6-iodophenol,,58456-91-0,exact,,,,2-aminomethyl-4-t-butyl-6-iodophenol,C013753,58456-91-0,exact,,,,2-Aminomethyl-4-T-Butyl-6-Iodophenol,C0092581,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000334,MeSH_PA,C063193,alanyl-prolyl-glycyl-tryptophanamide,126675-52-3,Alanyl-prolyl-glycyl-tryptophanamide,ChemID+,exact,,,,,,,,Alanyl-prolyl-glycyl-tryptophanamide,,126675-52-3,exact,,,,alanyl-prolyl-glycyl-tryptophanamide,C063193,126675-52-3,exact,,,,Alanyl-Prolyl-Glycyl-Tryptophanamide,C0051076,exact,,,,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000335,MeSH_PA,C068301,carboxy-seminaphthorhodaminefluoride,,,,,,,,,,,,,,,,,,,carboxy-seminaphthorhodaminefluoride,C068301,,exact,,,,Carboxy-Seminaphthorhodaminefluoride,C0108443,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000336,MeSH_PA,C068301,carboxy-seminaphthorhodaminefluoride,,,,,,,,,,,,,,,,,,,carboxy-seminaphthorhodaminefluoride,C068301,,exact,,,,Carboxy-Seminaphthorhodaminefluoride,C0108443,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000337,MeSH_PA,C068301,carboxy-seminaphthorhodaminefluoride,,,,,,,,,,,,,,,,,,,carboxy-seminaphthorhodaminefluoride,C068301,,exact,,,,Carboxy-Seminaphthorhodaminefluoride,C0108443,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000338,MeSH_PA,C068301,carboxy-seminaphthorhodaminefluoride,,,,,,,,,,,,,,,,,,,carboxy-seminaphthorhodaminefluoride,C068301,,exact,,,,Carboxy-Seminaphthorhodaminefluoride,C0108443,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000339,MeSH_PA,C027606,L-glutamic acid-L-tyrosine copolymer,31325-39-0,L-Glutamic acid-L-tyrosine copolymer,ChemID+,exact,,,,,,,,L-Glutamic acid-L-tyrosine copolymer,,31325-39-0,exact,,,,L-glutamic acid-L-tyrosine copolymer,C027606,31325-39-0,exact,,,,L-Glutamic Acid-L-Tyrosine Copolymer,C0064543,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000340,MeSH_PA,C027606,L-glutamic acid-L-tyrosine copolymer,31325-39-0,L-Glutamic acid-L-tyrosine copolymer,ChemID+,exact,,,,,,,,L-Glutamic acid-L-tyrosine copolymer,,31325-39-0,exact,,,,L-glutamic acid-L-tyrosine copolymer,C027606,31325-39-0,exact,,,,L-Glutamic Acid-L-Tyrosine Copolymer,C0064543,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_000341,MeSH_PA,C046846,mefloquine-sulfadoxine-pyrimethamine,69191-18-0,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,ChemID+,<syn per source>,,,,,,,,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,,69191-18-0,BT of salt/deriv/analog/df,Mefloquine-sulfadoxine-pyrimethamine,exact,,mefloquine-sulfadoxine-pyrimethamine,C046846,69191-18-0,exact,,,,Mefloquine-Sulfadoxine-Pyrimethamine,C0208248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000342,MeSH_PA,C046846,mefloquine-sulfadoxine-pyrimethamine,69191-18-0,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,ChemID+,<syn per source>,,,,,,,,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,,69191-18-0,BT of salt/deriv/analog/df,Mefloquine-sulfadoxine-pyrimethamine,exact,,mefloquine-sulfadoxine-pyrimethamine,C046846,69191-18-0,exact,,,,Mefloquine-Sulfadoxine-Pyrimethamine,C0208248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antimalarials,Antimalarials,Y,quasi syn therclass-to-disease,Malaria,Malaria,C0024530,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antimalarials,Antimalarials,C0003374,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000343,MeSH_PA,C046846,mefloquine-sulfadoxine-pyrimethamine,69191-18-0,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,ChemID+,<syn per source>,,,,,,,,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,,69191-18-0,BT of salt/deriv/analog/df,Mefloquine-sulfadoxine-pyrimethamine,exact,,mefloquine-sulfadoxine-pyrimethamine,C046846,69191-18-0,exact,,,,Mefloquine-Sulfadoxine-Pyrimethamine,C0208248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000344,MeSH_PA,C046846,mefloquine-sulfadoxine-pyrimethamine,69191-18-0,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,ChemID+,<syn per source>,,,,,,,,Mefloquine hydrochloride mixture with pyrimethamine and sulfadoxine,,69191-18-0,BT of salt/deriv/analog/df,Mefloquine-sulfadoxine-pyrimethamine,exact,,mefloquine-sulfadoxine-pyrimethamine,C046846,69191-18-0,exact,,,,Mefloquine-Sulfadoxine-Pyrimethamine,C0208248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiprotozoal Agents,Antiprotozoal Agents,Y,quasi syn therclass-to-disease,Protozoan Infections,Protozoan Infections,C0033740,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiprotozoal Agents,Antiprotozoal Agents,C0003416,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000345,MeSH_PA,C104820,N-(3-(aminomethyl)benzyl)acetamidine,,,,,,,,,,,,N-(3-(Aminomethyl)benzyl)acetamidine,,C104820000,exact,,,,N-(3-(aminomethyl)benzyl)acetamidine,C104820,,exact,,,,N-(3-(Aminomethyl)Benzyl)Acetamidine,C0536682,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000346,MeSH_PA,C067744,N-gamma-glutamylcysteine ethyl ester,114627-30-4,N-gamma-Glutamylcysteine ethyl ester,ChemID+,exact,,,,,,,,N-gamma-Glutamylcysteine ethyl ester,,114627-30-4,exact,,,,N-gamma-glutamylcysteine ethyl ester,C067744,114627-30-4,exact,,,,N-Gamma-Glutamylcysteine Ethyl Ester,C0131126,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-HIV Agents,Anti-HIV Agents,Y,quasi syn therclass-to-disease,Hiv Infections,Hiv Infections,C0019693,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Hiv Agents,Anti-Hiv Agents,C0376565,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000347,MeSH_PA,C067744,N-gamma-glutamylcysteine ethyl ester,114627-30-4,N-gamma-Glutamylcysteine ethyl ester,ChemID+,exact,,,,,,,,N-gamma-Glutamylcysteine ethyl ester,,114627-30-4,exact,,,,N-gamma-glutamylcysteine ethyl ester,C067744,114627-30-4,exact,,,,N-Gamma-Glutamylcysteine Ethyl Ester,C0131126,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000348,MeSH_PA,C067744,N-gamma-glutamylcysteine ethyl ester,114627-30-4,N-gamma-Glutamylcysteine ethyl ester,ChemID+,exact,,,,,,,,N-gamma-Glutamylcysteine ethyl ester,,114627-30-4,exact,,,,N-gamma-glutamylcysteine ethyl ester,C067744,114627-30-4,exact,,,,N-Gamma-Glutamylcysteine Ethyl Ester,C0131126,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Retroviral Agents,Anti-Retroviral Agents,Y,quasi syn therclass-to-disease,retroviral infections,Retroviridae Infections,C0035369,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Retroviral Agents,Anti-Retroviral Agents,C0599685,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000349,MeSH_PA,C067744,N-gamma-glutamylcysteine ethyl ester,114627-30-4,N-gamma-Glutamylcysteine ethyl ester,ChemID+,exact,,,,,,,,N-gamma-Glutamylcysteine ethyl ester,,114627-30-4,exact,,,,N-gamma-glutamylcysteine ethyl ester,C067744,114627-30-4,exact,,,,N-Gamma-Glutamylcysteine Ethyl Ester,C0131126,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000350,MeSH_PA,C041262,N-methyl-D-glucamine dithiocarbamate,94161-07-6,N-methyl-D-glucamine dithiocarbamate,ChemID+,exact,,,,,,,,N-methyl-D-glucamine dithiocarbamate,,94161-07-6,exact,,,,N-methyl-D-glucamine dithiocarbamate,C041262,91840-27-6,exact,,,,N-Methyl-D-Glucamine Dithiocarbamate,C0068087,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000351,MeSH_PA,C041262,N-methyl-D-glucamine dithiocarbamate,94161-07-6,N-methyl-D-glucamine dithiocarbamate,ChemID+,exact,,,,,,,,N-methyl-D-glucamine dithiocarbamate,,94161-07-6,exact,,,,N-methyl-D-glucamine dithiocarbamate,C041262,91840-27-6,exact,,,,N-Methyl-D-Glucamine Dithiocarbamate,C0068087,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Iron Chelating Agents,Iron Chelating Agents,Y,quasi syn therclass-to-function,iron chelating activity,Iron Chelating Activity [Moa],C2757050,S,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Iron Chelating Agents,Iron Chelating Agents,C0022086,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,
1_000352,MeSH_PA,C018406,1-(3-trifluoromethylphenyl)piperazine,15532-75-9,1-(3-Trifluoromethylphenyl)piperazine,ChemID+,exact,,,,,,,,1-(3-Trifluoromethylphenyl)piperazine,,15532-75-9,exact,,,,1-(3-trifluoromethylphenyl)piperazine,C018406,15532-75-9,exact,,,,1-(3-Trifluoromethylphenyl)Piperazine,C0044180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000353,MeSH_PA,C018406,1-(3-trifluoromethylphenyl)piperazine,15532-75-9,1-(3-Trifluoromethylphenyl)piperazine,ChemID+,exact,,,,,,,,1-(3-Trifluoromethylphenyl)piperazine,,15532-75-9,exact,,,,1-(3-trifluoromethylphenyl)piperazine,C018406,15532-75-9,exact,,,,1-(3-Trifluoromethylphenyl)Piperazine,C0044180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000354,MeSH_PA,C018406,1-(3-trifluoromethylphenyl)piperazine,15532-75-9,1-(3-Trifluoromethylphenyl)piperazine,ChemID+,exact,,,,,,,,1-(3-Trifluoromethylphenyl)piperazine,,15532-75-9,exact,,,,1-(3-trifluoromethylphenyl)piperazine,C018406,15532-75-9,exact,,,,1-(3-Trifluoromethylphenyl)Piperazine,C0044180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,20,Serotonin Receptor Agonists,Serotonin Receptor Agonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),serotonin receptor agonists,Serotonin Agonists,C0162757,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000355,MeSH_PA,C023863,1-aminocyclopropane-1-carboxylic acid,22059-21-8,1-Aminocyclopropane-1-carboxylic acid,ChemID+,exact,1-aminocyclopropanecarboxylic acid,18053,22059-21-8,<syn per source>,1-aminocyclopropane-1-carboxylic acid,exact,,1-Aminocyclopropane-1-carboxylic acid,,22059-21-8,exact,,,,,,,,,,,1-Aminocyclopropane-1-Carboxylic Acid,C0044279,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000356,MeSH_PA,C023863,1-aminocyclopropane-1-carboxylic acid,22059-21-8,1-Aminocyclopropane-1-carboxylic acid,ChemID+,exact,1-aminocyclopropanecarboxylic acid,18053,22059-21-8,<syn per source>,1-aminocyclopropane-1-carboxylic acid,exact,,1-Aminocyclopropane-1-carboxylic acid,,22059-21-8,exact,,,,,,,,,,,1-Aminocyclopropane-1-Carboxylic Acid,C0044279,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000357,MeSH_PA,C023863,1-aminocyclopropane-1-carboxylic acid,22059-21-8,1-Aminocyclopropane-1-carboxylic acid,ChemID+,exact,1-aminocyclopropanecarboxylic acid,18053,22059-21-8,<syn per source>,1-aminocyclopropane-1-carboxylic acid,exact,,1-Aminocyclopropane-1-carboxylic acid,,22059-21-8,exact,,,,,,,,,,,1-Aminocyclopropane-1-Carboxylic Acid,C0044279,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000358,MeSH_PA,C000971,"2,3-dihydro-1H-imidazo(1,2-b)pyrazole",6714-29-0,"2,3-Dihydro-1H-imidazo(1,2-b)pyrazole",ChemID+,exact,,,,,,,,"2,3-Dihydro-1H-imidazo(1,2-b)pyrazole",,6714-29-0,exact,,,,"2,3-dihydro-1H-imidazo(1,2-b)pyrazole",C000971,6714-29-0,exact,,,,"2,3-Dihydro-1H-Imidazo(1,2-B)Pyrazole",C0045368,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000359,MeSH_PA,C012944,"3,3'-dipropyl-2,2'-thiadicarbocyanine",53213-94-8,"3,3'-dipropyl-2,2'-thiadicarbocyanine",ChemID+,exact,,,,,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",,53213-94-8,exact,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",C012944,53213-94-8,exact,,,,"3,3'-Dipropyl-2,2'-Thiadicarbocyanine",C0046901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000360,MeSH_PA,C012944,"3,3'-dipropyl-2,2'-thiadicarbocyanine",53213-94-8,"3,3'-dipropyl-2,2'-thiadicarbocyanine",ChemID+,exact,,,,,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",,53213-94-8,exact,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",C012944,53213-94-8,exact,,,,"3,3'-Dipropyl-2,2'-Thiadicarbocyanine",C0046901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000361,MeSH_PA,C012944,"3,3'-dipropyl-2,2'-thiadicarbocyanine",53213-94-8,"3,3'-dipropyl-2,2'-thiadicarbocyanine",ChemID+,exact,,,,,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",,53213-94-8,exact,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",C012944,53213-94-8,exact,,,,"3,3'-Dipropyl-2,2'-Thiadicarbocyanine",C0046901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000362,MeSH_PA,C012944,"3,3'-dipropyl-2,2'-thiadicarbocyanine",53213-94-8,"3,3'-dipropyl-2,2'-thiadicarbocyanine",ChemID+,exact,,,,,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",,53213-94-8,exact,,,,"3,3'-dipropyl-2,2'-thiadicarbocyanine",C012944,53213-94-8,exact,,,,"3,3'-Dipropyl-2,2'-Thiadicarbocyanine",C0046901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000363,MeSH_PA,C090665,"4,7beta-dimethyl-4-azacholestan-3-one",158493-17-5,"4,7beta-Dimethyl-4-azacholestan-3-one",ChemID+,exact,,,,,,,,"4,7beta-Dimethyl-4-azacholestan-3-one",,158493-17-5,exact,,,,"4,7beta-dimethyl-4-azacholestan-3-one",C090665,,exact,,,,"4,7Beta-Dimethyl-4-Azacholestan-3-One",C0291374,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,inhibitor,inhibits,Inhibitors,5-alpha Reductase Inhibitors,5-alpha Reductase Inhibitors,Y,quasi syn therclass-to-function,Steroid 5-Alpha Reductase Activity,Steroid 5-Alpha Reductase Activity,C2254641,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),5-Alpha Reductase Inhibitors,5-Alpha Reductase Inhibitors,C2936788,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000364,MeSH_PA,C090665,"4,7beta-dimethyl-4-azacholestan-3-one",158493-17-5,"4,7beta-Dimethyl-4-azacholestan-3-one",ChemID+,exact,,,,,,,,"4,7beta-Dimethyl-4-azacholestan-3-one",,158493-17-5,exact,,,,"4,7beta-dimethyl-4-azacholestan-3-one",C090665,,exact,,,,"4,7Beta-Dimethyl-4-Azacholestan-3-One",C0291374,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000365,MeSH_PA,C010959,5'-(4-fluorosulfonylbenzoyl)adenosine,78859-42-4,5'-(4-(Fluorosulfonyl)benzoyl)adenosine,ChemID+,syn no\W,,,,,,,,5'-(4-(Fluorosulfonyl)benzoyl)adenosine,,78859-42-4,syn no\W,,,,5'-(4-fluorosulfonylbenzoyl)adenosine,C010959,78859-42-4,exact,,,,5'-(4-Fluorosulfonylbenzoyl)Adenosine,C0676471,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000366,MeSH_PA,C010959,5'-(4-fluorosulfonylbenzoyl)adenosine,78859-42-4,5'-(4-(Fluorosulfonyl)benzoyl)adenosine,ChemID+,syn no\W,,,,,,,,5'-(4-(Fluorosulfonyl)benzoyl)adenosine,,78859-42-4,syn no\W,,,,5'-(4-fluorosulfonylbenzoyl)adenosine,C010959,78859-42-4,exact,,,,5'-(4-Fluorosulfonylbenzoyl)Adenosine,C0676471,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000367,MeSH_PA,C031349,"7-hydroxy-2-N,N-dipropylaminotetralin",74938-11-7,"7-Hydroxy-2-N,N-dipropylaminotetralin",ChemID+,exact,,,,,,,,"7-Hydroxy-2-N,N-dipropylaminotetralin",,74938-11-7,exact,,,,"7-hydroxy-2-N,N-dipropylaminotetralin",C031349,74938-11-7,exact,,,,"7-Hydroxy-2-N,N-Dipropylaminotetralin",C0049894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000368,MeSH_PA,C031349,"7-hydroxy-2-N,N-dipropylaminotetralin",74938-11-7,"7-Hydroxy-2-N,N-dipropylaminotetralin",ChemID+,exact,,,,,,,,"7-Hydroxy-2-N,N-dipropylaminotetralin",,74938-11-7,exact,,,,"7-hydroxy-2-N,N-dipropylaminotetralin",C031349,74938-11-7,exact,,,,"7-Hydroxy-2-N,N-Dipropylaminotetralin",C0049894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000369,MeSH_PA,C031349,"7-hydroxy-2-N,N-dipropylaminotetralin",74938-11-7,"7-Hydroxy-2-N,N-dipropylaminotetralin",ChemID+,exact,,,,,,,,"7-Hydroxy-2-N,N-dipropylaminotetralin",,74938-11-7,exact,,,,"7-hydroxy-2-N,N-dipropylaminotetralin",C031349,74938-11-7,exact,,,,"7-Hydroxy-2-N,N-Dipropylaminotetralin",C0049894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000370,MeSH_PA,C007061,C.I. Fluorescent Brightening Agent 28,4404-43-7,C.I. Fluorescent brightening agent 28,ChemID+,exact,"4,4'-bis(\{4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl\}amino)stilbene-2,2'-disulfonic acid",50010,4404-43-7,<syn per source>,C.I. Fluorescent brightening agent 28,exact,,C.I. Fluorescent brightening agent 28,,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C007061,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C0054393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000371,MeSH_PA,C007061,C.I. Fluorescent Brightening Agent 28,4404-43-7,C.I. Fluorescent brightening agent 28,ChemID+,exact,"4,4'-bis(\{4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl\}amino)stilbene-2,2'-disulfonic acid",50010,4404-43-7,<syn per source>,C.I. Fluorescent brightening agent 28,exact,,C.I. Fluorescent brightening agent 28,,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C007061,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C0054393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Contrast Media,Contrast Media,Y,exact (CUI-based),Contrast Media,Contrast Media,C0009924,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000372,MeSH_PA,C007061,C.I. Fluorescent Brightening Agent 28,4404-43-7,C.I. Fluorescent brightening agent 28,ChemID+,exact,"4,4'-bis(\{4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl\}amino)stilbene-2,2'-disulfonic acid",50010,4404-43-7,<syn per source>,C.I. Fluorescent brightening agent 28,exact,,C.I. Fluorescent brightening agent 28,,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C007061,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C0054393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000373,MeSH_PA,C007061,C.I. Fluorescent Brightening Agent 28,4404-43-7,C.I. Fluorescent brightening agent 28,ChemID+,exact,"4,4'-bis(\{4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl\}amino)stilbene-2,2'-disulfonic acid",50010,4404-43-7,<syn per source>,C.I. Fluorescent brightening agent 28,exact,,C.I. Fluorescent brightening agent 28,,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C007061,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C0054393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000374,MeSH_PA,C007061,C.I. Fluorescent Brightening Agent 28,4404-43-7,C.I. Fluorescent brightening agent 28,ChemID+,exact,"4,4'-bis(\{4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl\}amino)stilbene-2,2'-disulfonic acid",50010,4404-43-7,<syn per source>,C.I. Fluorescent brightening agent 28,exact,,C.I. Fluorescent brightening agent 28,,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C007061,4404-43-7,exact,,,,C.I. Fluorescent Brightening Agent 28,C0054393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000375,MeSH_PA,C089486,carbobenzoxy-leucyl-leucyl-norvalinal,,,,,,,,,,,,,,,,,,,carbobenzoxy-leucyl-leucyl-norvalinal,C089486,,exact,,,,Carbobenzoxy-Leucyl-Leucyl-Norvalinal,C0259423,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000376,MeSH_PA,C089486,carbobenzoxy-leucyl-leucyl-norvalinal,,,,,,,,,,,,,,,,,,,carbobenzoxy-leucyl-leucyl-norvalinal,C089486,,exact,,,,Carbobenzoxy-Leucyl-Leucyl-Norvalinal,C0259423,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000377,MeSH_PA,C113896,dimethoxy-4-indophenyl-2-aminopropane,,,,,,,,,,,,,,,,,,,dimethoxy-4-indophenyl-2-aminopropane,C113896,,exact,,,,Dimethoxy-4-Indophenyl-2-Aminopropane,C0756237,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000378,MeSH_PA,C113896,dimethoxy-4-indophenyl-2-aminopropane,,,,,,,,,,,,,,,,,,,dimethoxy-4-indophenyl-2-aminopropane,C113896,,exact,,,,Dimethoxy-4-Indophenyl-2-Aminopropane,C0756237,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000379,MeSH_PA,C113896,dimethoxy-4-indophenyl-2-aminopropane,,,,,,,,,,,,,,,,,,,dimethoxy-4-indophenyl-2-aminopropane,C113896,,exact,,,,Dimethoxy-4-Indophenyl-2-Aminopropane,C0756237,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,20,Serotonin Receptor Agonists,Serotonin Receptor Agonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),serotonin receptor agonists,Serotonin Agonists,C0162757,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000380,MeSH_PA,C049554,glycyl-arginyl-glycyl-aspartyl-serine,96426-21-0,Glycyl-arginyl-glycyl-aspartyl-serine,ChemID+,exact,,,,,,,,Glycyl-arginyl-glycyl-aspartyl-serine,,96426-21-0,exact,,,,glycyl-arginyl-glycyl-aspartyl-serine,C049554,96426-21-0,exact,,,,Glycyl-Arginyl-Glycyl-Aspartyl-Serine,C0061708,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000381,MeSH_PA,C049554,glycyl-arginyl-glycyl-aspartyl-serine,96426-21-0,Glycyl-arginyl-glycyl-aspartyl-serine,ChemID+,exact,,,,,,,,Glycyl-arginyl-glycyl-aspartyl-serine,,96426-21-0,exact,,,,glycyl-arginyl-glycyl-aspartyl-serine,C049554,96426-21-0,exact,,,,Glycyl-Arginyl-Glycyl-Aspartyl-Serine,C0061708,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000382,MeSH_PA,C049554,glycyl-arginyl-glycyl-aspartyl-serine,96426-21-0,Glycyl-arginyl-glycyl-aspartyl-serine,ChemID+,exact,,,,,,,,Glycyl-arginyl-glycyl-aspartyl-serine,,96426-21-0,exact,,,,glycyl-arginyl-glycyl-aspartyl-serine,C049554,96426-21-0,exact,,,,Glycyl-Arginyl-Glycyl-Aspartyl-Serine,C0061708,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000383,MeSH_PA,C109153,(2-sulfonatoethyl)methanethiosulfonate,155450-07-0,(2-sulfonatoethyl)methanethiosulfonate,CTD,exact,,,,,,,,,,,,,,,(2-sulfonatoethyl)methanethiosulfonate,C109153,155450-07-0,exact,,,,(2-Sulfonatoethyl)Methanethiosulfonate,C0668026,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000384,MeSH_PA,C109153,(2-sulfonatoethyl)methanethiosulfonate,155450-07-0,(2-sulfonatoethyl)methanethiosulfonate,CTD,exact,,,,,,,,,,,,,,,(2-sulfonatoethyl)methanethiosulfonate,C109153,155450-07-0,exact,,,,(2-Sulfonatoethyl)Methanethiosulfonate,C0668026,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sulfhydryl Reagents,Sulfhydryl Reagents,Y,exact (CUI-based),Sulfhydryl Reagents,Sulfhydryl Reagents,C0038738,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000385,MeSH_PA,C086335,"(5,6-dimethoxyindan-2-yl)dipropylamine",83598-46-3,"(5,6-dimethoxyindan-2-yl)dipropylamine",ChemID+,exact,,,,,,,,"(5,6-dimethoxyindan-2-yl)dipropylamine",,83598-46-3,exact,,,,"(5,6-dimethoxyindan-2-yl)dipropylamine",C086335,153570-58-2,exact,,,,"(5,6-Dimethoxyindan-2-Yl)Dipropylamine",C0753884,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000386,MeSH_PA,C086335,"(5,6-dimethoxyindan-2-yl)dipropylamine",83598-46-3,"(5,6-dimethoxyindan-2-yl)dipropylamine",ChemID+,exact,,,,,,,,"(5,6-dimethoxyindan-2-yl)dipropylamine",,83598-46-3,exact,,,,"(5,6-dimethoxyindan-2-yl)dipropylamine",C086335,153570-58-2,exact,,,,"(5,6-Dimethoxyindan-2-Yl)Dipropylamine",C0753884,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000387,MeSH_PA,C086335,"(5,6-dimethoxyindan-2-yl)dipropylamine",83598-46-3,"(5,6-dimethoxyindan-2-yl)dipropylamine",ChemID+,exact,,,,,,,,"(5,6-dimethoxyindan-2-yl)dipropylamine",,83598-46-3,exact,,,,"(5,6-dimethoxyindan-2-yl)dipropylamine",C086335,153570-58-2,exact,,,,"(5,6-Dimethoxyindan-2-Yl)Dipropylamine",C0753884,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000388,MeSH_PA,C037357,"1-(1-glycero)dodeca-1,3,5,7,9-pentaene",84000-59-9,"1-(1-glycero)Dodeca-1,3,5,7,9-pentaene",ChemID+,exact,,,,,,,,"1-(1-glycero)Dodeca-1,3,5,7,9-pentaene",,84000-59-9,exact,,,,"1-(1-glycero)dodeca-1,3,5,7,9-pentaene",C037357,84000-59-9,exact,,,,"1-(1-Glycero)Dodeca-1,3,5,7,9-Pentaene",C0044093,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000389,MeSH_PA,C037357,"1-(1-glycero)dodeca-1,3,5,7,9-pentaene",84000-59-9,"1-(1-glycero)Dodeca-1,3,5,7,9-pentaene",ChemID+,exact,,,,,,,,"1-(1-glycero)Dodeca-1,3,5,7,9-pentaene",,84000-59-9,exact,,,,"1-(1-glycero)dodeca-1,3,5,7,9-pentaene",C037357,84000-59-9,exact,,,,"1-(1-Glycero)Dodeca-1,3,5,7,9-Pentaene",C0044093,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000390,MeSH_PA,C053896,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",89073-57-4,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",,89073-57-4,exact,,,,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",C053896,89073-57-4,exact,,,,"1,3-Dipropyl-8-(4-Sulfophenyl)Xanthine",C0043960,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000391,MeSH_PA,C053896,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",89073-57-4,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",,89073-57-4,exact,,,,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",C053896,89073-57-4,exact,,,,"1,3-Dipropyl-8-(4-Sulfophenyl)Xanthine",C0043960,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000392,MeSH_PA,C053896,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",89073-57-4,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",,89073-57-4,exact,,,,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",C053896,89073-57-4,exact,,,,"1,3-Dipropyl-8-(4-Sulfophenyl)Xanthine",C0043960,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000393,MeSH_PA,C053896,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",89073-57-4,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(4-sulfophenyl)xanthine",,89073-57-4,exact,,,,"1,3-dipropyl-8-(4-sulfophenyl)xanthine",C053896,89073-57-4,exact,,,,"1,3-Dipropyl-8-(4-Sulfophenyl)Xanthine",C0043960,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000394,MeSH_PA,C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",950-99-2,Chromanol,ChemID+,<syn per source>,,,,,,,,Chromanol,,950-99-2,<syn per source>,"2,2,5,7,8-Pentamethyl-1-hydroxychroman",exact,,"2,2,5,7,8-pentamethyl-1-hydroxychroman",C029141,950-99-2,exact,,,,"2,2,5,7,8-Pentamethyl-1-Hydroxychroman",C0045280,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000395,MeSH_PA,C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",950-99-2,Chromanol,ChemID+,<syn per source>,,,,,,,,Chromanol,,950-99-2,<syn per source>,"2,2,5,7,8-Pentamethyl-1-hydroxychroman",exact,,"2,2,5,7,8-pentamethyl-1-hydroxychroman",C029141,950-99-2,exact,,,,"2,2,5,7,8-Pentamethyl-1-Hydroxychroman",C0045280,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000396,MeSH_PA,C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",76543-15-2,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",,76543-15-2,exact,,,,"2,3-bis(3'-hydroxybenzyl)butyrolactone",C029497,76543-15-2,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butyrolactone",C0045341,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,,,causes,,#VALUE!,Estrogens,Estrogens,Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),Estrogens,Estrogens,C0014939,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1.9.1_Steroid,
1_000397,MeSH_PA,C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",76543-15-2,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",,76543-15-2,exact,,,,"2,3-bis(3'-hydroxybenzyl)butyrolactone",C029497,76543-15-2,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butyrolactone",C0045341,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,,,causes,,#VALUE!,"Estrogens, Non-Steroidal","Estrogens, Non-Steroidal",Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),"Estrogens, Non-Steroidal","Estrogens, Non-Steroidal",C0014940,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1_Organic Chemical,
1_000398,MeSH_PA,C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",76543-15-2,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",,76543-15-2,exact,,,,"2,3-bis(3'-hydroxybenzyl)butyrolactone",C029497,76543-15-2,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butyrolactone",C0045341,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,,,,,#VALUE!,Hormones,Hormones,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormones,Hormones,C0019932,P,A1.4.1.1.3.2_Hormone,,,
1_000399,MeSH_PA,C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",76543-15-2,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",,76543-15-2,exact,,,,"2,3-bis(3'-hydroxybenzyl)butyrolactone",C029497,76543-15-2,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butyrolactone",C0045341,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000400,MeSH_PA,C029497,"2,3-bis(3'-hydroxybenzyl)butyrolactone",76543-15-2,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butyrolactone",,76543-15-2,exact,,,,"2,3-bis(3'-hydroxybenzyl)butyrolactone",C029497,76543-15-2,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butyrolactone",C0045341,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,,,causes,,#VALUE!,Phytoestrogens,Phytoestrogens,Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),Phytoestrogens,Phytoestrogens,C0071011,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1.9.1_Steroid,
1_000401,MeSH_PA,C050147,"3-(2,2,2-trimethylhydrazine)propionate",76144-81-5,Meldonium,ChemID+,<syn per source>,,,,,,,,Meldonium,Meldonium [INN],76144-81-5,<syn per source>,"3-(2,2,2-trimethylhydrazine)propionate",exact,,"3-(2,2,2-trimethylhydrazine)propionate",C050147,76144-81-5,exact,,,,"3-(2,2,2-Trimethylhydrazine)Propionate",C0047115,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,adjuvant,adju,1,"Adjuvants, Immunologic","Adjuvants, Immunologic",Y,quasi syn therclass-to-function,Active Immunity,Active Immunity,C0020965,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),"adjuvants, immunologic",Immunologic Adjuvants,C0001551,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_000402,MeSH_PA,C050147,"3-(2,2,2-trimethylhydrazine)propionate",76144-81-5,Meldonium,ChemID+,<syn per source>,,,,,,,,Meldonium,Meldonium [INN],76144-81-5,<syn per source>,"3-(2,2,2-trimethylhydrazine)propionate",exact,,"3-(2,2,2-trimethylhydrazine)propionate",C050147,76144-81-5,exact,,,,"3-(2,2,2-Trimethylhydrazine)Propionate",C0047115,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000403,MeSH_PA,C050147,"3-(2,2,2-trimethylhydrazine)propionate",76144-81-5,Meldonium,ChemID+,<syn per source>,,,,,,,,Meldonium,Meldonium [INN],76144-81-5,<syn per source>,"3-(2,2,2-trimethylhydrazine)propionate",exact,,"3-(2,2,2-trimethylhydrazine)propionate",C050147,76144-81-5,exact,,,,"3-(2,2,2-Trimethylhydrazine)Propionate",C0047115,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000404,MeSH_PA,C088936,"3-(2,4-dimethoxybenzylidene)anabaseine",156223-05-1,"3-(2,4-dimethoxybenzylidene)anabaseine",ChemID+,exact,,,,,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",,156223-05-1,exact,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",C088936,156223-05-1,exact,,,,"3-(2,4-Dimethoxybenzylidene)Anabaseine",C0258258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000405,MeSH_PA,C088936,"3-(2,4-dimethoxybenzylidene)anabaseine",156223-05-1,"3-(2,4-dimethoxybenzylidene)anabaseine",ChemID+,exact,,,,,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",,156223-05-1,exact,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",C088936,156223-05-1,exact,,,,"3-(2,4-Dimethoxybenzylidene)Anabaseine",C0258258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,13,Cholinergic Agonists,Cholinergic Agonists,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agonists,Cholinergic Agonists,C0242894,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000406,MeSH_PA,C088936,"3-(2,4-dimethoxybenzylidene)anabaseine",156223-05-1,"3-(2,4-dimethoxybenzylidene)anabaseine",ChemID+,exact,,,,,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",,156223-05-1,exact,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",C088936,156223-05-1,exact,,,,"3-(2,4-Dimethoxybenzylidene)Anabaseine",C0258258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000407,MeSH_PA,C088936,"3-(2,4-dimethoxybenzylidene)anabaseine",156223-05-1,"3-(2,4-dimethoxybenzylidene)anabaseine",ChemID+,exact,,,,,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",,156223-05-1,exact,,,,"3-(2,4-dimethoxybenzylidene)anabaseine",C088936,156223-05-1,exact,,,,"3-(2,4-Dimethoxybenzylidene)Anabaseine",C0258258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,11,Nicotinic Agonists,Nicotinic Agonists,Y,quasi syn therclass-to-function,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,C1148665,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nicotinic Agonists,Nicotinic Agonists,C0242948,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000408,MeSH_PA,C026845,4-methylumbelliferyl-galactopyranoside,6160-78-7,4-Methylumbelliferyl-galactopyranoside,ChemID+,exact,,,,,,,,4-Methylumbelliferyl-galactopyranoside,,6160-78-7,exact,,,,4-methylumbelliferyl-galactopyranoside,C026845,6160-78-7,exact,,,,4-Methylumbelliferyl-Galactopyranoside,C0048528,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000409,MeSH_PA,C026845,4-methylumbelliferyl-galactopyranoside,6160-78-7,4-Methylumbelliferyl-galactopyranoside,ChemID+,exact,,,,,,,,4-Methylumbelliferyl-galactopyranoside,,6160-78-7,exact,,,,4-methylumbelliferyl-galactopyranoside,C026845,6160-78-7,exact,,,,4-Methylumbelliferyl-Galactopyranoside,C0048528,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000410,MeSH_PA,C026845,4-methylumbelliferyl-galactopyranoside,6160-78-7,4-Methylumbelliferyl-galactopyranoside,ChemID+,exact,,,,,,,,4-Methylumbelliferyl-galactopyranoside,,6160-78-7,exact,,,,4-methylumbelliferyl-galactopyranoside,C026845,6160-78-7,exact,,,,4-Methylumbelliferyl-Galactopyranoside,C0048528,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000411,MeSH_PA,C026845,4-methylumbelliferyl-galactopyranoside,6160-78-7,4-Methylumbelliferyl-galactopyranoside,ChemID+,exact,,,,,,,,4-Methylumbelliferyl-galactopyranoside,,6160-78-7,exact,,,,4-methylumbelliferyl-galactopyranoside,C026845,6160-78-7,exact,,,,4-Methylumbelliferyl-Galactopyranoside,C0048528,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000412,MeSH_PA,C048350,5-(4-acetamidophenyl)pyrazin-2(1H)-one,89541-55-9,5-(4-Acetamidophenyl)pyrazin-2(1H)-one,ChemID+,exact,,,,,,,,5-(4-Acetamidophenyl)pyrazin-2(1H)-one,,89541-55-9,exact,,,,5-(4-acetamidophenyl)pyrazin-2(1H)-one,C048350,89541-55-9,exact,,,,5-(4-Acetamidophenyl)Pyrazin-2(1H)-One,C0098037,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,tonic,,#VALUE!,Cardiotonic Agents,Cardiotonic Agents,Y,quasi syn therclass-to-disease,Heart Diseases,Heart Diseases,C0018799,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiotonic Agents,Cardiotonic Agents,C0007209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000413,MeSH_PA,C048350,5-(4-acetamidophenyl)pyrazin-2(1H)-one,89541-55-9,5-(4-Acetamidophenyl)pyrazin-2(1H)-one,ChemID+,exact,,,,,,,,5-(4-Acetamidophenyl)pyrazin-2(1H)-one,,89541-55-9,exact,,,,5-(4-acetamidophenyl)pyrazin-2(1H)-one,C048350,89541-55-9,exact,,,,5-(4-Acetamidophenyl)Pyrazin-2(1H)-One,C0098037,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000414,MeSH_PA,C048350,5-(4-acetamidophenyl)pyrazin-2(1H)-one,89541-55-9,5-(4-Acetamidophenyl)pyrazin-2(1H)-one,ChemID+,exact,,,,,,,,5-(4-Acetamidophenyl)pyrazin-2(1H)-one,,89541-55-9,exact,,,,5-(4-acetamidophenyl)pyrazin-2(1H)-one,C048350,89541-55-9,exact,,,,5-(4-Acetamidophenyl)Pyrazin-2(1H)-One,C0098037,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000415,MeSH_PA,C011421,5-chloro-2-methyl-4-isothiazolin-3-one,26172-55-4,5-Chloro-2-methyl-4-isothiazolin-3-one,ChemID+,exact,chloromethylisothiazolinone,53621,26172-55-4,<syn per source>,5-Chloro-2-methyl-4-isothiazolin-3-one,exact,,5-Chloro-2-methyl-4-isothiazolin-3-one,,26172-55-4,exact,,,,5-chloro-2-methyl-4-isothiazolin-3-one,C011421,26172-55-4,exact,,,,5-Chloro-2-Methyl-4-Isothiazolin-3-One,C0049104,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000416,MeSH_PA,C011421,5-chloro-2-methyl-4-isothiazolin-3-one,26172-55-4,5-Chloro-2-methyl-4-isothiazolin-3-one,ChemID+,exact,chloromethylisothiazolinone,53621,26172-55-4,<syn per source>,5-Chloro-2-methyl-4-isothiazolin-3-one,exact,,5-Chloro-2-methyl-4-isothiazolin-3-one,,26172-55-4,exact,,,,5-chloro-2-methyl-4-isothiazolin-3-one,C011421,26172-55-4,exact,,,,5-Chloro-2-Methyl-4-Isothiazolin-3-One,C0049104,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,dis,,#VALUE!,Disinfectants,Disinfectants,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Disinfectants,Disinfectants,C0012682,P,A1.4_Substance,,,
1_000417,MeSH_PA,C052335,6-methoxy-N-(3-sulfopropyl)quinolinium,83907-40-8,6-Methoxy-N-(3-sulfopropyl)quinolinium,ChemID+,exact,,,,,,,,6-Methoxy-N-(3-sulfopropyl)quinolinium,,83907-40-8,exact,,,,6-methoxy-N-(3-sulfopropyl)quinolinium,C052335,83907-40-8,exact,,,,6-Methoxy-N-(3-Sulfopropyl)Quinolinium,C0049643,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000418,MeSH_PA,C052335,6-methoxy-N-(3-sulfopropyl)quinolinium,83907-40-8,6-Methoxy-N-(3-sulfopropyl)quinolinium,ChemID+,exact,,,,,,,,6-Methoxy-N-(3-sulfopropyl)quinolinium,,83907-40-8,exact,,,,6-methoxy-N-(3-sulfopropyl)quinolinium,C052335,83907-40-8,exact,,,,6-Methoxy-N-(3-Sulfopropyl)Quinolinium,C0049643,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000419,MeSH_PA,C052335,6-methoxy-N-(3-sulfopropyl)quinolinium,83907-40-8,6-Methoxy-N-(3-sulfopropyl)quinolinium,ChemID+,exact,,,,,,,,6-Methoxy-N-(3-sulfopropyl)quinolinium,,83907-40-8,exact,,,,6-methoxy-N-(3-sulfopropyl)quinolinium,C052335,83907-40-8,exact,,,,6-Methoxy-N-(3-Sulfopropyl)Quinolinium,C0049643,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000420,MeSH_PA,C052335,6-methoxy-N-(3-sulfopropyl)quinolinium,83907-40-8,6-Methoxy-N-(3-sulfopropyl)quinolinium,ChemID+,exact,,,,,,,,6-Methoxy-N-(3-sulfopropyl)quinolinium,,83907-40-8,exact,,,,6-methoxy-N-(3-sulfopropyl)quinolinium,C052335,83907-40-8,exact,,,,6-Methoxy-N-(3-Sulfopropyl)Quinolinium,C0049643,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000421,ChEBI,,6-O-methyl-2-deprenylrheediaxanthone B,,,,,6-O-methyl-2-deprenylrheediaxanthone B,66366,,exact,,,,,,,,,,,6-O-methyl-2-deprenylrheediaxanthone B,C486261,,exact,,,,6-O-Methyl-2-Deprenylrheediaxanthone B,C1451927,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antioxidant,antioxidant,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact 1,antioxidant,Antioxidants,C0003402,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000422,MeSH_PA,C048886,"7,8-(methylenedioxy)-14-hydroxyberbane",104786-63-2,"7,8-(methylenedioxy)-14-hydroxyberbane",ChemID+,exact,,,,,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",,104786-63-2,exact,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",C048886,104786-63-2,exact,,,,"7,8-(Methylenedioxy)-14-Hydroxyberbane",C0099550,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Adrenergic Agents,Adrenergic Agents,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Agents,Adrenergic Agents,C0001637,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000423,MeSH_PA,C048886,"7,8-(methylenedioxy)-14-hydroxyberbane",104786-63-2,"7,8-(methylenedioxy)-14-hydroxyberbane",ChemID+,exact,,,,,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",,104786-63-2,exact,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",C048886,104786-63-2,exact,,,,"7,8-(Methylenedioxy)-14-Hydroxyberbane",C0099550,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adrenergic alpha-Antagonists,Adrenergic alpha-Antagonists,Y,quasi syn therclass-to-function,Alpha-Adrenergic Receptor Function,Alpha-Adrenergic Receptor Function,C0544651,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Alpha-Antagonists,Adrenergic Alpha-Antagonists,C0001641,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000424,MeSH_PA,C048886,"7,8-(methylenedioxy)-14-hydroxyberbane",104786-63-2,"7,8-(methylenedioxy)-14-hydroxyberbane",ChemID+,exact,,,,,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",,104786-63-2,exact,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",C048886,104786-63-2,exact,,,,"7,8-(Methylenedioxy)-14-Hydroxyberbane",C0099550,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adrenergic Antagonists,Adrenergic Antagonists,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Antagonists,Adrenergic Antagonists,C0242889,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000425,MeSH_PA,C048886,"7,8-(methylenedioxy)-14-hydroxyberbane",104786-63-2,"7,8-(methylenedioxy)-14-hydroxyberbane",ChemID+,exact,,,,,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",,104786-63-2,exact,,,,"7,8-(methylenedioxy)-14-hydroxyberbane",C048886,104786-63-2,exact,,,,"7,8-(Methylenedioxy)-14-Hydroxyberbane",C0099550,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000426,MeSH_PA,D017371,8-Hydroxy-2-(di-n-propylamino)tetralin,78950-78-4,8-Hydroxy-2-(di-n-propylamino)tetralin,ChemID+,exact,8-OH-DPAT,73364,78950-78-4,<syn per source>,8-Hydroxy-2-(di-n-propylamino)tetralin,exact,,8-Hydroxy-2-(di-n-propylamino)tetralin,,78950-78-4,exact,,,,8-Hydroxy-2-(di-n-propylamino)tetralin,D017371,78950-78-4,exact,,,,8-Hydroxy-2-(Di-N-Propylamino)Tetralin,C0050079,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000427,MeSH_PA,D017371,8-Hydroxy-2-(di-n-propylamino)tetralin,78950-78-4,8-Hydroxy-2-(di-n-propylamino)tetralin,ChemID+,exact,8-OH-DPAT,73364,78950-78-4,<syn per source>,8-Hydroxy-2-(di-n-propylamino)tetralin,exact,,8-Hydroxy-2-(di-n-propylamino)tetralin,,78950-78-4,exact,,,,8-Hydroxy-2-(di-n-propylamino)tetralin,D017371,78950-78-4,exact,,,,8-Hydroxy-2-(Di-N-Propylamino)Tetralin,C0050079,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000428,MeSH_PA,D017371,8-Hydroxy-2-(di-n-propylamino)tetralin,78950-78-4,8-Hydroxy-2-(di-n-propylamino)tetralin,ChemID+,exact,8-OH-DPAT,73364,78950-78-4,<syn per source>,8-Hydroxy-2-(di-n-propylamino)tetralin,exact,,8-Hydroxy-2-(di-n-propylamino)tetralin,,78950-78-4,exact,,,,8-Hydroxy-2-(di-n-propylamino)tetralin,D017371,78950-78-4,exact,,,,8-Hydroxy-2-(Di-N-Propylamino)Tetralin,C0050079,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,20,Serotonin Receptor Agonists,Serotonin Receptor Agonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),serotonin receptor agonists,Serotonin Agonists,C0162757,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000429,MeSH_PA,C066061,acetylphenylalanyl-prolyl-boroarginine,130982-43-3,Acetylphenylalanyl-prolyl-boroarginine,ChemID+,exact,,,,,,,,Acetylphenylalanyl-prolyl-boroarginine,,130982-43-3,exact,,,,acetylphenylalanyl-prolyl-boroarginine,C066061,130982-43-3,exact,,,,Acetylphenylalanyl-Prolyl-Boroarginine,C0101197,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000430,MeSH_PA,C066061,acetylphenylalanyl-prolyl-boroarginine,130982-43-3,Acetylphenylalanyl-prolyl-boroarginine,ChemID+,exact,,,,,,,,Acetylphenylalanyl-prolyl-boroarginine,,130982-43-3,exact,,,,acetylphenylalanyl-prolyl-boroarginine,C066061,130982-43-3,exact,,,,Acetylphenylalanyl-Prolyl-Boroarginine,C0101197,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulating,,#VALUE!,Fibrin Modulating Agents,Fibrin Modulating Agents,Y,quasi syn therclass-to-disease,Fibrin Deposition,Fibrin Deposition,C0333565,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Fibrin Modulating Agents,Fibrin Modulating Agents,C1563784,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000431,MeSH_PA,C066061,acetylphenylalanyl-prolyl-boroarginine,130982-43-3,Acetylphenylalanyl-prolyl-boroarginine,ChemID+,exact,,,,,,,,Acetylphenylalanyl-prolyl-boroarginine,,130982-43-3,exact,,,,acetylphenylalanyl-prolyl-boroarginine,C066061,130982-43-3,exact,,,,Acetylphenylalanyl-Prolyl-Boroarginine,C0101197,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Fibrinolytic Agents,Fibrinolytic Agents,Y,quasi syn therclass-to-function,Fibrinolysis,Fibrinolysis,C0016017,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Fibrinolytic Agents,Fibrinolytic Agents,C0016018,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000432,MeSH_PA,C066061,acetylphenylalanyl-prolyl-boroarginine,130982-43-3,Acetylphenylalanyl-prolyl-boroarginine,ChemID+,exact,,,,,,,,Acetylphenylalanyl-prolyl-boroarginine,,130982-43-3,exact,,,,acetylphenylalanyl-prolyl-boroarginine,C066061,130982-43-3,exact,,,,Acetylphenylalanyl-Prolyl-Boroarginine,C0101197,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000433,MeSH_PA,C066061,acetylphenylalanyl-prolyl-boroarginine,130982-43-3,Acetylphenylalanyl-prolyl-boroarginine,ChemID+,exact,,,,,,,,Acetylphenylalanyl-prolyl-boroarginine,,130982-43-3,exact,,,,acetylphenylalanyl-prolyl-boroarginine,C066061,130982-43-3,exact,,,,Acetylphenylalanyl-Prolyl-Boroarginine,C0101197,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000434,MeSH_PA,D005405,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",64854-64-4,FK 33-824,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,FK 33-824,,64854-64-4,BT of salt/deriv/analog/df + <syn per source>,"(D-Ala2,MePhe4,Met5(O))enkephalinol",BT of salt/deriv/analog/df,,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",D005405,64854-64-4,exact,,,,"D-Ala(2),Mephe(4),Met(0)-Ol-Enkephalin",C0949300,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000435,MeSH_PA,D005405,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",64854-64-4,FK 33-824,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,FK 33-824,,64854-64-4,BT of salt/deriv/analog/df + <syn per source>,"(D-Ala2,MePhe4,Met5(O))enkephalinol",BT of salt/deriv/analog/df,,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",D005405,64854-64-4,exact,,,,"D-Ala(2),Mephe(4),Met(0)-Ol-Enkephalin",C0949300,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000436,MeSH_PA,D005405,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",64854-64-4,FK 33-824,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,FK 33-824,,64854-64-4,BT of salt/deriv/analog/df + <syn per source>,"(D-Ala2,MePhe4,Met5(O))enkephalinol",BT of salt/deriv/analog/df,,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",D005405,64854-64-4,exact,,,,"D-Ala(2),Mephe(4),Met(0)-Ol-Enkephalin",C0949300,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000437,MeSH_PA,D005405,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",64854-64-4,FK 33-824,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,FK 33-824,,64854-64-4,BT of salt/deriv/analog/df + <syn per source>,"(D-Ala2,MePhe4,Met5(O))enkephalinol",BT of salt/deriv/analog/df,,"D-Ala(2),MePhe(4),Met(0)-ol-enkephalin",D005405,64854-64-4,exact,,,,"D-Ala(2),Mephe(4),Met(0)-Ol-Enkephalin",C0949300,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000438,MeSH_PA,C031838,N-(deoxyguanosin-8-yl)-2-aminofluorene,73051-69-1,N-(Deoxyguanosin-8-yl)-2-aminofluorene,ChemID+,exact,N-(deoxyguanosin-8-yl)-2-aminofluorene,75814,73051-69-1,exact,,,,N-(Deoxyguanosin-8-yl)-2-aminofluorene,,73051-69-1,exact,,,,N-(deoxyguanosin-8-yl)-2-aminofluorene,C031838,73051-69-1,exact,,,,N-(Deoxyguanosin-8-Yl)-2-Aminofluorene,C0067578,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000439,MeSH_PA,C031838,N-(deoxyguanosin-8-yl)-2-aminofluorene,73051-69-1,N-(Deoxyguanosin-8-yl)-2-aminofluorene,ChemID+,exact,N-(deoxyguanosin-8-yl)-2-aminofluorene,75814,73051-69-1,exact,,,,N-(Deoxyguanosin-8-yl)-2-aminofluorene,,73051-69-1,exact,,,,N-(deoxyguanosin-8-yl)-2-aminofluorene,C031838,73051-69-1,exact,,,,N-(Deoxyguanosin-8-Yl)-2-Aminofluorene,C0067578,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000440,MeSH_PA,C079148,(3-aminopropyl)(n-butyl)phosphinic acid,123690-78-8,(3-aminopropyl)(n-butyl)phosphinic acid,ChemID+,exact,,,,,,,,(3-aminopropyl)(n-butyl)phosphinic acid,,123690-78-8,exact,,,,(3-aminopropyl)(n-butyl)phosphinic acid,C079148,145537-81-1,exact,,,,(3-Aminopropyl)(N-Butyl)Phosphinic Acid,C0212361,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000441,MeSH_PA,C079148,(3-aminopropyl)(n-butyl)phosphinic acid,123690-78-8,(3-aminopropyl)(n-butyl)phosphinic acid,ChemID+,exact,,,,,,,,(3-aminopropyl)(n-butyl)phosphinic acid,,123690-78-8,exact,,,,(3-aminopropyl)(n-butyl)phosphinic acid,C079148,145537-81-1,exact,,,,(3-Aminopropyl)(N-Butyl)Phosphinic Acid,C0212361,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,,#VALUE!,GABA Agents,GABA Agents,Y,quasi syn therclass-to-function,"Synaptic Transmission, Gabaergic","Synaptic Transmission, Gabaergic",C1816494,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Gaba Agents,Gaba Agents,C0242898,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000442,MeSH_PA,C079148,(3-aminopropyl)(n-butyl)phosphinic acid,123690-78-8,(3-aminopropyl)(n-butyl)phosphinic acid,ChemID+,exact,,,,,,,,(3-aminopropyl)(n-butyl)phosphinic acid,,123690-78-8,exact,,,,(3-aminopropyl)(n-butyl)phosphinic acid,C079148,145537-81-1,exact,,,,(3-Aminopropyl)(N-Butyl)Phosphinic Acid,C0212361,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,antagonist,antagonist,#VALUE!,GABA Antagonists,GABA Antagonists,Y,quasi syn therclass-to-function,"Synaptic Transmission, Gabaergic","Synaptic Transmission, Gabaergic",C1816494,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Gaba Antagonists,Gaba Antagonists,C0242975,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000443,MeSH_PA,C079148,(3-aminopropyl)(n-butyl)phosphinic acid,123690-78-8,(3-aminopropyl)(n-butyl)phosphinic acid,ChemID+,exact,,,,,,,,(3-aminopropyl)(n-butyl)phosphinic acid,,123690-78-8,exact,,,,(3-aminopropyl)(n-butyl)phosphinic acid,C079148,145537-81-1,exact,,,,(3-Aminopropyl)(N-Butyl)Phosphinic Acid,C0212361,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000444,MeSH_PA,C079148,(3-aminopropyl)(n-butyl)phosphinic acid,123690-78-8,(3-aminopropyl)(n-butyl)phosphinic acid,ChemID+,exact,,,,,,,,(3-aminopropyl)(n-butyl)phosphinic acid,,123690-78-8,exact,,,,(3-aminopropyl)(n-butyl)phosphinic acid,C079148,145537-81-1,exact,,,,(3-Aminopropyl)(N-Butyl)Phosphinic Acid,C0212361,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000445,MeSH_PA,C079148,(3-aminopropyl)(n-butyl)phosphinic acid,123690-78-8,(3-aminopropyl)(n-butyl)phosphinic acid,ChemID+,exact,,,,,,,,(3-aminopropyl)(n-butyl)phosphinic acid,,123690-78-8,exact,,,,(3-aminopropyl)(n-butyl)phosphinic acid,C079148,145537-81-1,exact,,,,(3-Aminopropyl)(N-Butyl)Phosphinic Acid,C0212361,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000446,MeSH_PA,C073525,"1,3-dipropyl-8-(3-noradamantyl)xanthine",136199-02-5,Rolofylline,ChemID+,<syn per source>,,,,,,,,Rolofylline,Rolofylline [USAN:INN],136199-02-5,<syn per source>,"1,3-Dipropyl-8-(3-noradamantyl)xanthine",exact,,"1,3-dipropyl-8-(3-noradamantyl)xanthine",C073525,136199-02-5,exact,,,,"1,3-Dipropyl-8-(3-Noradamantyl)Xanthine",C0166128,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Diuretics,Diuretics,Y,quasi syn therclass-to-function,Diuresis,Diuresis,C0012797,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Diuretics,Diuretics,C0012798,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000447,MeSH_PA,C073525,"1,3-dipropyl-8-(3-noradamantyl)xanthine",136199-02-5,Rolofylline,ChemID+,<syn per source>,,,,,,,,Rolofylline,Rolofylline [USAN:INN],136199-02-5,<syn per source>,"1,3-Dipropyl-8-(3-noradamantyl)xanthine",exact,,"1,3-dipropyl-8-(3-noradamantyl)xanthine",C073525,136199-02-5,exact,,,,"1,3-Dipropyl-8-(3-Noradamantyl)Xanthine",C0166128,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Natriuretic Agents,Natriuretic Agents,Y,quasi syn therclass-to-function,Natriuresis,Natriuresis,C0027477,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Natriuretic Agents,Natriuretic Agents,C1258001,P,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,
1_000448,MeSH_PA,C050386,"1-methyl-1,2,3,4-tetrahydroisoquinoline",4965-09-7,"1-Methyl-1,2,3,4-tetrahydroisoquinoline",ChemID+,exact,,,,,,,,"1-Methyl-1,2,3,4-tetrahydroisoquinoline",,4965-09-7,exact,,,,"1-methyl-1,2,3,4-tetrahydroisoquinoline",C050386,4965-09-7,exact,,,,"1-Methyl-1,2,3,4-Tetrahydroisoquinoline",C0044430,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000449,MeSH_PA,C050386,"1-methyl-1,2,3,4-tetrahydroisoquinoline",4965-09-7,"1-Methyl-1,2,3,4-tetrahydroisoquinoline",ChemID+,exact,,,,,,,,"1-Methyl-1,2,3,4-tetrahydroisoquinoline",,4965-09-7,exact,,,,"1-methyl-1,2,3,4-tetrahydroisoquinoline",C050386,4965-09-7,exact,,,,"1-Methyl-1,2,3,4-Tetrahydroisoquinoline",C0044430,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000450,MeSH_PA,C050386,"1-methyl-1,2,3,4-tetrahydroisoquinoline",4965-09-7,"1-Methyl-1,2,3,4-tetrahydroisoquinoline",ChemID+,exact,,,,,,,,"1-Methyl-1,2,3,4-tetrahydroisoquinoline",,4965-09-7,exact,,,,"1-methyl-1,2,3,4-tetrahydroisoquinoline",C050386,4965-09-7,exact,,,,"1-Methyl-1,2,3,4-Tetrahydroisoquinoline",C0044430,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000451,MeSH_PA,C029216,"2-amino-3-methylimidazo(4,5-f)quinoline",76180-96-6,"2-Amino-3-methylimidazo(4,5-f)quinoline",ChemID+,exact,,,,,,,,"2-Amino-3-methylimidazo(4,5-f)quinoline",,76180-96-6,exact,,,,"2-amino-3-methylimidazo(4,5-f)quinoline",C029216,76180-96-6,exact,,,,"2-Amino-3-Methylimidazo(4,5-F)Quinoline",C0045826,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000452,MeSH_PA,C029216,"2-amino-3-methylimidazo(4,5-f)quinoline",76180-96-6,"2-Amino-3-methylimidazo(4,5-f)quinoline",ChemID+,exact,,,,,,,,"2-Amino-3-methylimidazo(4,5-f)quinoline",,76180-96-6,exact,,,,"2-amino-3-methylimidazo(4,5-f)quinoline",C029216,76180-96-6,exact,,,,"2-Amino-3-Methylimidazo(4,5-F)Quinoline",C0045826,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000453,MeSH_PA,C029216,"2-amino-3-methylimidazo(4,5-f)quinoline",76180-96-6,"2-Amino-3-methylimidazo(4,5-f)quinoline",ChemID+,exact,,,,,,,,"2-Amino-3-methylimidazo(4,5-f)quinoline",,76180-96-6,exact,,,,"2-amino-3-methylimidazo(4,5-f)quinoline",C029216,76180-96-6,exact,,,,"2-Amino-3-Methylimidazo(4,5-F)Quinoline",C0045826,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000454,MeSH_PA,C019133,"3-amino-1-methyl-5H-pyrido(4,3-b)indole",62450-07-1,Trp-P-2,ChemID+,<syn per source>,"3-Amino-1-methyl-5H-pyrido[4,3-b]indole",34328,,syn no\W,,,,Trp-P-2,,62450-07-1,<syn per source>,"3-Amino-1-methyl-5H-pyrido(4,3-b)indole",exact,,"3-amino-1-methyl-5H-pyrido(4,3-b)indole",C019133,,exact,,,,"3-Amino-1-Methyl-5H-Pyrido(4,3-B)Indole",C0077414,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000455,MeSH_PA,C019133,"3-amino-1-methyl-5H-pyrido(4,3-b)indole",62450-07-1,Trp-P-2,ChemID+,<syn per source>,"3-Amino-1-methyl-5H-pyrido[4,3-b]indole",34328,,syn no\W,,,,Trp-P-2,,62450-07-1,<syn per source>,"3-Amino-1-methyl-5H-pyrido(4,3-b)indole",exact,,"3-amino-1-methyl-5H-pyrido(4,3-b)indole",C019133,,exact,,,,"3-Amino-1-Methyl-5H-Pyrido(4,3-B)Indole",C0077414,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000456,MeSH_PA,C019133,"3-amino-1-methyl-5H-pyrido(4,3-b)indole",62450-07-1,Trp-P-2,ChemID+,<syn per source>,"3-Amino-1-methyl-5H-pyrido[4,3-b]indole",34328,,syn no\W,,,,Trp-P-2,,62450-07-1,<syn per source>,"3-Amino-1-methyl-5H-pyrido(4,3-b)indole",exact,,"3-amino-1-methyl-5H-pyrido(4,3-b)indole",C019133,,exact,,,,"3-Amino-1-Methyl-5H-Pyrido(4,3-B)Indole",C0077414,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000457,MeSH_PA,C034940,3-amino-2-hydroxy-4-phenylbutanoic acid,62084-21-3,Phenylnorstatine,ChemID+,<syn per source>,,,,,,,,Phenylnorstatine,,62084-21-3,<syn per source>,3-Amino-2-hydroxy-4-phenylbutanoic acid,exact,,3-amino-2-hydroxy-4-phenylbutanoic acid,C034940,62084-21-3,exact,,,,3-Amino-2-Hydroxy-4-Phenylbutanoic Acid,C0047204,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000458,MeSH_PA,C034940,3-amino-2-hydroxy-4-phenylbutanoic acid,62084-21-3,Phenylnorstatine,ChemID+,<syn per source>,,,,,,,,Phenylnorstatine,,62084-21-3,<syn per source>,3-Amino-2-hydroxy-4-phenylbutanoic acid,exact,,3-amino-2-hydroxy-4-phenylbutanoic acid,C034940,62084-21-3,exact,,,,3-Amino-2-Hydroxy-4-Phenylbutanoic Acid,C0047204,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antimalarials,Antimalarials,Y,quasi syn therclass-to-disease,Malaria,Malaria,C0024530,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antimalarials,Antimalarials,C0003374,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000459,MeSH_PA,C034940,3-amino-2-hydroxy-4-phenylbutanoic acid,62084-21-3,Phenylnorstatine,ChemID+,<syn per source>,,,,,,,,Phenylnorstatine,,62084-21-3,<syn per source>,3-Amino-2-hydroxy-4-phenylbutanoic acid,exact,,3-amino-2-hydroxy-4-phenylbutanoic acid,C034940,62084-21-3,exact,,,,3-Amino-2-Hydroxy-4-Phenylbutanoic Acid,C0047204,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000460,MeSH_PA,C034940,3-amino-2-hydroxy-4-phenylbutanoic acid,62084-21-3,Phenylnorstatine,ChemID+,<syn per source>,,,,,,,,Phenylnorstatine,,62084-21-3,<syn per source>,3-Amino-2-hydroxy-4-phenylbutanoic acid,exact,,3-amino-2-hydroxy-4-phenylbutanoic acid,C034940,62084-21-3,exact,,,,3-Amino-2-Hydroxy-4-Phenylbutanoic Acid,C0047204,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiprotozoal Agents,Antiprotozoal Agents,Y,quasi syn therclass-to-disease,Protozoan Infections,Protozoan Infections,C0033740,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiprotozoal Agents,Antiprotozoal Agents,C0003416,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000461,MeSH_PA,C034940,3-amino-2-hydroxy-4-phenylbutanoic acid,62084-21-3,Phenylnorstatine,ChemID+,<syn per source>,,,,,,,,Phenylnorstatine,,62084-21-3,<syn per source>,3-Amino-2-hydroxy-4-phenylbutanoic acid,exact,,3-amino-2-hydroxy-4-phenylbutanoic acid,C034940,62084-21-3,exact,,,,3-Amino-2-Hydroxy-4-Phenylbutanoic Acid,C0047204,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000462,MeSH_PA,C034940,3-amino-2-hydroxy-4-phenylbutanoic acid,62084-21-3,Phenylnorstatine,ChemID+,<syn per source>,,,,,,,,Phenylnorstatine,,62084-21-3,<syn per source>,3-Amino-2-hydroxy-4-phenylbutanoic acid,exact,,3-amino-2-hydroxy-4-phenylbutanoic acid,C034940,62084-21-3,exact,,,,3-Amino-2-Hydroxy-4-Phenylbutanoic Acid,C0047204,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000463,MeSH_PA,C013097,3-maleimidobenzoyl N-hydroxysuccinimide,58626-38-3,3-Maleimidobenzoyl N-hydroxysuccinimide,ChemID+,exact,,,,,,,,3-Maleimidobenzoyl N-hydroxysuccinimide,,58626-38-3,exact,,,,3-maleimidobenzoyl N-hydroxysuccinimide,C013097,58626-38-3,exact,,,,3-Maleimidobenzoyl N-Hydroxysuccinimide,C0047536,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000464,MeSH_PA,C002010,4-(2-aminoethyl)benzenesulfonylfluoride,34284-75-8,4-(2-Aminoethyl)benzenesulfonylfluoride,ChemID+,exact,,,,,,,,4-(2-Aminoethyl)benzenesulfonylfluoride,,34284-75-8,exact,,,,4-(2-aminoethyl)benzenesulfonylfluoride,C002010,34284-75-8,exact,,,,4-(2-Aminoethyl)Benzenesulfonylfluoride,C0047895,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000465,MeSH_PA,C002010,4-(2-aminoethyl)benzenesulfonylfluoride,34284-75-8,4-(2-Aminoethyl)benzenesulfonylfluoride,ChemID+,exact,,,,,,,,4-(2-Aminoethyl)benzenesulfonylfluoride,,34284-75-8,exact,,,,4-(2-aminoethyl)benzenesulfonylfluoride,C002010,34284-75-8,exact,,,,4-(2-Aminoethyl)Benzenesulfonylfluoride,C0047895,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000466,MeSH_PA,C002010,4-(2-aminoethyl)benzenesulfonylfluoride,34284-75-8,4-(2-Aminoethyl)benzenesulfonylfluoride,ChemID+,exact,,,,,,,,4-(2-Aminoethyl)benzenesulfonylfluoride,,34284-75-8,exact,,,,4-(2-aminoethyl)benzenesulfonylfluoride,C002010,34284-75-8,exact,,,,4-(2-Aminoethyl)Benzenesulfonylfluoride,C0047895,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000467,MeSH_PA,C002010,4-(2-aminoethyl)benzenesulfonylfluoride,34284-75-8,4-(2-Aminoethyl)benzenesulfonylfluoride,ChemID+,exact,,,,,,,,4-(2-Aminoethyl)benzenesulfonylfluoride,,34284-75-8,exact,,,,4-(2-aminoethyl)benzenesulfonylfluoride,C002010,34284-75-8,exact,,,,4-(2-Aminoethyl)Benzenesulfonylfluoride,C0047895,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Trypsin Inhibitors,Trypsin Inhibitors,Y,quasi syn therclass-to-function,Trypsin Activity,Trypsin Activity,C1150284,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Trypsin Inhibitors,Trypsin Inhibitors,C0041242,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",
1_000468,MeSH_PA,C032930,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",29270-56-2,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",,29270-56-2,exact,,,,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",C032930,29270-56-2,exact,,,,"7-Fluoro-4-Nitrobenzo-2-Oxa-1,3-Diazole",C0049887,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000469,MeSH_PA,C032930,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",29270-56-2,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",,29270-56-2,exact,,,,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",C032930,29270-56-2,exact,,,,"7-Fluoro-4-Nitrobenzo-2-Oxa-1,3-Diazole",C0049887,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000470,MeSH_PA,C032930,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",29270-56-2,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",,29270-56-2,exact,,,,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",C032930,29270-56-2,exact,,,,"7-Fluoro-4-Nitrobenzo-2-Oxa-1,3-Diazole",C0049887,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000471,MeSH_PA,C032930,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",29270-56-2,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"7-Fluoro-4-nitrobenzo-2-oxa-1,3-diazole",,29270-56-2,exact,,,,"7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole",C032930,29270-56-2,exact,,,,"7-Fluoro-4-Nitrobenzo-2-Oxa-1,3-Diazole",C0049887,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000472,MeSH_PA,C099158,acetyl-aspartyl-glutamyl-valyl-aspartal,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,exact,,,,acetyl-aspartyl-glutamyl-valyl-aspartal,C099158,,exact,,,,Acetyl-Aspartyl-Glutamyl-Valyl-Aspartal,C0388991,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000473,MeSH_PA,C099158,acetyl-aspartyl-glutamyl-valyl-aspartal,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,exact,,,,acetyl-aspartyl-glutamyl-valyl-aspartal,C099158,,exact,,,,Acetyl-Aspartyl-Glutamyl-Valyl-Aspartal,C0388991,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000474,MeSH_PA,C099158,acetyl-aspartyl-glutamyl-valyl-aspartal,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,exact,,,,acetyl-aspartyl-glutamyl-valyl-aspartal,C099158,,exact,,,,Acetyl-Aspartyl-Glutamyl-Valyl-Aspartal,C0388991,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000475,MeSH_PA,C000245,N-(4-(2-benzimidazolyl)phenyl)maleimide,27030-97-3,N-(4-(2-Benzimidazolyl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(2-Benzimidazolyl)phenyl)maleimide,,27030-97-3,exact,,,,N-(4-(2-benzimidazolyl)phenyl)maleimide,C000245,27030-97-3,exact,,,,N-(4-(2-Benzimidazolyl)Phenyl)Maleimide,C0067510,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000476,MeSH_PA,C000245,N-(4-(2-benzimidazolyl)phenyl)maleimide,27030-97-3,N-(4-(2-Benzimidazolyl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(2-Benzimidazolyl)phenyl)maleimide,,27030-97-3,exact,,,,N-(4-(2-benzimidazolyl)phenyl)maleimide,C000245,27030-97-3,exact,,,,N-(4-(2-Benzimidazolyl)Phenyl)Maleimide,C0067510,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000477,MeSH_PA,C000245,N-(4-(2-benzimidazolyl)phenyl)maleimide,27030-97-3,N-(4-(2-Benzimidazolyl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(2-Benzimidazolyl)phenyl)maleimide,,27030-97-3,exact,,,,N-(4-(2-benzimidazolyl)phenyl)maleimide,C000245,27030-97-3,exact,,,,N-(4-(2-Benzimidazolyl)Phenyl)Maleimide,C0067510,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000478,MeSH_PA,C000245,N-(4-(2-benzimidazolyl)phenyl)maleimide,27030-97-3,N-(4-(2-Benzimidazolyl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(2-Benzimidazolyl)phenyl)maleimide,,27030-97-3,exact,,,,N-(4-(2-benzimidazolyl)phenyl)maleimide,C000245,27030-97-3,exact,,,,N-(4-(2-Benzimidazolyl)Phenyl)Maleimide,C0067510,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000479,MeSH_PA,C014627,N-isopropyl-N-phenyl-4-phenylenediamine,101-72-4,4-(Isopropylamino)diphenylamine,ChemID+,<syn per source>,,,,,,,,4-(Isopropylamino)diphenylamine,,101-72-4,<syn per source>,N-Isopropyl-N-phenyl-4-phenylenediamine,exact,,N-isopropyl-N-phenyl-4-phenylenediamine,C014627,101-72-4,exact,,,,N-Isopropyl-N-Phenyl-4-Phenylenediamine,C0068065,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000480,MeSH_PA,C014627,N-isopropyl-N-phenyl-4-phenylenediamine,101-72-4,4-(Isopropylamino)diphenylamine,ChemID+,<syn per source>,,,,,,,,4-(Isopropylamino)diphenylamine,,101-72-4,<syn per source>,N-Isopropyl-N-phenyl-4-phenylenediamine,exact,,N-isopropyl-N-phenyl-4-phenylenediamine,C014627,101-72-4,exact,,,,N-Isopropyl-N-Phenyl-4-Phenylenediamine,C0068065,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000481,ChEBI,,perfluoro-N-methyldecahydroisoquinoline,86714-34-3,Perfluoro-N-methyldecahydroisoquinoline,ChemID+,exact,perfluoro-N-methyldecahydroisoquinoline,38859,86714-34-3,exact,,,,Perfluoro-N-methyldecahydroisoquinoline,,86714-34-3,exact,,,,perfluoro-N-methyldecahydroisoquinoline,C065081,86714-34-3,exact,,,,Perfluoro-N-Methyldecahydroisoquinoline,C0083986,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,blood substitute,blood substitute,Y,quasi syn therclass-to-disease,Blood Loss,Blood Loss,C3163616,P,Y,A2.2_Finding,,,,exact 1,blood substitute,Blood Substitutes,C0005836,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000482,MeSH_PA,C063076,tyrosyl-arginyl-phenylalanyl-lysinamide,118476-85-0,Tyrosyl-arginyl-phenylalanyl-lysinamide,ChemID+,exact,,,,,,,,Tyrosyl-arginyl-phenylalanyl-lysinamide,,118476-85-0,exact,,,,tyrosyl-arginyl-phenylalanyl-lysinamide,C063076,118476-85-0,exact,,,,Tyrosyl-Arginyl-Phenylalanyl-Lysinamide,C0077580,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000483,MeSH_PA,C063076,tyrosyl-arginyl-phenylalanyl-lysinamide,118476-85-0,Tyrosyl-arginyl-phenylalanyl-lysinamide,ChemID+,exact,,,,,,,,Tyrosyl-arginyl-phenylalanyl-lysinamide,,118476-85-0,exact,,,,tyrosyl-arginyl-phenylalanyl-lysinamide,C063076,118476-85-0,exact,,,,Tyrosyl-Arginyl-Phenylalanyl-Lysinamide,C0077580,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,Y,quasi syn therclass-to-disease,Cardiac Arrhythmia,Cardiac Arrhythmia,C0003811,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,C0003195,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000484,MeSH_PA,C063076,tyrosyl-arginyl-phenylalanyl-lysinamide,118476-85-0,Tyrosyl-arginyl-phenylalanyl-lysinamide,ChemID+,exact,,,,,,,,Tyrosyl-arginyl-phenylalanyl-lysinamide,,118476-85-0,exact,,,,tyrosyl-arginyl-phenylalanyl-lysinamide,C063076,118476-85-0,exact,,,,Tyrosyl-Arginyl-Phenylalanyl-Lysinamide,C0077580,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000485,MeSH_PA,C063076,tyrosyl-arginyl-phenylalanyl-lysinamide,118476-85-0,Tyrosyl-arginyl-phenylalanyl-lysinamide,ChemID+,exact,,,,,,,,Tyrosyl-arginyl-phenylalanyl-lysinamide,,118476-85-0,exact,,,,tyrosyl-arginyl-phenylalanyl-lysinamide,C063076,118476-85-0,exact,,,,Tyrosyl-Arginyl-Phenylalanyl-Lysinamide,C0077580,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000486,MeSH_PA,C063076,tyrosyl-arginyl-phenylalanyl-lysinamide,118476-85-0,Tyrosyl-arginyl-phenylalanyl-lysinamide,ChemID+,exact,,,,,,,,Tyrosyl-arginyl-phenylalanyl-lysinamide,,118476-85-0,exact,,,,tyrosyl-arginyl-phenylalanyl-lysinamide,C063076,118476-85-0,exact,,,,Tyrosyl-Arginyl-Phenylalanyl-Lysinamide,C0077580,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000487,MeSH_PA,C063076,tyrosyl-arginyl-phenylalanyl-lysinamide,118476-85-0,Tyrosyl-arginyl-phenylalanyl-lysinamide,ChemID+,exact,,,,,,,,Tyrosyl-arginyl-phenylalanyl-lysinamide,,118476-85-0,exact,,,,tyrosyl-arginyl-phenylalanyl-lysinamide,C063076,118476-85-0,exact,,,,Tyrosyl-Arginyl-Phenylalanyl-Lysinamide,C0077580,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000488,MeSH_PA,C081571,tyrosyl-isoleucyl-glycyl-seryl-arginine,110590-64-2,Tyrosyl-isoleucyl-glycyl-seryl-arginine,ChemID+,exact,,,,,,,,Tyrosyl-isoleucyl-glycyl-seryl-arginine,,110590-64-2,exact,,,,tyrosyl-isoleucyl-glycyl-seryl-arginine,C081571,110590-64-2,exact,,,,Tyrosyl-Isoleucyl-Glycyl-Seryl-Arginine,C0216949,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000489,MeSH_PA,C011775,"(3,4-dihydroxyphenylamino)-2-imidazoline",57101-49-2,"(3,4-Dihydroxyphenylamino)-2-imidazoline",ChemID+,exact,,,,,,,,"(3,4-Dihydroxyphenylamino)-2-imidazoline",,57101-49-2,exact,,,,"(3,4-dihydroxyphenylamino)-2-imidazoline",C011775,57101-49-2,exact,,,,"(3,4-Dihydroxyphenylamino)-2-Imidazoline",C0043599,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000490,MeSH_PA,C011775,"(3,4-dihydroxyphenylamino)-2-imidazoline",57101-49-2,"(3,4-Dihydroxyphenylamino)-2-imidazoline",ChemID+,exact,,,,,,,,"(3,4-Dihydroxyphenylamino)-2-imidazoline",,57101-49-2,exact,,,,"(3,4-dihydroxyphenylamino)-2-imidazoline",C011775,57101-49-2,exact,,,,"(3,4-Dihydroxyphenylamino)-2-Imidazoline",C0043599,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000491,MeSH_PA,C011775,"(3,4-dihydroxyphenylamino)-2-imidazoline",57101-49-2,"(3,4-Dihydroxyphenylamino)-2-imidazoline",ChemID+,exact,,,,,,,,"(3,4-Dihydroxyphenylamino)-2-imidazoline",,57101-49-2,exact,,,,"(3,4-dihydroxyphenylamino)-2-imidazoline",C011775,57101-49-2,exact,,,,"(3,4-Dihydroxyphenylamino)-2-Imidazoline",C0043599,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000492,MeSH_PA,C030838,"1-(4-carboxyphenyl)-3,3-dimethyltriazene",7203-91-0,"1-(4-carboxyphenyl)-3,3-dimethyltriazene",CTD,exact,,,,,,,,,,,,,,,"1-(4-carboxyphenyl)-3,3-dimethyltriazene",C030838,7203-91-0,exact,,,,"1-(4-Carboxyphenyl)-3,3-Dimethyltriazene",C0088835,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000493,MeSH_PA,C084012,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",86831-65-4,"Hydrazine, 1,1-diethyl-2-hydroxy-2-nitroso-, ion(1-)",ChemID+,<syn per source>,,,,,,,,"Hydrazine, 1,1-diethyl-2-hydroxy-2-nitroso-, ion(1-)",,86831-65-4,<syn per source>,"1,1-Diethyl-2-hydroxy-2-nitrosohydrazine",exact,,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,exact,,,,"1,1-Diethyl-2-Hydroxy-2-Nitrosohydrazine",C0248424,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000494,MeSH_PA,C084012,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",86831-65-4,"Hydrazine, 1,1-diethyl-2-hydroxy-2-nitroso-, ion(1-)",ChemID+,<syn per source>,,,,,,,,"Hydrazine, 1,1-diethyl-2-hydroxy-2-nitroso-, ion(1-)",,86831-65-4,<syn per source>,"1,1-Diethyl-2-hydroxy-2-nitrosohydrazine",exact,,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,exact,,,,"1,1-Diethyl-2-Hydroxy-2-Nitrosohydrazine",C0248424,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Nitric Oxide Donors,Nitric Oxide Donors,Y,quasi syn therclass-to-function,Nitric Oxide Metabolic Process,Nitric Oxide Metabolic Process,C1158468,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nitric Oxide Donors,Nitric Oxide Donors,C0600437,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000495,MeSH_PA,C074153,"1,4-phenylenebis(methylene)selenocyanate",85539-83-9,"1,4-Phenylenebis(methylene)selenocyanate",ChemID+,exact,,,,,,,,"1,4-Phenylenebis(methylene)selenocyanate",,85539-83-9,exact,,,,"1,4-phenylenebis(methylene)selenocyanate",C074153,85539-83-9,exact,,,,"1,4-Phenylenebis(Methylene)Selenocyanate",C0167369,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticarcinogenic Agents,Anticarcinogenic Agents,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Anticarcinogenic Agents,Anticarcinogenic Agents,C0085169,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000496,MeSH_PA,C074153,"1,4-phenylenebis(methylene)selenocyanate",85539-83-9,"1,4-Phenylenebis(methylene)selenocyanate",ChemID+,exact,,,,,,,,"1,4-Phenylenebis(methylene)selenocyanate",,85539-83-9,exact,,,,"1,4-phenylenebis(methylene)selenocyanate",C074153,85539-83-9,exact,,,,"1,4-Phenylenebis(Methylene)Selenocyanate",C0167369,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000497,MeSH_PA,C074153,"1,4-phenylenebis(methylene)selenocyanate",85539-83-9,"1,4-Phenylenebis(methylene)selenocyanate",ChemID+,exact,,,,,,,,"1,4-Phenylenebis(methylene)selenocyanate",,85539-83-9,exact,,,,"1,4-phenylenebis(methylene)selenocyanate",C074153,85539-83-9,exact,,,,"1,4-Phenylenebis(Methylene)Selenocyanate",C0167369,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000498,MeSH_PA,C036535,"1,6-bis(cyclohexyloximinocarbonyl)hexane",83654-05-1,"1,6-Bis(cyclohexyloximinocarbonyl)hexane",ChemID+,exact,,,,,,,,"1,6-Bis(cyclohexyloximinocarbonyl)hexane",,83654-05-1,exact,,,,"1,6-bis(cyclohexyloximinocarbonyl)hexane",C036535,83654-05-1,exact,,,,"1,6-Bis(Cyclohexyloximinocarbonyl)Hexane",C0088478,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000499,MeSH_PA,C036535,"1,6-bis(cyclohexyloximinocarbonyl)hexane",83654-05-1,"1,6-Bis(cyclohexyloximinocarbonyl)hexane",ChemID+,exact,,,,,,,,"1,6-Bis(cyclohexyloximinocarbonyl)hexane",,83654-05-1,exact,,,,"1,6-bis(cyclohexyloximinocarbonyl)hexane",C036535,83654-05-1,exact,,,,"1,6-Bis(Cyclohexyloximinocarbonyl)Hexane",C0088478,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000500,MeSH_PA,C029498,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",76543-16-3,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",,76543-16-3,exact,,,,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",C029498,76543-16-3,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butane-1,4-Diol",C0045340,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,causes,,#VALUE!,Estrogens,Estrogens,Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),Estrogens,Estrogens,C0014939,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1.9.1_Steroid,
1_000501,MeSH_PA,C029498,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",76543-16-3,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",,76543-16-3,exact,,,,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",C029498,76543-16-3,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butane-1,4-Diol",C0045340,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,causes,,#VALUE!,"Estrogens, Non-Steroidal","Estrogens, Non-Steroidal",Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),"Estrogens, Non-Steroidal","Estrogens, Non-Steroidal",C0014940,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1_Organic Chemical,
1_000502,MeSH_PA,C029498,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",76543-16-3,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",,76543-16-3,exact,,,,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",C029498,76543-16-3,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butane-1,4-Diol",C0045340,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,,,#VALUE!,Hormones,Hormones,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormones,Hormones,C0019932,P,A1.4.1.1.3.2_Hormone,,,
1_000503,MeSH_PA,C029498,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",76543-16-3,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",,76543-16-3,exact,,,,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",C029498,76543-16-3,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butane-1,4-Diol",C0045340,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000504,MeSH_PA,C029498,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",76543-16-3,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",ChemID+,exact,,,,,,,,"2,3-Bis(3'-hydroxybenzyl)butane-1,4-diol",,76543-16-3,exact,,,,"2,3-bis(3'-hydroxybenzyl)butane-1,4-diol",C029498,76543-16-3,exact,,,,"2,3-Bis(3'-Hydroxybenzyl)Butane-1,4-Diol",C0045340,exact,,,,A1.4.1.2.1.9.1_Steroid,,,,causes,,#VALUE!,Phytoestrogens,Phytoestrogens,Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),Phytoestrogens,Phytoestrogens,C0071011,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1.9.1_Steroid,
1_000505,MeSH_PA,C049929,2-acetyl-4(5)-tetrahydroxybutylimidazole,94944-70-4,2-Acetyl-4(5)-tetrahydroxybutylimidazole,ChemID+,exact,,,,,,,,2-Acetyl-4(5)-tetrahydroxybutylimidazole,,94944-70-4,exact,,,,2-acetyl-4(5)-tetrahydroxybutylimidazole,C049929,94944-70-4,exact,,,,2-Acetyl-4(5)-Tetrahydroxybutylimidazole,C0045796,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000506,MeSH_PA,C049929,2-acetyl-4(5)-tetrahydroxybutylimidazole,94944-70-4,2-Acetyl-4(5)-tetrahydroxybutylimidazole,ChemID+,exact,,,,,,,,2-Acetyl-4(5)-tetrahydroxybutylimidazole,,94944-70-4,exact,,,,2-acetyl-4(5)-tetrahydroxybutylimidazole,C049929,94944-70-4,exact,,,,2-Acetyl-4(5)-Tetrahydroxybutylimidazole,C0045796,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_000507,MeSH_PA,C082408,4-amidinoindan-1-one 2'-amidinohydrazone,149400-88-4,Sardomozide,ChemID+,<syn per source>,,,,,,,,Sardomozide,Sardomozide [INN],149400-88-4,<syn per source>,4-Amidinoindan-1-one 2'-amidinohydrazone,exact,,4-amidinoindan-1-one 2'-amidinohydrazone,C082408,149400-88-4,exact,,,,4-Amidinoindan-1-One 2'-Amidinohydrazone,C0218593,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000508,MeSH_PA,C082408,4-amidinoindan-1-one 2'-amidinohydrazone,149400-88-4,Sardomozide,ChemID+,<syn per source>,,,,,,,,Sardomozide,Sardomozide [INN],149400-88-4,<syn per source>,4-Amidinoindan-1-one 2'-amidinohydrazone,exact,,4-amidinoindan-1-one 2'-amidinohydrazone,C082408,149400-88-4,exact,,,,4-Amidinoindan-1-One 2'-Amidinohydrazone,C0218593,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000509,MeSH_PA,C015952,"4-iodo-2,5-dimethoxyphenylisopropylamine",64584-34-5,"4-Iodo-2,5-dimethoxyphenylisopropylamine",ChemID+,exact,"2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine",64629,64584-34-5,<syn per source>,"4-Iodo-2,5-dimethoxyphenylisopropylamine",exact,,"4-Iodo-2,5-dimethoxyphenylisopropylamine",,64584-34-5,exact,,,,"4-iodo-2,5-dimethoxyphenylisopropylamine",C015952,64584-34-5,exact,,,,"4-Iodo-2,5-Dimethoxyphenylisopropylamine",C0048408,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000510,MeSH_PA,C015952,"4-iodo-2,5-dimethoxyphenylisopropylamine",64584-34-5,"4-Iodo-2,5-dimethoxyphenylisopropylamine",ChemID+,exact,"2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine",64629,64584-34-5,<syn per source>,"4-Iodo-2,5-dimethoxyphenylisopropylamine",exact,,"4-Iodo-2,5-dimethoxyphenylisopropylamine",,64584-34-5,exact,,,,"4-iodo-2,5-dimethoxyphenylisopropylamine",C015952,64584-34-5,exact,,,,"4-Iodo-2,5-Dimethoxyphenylisopropylamine",C0048408,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hallucinogens,Hallucinogens,Y,quasi syn therclass-to-function,Perception,Perception,C0030971,P,Y,B2.2.1.1.1.1_Mental Process,,,,exact (CUI-based),Hallucinogens,Hallucinogens,C0018533,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_000511,MeSH_PA,C015952,"4-iodo-2,5-dimethoxyphenylisopropylamine",64584-34-5,"4-Iodo-2,5-dimethoxyphenylisopropylamine",ChemID+,exact,"2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine",64629,64584-34-5,<syn per source>,"4-Iodo-2,5-dimethoxyphenylisopropylamine",exact,,"4-Iodo-2,5-dimethoxyphenylisopropylamine",,64584-34-5,exact,,,,"4-iodo-2,5-dimethoxyphenylisopropylamine",C015952,64584-34-5,exact,,,,"4-Iodo-2,5-Dimethoxyphenylisopropylamine",C0048408,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000512,MeSH_PA,C015952,"4-iodo-2,5-dimethoxyphenylisopropylamine",64584-34-5,"4-Iodo-2,5-dimethoxyphenylisopropylamine",ChemID+,exact,"2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine",64629,64584-34-5,<syn per source>,"4-Iodo-2,5-dimethoxyphenylisopropylamine",exact,,"4-Iodo-2,5-dimethoxyphenylisopropylamine",,64584-34-5,exact,,,,"4-iodo-2,5-dimethoxyphenylisopropylamine",C015952,64584-34-5,exact,,,,"4-Iodo-2,5-Dimethoxyphenylisopropylamine",C0048408,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000513,MeSH_PA,C015952,"4-iodo-2,5-dimethoxyphenylisopropylamine",64584-34-5,"4-Iodo-2,5-dimethoxyphenylisopropylamine",ChemID+,exact,"2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine",64629,64584-34-5,<syn per source>,"4-Iodo-2,5-dimethoxyphenylisopropylamine",exact,,"4-Iodo-2,5-dimethoxyphenylisopropylamine",,64584-34-5,exact,,,,"4-iodo-2,5-dimethoxyphenylisopropylamine",C015952,64584-34-5,exact,,,,"4-Iodo-2,5-Dimethoxyphenylisopropylamine",C0048408,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000514,MeSH_PA,C015952,"4-iodo-2,5-dimethoxyphenylisopropylamine",64584-34-5,"4-Iodo-2,5-dimethoxyphenylisopropylamine",ChemID+,exact,"2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine",64629,64584-34-5,<syn per source>,"4-Iodo-2,5-dimethoxyphenylisopropylamine",exact,,"4-Iodo-2,5-dimethoxyphenylisopropylamine",,64584-34-5,exact,,,,"4-iodo-2,5-dimethoxyphenylisopropylamine",C015952,64584-34-5,exact,,,,"4-Iodo-2,5-Dimethoxyphenylisopropylamine",C0048408,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,20,Serotonin Receptor Agonists,Serotonin Receptor Agonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),serotonin receptor agonists,Serotonin Agonists,C0162757,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000515,MeSH_PA,C014289,5-(tetradecyloxy)-2-furancarboxylic acid,54857-86-2,5-(Tetradecyloxy)-2-furancarboxylic acid,ChemID+,exact,5-(tetradecyloxy)-2-furoic acid,77936,54857-86-2,<syn per source>,5-(Tetradecyloxy)-2-furancarboxylic acid,exact,,5-(Tetradecyloxy)-2-furancarboxylic acid,,54857-86-2,exact,,,,5-(tetradecyloxy)-2-furancarboxylic acid,C014289,54857-86-2,exact,,,,5-(Tetradecyloxy)-2-Furancarboxylic Acid,C0146177,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antimetabolites,Antimetabolites,Y,quasi syn therclass-to-function,Metabolism,Metabolism,C0025519,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Antimetabolites,Antimetabolites,C0003376,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000516,MeSH_PA,C014289,5-(tetradecyloxy)-2-furancarboxylic acid,54857-86-2,5-(Tetradecyloxy)-2-furancarboxylic acid,ChemID+,exact,5-(tetradecyloxy)-2-furoic acid,77936,54857-86-2,<syn per source>,5-(Tetradecyloxy)-2-furancarboxylic acid,exact,,5-(Tetradecyloxy)-2-furancarboxylic acid,,54857-86-2,exact,,,,5-(tetradecyloxy)-2-furancarboxylic acid,C014289,54857-86-2,exact,,,,5-(Tetradecyloxy)-2-Furancarboxylic Acid,C0146177,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,hypo,,#VALUE!,Hypolipidemic Agents,Hypolipidemic Agents,Y,quasi syn therclass-to-disease,Hyperlipidemia,Hyperlipidemia,C0020473,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypolipidemic Agents,Hypolipidemic Agents,C0086440,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000517,MeSH_PA,C014289,5-(tetradecyloxy)-2-furancarboxylic acid,54857-86-2,5-(Tetradecyloxy)-2-furancarboxylic acid,ChemID+,exact,5-(tetradecyloxy)-2-furoic acid,77936,54857-86-2,<syn per source>,5-(Tetradecyloxy)-2-furancarboxylic acid,exact,,5-(Tetradecyloxy)-2-furancarboxylic acid,,54857-86-2,exact,,,,5-(tetradecyloxy)-2-furancarboxylic acid,C014289,54857-86-2,exact,,,,5-(Tetradecyloxy)-2-Furancarboxylic Acid,C0146177,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,regulating,,#VALUE!,Lipid Regulating Agents,Lipid Regulating Agents,Y,quasi syn therclass-to-function,Lipid Metabolism,Lipid Metabolism,C0598783,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipid Regulating Agents,Lipid Regulating Agents,C2936244,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000518,MeSH_PA,C001026,5-dimethylaminonaphthalene-1-sulfonamide,1431-39-6,5-Dimethylaminonaphthalene-1-sulfonamide,ChemID+,exact,,,,,,,,5-Dimethylaminonaphthalene-1-sulfonamide,,1431-39-6,exact,,,,5-dimethylaminonaphthalene-1-sulfonamide,C001026,1431-39-6,exact,,,,5-Dimethylaminonaphthalene-1-Sulfonamide,C0049150,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000519,MeSH_PA,C001026,5-dimethylaminonaphthalene-1-sulfonamide,1431-39-6,5-Dimethylaminonaphthalene-1-sulfonamide,ChemID+,exact,,,,,,,,5-Dimethylaminonaphthalene-1-sulfonamide,,1431-39-6,exact,,,,5-dimethylaminonaphthalene-1-sulfonamide,C001026,1431-39-6,exact,,,,5-Dimethylaminonaphthalene-1-Sulfonamide,C0049150,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000520,MeSH_PA,C001026,5-dimethylaminonaphthalene-1-sulfonamide,1431-39-6,5-Dimethylaminonaphthalene-1-sulfonamide,ChemID+,exact,,,,,,,,5-Dimethylaminonaphthalene-1-sulfonamide,,1431-39-6,exact,,,,5-dimethylaminonaphthalene-1-sulfonamide,C001026,1431-39-6,exact,,,,5-Dimethylaminonaphthalene-1-Sulfonamide,C0049150,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000521,MeSH_PA,C001026,5-dimethylaminonaphthalene-1-sulfonamide,1431-39-6,5-Dimethylaminonaphthalene-1-sulfonamide,ChemID+,exact,,,,,,,,5-Dimethylaminonaphthalene-1-sulfonamide,,1431-39-6,exact,,,,5-dimethylaminonaphthalene-1-sulfonamide,C001026,1431-39-6,exact,,,,5-Dimethylaminonaphthalene-1-Sulfonamide,C0049150,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000522,ChEBI,,"5-hydroxy-7,2',4',5'-tetramethoxyflavone",,,,,"5-hydroxy-7,2',4',5'-tetramethoxyflavone",66040,,exact,,,,,,,,,,,"5-hydroxy-7,2',4',5'-tetramethoxyflavone",C091095,,exact,,,,"5-Hydroxy-7,2',4',5'-Tetramethoxyflavone",C0292300,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,antibacterial agent,antibacterial agent,Y,quasi syn therclass-to-disease,Bacterial Infections,Bacterial Infections,C0004623,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,antibacterial agent,Anti-Bacterial Agents,C0279516,S,A1.4.1.1.1.1_Antibiotic,,,
1_000523,MeSH_PA,C015929,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",41941-66-6,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",ChemID+,exact,,,,,,,,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",,41941-66-6,exact,,,,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",C015929,41941-66-6,exact,,,,"8-((4-Chlorophenyl)Thio)Cyclic-3',5'-Amp",C0050001,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000524,MeSH_PA,C015929,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",41941-66-6,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",ChemID+,exact,,,,,,,,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",,41941-66-6,exact,,,,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",C015929,41941-66-6,exact,,,,"8-((4-Chlorophenyl)Thio)Cyclic-3',5'-Amp",C0050001,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000525,MeSH_PA,C015929,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",41941-66-6,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",ChemID+,exact,,,,,,,,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",,41941-66-6,exact,,,,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",C015929,41941-66-6,exact,,,,"8-((4-Chlorophenyl)Thio)Cyclic-3',5'-Amp",C0050001,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000526,MeSH_PA,C015929,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",41941-66-6,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",ChemID+,exact,,,,,,,,"8-((4-Chlorophenyl)thio)cyclic-3',5'-amp",,41941-66-6,exact,,,,"8-((4-chlorophenyl)thio)cyclic-3',5'-AMP",C015929,41941-66-6,exact,,,,"8-((4-Chlorophenyl)Thio)Cyclic-3',5'-Amp",C0050001,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000527,MeSH_PA,C055656,"8-((4-chlorophenyl)thio)cyclic-3',5'-GMP",54364-02-2,"8-((4-Chlorophenyl)thio)cyclic-3',5'-GMP",ChemID+,exact,,,,,,,,"8-((4-Chlorophenyl)thio)cyclic-3',5'-GMP",,54364-02-2,exact,,,,"8-((4-chlorophenyl)thio)cyclic-3',5'-GMP",C055656,54364-02-2,exact,,,,"8-((4-Chlorophenyl)Thio)Cyclic-3',5'-Gmp",C0164985,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000528,MeSH_PA,C055656,"8-((4-chlorophenyl)thio)cyclic-3',5'-GMP",54364-02-2,"8-((4-Chlorophenyl)thio)cyclic-3',5'-GMP",ChemID+,exact,,,,,,,,"8-((4-Chlorophenyl)thio)cyclic-3',5'-GMP",,54364-02-2,exact,,,,"8-((4-chlorophenyl)thio)cyclic-3',5'-GMP",C055656,54364-02-2,exact,,,,"8-((4-Chlorophenyl)Thio)Cyclic-3',5'-Gmp",C0164985,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000529,MeSH_PA,C475021,Colgate Simply White Clear Whitening Gel,,,,,,,,,,,,,,,,,,,Colgate Simply White Clear Whitening Gel,C475021,,exact,,,,Colgate Simply White Clear Whitening Gel,C1259156,exact,,,,A1.4.1.1.2_Biomedical or Dental Material,,,,causes,,#VALUE!,Oxidants,Oxidants,Y,quasi syn therclass-to-function,Oxidation,Oxidation,C0030011,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Oxidants,Oxidants,C0085403,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_000530,MeSH_PA,C475021,Colgate Simply White Clear Whitening Gel,,,,,,,,,,,,,,,,,,,Colgate Simply White Clear Whitening Gel,C475021,,exact,,,,Colgate Simply White Clear Whitening Gel,C1259156,exact,,,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,#VALUE!,Tooth Bleaching Agents,Tooth Bleaching Agents,Y,quasi syn therclass-to-disease,Tooth Discoloration,Tooth Discoloration,C0040434,P,Y,A2.2_Finding,,,,exact (CUI-based),Tooth Bleaching Agents,Tooth Bleaching Agents,C2936347,P,A1.4_Substance,,,
1_000531,MeSH_PA,C041319,isoleucyl-prolyl-arginine-4-nitroanilide,77672-35-6,Isoleucyl-prolyl-arginine-4-nitroanilide,ChemID+,exact,,,,,,,,Isoleucyl-prolyl-arginine-4-nitroanilide,,77672-35-6,exact,,,,isoleucyl-prolyl-arginine-4-nitroanilide,C041319,77672-35-6,exact,,,,Isoleucyl-Prolyl-Arginine-4-Nitroanilide,C0063991,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Chromogenic Compounds,Chromogenic Compounds,Y,exact (CUI-based),Chromogenic Compounds,Chromogenic Compounds,C0008583,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000532,MeSH_PA,C041319,isoleucyl-prolyl-arginine-4-nitroanilide,77672-35-6,Isoleucyl-prolyl-arginine-4-nitroanilide,ChemID+,exact,,,,,,,,Isoleucyl-prolyl-arginine-4-nitroanilide,,77672-35-6,exact,,,,isoleucyl-prolyl-arginine-4-nitroanilide,C041319,77672-35-6,exact,,,,Isoleucyl-Prolyl-Arginine-4-Nitroanilide,C0063991,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000533,MeSH_PA,C041319,isoleucyl-prolyl-arginine-4-nitroanilide,77672-35-6,Isoleucyl-prolyl-arginine-4-nitroanilide,ChemID+,exact,,,,,,,,Isoleucyl-prolyl-arginine-4-nitroanilide,,77672-35-6,exact,,,,isoleucyl-prolyl-arginine-4-nitroanilide,C041319,77672-35-6,exact,,,,Isoleucyl-Prolyl-Arginine-4-Nitroanilide,C0063991,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000534,MeSH_PA,C009686,N-ethyl-5-phenylisoxazolium-3'-sulfonate,4156-16-5,N-ethyl-5-phenylisoxazolium-3'-sulfonate,ChemID+,exact,,,,,,,,N-ethyl-5-phenylisoxazolium-3'-sulfonate,,4156-16-5,exact,,,,N-ethyl-5-phenylisoxazolium-3'-sulfonate,C009686,4156-16-5,exact,,,,N-Ethyl-5-Phenylisoxazolium-3'-Sulfonate,C0131076,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000535,ChEBI,,"2',6'-dihydroxy-4'-methoxydihydrochalcone",35241-55-5,"2',6'-dihydroxy-4'-methoxydihydrochalcone",ChEBI,exact,"2',6'-dihydroxy-4'-methoxydihydrochalcone",28523,35241-55-5,exact,,,,"2',6'-Dihydroxy-4'-methoxychalcone",,77129-49-8,NT salt/deriv/analog/df,,,,"2',6'-dihydroxy-4'-methoxydihydrochalcone",C424502,,exact,,,,"2',6'-Dihydroxy-4'-Methoxydihydrochalcone",C0965649,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,antiplasmodial drug,antiplasmodial drug,Y,quasi syn therclass-to-disease,plasmodium infections,Malaria,C0024530,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_000536,ChEBI,,"2',6'-dihydroxy-4'-methoxydihydrochalcone",35241-55-5,"2',6'-dihydroxy-4'-methoxydihydrochalcone",ChEBI,exact,"2',6'-dihydroxy-4'-methoxydihydrochalcone",28523,35241-55-5,exact,,,,"2',6'-Dihydroxy-4'-methoxychalcone",,77129-49-8,NT salt/deriv/analog/df,,,,"2',6'-dihydroxy-4'-methoxydihydrochalcone",C424502,,exact,,,,"2',6'-Dihydroxy-4'-Methoxydihydrochalcone",C0965649,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,radical scavenger,radical scavenger,Y,quasi syn therclass-to-function,Free Radical Scavenging [Moa],Free Radical Scavenging [Moa],C1517315,P,Y,B2.2.1.1.4_Molecular Function,,,,quasi syn,Free Radical Scavengers,Free Radical Scavengers,C0079381,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_000537,MeSH_PA,C033830,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",77779-60-3,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",ChemID+,exact,,,,,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",,77779-60-3,exact,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C033830,77779-60-3,exact,,,,"2-Phenylpyrazolo(4,3-C)Quinolin-3(5H)-One",C0093669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000538,MeSH_PA,C033830,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",77779-60-3,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",ChemID+,exact,,,,,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",,77779-60-3,exact,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C033830,77779-60-3,exact,,,,"2-Phenylpyrazolo(4,3-C)Quinolin-3(5H)-One",C0093669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Stimulants,Central Nervous System Stimulants,Y,quasi syn therclass-to-function,central nervous system stimulation,Central Nervous System Stimulation [Pe],C2917138,S,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Central Nervous System Stimulants,Central Nervous System Stimulants,C0002763,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000539,MeSH_PA,C033830,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",77779-60-3,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",ChemID+,exact,,,,,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",,77779-60-3,exact,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C033830,77779-60-3,exact,,,,"2-Phenylpyrazolo(4,3-C)Quinolin-3(5H)-One",C0093669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Convulsants,Convulsants,Y,quasi syn therclass-to-function,Convulsant Effect,Convulsant Effect,C3179492,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Convulsants,Convulsants,C0009950,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_000540,MeSH_PA,C033830,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",77779-60-3,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",ChemID+,exact,,,,,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",,77779-60-3,exact,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C033830,77779-60-3,exact,,,,"2-Phenylpyrazolo(4,3-C)Quinolin-3(5H)-One",C0093669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,GABA Agents,GABA Agents,Y,quasi syn therclass-to-function,"Synaptic Transmission, Gabaergic","Synaptic Transmission, Gabaergic",C1816494,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Gaba Agents,Gaba Agents,C0242898,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000541,MeSH_PA,C033830,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",77779-60-3,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",ChemID+,exact,,,,,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",,77779-60-3,exact,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C033830,77779-60-3,exact,,,,"2-Phenylpyrazolo(4,3-C)Quinolin-3(5H)-One",C0093669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,6,GABA Agonists,GABA Agonists,Y,quasi syn therclass-to-function,"Synaptic Transmission, Gabaergic","Synaptic Transmission, Gabaergic",C1816494,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Gaba Agonists,Gaba Agonists,C0242974,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000542,MeSH_PA,C033830,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",77779-60-3,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",ChemID+,exact,,,,,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",,77779-60-3,exact,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C033830,77779-60-3,exact,,,,"2-Phenylpyrazolo(4,3-C)Quinolin-3(5H)-One",C0093669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,GABA Antagonists,GABA Antagonists,Y,quasi syn therclass-to-function,"Synaptic Transmission, Gabaergic","Synaptic Transmission, Gabaergic",C1816494,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Gaba Antagonists,Gaba Antagonists,C0242975,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000543,MeSH_PA,C033830,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",77779-60-3,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",ChemID+,exact,,,,,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",,77779-60-3,exact,,,,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C033830,77779-60-3,exact,,,,"2-Phenylpyrazolo(4,3-C)Quinolin-3(5H)-One",C0093669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000544,MeSH_PA,C072857,"3-(cis-2,6-dimethylpiperidino)sydnonimine",137500-42-6,Darsidomine,ChemID+,<syn per source>,,,,,,,,Darsidomine,Darsidomine [INN],137500-42-6,<syn per source>,"3-(cis-2,6-dimethylpiperidino)sydnonimine",exact,,"3-(cis-2,6-dimethylpiperidino)sydnonimine",C072857,137500-42-6,exact,,,,"3-(Cis-2,6-Dimethylpiperidino)Sydnonimine",C0209923,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000545,MeSH_PA,C072857,"3-(cis-2,6-dimethylpiperidino)sydnonimine",137500-42-6,Darsidomine,ChemID+,<syn per source>,,,,,,,,Darsidomine,Darsidomine [INN],137500-42-6,<syn per source>,"3-(cis-2,6-dimethylpiperidino)sydnonimine",exact,,"3-(cis-2,6-dimethylpiperidino)sydnonimine",C072857,137500-42-6,exact,,,,"3-(Cis-2,6-Dimethylpiperidino)Sydnonimine",C0209923,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Vasodilator Agents,Vasodilator Agents,Y,quasi syn therclass-to-function,Vasodilation,Vasodilation,C0042401,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Vasodilator Agents,Vasodilator Agents,C0042402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000546,ChEBI,,5-bromo-8-methoxy-1-methyl-beta-carboline,,,,,5-bromo-8-methoxy-1-methyl-beta-carboline,65524,,exact,,,,,,,,,,,5-bromo-8-methoxy-1-methyl-beta-carboline,C540709,,exact,,,,5-Bromo-8-Methoxy-1-Methyl-Beta-Carboline,C2715898,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,antibacterial agent,antibacterial agent,Y,quasi syn therclass-to-disease,Bacterial Infections,Bacterial Infections,C0004623,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,antibacterial agent,Anti-Bacterial Agents,C0279516,S,A1.4.1.1.1.1_Antibiotic,,,
1_000547,ChEBI,,5-bromo-8-methoxy-1-methyl-beta-carboline,,,,,5-bromo-8-methoxy-1-methyl-beta-carboline,65524,,exact,,,,,,,,,,,5-bromo-8-methoxy-1-methyl-beta-carboline,C540709,,exact,,,,5-Bromo-8-Methoxy-1-Methyl-Beta-Carboline,C2715898,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antifungal agent,antifungal agent,Y,quasi syn therclass-to-disease,fungal infections,Mycoses,C0026946,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,antifungal agent,Antifungal Agents,C0003308,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000548,ChEBI,,5-bromo-8-methoxy-1-methyl-beta-carboline,,,,,5-bromo-8-methoxy-1-methyl-beta-carboline,65524,,exact,,,,,,,,,,,5-bromo-8-methoxy-1-methyl-beta-carboline,C540709,,exact,,,,5-Bromo-8-Methoxy-1-Methyl-Beta-Carboline,C2715898,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antineoplastic agent,antineoplastic agent,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact 1,antineoplastic agent,Antineoplastic Agents,C0003392,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000549,ChEBI,,5-hydroxy-2-methylchromone-7-O-rutinoside,,,,,5-hydroxy-2-methylchromone-7-O-rutinoside,66371,,exact,,,,,,,,,,,5-hydroxy-2-methylchromone-7-O-rutinoside,C550780,,exact,,,,5-Hydroxy-2-Methylchromone-7-O-Rutinoside,C2935309,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.8_Carbohydrate,,,anti,,#VALUE!,antineoplastic agent,antineoplastic agent,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact 1,antineoplastic agent,Antineoplastic Agents,C0003392,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000550,MeSH_PA,C028877,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",73413-78-2,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",ChemID+,exact,,,,,,,,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",,73413-78-2,exact,,,,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",C028877,73413-78-2,exact,,,,"7-Nitrobenz-2-Oxa-1,3-Diazole-Phallacidin",C0049951,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000551,MeSH_PA,C028877,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",73413-78-2,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",ChemID+,exact,,,,,,,,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",,73413-78-2,exact,,,,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",C028877,73413-78-2,exact,,,,"7-Nitrobenz-2-Oxa-1,3-Diazole-Phallacidin",C0049951,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000552,MeSH_PA,C028877,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",73413-78-2,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",ChemID+,exact,,,,,,,,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",,73413-78-2,exact,,,,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",C028877,73413-78-2,exact,,,,"7-Nitrobenz-2-Oxa-1,3-Diazole-Phallacidin",C0049951,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000553,MeSH_PA,C028877,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",73413-78-2,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",ChemID+,exact,,,,,,,,"7-Nitrobenz-2-oxa-1,3-diazole-phallacidin",,73413-78-2,exact,,,,"7-nitrobenz-2-oxa-1,3-diazole-phallacidin",C028877,73413-78-2,exact,,,,"7-Nitrobenz-2-Oxa-1,3-Diazole-Phallacidin",C0049951,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000554,MeSH_PA,C046465,"8-amino-1,3,6-naphthalenetrisulfonic acid",117-42-0,"8-Amino-1,3,6-naphthalenetrisulfonic acid",ChemID+,exact,,,,,,,,"8-Amino-1,3,6-naphthalenetrisulfonic acid",,117-42-0,exact,,,,"8-amino-1,3,6-naphthalenetrisulfonic acid",C046465,117-42-0,exact,,,,"8-Amino-1,3,6-Naphthalenetrisulfonic Acid",C0050021,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000555,MeSH_PA,C046465,"8-amino-1,3,6-naphthalenetrisulfonic acid",117-42-0,"8-Amino-1,3,6-naphthalenetrisulfonic acid",ChemID+,exact,,,,,,,,"8-Amino-1,3,6-naphthalenetrisulfonic acid",,117-42-0,exact,,,,"8-amino-1,3,6-naphthalenetrisulfonic acid",C046465,117-42-0,exact,,,,"8-Amino-1,3,6-Naphthalenetrisulfonic Acid",C0050021,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000556,MeSH_PA,C046465,"8-amino-1,3,6-naphthalenetrisulfonic acid",117-42-0,"8-Amino-1,3,6-naphthalenetrisulfonic acid",ChemID+,exact,,,,,,,,"8-Amino-1,3,6-naphthalenetrisulfonic acid",,117-42-0,exact,,,,"8-amino-1,3,6-naphthalenetrisulfonic acid",C046465,117-42-0,exact,,,,"8-Amino-1,3,6-Naphthalenetrisulfonic Acid",C0050021,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000557,MeSH_PA,C046465,"8-amino-1,3,6-naphthalenetrisulfonic acid",117-42-0,"8-Amino-1,3,6-naphthalenetrisulfonic acid",ChemID+,exact,,,,,,,,"8-Amino-1,3,6-naphthalenetrisulfonic acid",,117-42-0,exact,,,,"8-amino-1,3,6-naphthalenetrisulfonic acid",C046465,117-42-0,exact,,,,"8-Amino-1,3,6-Naphthalenetrisulfonic Acid",C0050021,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000558,MeSH_PA,C012275,"P(1),P(5)-di(adenosine-5'-)pentaphosphate",50304-44-4,"P(1),P(5)-Di(adenosine-5'-)pentaphosphate",ChemID+,exact,"P(1),P(5)-bis(5'-adenosyl) pentaphosphate",28898,50304-44-4,<syn per source>,"P(1),P(5)-Di(adenosine-5'-)pentaphosphate",exact,,"P(1),P(5)-Di(adenosine-5'-)pentaphosphate",,50304-44-4,exact,,,,"P(1),P(5)-di(adenosine-5'-)pentaphosphate",C012275,50304-44-4,exact,,,,"P(1),P(5)-Di(Adenosine-5'-)Pentaphosphate",C0069894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000559,MeSH_PA,C012275,"P(1),P(5)-di(adenosine-5'-)pentaphosphate",50304-44-4,"P(1),P(5)-Di(adenosine-5'-)pentaphosphate",ChemID+,exact,"P(1),P(5)-bis(5'-adenosyl) pentaphosphate",28898,50304-44-4,<syn per source>,"P(1),P(5)-Di(adenosine-5'-)pentaphosphate",exact,,"P(1),P(5)-Di(adenosine-5'-)pentaphosphate",,50304-44-4,exact,,,,"P(1),P(5)-di(adenosine-5'-)pentaphosphate",C012275,50304-44-4,exact,,,,"P(1),P(5)-Di(Adenosine-5'-)Pentaphosphate",C0069894,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,causes,,#VALUE!,Vasoconstrictor Agents,Vasoconstrictor Agents,Y,quasi syn therclass-to-function,vasoconstriction,Vascular Constriction (Function),C0042396,S,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Vasoconstrictor Agents,Vasoconstrictor Agents,C0042397,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000560,MeSH_PA,C007510,"1,2-dipalmitoyl-3-phosphatidylethanolamine",3026-45-7,"1,2-dipalmitoyl-3-phosphatidylethanolamine",CTD,exact,,,,,,,,,,,,,,,"1,2-dipalmitoyl-3-phosphatidylethanolamine",C007510,3026-45-7,exact,,,,"1,2-Dipalmitoyl-3-Phosphatidylethanolamine",C0043843,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000561,MeSH_PA,C007510,"1,2-dipalmitoyl-3-phosphatidylethanolamine",3026-45-7,"1,2-dipalmitoyl-3-phosphatidylethanolamine",CTD,exact,,,,,,,,,,,,,,,"1,2-dipalmitoyl-3-phosphatidylethanolamine",C007510,3026-45-7,exact,,,,"1,2-Dipalmitoyl-3-Phosphatidylethanolamine",C0043843,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000562,MeSH_PA,C040051,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",85278-66-6,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",ChemID+,exact,,,,,,,,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",,85278-66-6,exact,,,,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",C040051,85278-66-6,exact,,,,"2-(3,4-Dimethoxyphenyl)-3-Fluoroallylamine",C0045694,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anthelmintics,Anthelmintics,Y,quasi syn therclass-to-disease,Helminthiasis,Helminthiasis,C0018889,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anthelmintics,Anthelmintics,C0003158,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000563,MeSH_PA,C040051,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",85278-66-6,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",ChemID+,exact,,,,,,,,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",,85278-66-6,exact,,,,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",C040051,85278-66-6,exact,,,,"2-(3,4-Dimethoxyphenyl)-3-Fluoroallylamine",C0045694,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000564,MeSH_PA,C040051,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",85278-66-6,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",ChemID+,exact,,,,,,,,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",,85278-66-6,exact,,,,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",C040051,85278-66-6,exact,,,,"2-(3,4-Dimethoxyphenyl)-3-Fluoroallylamine",C0045694,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antinematodal Agents,Antinematodal Agents,Y,quasi syn therclass-to-disease,Nematode Infections,Nematode Infections,C0027583,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antinematodal Agents,Antinematodal Agents,C0003391,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000565,MeSH_PA,C040051,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",85278-66-6,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",ChemID+,exact,,,,,,,,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",,85278-66-6,exact,,,,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",C040051,85278-66-6,exact,,,,"2-(3,4-Dimethoxyphenyl)-3-Fluoroallylamine",C0045694,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000566,MeSH_PA,C040051,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",85278-66-6,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",ChemID+,exact,,,,,,,,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",,85278-66-6,exact,,,,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",C040051,85278-66-6,exact,,,,"2-(3,4-Dimethoxyphenyl)-3-Fluoroallylamine",C0045694,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000567,MeSH_PA,C040051,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",85278-66-6,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",ChemID+,exact,,,,,,,,"2-(3,4-Dimethoxyphenyl)-3-fluoroallylamine",,85278-66-6,exact,,,,"2-(3,4-dimethoxyphenyl)-3-fluoroallylamine",C040051,85278-66-6,exact,,,,"2-(3,4-Dimethoxyphenyl)-3-Fluoroallylamine",C0045694,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Monoamine Oxidase Inhibitors,Monoamine Oxidase Inhibitors,Y,quasi syn therclass-to-function,amine oxidase activity,Primary Amine Oxidase Activity,C1151830,S,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Monoamine Oxidase Inhibitors,Monoamine Oxidase Inhibitors,C0026457,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000568,MeSH_PA,C009497,2-(4-toluidino)-6-naphthalenesulfonic acid,7724-15-4,2-(4-Toluidino)-6-naphthalenesulfonic acid,ChemID+,exact,,,,,,,,2-(4-Toluidino)-6-naphthalenesulfonic acid,,7724-15-4,exact,,,,2-(4-toluidino)-6-naphthalenesulfonic acid,C009497,7724-15-4,exact,,,,2-(4-Toluidino)-6-Naphthalenesulfonic Acid,C0045733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000569,MeSH_PA,C009497,2-(4-toluidino)-6-naphthalenesulfonic acid,7724-15-4,2-(4-Toluidino)-6-naphthalenesulfonic acid,ChemID+,exact,,,,,,,,2-(4-Toluidino)-6-naphthalenesulfonic acid,,7724-15-4,exact,,,,2-(4-toluidino)-6-naphthalenesulfonic acid,C009497,7724-15-4,exact,,,,2-(4-Toluidino)-6-Naphthalenesulfonic Acid,C0045733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000570,MeSH_PA,C009497,2-(4-toluidino)-6-naphthalenesulfonic acid,7724-15-4,2-(4-Toluidino)-6-naphthalenesulfonic acid,ChemID+,exact,,,,,,,,2-(4-Toluidino)-6-naphthalenesulfonic acid,,7724-15-4,exact,,,,2-(4-toluidino)-6-naphthalenesulfonic acid,C009497,7724-15-4,exact,,,,2-(4-Toluidino)-6-Naphthalenesulfonic Acid,C0045733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000571,MeSH_PA,C009497,2-(4-toluidino)-6-naphthalenesulfonic acid,7724-15-4,2-(4-Toluidino)-6-naphthalenesulfonic acid,ChemID+,exact,,,,,,,,2-(4-Toluidino)-6-naphthalenesulfonic acid,,7724-15-4,exact,,,,2-(4-toluidino)-6-naphthalenesulfonic acid,C009497,7724-15-4,exact,,,,2-(4-Toluidino)-6-Naphthalenesulfonic Acid,C0045733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000572,MeSH_PA,C016358,"2,4-diamino-5-adamantyl-6-methylpyrimidine",31935-08-7,"2,4-Diamino-5-adamantyl-6-methylpyrimidine",ChemID+,exact,,,,,,,,"2,4-Diamino-5-adamantyl-6-methylpyrimidine",,31935-08-7,exact,,,,"2,4-diamino-5-adamantyl-6-methylpyrimidine",C016358,31935-08-7,exact,,,,"2,4-Diamino-5-Adamantyl-6-Methylpyrimidine",C0045465,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000573,MeSH_PA,C016358,"2,4-diamino-5-adamantyl-6-methylpyrimidine",31935-08-7,"2,4-Diamino-5-adamantyl-6-methylpyrimidine",ChemID+,exact,,,,,,,,"2,4-Diamino-5-adamantyl-6-methylpyrimidine",,31935-08-7,exact,,,,"2,4-diamino-5-adamantyl-6-methylpyrimidine",C016358,31935-08-7,exact,,,,"2,4-Diamino-5-Adamantyl-6-Methylpyrimidine",C0045465,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000574,MeSH_PA,C016358,"2,4-diamino-5-adamantyl-6-methylpyrimidine",31935-08-7,"2,4-Diamino-5-adamantyl-6-methylpyrimidine",ChemID+,exact,,,,,,,,"2,4-Diamino-5-adamantyl-6-methylpyrimidine",,31935-08-7,exact,,,,"2,4-diamino-5-adamantyl-6-methylpyrimidine",C016358,31935-08-7,exact,,,,"2,4-Diamino-5-Adamantyl-6-Methylpyrimidine",C0045465,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Folic Acid Antagonists,Folic Acid Antagonists,Y,quasi syn therclass-to-disease,Folic Acid Overdose,Folic Acid Overdose,C0573830,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Folic Acid Antagonists,Folic Acid Antagonists,C0016411,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000575,ChEBI,,"3',4',5-trihydroxy-3,6,7-trimethoxyflavone",578-71-2,"3,4',5-Trihydroxy-3',6,7-trimethoxyflavone",ChemID+,syn no\W,"3',4',5-trihydroxy-3,6,7-trimethoxyflavone",18016,,exact,,,,"3,4',5-Trihydroxy-3',6,7-trimethoxyflavone",,578-71-2,syn no\W,,,,chrysosplenol D,C568008,,<syn per source>,"3',4',5-trihydroxy-3,6,7-trimethoxyflavone",exact,,"3',4',5-Trihydroxy-3,6,7-Trimethoxyflavone",C3252491,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antineoplastic agent,antineoplastic agent,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact 1,antineoplastic agent,Antineoplastic Agents,C0003392,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000576,MeSH_PA,C052873,3'-azido-3'-deoxythymidine 5'-triphosphate,92586-35-1,Zidovudine triphosphate,ChemID+,<syn per source>,,,,,,,,Zidovudine triphosphate,,92586-35-1,<syn per source>,3'-Azido-3'-deoxythymidine 5'-triphosphate,exact,,3'-azido-3'-deoxythymidine 5'-triphosphate,C052873,92586-35-1,exact,,,,3'-Azido-3'-Deoxythymidine 5'-Triphosphate,C0046793,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-HIV Agents,Anti-HIV Agents,Y,quasi syn therclass-to-disease,Hiv Infections,Hiv Infections,C0019693,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Hiv Agents,Anti-Hiv Agents,C0376565,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000577,MeSH_PA,C052873,3'-azido-3'-deoxythymidine 5'-triphosphate,92586-35-1,Zidovudine triphosphate,ChemID+,<syn per source>,,,,,,,,Zidovudine triphosphate,,92586-35-1,<syn per source>,3'-Azido-3'-deoxythymidine 5'-triphosphate,exact,,3'-azido-3'-deoxythymidine 5'-triphosphate,C052873,92586-35-1,exact,,,,3'-Azido-3'-Deoxythymidine 5'-Triphosphate,C0046793,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000578,MeSH_PA,C052873,3'-azido-3'-deoxythymidine 5'-triphosphate,92586-35-1,Zidovudine triphosphate,ChemID+,<syn per source>,,,,,,,,Zidovudine triphosphate,,92586-35-1,<syn per source>,3'-Azido-3'-deoxythymidine 5'-triphosphate,exact,,3'-azido-3'-deoxythymidine 5'-triphosphate,C052873,92586-35-1,exact,,,,3'-Azido-3'-Deoxythymidine 5'-Triphosphate,C0046793,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Retroviral Agents,Anti-Retroviral Agents,Y,quasi syn therclass-to-disease,retroviral infections,Retroviridae Infections,C0035369,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Retroviral Agents,Anti-Retroviral Agents,C0599685,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000579,MeSH_PA,C052873,3'-azido-3'-deoxythymidine 5'-triphosphate,92586-35-1,Zidovudine triphosphate,ChemID+,<syn per source>,,,,,,,,Zidovudine triphosphate,,92586-35-1,<syn per source>,3'-Azido-3'-deoxythymidine 5'-triphosphate,exact,,3'-azido-3'-deoxythymidine 5'-triphosphate,C052873,92586-35-1,exact,,,,3'-Azido-3'-Deoxythymidine 5'-Triphosphate,C0046793,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000580,MeSH_PA,C095489,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",138026-71-8,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",ChemID+,exact,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",51107,,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",,138026-71-8,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",C095489,,exact,,,,"4,4-Difluoro-4-Bora-3A,4A-Diaza-S-Indacene",C1176304,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000581,MeSH_PA,C095489,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",138026-71-8,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",ChemID+,exact,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",51107,,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",,138026-71-8,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",C095489,,exact,,,,"4,4-Difluoro-4-Bora-3A,4A-Diaza-S-Indacene",C1176304,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000582,MeSH_PA,C095489,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",138026-71-8,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",ChemID+,exact,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",51107,,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",,138026-71-8,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",C095489,,exact,,,,"4,4-Difluoro-4-Bora-3A,4A-Diaza-S-Indacene",C1176304,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000583,MeSH_PA,C095489,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",138026-71-8,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",ChemID+,exact,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",51107,,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",,138026-71-8,exact,,,,"4,4-difluoro-4-bora-3a,4a-diaza-s-indacene",C095489,,exact,,,,"4,4-Difluoro-4-Bora-3A,4A-Diaza-S-Indacene",C1176304,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000584,MeSH_PA,C042375,"4-diphenylacetoxy-1,1-dimethylpiperidinium",81405-11-0,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",ChemID+,exact,4-DAMP(1+),73467,81405-11-0,<syn per source>,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",exact,,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",,81405-11-0,exact,,,,"4-diphenylacetoxy-1,1-dimethylpiperidinium",C042375,81405-11-0,exact,,,,"4-Diphenylacetoxy-1,1-Dimethylpiperidinium",C0048255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000585,MeSH_PA,C042375,"4-diphenylacetoxy-1,1-dimethylpiperidinium",81405-11-0,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",ChemID+,exact,4-DAMP(1+),73467,81405-11-0,<syn per source>,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",exact,,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",,81405-11-0,exact,,,,"4-diphenylacetoxy-1,1-dimethylpiperidinium",C042375,81405-11-0,exact,,,,"4-Diphenylacetoxy-1,1-Dimethylpiperidinium",C0048255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000586,MeSH_PA,C042375,"4-diphenylacetoxy-1,1-dimethylpiperidinium",81405-11-0,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",ChemID+,exact,4-DAMP(1+),73467,81405-11-0,<syn per source>,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",exact,,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",,81405-11-0,exact,,,,"4-diphenylacetoxy-1,1-dimethylpiperidinium",C042375,81405-11-0,exact,,,,"4-Diphenylacetoxy-1,1-Dimethylpiperidinium",C0048255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Cholinergic Antagonists,Cholinergic Antagonists,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Antagonists,Cholinergic Antagonists,C0242897,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000587,MeSH_PA,C042375,"4-diphenylacetoxy-1,1-dimethylpiperidinium",81405-11-0,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",ChemID+,exact,4-DAMP(1+),73467,81405-11-0,<syn per source>,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",exact,,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",,81405-11-0,exact,,,,"4-diphenylacetoxy-1,1-dimethylpiperidinium",C042375,81405-11-0,exact,,,,"4-Diphenylacetoxy-1,1-Dimethylpiperidinium",C0048255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Muscarinic Antagonists,Muscarinic Antagonists,Y,quasi syn therclass-to-function,Muscarinic Acetylcholine Receptor Activity,Muscarinic Acetylcholine Receptor Activity,C1148664,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Muscarinic Antagonists,Muscarinic Antagonists,C0003385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000588,MeSH_PA,C042375,"4-diphenylacetoxy-1,1-dimethylpiperidinium",81405-11-0,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",ChemID+,exact,4-DAMP(1+),73467,81405-11-0,<syn per source>,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",exact,,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",,81405-11-0,exact,,,,"4-diphenylacetoxy-1,1-dimethylpiperidinium",C042375,81405-11-0,exact,,,,"4-Diphenylacetoxy-1,1-Dimethylpiperidinium",C0048255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000589,MeSH_PA,C042375,"4-diphenylacetoxy-1,1-dimethylpiperidinium",81405-11-0,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",ChemID+,exact,4-DAMP(1+),73467,81405-11-0,<syn per source>,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",exact,,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",,81405-11-0,exact,,,,"4-diphenylacetoxy-1,1-dimethylpiperidinium",C042375,81405-11-0,exact,,,,"4-Diphenylacetoxy-1,1-Dimethylpiperidinium",C0048255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Parasympatholytics,Parasympatholytics,Y,quasi syn therclass-to-function,Parasympatholytic Effect,Parasympatholytic Effect,C3179241,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Parasympatholytics,Parasympatholytics,C0030511,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000590,MeSH_PA,C042375,"4-diphenylacetoxy-1,1-dimethylpiperidinium",81405-11-0,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",ChemID+,exact,4-DAMP(1+),73467,81405-11-0,<syn per source>,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",exact,,"4-Diphenylacetoxy-1,1-dimethylpiperidinium",,81405-11-0,exact,,,,"4-diphenylacetoxy-1,1-dimethylpiperidinium",C042375,81405-11-0,exact,,,,"4-Diphenylacetoxy-1,1-Dimethylpiperidinium",C0048255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000591,ChEBI,,"7,8-didemethyl-8-hydroxy-5-deazariboflavin",37333-48-5,Factor 420,ChemID+,<syn per source>,"7,8-didemethyl-8-hydroxy-5-deazariboflavin",43034,37333-48-5,exact,,,,Factor 420,,37333-48-5,<syn per source>,"7,8-Didemethyl-8-hydroxy-5-deazariboflavin",exact,,factor 420,C007701,37333-48-5,<syn per source>,"7,8-didemethyl-8-hydroxy-5-deazariboflavin",exact,,"7,8-Didemethyl-8-Hydroxy-5-Deazariboflavin",C0099562,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,prosthetic group,prosthetic group,Y,NT,Reagents,Reagents,C0034760,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000592,ChEBI,,7-hydroxy-6-methyl-8-(1-D-ribityl)lumazine,2184-54-5,Masuda's compound V,ChemID+,<syn per source>,7-hydroxy-6-methyl-8-(1-D-ribityl)lumazine,27581,2184-54-5,exact,,,,Masuda's compound V,,2184-54-5,<syn per source>,7-Hydroxy-6-methyl-8-(1-D-ribityl)lumazine,exact,,Masuda's Compound V,C008332,2184-54-5,<syn per source>,7-hydroxy-6-methyl-8-(1-D-ribityl)lumazine,exact,,7-Hydroxy-6-Methyl-8-(1-D-Ribityl)Lumazine,C0099850,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits, inhibitor,riboflavin synthetase inhibitor,riboflavin synthetase inhibitor,Y,quasi syn therclass-to-function,Riboflavin Synthetase Activity,Riboflavin Synthetase Activity,C2261757,P,Y,B2.2.1.1.4_Molecular Function,,,,,,,,,,,,
1_000593,MeSH_PA,C045895,"9-((2,3-dihydroxy-1-propoxy)methyl)guanine",96429-66-2,"9-((2,3-Dihydroxy-1-propoxy)methyl)guanine",ChemID+,exact,,,,,,,,"9-((2,3-Dihydroxy-1-propoxy)methyl)guanine",,96429-66-2,exact,,,,"9-((2,3-dihydroxy-1-propoxy)methyl)guanine",C045895,96429-66-2,exact,,,,"9-((2,3-Dihydroxy-1-Propoxy)Methyl)Guanine",C0050163,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000594,MeSH_PA,C045895,"9-((2,3-dihydroxy-1-propoxy)methyl)guanine",96429-66-2,"9-((2,3-Dihydroxy-1-propoxy)methyl)guanine",ChemID+,exact,,,,,,,,"9-((2,3-Dihydroxy-1-propoxy)methyl)guanine",,96429-66-2,exact,,,,"9-((2,3-dihydroxy-1-propoxy)methyl)guanine",C045895,96429-66-2,exact,,,,"9-((2,3-Dihydroxy-1-Propoxy)Methyl)Guanine",C0050163,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000595,MeSH_PA,C043105,methoxyethylene-maleic anhydride copolymer,9011-16-9,"2,5-Furandione, polymer with methoxyethylene",ChemID+,<syn per source>,,,,,,,,"2,5-Furandione, polymer with methoxyethylene",,9011-16-9,<syn per source>,Methoxyethylene-maleic anhydride copolymer,exact,,methoxyethylene-maleic anhydride copolymer,C043105,9011-16-9,exact,,,,Methoxyethylene-Maleic Anhydride Copolymer,C0164183,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Delayed-Action Preparations,Delayed-Action Preparations,Y,exact (CUI-based),Delayed-Action Preparations,Delayed-Action Preparations,C0011202,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000596,MeSH_PA,C044388,N-(2-aminoethyl)-5-isoquinolinesulfonamide,84468-17-7,N-(2-Aminoethyl)-5-isoquinolinesulfonamide,ChemID+,exact,,,,,,,,N-(2-Aminoethyl)-5-isoquinolinesulfonamide,,84468-17-7,exact,,,,N-(2-aminoethyl)-5-isoquinolinesulfonamide,C044388,84468-17-7,exact,,,,N-(2-Aminoethyl)-5-Isoquinolinesulfonamide,C0067456,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000597,MeSH_PA,C044388,N-(2-aminoethyl)-5-isoquinolinesulfonamide,84468-17-7,N-(2-Aminoethyl)-5-isoquinolinesulfonamide,ChemID+,exact,,,,,,,,N-(2-Aminoethyl)-5-isoquinolinesulfonamide,,84468-17-7,exact,,,,N-(2-aminoethyl)-5-isoquinolinesulfonamide,C044388,84468-17-7,exact,,,,N-(2-Aminoethyl)-5-Isoquinolinesulfonamide,C0067456,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protein Kinase Inhibitors,Protein Kinase Inhibitors,Y,quasi syn therclass-to-function,Protein Kinase Activity,Protein Kinase Activity,C1150527,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Protein Kinase Inhibitors,Protein Kinase Inhibitors,C1449702,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,
1_000598,MeSH_PA,C095284,"1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one",,,,,,,,,,,,"1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1-one",,C095284000,exact,,,,"1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one",C095284,,exact,,,,"1H-(1,2,4)Oxadiazolo(4,3-A)Quinoxalin-1-One",C0380770,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000599,ChEBI,,"1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene",,,,,"1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene",65845,,exact,,,,,,,,,,,"4-endoperoxy-bisabola-2,10-diene",C412948,,<syn per source>,"1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene",exact,,"1R,4S,6R-1,4-Endoperoxy-Bisabola-2,10-Diene",C0960602,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,antineoplastic agent,antineoplastic agent,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact 1,antineoplastic agent,Antineoplastic Agents,C0003392,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000600,ChEBI,,"1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene",,,,,"1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene",65845,,exact,,,,,,,,,,,"4-endoperoxy-bisabola-2,10-diene",C412948,,<syn per source>,"1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene",exact,,"1R,4S,6R-1,4-Endoperoxy-Bisabola-2,10-Diene",C0960602,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,antiplasmodial drug,antiplasmodial drug,Y,quasi syn therclass-to-disease,plasmodium infections,Malaria,C0024530,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_000601,MeSH_PA,C036989,"2-amino-3,4-dimethylimidazo(4,5-f)quinoline",77094-11-2,"2-Amino-3,4-dimethylimidazo(4,5-f)quinoline",ChemID+,exact,,,,,,,,"2-Amino-3,4-dimethylimidazo(4,5-f)quinoline",,77094-11-2,exact,,,,"2-amino-3,4-dimethylimidazo(4,5-f)quinoline",C036989,77094-11-2,exact,,,,"2-Amino-3,4-Dimethylimidazo(4,5-F)Quinoline",C0045819,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000602,MeSH_PA,C036989,"2-amino-3,4-dimethylimidazo(4,5-f)quinoline",77094-11-2,"2-Amino-3,4-dimethylimidazo(4,5-f)quinoline",ChemID+,exact,,,,,,,,"2-Amino-3,4-dimethylimidazo(4,5-f)quinoline",,77094-11-2,exact,,,,"2-amino-3,4-dimethylimidazo(4,5-f)quinoline",C036989,77094-11-2,exact,,,,"2-Amino-3,4-Dimethylimidazo(4,5-F)Quinoline",C0045819,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000603,MeSH_PA,C036989,"2-amino-3,4-dimethylimidazo(4,5-f)quinoline",77094-11-2,"2-Amino-3,4-dimethylimidazo(4,5-f)quinoline",ChemID+,exact,,,,,,,,"2-Amino-3,4-dimethylimidazo(4,5-f)quinoline",,77094-11-2,exact,,,,"2-amino-3,4-dimethylimidazo(4,5-f)quinoline",C036989,77094-11-2,exact,,,,"2-Amino-3,4-Dimethylimidazo(4,5-F)Quinoline",C0045819,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000604,MeSH_PA,C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",62450-06-0,Trp-P-1,ChemID+,<syn per source>,,,,,,,,Trp-P-1,,62450-06-0,<syn per source>,"3-Amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",exact,,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,,exact,,,,"3-Amino-1,4-Dimethyl-5H-Pyrido(4,3-B)Indole",C0077413,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000605,MeSH_PA,C019132,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",62450-06-0,Trp-P-1,ChemID+,<syn per source>,,,,,,,,Trp-P-1,,62450-06-0,<syn per source>,"3-Amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",exact,,"3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole",C019132,,exact,,,,"3-Amino-1,4-Dimethyl-5H-Pyrido(4,3-B)Indole",C0077413,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000606,MeSH_PA,C052247,4-(4-diethylaminostyryl)-N-methylpyridinium,105802-46-8,4-(4-Diethylaminostyryl)-N-methylpyridinium,ChemID+,exact,,,,,,,,4-(4-Diethylaminostyryl)-N-methylpyridinium,,105802-46-8,exact,,,,4-(4-diethylaminostyryl)-N-methylpyridinium,C052247,105802-46-8,exact,,,,4-(4-Diethylaminostyryl)-N-Methylpyridinium,C0047916,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000607,MeSH_PA,C052247,4-(4-diethylaminostyryl)-N-methylpyridinium,105802-46-8,4-(4-Diethylaminostyryl)-N-methylpyridinium,ChemID+,exact,,,,,,,,4-(4-Diethylaminostyryl)-N-methylpyridinium,,105802-46-8,exact,,,,4-(4-diethylaminostyryl)-N-methylpyridinium,C052247,105802-46-8,exact,,,,4-(4-Diethylaminostyryl)-N-Methylpyridinium,C0047916,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000608,MeSH_PA,C052247,4-(4-diethylaminostyryl)-N-methylpyridinium,105802-46-8,4-(4-Diethylaminostyryl)-N-methylpyridinium,ChemID+,exact,,,,,,,,4-(4-Diethylaminostyryl)-N-methylpyridinium,,105802-46-8,exact,,,,4-(4-diethylaminostyryl)-N-methylpyridinium,C052247,105802-46-8,exact,,,,4-(4-Diethylaminostyryl)-N-Methylpyridinium,C0047916,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000609,MeSH_PA,C052247,4-(4-diethylaminostyryl)-N-methylpyridinium,105802-46-8,4-(4-Diethylaminostyryl)-N-methylpyridinium,ChemID+,exact,,,,,,,,4-(4-Diethylaminostyryl)-N-methylpyridinium,,105802-46-8,exact,,,,4-(4-diethylaminostyryl)-N-methylpyridinium,C052247,105802-46-8,exact,,,,4-(4-Diethylaminostyryl)-N-Methylpyridinium,C0047916,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000610,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000611,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000612,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000613,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000614,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000615,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000616,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,Y,quasi syn therclass-to-function,Lipoxygenase Activity,Lipoxygenase Activity,C1151586,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,C0085385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000617,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000618,MeSH_PA,C053726,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",93211-49-5,L 651392,ChemID+,<syn per source>,,,,,,,,L 651392,,93211-49-5,<syn per source>,"4-Bromo-2,7-dimethoxy-3H-phenothiazin-3-one",exact,,"4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one",C053726,93211-49-5,exact,,,,"4-Bromo-2,7-Dimethoxy-3H-Phenothiazin-3-One",C0096801,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000619,MeSH_PA,C037399,4-methyl-4-aza-3-oxopregnane-20-carboxylate,85531-68-6,4-Methyl-4-aza-3-oxopregnane-20-carboxylate,ChemID+,exact,,,,,,,,4-Methyl-4-aza-3-oxopregnane-20-carboxylate,,85531-68-6,exact,,,,4-methyl-4-aza-3-oxopregnane-20-carboxylate,C037399,92472-61-2,exact,,,,4-Methyl-4-Aza-3-Oxopregnane-20-Carboxylate,C0048476,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,inhibitor,inhibits,Inhibitors,5-alpha Reductase Inhibitors,5-alpha Reductase Inhibitors,Y,quasi syn therclass-to-function,Steroid 5-Alpha Reductase Activity,Steroid 5-Alpha Reductase Activity,C2254641,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),5-Alpha Reductase Inhibitors,5-Alpha Reductase Inhibitors,C2936788,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000620,MeSH_PA,C037399,4-methyl-4-aza-3-oxopregnane-20-carboxylate,85531-68-6,4-Methyl-4-aza-3-oxopregnane-20-carboxylate,ChemID+,exact,,,,,,,,4-Methyl-4-aza-3-oxopregnane-20-carboxylate,,85531-68-6,exact,,,,4-methyl-4-aza-3-oxopregnane-20-carboxylate,C037399,92472-61-2,exact,,,,4-Methyl-4-Aza-3-Oxopregnane-20-Carboxylate,C0048476,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000621,MeSH_PA,C039599,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,77858-21-0,Velaresol,ChemID+,<syn per source>,,,,,,,,Velaresol,Velaresol [INN:BAN],77858-21-0,<syn per source>,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,exact,,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,C039599,77858-21-0,exact,,,,5-(2-Formyl-3-Hydroxyphenoxy)Pentanoic Acid,C0950600,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antisickling Agents,Antisickling Agents,Y,quasi syn therclass-to-disease,"Anemia, Sickle Cell","Anemia, Sickle Cell",C0002895,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antisickling Agents,Antisickling Agents,C0003429,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000622,MeSH_PA,C039599,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,77858-21-0,Velaresol,ChemID+,<syn per source>,,,,,,,,Velaresol,Velaresol [INN:BAN],77858-21-0,<syn per source>,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,exact,,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,C039599,77858-21-0,exact,,,,5-(2-Formyl-3-Hydroxyphenoxy)Pentanoic Acid,C0950600,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000623,MeSH_PA,C039599,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,77858-21-0,Velaresol,ChemID+,<syn per source>,,,,,,,,Velaresol,Velaresol [INN:BAN],77858-21-0,<syn per source>,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,exact,,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,C039599,77858-21-0,exact,,,,5-(2-Formyl-3-Hydroxyphenoxy)Pentanoic Acid,C0950600,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000624,MeSH_PA,C039599,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,77858-21-0,Velaresol,ChemID+,<syn per source>,,,,,,,,Velaresol,Velaresol [INN:BAN],77858-21-0,<syn per source>,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,exact,,5-(2-formyl-3-hydroxyphenoxy)pentanoic acid,C039599,77858-21-0,exact,,,,5-(2-Formyl-3-Hydroxyphenoxy)Pentanoic Acid,C0950600,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Protective Agents,Radiation-Protective Agents,Y,quasi syn therclass-to-function,Radiation-Protective Effect,Radiation-Protective Effect,C3179279,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Protective Agents,Radiation-Protective Agents,C0034540,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000625,MeSH_PA,C044888,5-bromo-4-chloro-3-indolyl beta-galactoside,7240-90-6,5-Bromo-4-chloro-3-indolyl beta-galactoside,ChemID+,exact,5-bromo-4-chloro-3-indolyl beta-D-galactoside,75055,7240-90-6,<syn per source>,5-bromo-4-chloro-3-indolyl beta-galactoside,exact,,5-Bromo-4-chloro-3-indolyl beta-galactoside,,7240-90-6,exact,,,,5-bromo-4-chloro-3-indolyl beta-galactoside,C044888,7240-90-6,exact,,,,5-Bromo-4-Chloro-3-Indolyl Beta-Galactoside,C0049081,exact,,,,A1.4.1.2.1.8_Carbohydrate,,,,,,#VALUE!,Chromogenic Compounds,Chromogenic Compounds,Y,exact (CUI-based),Chromogenic Compounds,Chromogenic Compounds,C0008583,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000626,MeSH_PA,C044888,5-bromo-4-chloro-3-indolyl beta-galactoside,7240-90-6,5-Bromo-4-chloro-3-indolyl beta-galactoside,ChemID+,exact,5-bromo-4-chloro-3-indolyl beta-D-galactoside,75055,7240-90-6,<syn per source>,5-bromo-4-chloro-3-indolyl beta-galactoside,exact,,5-Bromo-4-chloro-3-indolyl beta-galactoside,,7240-90-6,exact,,,,5-bromo-4-chloro-3-indolyl beta-galactoside,C044888,7240-90-6,exact,,,,5-Bromo-4-Chloro-3-Indolyl Beta-Galactoside,C0049081,exact,,,,A1.4.1.2.1.8_Carbohydrate,,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000627,MeSH_PA,C044888,5-bromo-4-chloro-3-indolyl beta-galactoside,7240-90-6,5-Bromo-4-chloro-3-indolyl beta-galactoside,ChemID+,exact,5-bromo-4-chloro-3-indolyl beta-D-galactoside,75055,7240-90-6,<syn per source>,5-bromo-4-chloro-3-indolyl beta-galactoside,exact,,5-Bromo-4-chloro-3-indolyl beta-galactoside,,7240-90-6,exact,,,,5-bromo-4-chloro-3-indolyl beta-galactoside,C044888,7240-90-6,exact,,,,5-Bromo-4-Chloro-3-Indolyl Beta-Galactoside,C0049081,exact,,,,A1.4.1.2.1.8_Carbohydrate,,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000628,MeSH_PA,C058176,5-nitro-2-(3-phenylpropylamino)benzoic acid,107254-86-4,5-Nitro-2-(3-phenylpropylamino)benzoic acid,ChemID+,exact,5-Nitro-2-(3-phenylpropylamino)benzoic acid,81921,,exact,,,,5-Nitro-2-(3-phenylpropylamino)benzoic acid,,107254-86-4,exact,,,,5-nitro-2-(3-phenylpropylamino)benzoic acid,C058176,107254-86-4,exact,,,,5-Nitro-2-(3-Phenylpropylamino)Benzoic Acid,C0049330,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Angiogenesis Inhibitors,Angiogenesis Inhibitors,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Inhibitors,Angiogenesis Inhibitors,C0596087,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000629,MeSH_PA,C058176,5-nitro-2-(3-phenylpropylamino)benzoic acid,107254-86-4,5-Nitro-2-(3-phenylpropylamino)benzoic acid,ChemID+,exact,5-Nitro-2-(3-phenylpropylamino)benzoic acid,81921,,exact,,,,5-Nitro-2-(3-phenylpropylamino)benzoic acid,,107254-86-4,exact,,,,5-nitro-2-(3-phenylpropylamino)benzoic acid,C058176,107254-86-4,exact,,,,5-Nitro-2-(3-Phenylpropylamino)Benzoic Acid,C0049330,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulating agent,,#VALUE!,Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,C1257849,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000630,MeSH_PA,C058176,5-nitro-2-(3-phenylpropylamino)benzoic acid,107254-86-4,5-Nitro-2-(3-phenylpropylamino)benzoic acid,ChemID+,exact,5-Nitro-2-(3-phenylpropylamino)benzoic acid,81921,,exact,,,,5-Nitro-2-(3-phenylpropylamino)benzoic acid,,107254-86-4,exact,,,,5-nitro-2-(3-phenylpropylamino)benzoic acid,C058176,107254-86-4,exact,,,,5-Nitro-2-(3-Phenylpropylamino)Benzoic Acid,C0049330,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000631,MeSH_PA,C058176,5-nitro-2-(3-phenylpropylamino)benzoic acid,107254-86-4,5-Nitro-2-(3-phenylpropylamino)benzoic acid,ChemID+,exact,5-Nitro-2-(3-phenylpropylamino)benzoic acid,81921,,exact,,,,5-Nitro-2-(3-phenylpropylamino)benzoic acid,,107254-86-4,exact,,,,5-nitro-2-(3-phenylpropylamino)benzoic acid,C058176,107254-86-4,exact,,,,5-Nitro-2-(3-Phenylpropylamino)Benzoic Acid,C0049330,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Growth Inhibitors,Growth Inhibitors,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Inhibitors,Growth Inhibitors,C0018282,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000632,MeSH_PA,C058176,5-nitro-2-(3-phenylpropylamino)benzoic acid,107254-86-4,5-Nitro-2-(3-phenylpropylamino)benzoic acid,ChemID+,exact,5-Nitro-2-(3-phenylpropylamino)benzoic acid,81921,,exact,,,,5-Nitro-2-(3-phenylpropylamino)benzoic acid,,107254-86-4,exact,,,,5-nitro-2-(3-phenylpropylamino)benzoic acid,C058176,107254-86-4,exact,,,,5-Nitro-2-(3-Phenylpropylamino)Benzoic Acid,C0049330,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000633,MeSH_PA,C012153,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",61563-24-4,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",ChEBI,exact,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",160129,61563-24-4,exact,,,,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",,57987-77-6,exact,,,,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",C012153,57987-77-6,exact,,,,"7,8-Dichloro-1,2,3,4-Tetrahydroisoquinoline",C0099559,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000634,MeSH_PA,C012153,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",61563-24-4,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",ChEBI,exact,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",160129,61563-24-4,exact,,,,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",,57987-77-6,exact,,,,"7,8-dichloro-1,2,3,4-tetrahydroisoquinoline",C012153,57987-77-6,exact,,,,"7,8-Dichloro-1,2,3,4-Tetrahydroisoquinoline",C0099559,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Monoamine Oxidase Inhibitors,Monoamine Oxidase Inhibitors,Y,quasi syn therclass-to-function,amine oxidase activity,Primary Amine Oxidase Activity,C1151830,S,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Monoamine Oxidase Inhibitors,Monoamine Oxidase Inhibitors,C0026457,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000635,MeSH_PA,C037802,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",84806-27-9,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",ChemID+,exact,,,,,,,,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",,84806-27-9,exact,,,,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",C037802,84806-27-9,exact,,,,"7-Fluorobenzo-2-Oxa-1,3-Diazole-4-Sulfonate",C0049891,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000636,MeSH_PA,C037802,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",84806-27-9,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",ChemID+,exact,,,,,,,,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",,84806-27-9,exact,,,,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",C037802,84806-27-9,exact,,,,"7-Fluorobenzo-2-Oxa-1,3-Diazole-4-Sulfonate",C0049891,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000637,MeSH_PA,C037802,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",84806-27-9,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",ChemID+,exact,,,,,,,,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",,84806-27-9,exact,,,,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",C037802,84806-27-9,exact,,,,"7-Fluorobenzo-2-Oxa-1,3-Diazole-4-Sulfonate",C0049891,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000638,MeSH_PA,C037802,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",84806-27-9,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",ChemID+,exact,,,,,,,,"7-Fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",,84806-27-9,exact,,,,"7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate",C037802,84806-27-9,exact,,,,"7-Fluorobenzo-2-Oxa-1,3-Diazole-4-Sulfonate",C0049891,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000639,MeSH_PA,C061593,"C6-(N1-methyl-1,2,3-trazolylmethylene)penem",102209-75-6,"C6-(N1-Methyl-1,2,3-trazolylmethylene)penem",ChemID+,exact,,,,,,,,"C6-(N1-Methyl-1,2,3-trazolylmethylene)penem",,102209-75-6,exact,,,,"C6-(N1-methyl-1,2,3-trazolylmethylene)penem",C061593,102209-75-6,exact,,,,"C6-(N1-Methyl-1,2,3-Trazolylmethylene)Penem",C0107919,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000640,MeSH_PA,C043435,polylactic acid-polyglycolic acid copolymer,,,,,,,,,,,,Polylactic acid-polyglycolic acid copolymer,,C043435000,exact,,,,polylactic acid-polyglycolic acid copolymer,C043435,,exact,,,,Polylactic Acid-Polyglycolic Acid Copolymer,C0071599,exact,,,,A1.4.1.1.2_Biomedical or Dental Material,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Biocompatible Materials,Biocompatible Materials,Y,exact (CUI-based),biocompatible materials,Biomaterials,C0005479,S,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,,,,,,,
1_000641,MeSH_PA,C026148,prolyl-phenylalanyl-arginine-4-nitroanilide,64816-19-9,Prolyl-phenylalanyl-arginine-4-nitroanilide,ChemID+,exact,,,,,,,,Prolyl-phenylalanyl-arginine-4-nitroanilide,,64816-19-9,exact,,,,prolyl-phenylalanyl-arginine-4-nitroanilide,C026148,64816-19-9,exact,,,,Prolyl-Phenylalanyl-Arginine-4-Nitroanilide,C0072141,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,,#VALUE!,Chromogenic Compounds,Chromogenic Compounds,Y,exact (CUI-based),Chromogenic Compounds,Chromogenic Compounds,C0008583,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000642,MeSH_PA,C026148,prolyl-phenylalanyl-arginine-4-nitroanilide,64816-19-9,Prolyl-phenylalanyl-arginine-4-nitroanilide,ChemID+,exact,,,,,,,,Prolyl-phenylalanyl-arginine-4-nitroanilide,,64816-19-9,exact,,,,prolyl-phenylalanyl-arginine-4-nitroanilide,C026148,64816-19-9,exact,,,,Prolyl-Phenylalanyl-Arginine-4-Nitroanilide,C0072141,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000643,MeSH_PA,C026148,prolyl-phenylalanyl-arginine-4-nitroanilide,64816-19-9,Prolyl-phenylalanyl-arginine-4-nitroanilide,ChemID+,exact,,,,,,,,Prolyl-phenylalanyl-arginine-4-nitroanilide,,64816-19-9,exact,,,,prolyl-phenylalanyl-arginine-4-nitroanilide,C026148,64816-19-9,exact,,,,Prolyl-Phenylalanyl-Arginine-4-Nitroanilide,C0072141,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000644,MeSH_PA,C062028,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,107767-55-5,Albifylline,ChemID+,<syn per source>,,,,,,,,Albifylline,,107767-55-5,<syn per source>,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,exact,,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,C062028,107767-55-5,exact,,,,1-(5-Hydroxy-5-Methylhexyl)-3-Methylxanthine,C0088887,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Asthmatic Agents,Anti-Asthmatic Agents,Y,quasi syn therclass-to-disease,Asthma,Asthma,C0004096,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Asthmatic Agents,Anti-Asthmatic Agents,C0282556,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000645,MeSH_PA,C062028,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,107767-55-5,Albifylline,ChemID+,<syn per source>,,,,,,,,Albifylline,,107767-55-5,<syn per source>,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,exact,,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,C062028,107767-55-5,exact,,,,1-(5-Hydroxy-5-Methylhexyl)-3-Methylxanthine,C0088887,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000646,MeSH_PA,C062028,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,107767-55-5,Albifylline,ChemID+,<syn per source>,,,,,,,,Albifylline,,107767-55-5,<syn per source>,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,exact,,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,C062028,107767-55-5,exact,,,,1-(5-Hydroxy-5-Methylhexyl)-3-Methylxanthine,C0088887,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Bronchodilator Agents,Bronchodilator Agents,Y,quasi syn therclass-to-function,bronchodilation,Bronchodilation [Pe],C1371299,S,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Bronchodilator Agents,Bronchodilator Agents,C0006280,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000647,MeSH_PA,C062028,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,107767-55-5,Albifylline,ChemID+,<syn per source>,,,,,,,,Albifylline,,107767-55-5,<syn per source>,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,exact,,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,C062028,107767-55-5,exact,,,,1-(5-Hydroxy-5-Methylhexyl)-3-Methylxanthine,C0088887,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000648,MeSH_PA,C062028,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,107767-55-5,Albifylline,ChemID+,<syn per source>,,,,,,,,Albifylline,,107767-55-5,<syn per source>,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,exact,,1-(5-hydroxy-5-methylhexyl)-3-methylxanthine,C062028,107767-55-5,exact,,,,1-(5-Hydroxy-5-Methylhexyl)-3-Methylxanthine,C0088887,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Respiratory System Agents,Respiratory System Agents,Y,quasi syn therclass-to-disease,respiratory disorders,Respiration Disorders,C0035204,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Respiratory System Agents,Respiratory System Agents,C0282686,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000649,MeSH_PA,C070046,"1,2-dioleoyloxy-3-(trimethylammonium)propane",113669-21-9,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",ChemID+,exact,,,,,,,,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",,113669-21-9,exact,,,,"1,2-dioleoyloxy-3-(trimethylammonium)propane",C070046,113669-21-9,exact,,,,"1,2-Dioleoyloxy-3-(Trimethylammonium)Propane",C0088100,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000650,MeSH_PA,C070046,"1,2-dioleoyloxy-3-(trimethylammonium)propane",113669-21-9,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",ChemID+,exact,,,,,,,,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",,113669-21-9,exact,,,,"1,2-dioleoyloxy-3-(trimethylammonium)propane",C070046,113669-21-9,exact,,,,"1,2-Dioleoyloxy-3-(Trimethylammonium)Propane",C0088100,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000651,MeSH_PA,C070046,"1,2-dioleoyloxy-3-(trimethylammonium)propane",113669-21-9,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",ChemID+,exact,,,,,,,,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",,113669-21-9,exact,,,,"1,2-dioleoyloxy-3-(trimethylammonium)propane",C070046,113669-21-9,exact,,,,"1,2-Dioleoyloxy-3-(Trimethylammonium)Propane",C0088100,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000652,MeSH_PA,C070046,"1,2-dioleoyloxy-3-(trimethylammonium)propane",113669-21-9,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",ChemID+,exact,,,,,,,,"1,2-Dioleoyloxy-3-(trimethylammonium)propane",,113669-21-9,exact,,,,"1,2-dioleoyloxy-3-(trimethylammonium)propane",C070046,113669-21-9,exact,,,,"1,2-Dioleoyloxy-3-(Trimethylammonium)Propane",C0088100,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000653,ChEBI,,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",28289-54-5,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",ChemID+,exact,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",17963,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",D015632,28289-54-5,exact,,,,"1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine",C0000097,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,neurotoxin,neurotoxin,Y,quasi syn therclass-to-disease,Chemically Induced Neurotoxicity,Chemically Induced Neurotoxicity,C1516456,P,Y,B2.3_Injury or Poisoning,,,,exact 1,neurotoxin,Neurotoxins,C0027934,S,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000654,MeSH_PA,D015632,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",28289-54-5,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",ChemID+,exact,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",17963,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",D015632,28289-54-5,exact,,,,"1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine",C0000097,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000655,MeSH_PA,D015632,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",28289-54-5,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",ChemID+,exact,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",17963,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",D015632,28289-54-5,exact,,,,"1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine",C0000097,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Neurotoxins,Neurotoxins,Y,quasi syn therclass-to-disease,Chemically Induced Neurotoxicity,Chemically Induced Neurotoxicity,C1516456,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Neurotoxins,Neurotoxins,C0027934,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000656,MeSH_PA,D015632,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",28289-54-5,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",ChemID+,exact,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",17963,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",D015632,28289-54-5,exact,,,,"1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine",C0000097,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000657,MeSH_PA,D015632,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",28289-54-5,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",ChemID+,exact,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",17963,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",,28289-54-5,exact,,,,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine",D015632,28289-54-5,exact,,,,"1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine",C0000097,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000658,MeSH_PA,C094210,"2,2'-(hydroxynitrosohydrazono)bis-ethanamine",146724-94-9,"2,2'-(hydroxynitrosohydrazono)bis-ethanamine",CTD,exact,,,,,,,,,,,,,,,"2,2'-(hydroxynitrosohydrazono)bis-ethanamine",C094210,146724-94-9,exact,,,,"2,2'-(Hydroxynitrosohydrazono)Bis-Ethanamine",C0298857,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000659,MeSH_PA,C094210,"2,2'-(hydroxynitrosohydrazono)bis-ethanamine",146724-94-9,"2,2'-(hydroxynitrosohydrazono)bis-ethanamine",CTD,exact,,,,,,,,,,,,,,,"2,2'-(hydroxynitrosohydrazono)bis-ethanamine",C094210,146724-94-9,exact,,,,"2,2'-(Hydroxynitrosohydrazono)Bis-Ethanamine",C0298857,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Nitric Oxide Donors,Nitric Oxide Donors,Y,quasi syn therclass-to-function,Nitric Oxide Metabolic Process,Nitric Oxide Metabolic Process,C1158468,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nitric Oxide Donors,Nitric Oxide Donors,C0600437,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000660,MeSH_PA,C035759,"3,3'-dithiobis(sulfosuccinimidyl propionate)",81069-02-5,"3,3'-Dithiobis(sulfosuccinimidyl propionate)",ChemID+,exact,,,,,,,,"3,3'-Dithiobis(sulfosuccinimidyl propionate)",,81069-02-5,exact,,,,"3,3'-dithiobis(sulfosuccinimidyl propionate)",C035759,81069-02-5,exact,,,,"3,3'-Dithiobis(Sulfosuccinimidyl Propionate)",C0046905,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000661,MeSH_PA,C035759,"3,3'-dithiobis(sulfosuccinimidyl propionate)",81069-02-5,"3,3'-Dithiobis(sulfosuccinimidyl propionate)",ChemID+,exact,,,,,,,,"3,3'-Dithiobis(sulfosuccinimidyl propionate)",,81069-02-5,exact,,,,"3,3'-dithiobis(sulfosuccinimidyl propionate)",C035759,81069-02-5,exact,,,,"3,3'-Dithiobis(Sulfosuccinimidyl Propionate)",C0046905,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000662,MeSH_PA,C520857,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,,,,,,,,,,,,,,,,,,,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,C520857,,exact,,,,3-Amino-1-(1-Boronic-Ethyl)Pyrrolidine-2-One,C1958132,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000663,MeSH_PA,C520857,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,,,,,,,,,,,,,,,,,,,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,C520857,,exact,,,,3-Amino-1-(1-Boronic-Ethyl)Pyrrolidine-2-One,C1958132,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000664,MeSH_PA,C520857,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,,,,,,,,,,,,,,,,,,,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,C520857,,exact,,,,3-Amino-1-(1-Boronic-Ethyl)Pyrrolidine-2-One,C1958132,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000665,MeSH_PA,C520857,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,,,,,,,,,,,,,,,,,,,3-amino-1-(1-boronic-ethyl)pyrrolidine-2-one,C520857,,exact,,,,3-Amino-1-(1-Boronic-Ethyl)Pyrrolidine-2-One,C1958132,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000666,MeSH_PA,C051171,5-methoxy-1-methyl-2-(n-propylamino)tetralin,85379-09-5,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,ChemID+,exact,"(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin",64117,85379-09-5,<syn per source>,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,exact,,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,,85379-09-5,exact,,,,5-methoxy-1-methyl-2-(n-propylamino)tetralin,C051171,85379-09-5,exact,,,,5-Methoxy-1-Methyl-2-(N-Propylamino)Tetralin,C0098525,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000667,MeSH_PA,C051171,5-methoxy-1-methyl-2-(n-propylamino)tetralin,85379-09-5,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,ChemID+,exact,"(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin",64117,85379-09-5,<syn per source>,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,exact,,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,,85379-09-5,exact,,,,5-methoxy-1-methyl-2-(n-propylamino)tetralin,C051171,85379-09-5,exact,,,,5-Methoxy-1-Methyl-2-(N-Propylamino)Tetralin,C0098525,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000668,MeSH_PA,C051171,5-methoxy-1-methyl-2-(n-propylamino)tetralin,85379-09-5,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,ChemID+,exact,"(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin",64117,85379-09-5,<syn per source>,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,exact,,5-Methoxy-1-methyl-2-(n-propylamino)tetralin,,85379-09-5,exact,,,,5-methoxy-1-methyl-2-(n-propylamino)tetralin,C051171,85379-09-5,exact,,,,5-Methoxy-1-Methyl-2-(N-Propylamino)Tetralin,C0098525,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000669,MeSH_PA,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,33458-93-4,6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,ChemID+,exact,,,,,,,,6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,,33458-93-4,exact,,,,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,33458-93-4,exact,,,,6-Isopropoxy-9-Oxoxanthene-2-Carboxylic Acid,C0099263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000670,MeSH_PA,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,33458-93-4,6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,ChemID+,exact,,,,,,,,6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,,33458-93-4,exact,,,,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,33458-93-4,exact,,,,6-Isopropoxy-9-Oxoxanthene-2-Carboxylic Acid,C0099263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000671,MeSH_PA,C053876,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,33458-93-4,6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,ChemID+,exact,,,,,,,,6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,,33458-93-4,exact,,,,6-isopropoxy-9-oxoxanthene-2-carboxylic acid,C053876,33458-93-4,exact,,,,6-Isopropoxy-9-Oxoxanthene-2-Carboxylic Acid,C0099263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Prostaglandin Antagonists,Prostaglandin Antagonists,Y,quasi syn therclass-to-function,Prostaglandin Receptor Activity,Prostaglandin Receptor Activity,C1152751,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Prostaglandin Antagonists,Prostaglandin Antagonists,C0033529,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000672,MeSH_PA,C028722,ethylene glycolylbis(succinimidyl succinate),70539-42-3,Ethylene glycolylbis(succinimidyl succinate),ChemID+,exact,,,,,,,,Ethylene glycolylbis(succinimidyl succinate),,70539-42-3,exact,,,,ethylene glycolylbis(succinimidyl succinate),C028722,70539-42-3,exact,,,,Ethylene Glycolylbis(Succinimidyl Succinate),C0059811,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000673,MeSH_PA,C028722,ethylene glycolylbis(succinimidyl succinate),70539-42-3,Ethylene glycolylbis(succinimidyl succinate),ChemID+,exact,,,,,,,,Ethylene glycolylbis(succinimidyl succinate),,70539-42-3,exact,,,,ethylene glycolylbis(succinimidyl succinate),C028722,70539-42-3,exact,,,,Ethylene Glycolylbis(Succinimidyl Succinate),C0059811,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000674,MeSH_PA,C028722,ethylene glycolylbis(succinimidyl succinate),70539-42-3,Ethylene glycolylbis(succinimidyl succinate),ChemID+,exact,,,,,,,,Ethylene glycolylbis(succinimidyl succinate),,70539-42-3,exact,,,,ethylene glycolylbis(succinimidyl succinate),C028722,70539-42-3,exact,,,,Ethylene Glycolylbis(Succinimidyl Succinate),C0059811,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000675,MeSH_PA,C063429,glucosaminylmuramyl-2-alanine-D-isoglutamine,97590-38-0,Glucosaminylmuramyl-2-alanine-D-isoglutamine,ChemID+,exact,,,,,,,,Glucosaminylmuramyl-2-alanine-D-isoglutamine,,97590-38-0,exact,,,,glucosaminylmuramyl-2-alanine-D-isoglutamine,C063429,97590-38-0,exact,,,,Glucosaminylmuramyl-2-Alanine-D-Isoglutamine,C0082715,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,adjuvant,adju,1,"Adjuvants, Immunologic","Adjuvants, Immunologic",Y,quasi syn therclass-to-function,Active Immunity,Active Immunity,C0020965,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),"adjuvants, immunologic",Immunologic Adjuvants,C0001551,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_000676,MeSH_PA,C063429,glucosaminylmuramyl-2-alanine-D-isoglutamine,97590-38-0,Glucosaminylmuramyl-2-alanine-D-isoglutamine,ChemID+,exact,,,,,,,,Glucosaminylmuramyl-2-alanine-D-isoglutamine,,97590-38-0,exact,,,,glucosaminylmuramyl-2-alanine-D-isoglutamine,C063429,97590-38-0,exact,,,,Glucosaminylmuramyl-2-Alanine-D-Isoglutamine,C0082715,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000677,MeSH_PA,C082299,"N-((1S,trans)-2-hydroxycyclopentyl)adenosine",124555-18-6,GR 79236,ChemID+,<syn per source>,,,,,,,,GR 79236,,124555-18-6,<syn per source>,"N-((1S,trans)-2-Hydroxycyclopentyl)adenosine",exact,,"N-((1S,trans)-2-hydroxycyclopentyl)adenosine",C082299,124555-18-6,exact,,,,"N-((1S,Trans)-2-Hydroxycyclopentyl)Adenosine",C0218380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antimetabolites,Antimetabolites,Y,quasi syn therclass-to-function,Metabolism,Metabolism,C0025519,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Antimetabolites,Antimetabolites,C0003376,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000678,MeSH_PA,C082299,"N-((1S,trans)-2-hydroxycyclopentyl)adenosine",124555-18-6,GR 79236,ChemID+,<syn per source>,,,,,,,,GR 79236,,124555-18-6,<syn per source>,"N-((1S,trans)-2-Hydroxycyclopentyl)adenosine",exact,,"N-((1S,trans)-2-hydroxycyclopentyl)adenosine",C082299,124555-18-6,exact,,,,"N-((1S,Trans)-2-Hydroxycyclopentyl)Adenosine",C0218380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,hypo,,#VALUE!,Hypolipidemic Agents,Hypolipidemic Agents,Y,quasi syn therclass-to-disease,Hyperlipidemia,Hyperlipidemia,C0020473,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypolipidemic Agents,Hypolipidemic Agents,C0086440,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000679,MeSH_PA,C082299,"N-((1S,trans)-2-hydroxycyclopentyl)adenosine",124555-18-6,GR 79236,ChemID+,<syn per source>,,,,,,,,GR 79236,,124555-18-6,<syn per source>,"N-((1S,trans)-2-Hydroxycyclopentyl)adenosine",exact,,"N-((1S,trans)-2-hydroxycyclopentyl)adenosine",C082299,124555-18-6,exact,,,,"N-((1S,Trans)-2-Hydroxycyclopentyl)Adenosine",C0218380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,regulating,,#VALUE!,Lipid Regulating Agents,Lipid Regulating Agents,Y,quasi syn therclass-to-function,Lipid Metabolism,Lipid Metabolism,C0598783,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipid Regulating Agents,Lipid Regulating Agents,C2936244,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000680,MeSH_PA,C013624,N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine,61499-28-3,N-Nitroso(2-hydroxypropyl)(2-oxopropyl)amine,ChemID+,exact,,,,,,,,N-Nitroso(2-hydroxypropyl)(2-oxopropyl)amine,,61499-28-3,exact,,,,N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine,C013624,61499-28-3,exact,,,,N-Nitroso(2-Hydroxypropyl)(2-Oxopropyl)Amine,C0068179,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000681,MeSH_PA,C013624,N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine,61499-28-3,N-Nitroso(2-hydroxypropyl)(2-oxopropyl)amine,ChemID+,exact,,,,,,,,N-Nitroso(2-hydroxypropyl)(2-oxopropyl)amine,,61499-28-3,exact,,,,N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine,C013624,61499-28-3,exact,,,,N-Nitroso(2-Hydroxypropyl)(2-Oxopropyl)Amine,C0068179,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000682,MeSH_PA,C018151,N-succinimidyl 3-(2-pyridyldithio)propionate,68181-17-9,N-Succinimidyl 3-(2-pyridyldithio)propionate,ChemID+,exact,,,,,,,,N-Succinimidyl 3-(2-pyridyldithio)propionate,,68181-17-9,exact,,,,N-succinimidyl 3-(2-pyridyldithio)propionate,C018151,68181-17-9,exact,,,,N-Succinimidyl 3-(2-Pyridyldithio)Propionate,C0068285,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000683,MeSH_PA,C018151,N-succinimidyl 3-(2-pyridyldithio)propionate,68181-17-9,N-Succinimidyl 3-(2-pyridyldithio)propionate,ChemID+,exact,,,,,,,,N-Succinimidyl 3-(2-pyridyldithio)propionate,,68181-17-9,exact,,,,N-succinimidyl 3-(2-pyridyldithio)propionate,C018151,68181-17-9,exact,,,,N-Succinimidyl 3-(2-Pyridyldithio)Propionate,C0068285,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000684,MeSH_PA,C056415,1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine,112726-66-6,1-(1-(2-Benzo(b)thienyl)cyclohexyl)piperidine,ChemID+,exact,,,,,,,,1-(1-(2-Benzo(b)thienyl)cyclohexyl)piperidine,,112726-66-6,exact,,,,1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine,C056415,112726-66-6,exact,,,,1-(1-(2-Benzo(B)Thienyl)Cyclohexyl)Piperidine,C0245420,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000685,MeSH_PA,C056415,1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine,112726-66-6,1-(1-(2-Benzo(b)thienyl)cyclohexyl)piperidine,ChemID+,exact,,,,,,,,1-(1-(2-Benzo(b)thienyl)cyclohexyl)piperidine,,112726-66-6,exact,,,,1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine,C056415,112726-66-6,exact,,,,1-(1-(2-Benzo(B)Thienyl)Cyclohexyl)Piperidine,C0245420,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000686,MeSH_PA,C056415,1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine,112726-66-6,1-(1-(2-Benzo(b)thienyl)cyclohexyl)piperidine,ChemID+,exact,,,,,,,,1-(1-(2-Benzo(b)thienyl)cyclohexyl)piperidine,,112726-66-6,exact,,,,1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine,C056415,112726-66-6,exact,,,,1-(1-(2-Benzo(B)Thienyl)Cyclohexyl)Piperidine,C0245420,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000687,MeSH_PA,D019307,1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine,84477-87-2,1-(5-Isoquinolinesulfonyl)-2-methylpiperazine,ChemID+,exact,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,43385,84477-87-2,<syn per source>,1-(5-Isoquinolinesulfonyl)-2-methylpiperazine,exact,,1-(5-Isoquinolinesulfonyl)-2-methylpiperazine,,84477-87-2,exact,,,,1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine,D019307,84477-87-2,exact,,,,1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine,C0044222,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000688,MeSH_PA,C037145,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,74389-68-7,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,ChemID+,exact,,,,,,,,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,,74389-68-7,exact,,,,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,C037145,74389-68-7,exact,,,,1-Hexadecyl-2-Acetyl-Glycero-3-Phosphocholine,C0044397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Adrenergic Agents,Adrenergic Agents,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Agents,Adrenergic Agents,C0001637,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000689,MeSH_PA,C037145,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,74389-68-7,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,ChemID+,exact,,,,,,,,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,,74389-68-7,exact,,,,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,C037145,74389-68-7,exact,,,,1-Hexadecyl-2-Acetyl-Glycero-3-Phosphocholine,C0044397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,antagonist,antagonist,#VALUE!,Adrenergic Antagonists,Adrenergic Antagonists,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Antagonists,Adrenergic Antagonists,C0242889,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000690,MeSH_PA,C037145,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,74389-68-7,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,ChemID+,exact,,,,,,,,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,,74389-68-7,exact,,,,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,C037145,74389-68-7,exact,,,,1-Hexadecyl-2-Acetyl-Glycero-3-Phosphocholine,C0044397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,antagonist,antagonist,#VALUE!,Adrenergic beta-Antagonists,Adrenergic beta-Antagonists,Y,quasi syn therclass-to-function,Beta-Adrenergic Receptor Function,Beta-Adrenergic Receptor Function,C0544652,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Beta-Antagonists,Adrenergic Beta-Antagonists,C0001645,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000691,MeSH_PA,C037145,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,74389-68-7,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,ChemID+,exact,,,,,,,,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,,74389-68-7,exact,,,,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,C037145,74389-68-7,exact,,,,1-Hexadecyl-2-Acetyl-Glycero-3-Phosphocholine,C0044397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000692,MeSH_PA,C037145,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,74389-68-7,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,ChemID+,exact,,,,,,,,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,,74389-68-7,exact,,,,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,C037145,74389-68-7,exact,,,,1-Hexadecyl-2-Acetyl-Glycero-3-Phosphocholine,C0044397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000693,MeSH_PA,C037145,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,74389-68-7,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,ChemID+,exact,,,,,,,,1-Hexadecyl-2-acetyl-glycero-3-phosphocholine,,74389-68-7,exact,,,,1-hexadecyl-2-acetyl-glycero-3-phosphocholine,C037145,74389-68-7,exact,,,,1-Hexadecyl-2-Acetyl-Glycero-3-Phosphocholine,C0044397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000694,MeSH_PA,C036990,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",77500-04-0,8-Methyl-IQX,ChemID+,<syn per source>,MeIQx,76604,77500-04-0,<syn per source>,"2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",syn no\W,,8-Methyl-IQX,,77500-04-0,<syn per source>,"2-Amino-3,8-dimethylimidazo(4,5-f)quinoxaline",exact,,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",C036990,77500-04-0,exact,,,,"2-Amino-3,8-Dimethylimidazo(4,5-F)Quinoxaline",C0045822,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000695,MeSH_PA,C036990,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",77500-04-0,8-Methyl-IQX,ChemID+,<syn per source>,MeIQx,76604,77500-04-0,<syn per source>,"2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",syn no\W,,8-Methyl-IQX,,77500-04-0,<syn per source>,"2-Amino-3,8-dimethylimidazo(4,5-f)quinoxaline",exact,,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",C036990,77500-04-0,exact,,,,"2-Amino-3,8-Dimethylimidazo(4,5-F)Quinoxaline",C0045822,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000696,MeSH_PA,C036990,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",77500-04-0,8-Methyl-IQX,ChemID+,<syn per source>,MeIQx,76604,77500-04-0,<syn per source>,"2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",syn no\W,,8-Methyl-IQX,,77500-04-0,<syn per source>,"2-Amino-3,8-dimethylimidazo(4,5-f)quinoxaline",exact,,"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline",C036990,77500-04-0,exact,,,,"2-Amino-3,8-Dimethylimidazo(4,5-F)Quinoxaline",C0045822,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000697,MeSH_PA,C064539,2-amino-4-methyl-5-phosphono-3-pentenoic acid,137424-81-8,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,ChemID+,exact,,,,,,,,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,,137424-81-8,exact,,,,,,,,,,,2-Amino-4-Methyl-5-Phosphono-3-Pentenoic Acid,C0092488,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000698,MeSH_PA,C064539,2-amino-4-methyl-5-phosphono-3-pentenoic acid,137424-81-8,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,ChemID+,exact,,,,,,,,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,,137424-81-8,exact,,,,,,,,,,,2-Amino-4-Methyl-5-Phosphono-3-Pentenoic Acid,C0092488,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000699,MeSH_PA,C064539,2-amino-4-methyl-5-phosphono-3-pentenoic acid,137424-81-8,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,ChemID+,exact,,,,,,,,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,,137424-81-8,exact,,,,,,,,,,,2-Amino-4-Methyl-5-Phosphono-3-Pentenoic Acid,C0092488,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000700,MeSH_PA,C064539,2-amino-4-methyl-5-phosphono-3-pentenoic acid,137424-81-8,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,ChemID+,exact,,,,,,,,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,,137424-81-8,exact,,,,,,,,,,,2-Amino-4-Methyl-5-Phosphono-3-Pentenoic Acid,C0092488,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000701,MeSH_PA,C064539,2-amino-4-methyl-5-phosphono-3-pentenoic acid,137424-81-8,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,ChemID+,exact,,,,,,,,2-Amino-4-methyl-5-phosphono-3-pentenoic acid,,137424-81-8,exact,,,,,,,,,,,2-Amino-4-Methyl-5-Phosphono-3-Pentenoic Acid,C0092488,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000702,MeSH_PA,C025508,"2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate",10556-88-4,"2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate",ChemID+,exact,,,,,,,,"2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate",,10556-88-4,exact,,,,"2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate",C025508,10556-88-4,exact,,,,"2-Nitro-4-Carboxyphenyl-N,N-Diphenylcarbamate",C0046427,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000703,MeSH_PA,C025508,"2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate",10556-88-4,"2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate",ChemID+,exact,,,,,,,,"2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate",,10556-88-4,exact,,,,"2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate",C025508,10556-88-4,exact,,,,"2-Nitro-4-Carboxyphenyl-N,N-Diphenylcarbamate",C0046427,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,C0031638,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000704,MeSH_PA,C025508,"2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate",10556-88-4,"2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate",ChemID+,exact,,,,,,,,"2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate",,10556-88-4,exact,,,,"2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate",C025508,10556-88-4,exact,,,,"2-Nitro-4-Carboxyphenyl-N,N-Diphenylcarbamate",C0046427,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000705,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000706,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000707,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Cholinergic Antagonists,Cholinergic Antagonists,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Antagonists,Cholinergic Antagonists,C0242897,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000708,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000709,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000710,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000711,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Nicotinic Antagonists,Nicotinic Antagonists,Y,quasi syn therclass-to-function,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,C1148665,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nicotinic Antagonists,Nicotinic Antagonists,C0242956,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000712,MeSH_PA,C033174,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,81340-56-9,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,ChemID+,exact,,,,,,,,3-(Trifluoromethyl)-3-(3-iodophenyl)diazirine,,81340-56-9,exact,,,,3-(trifluoromethyl)-3-(3-iodophenyl)diazirine,C033174,81340-56-9,exact,,,,3-(Trifluoromethyl)-3-(3-Iodophenyl)Diazirine,C0047180,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Photoaffinity Labels,Photoaffinity Labels,Y,exact (CUI-based),Photoaffinity Labels,Photoaffinity Labels,C0525025,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000713,MeSH_PA,C088383,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,147402-53-7,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,ChemID+,exact,,,,,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,,147402-53-7,exact,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,C088383,147402-53-7,exact,,,,3-Methyl-5-(1-Methyl-2-Pyrrolidinyl)Isoxazole,C0257129,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Anxiety Agents,Anti-Anxiety Agents,Y,quasi syn therclass-to-disease,Anxiety,Anxiety,C0003467,P,Y,B2.2.1.1.1.1_Mental Process,,,,exact (CUI-based),Anti-Anxiety Agents,Anti-Anxiety Agents,C0040616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000714,MeSH_PA,C088383,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,147402-53-7,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,ChemID+,exact,,,,,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,,147402-53-7,exact,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,C088383,147402-53-7,exact,,,,3-Methyl-5-(1-Methyl-2-Pyrrolidinyl)Isoxazole,C0257129,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000715,MeSH_PA,C088383,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,147402-53-7,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,ChemID+,exact,,,,,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,,147402-53-7,exact,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,C088383,147402-53-7,exact,,,,3-Methyl-5-(1-Methyl-2-Pyrrolidinyl)Isoxazole,C0257129,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000716,MeSH_PA,C088383,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,147402-53-7,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,ChemID+,exact,,,,,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,,147402-53-7,exact,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,C088383,147402-53-7,exact,,,,3-Methyl-5-(1-Methyl-2-Pyrrolidinyl)Isoxazole,C0257129,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000717,MeSH_PA,C088383,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,147402-53-7,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,ChemID+,exact,,,,,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,,147402-53-7,exact,,,,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole,C088383,147402-53-7,exact,,,,3-Methyl-5-(1-Methyl-2-Pyrrolidinyl)Isoxazole,C0257129,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Tranquilizing Agents,Tranquilizing Agents,Y,quasi syn therclass-to-function,Tranquilizing Effect,Tranquilizing Effect,C3179402,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Tranquilizing Agents,Tranquilizing Agents,C0040614,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000718,MeSH_PA,C095512,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",133550-30-8,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",ChemID+,exact,,,,,,,,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",,133550-30-8,exact,,,,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",C095512,,exact,,,,"Alpha-Cyano-(3,4-Dihydroxy)-N-Benzylcinnamide",C0663164,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000719,MeSH_PA,C095512,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",133550-30-8,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",ChemID+,exact,,,,,,,,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",,133550-30-8,exact,,,,"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide",C095512,,exact,,,,"Alpha-Cyano-(3,4-Dihydroxy)-N-Benzylcinnamide",C0663164,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000720,MeSH_PA,C061730,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,109628-27-5,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,ChemID+,exact,,,,,,,,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,,109628-27-5,exact,,,,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,C061730,109628-27-5,exact,,,,N-(6-Methoxy-8-Quinolyl)-4-Toluenesulfonamide,C0067558,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000721,MeSH_PA,C061730,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,109628-27-5,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,ChemID+,exact,,,,,,,,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,,109628-27-5,exact,,,,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,C061730,109628-27-5,exact,,,,N-(6-Methoxy-8-Quinolyl)-4-Toluenesulfonamide,C0067558,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000722,MeSH_PA,C061730,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,109628-27-5,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,ChemID+,exact,,,,,,,,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,,109628-27-5,exact,,,,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,C061730,109628-27-5,exact,,,,N-(6-Methoxy-8-Quinolyl)-4-Toluenesulfonamide,C0067558,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000723,MeSH_PA,C061730,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,109628-27-5,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,ChemID+,exact,,,,,,,,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,,109628-27-5,exact,,,,N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide,C061730,109628-27-5,exact,,,,N-(6-Methoxy-8-Quinolyl)-4-Toluenesulfonamide,C0067558,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000724,MeSH_PA,C033575,N-acetylmuramyl-alanylglutamine-n-butyl ester,74817-61-1,Murabutide,ChemID+,<syn per source>,,,,,,,,Murabutide,Murabutide [INN],74817-61-1,<syn per source>,N-Acetylmuramyl-alanylglutamine-n-butyl ester,exact,,N-acetylmuramyl-alanylglutamine-n-butyl ester,C033575,74817-61-1,exact,,,,N-Acetylmuramyl-Alanylglutamine-N-Butyl Ester,C0067757,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,adjuvant,adju,1,"Adjuvants, Immunologic","Adjuvants, Immunologic",Y,quasi syn therclass-to-function,Active Immunity,Active Immunity,C0020965,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),"adjuvants, immunologic",Immunologic Adjuvants,C0001551,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_000725,MeSH_PA,C033575,N-acetylmuramyl-alanylglutamine-n-butyl ester,74817-61-1,Murabutide,ChemID+,<syn per source>,,,,,,,,Murabutide,Murabutide [INN],74817-61-1,<syn per source>,N-Acetylmuramyl-alanylglutamine-n-butyl ester,exact,,N-acetylmuramyl-alanylglutamine-n-butyl ester,C033575,74817-61-1,exact,,,,N-Acetylmuramyl-Alanylglutamine-N-Butyl Ester,C0067757,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-HIV Agents,Anti-HIV Agents,Y,quasi syn therclass-to-disease,Hiv Infections,Hiv Infections,C0019693,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Hiv Agents,Anti-Hiv Agents,C0376565,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000726,MeSH_PA,C033575,N-acetylmuramyl-alanylglutamine-n-butyl ester,74817-61-1,Murabutide,ChemID+,<syn per source>,,,,,,,,Murabutide,Murabutide [INN],74817-61-1,<syn per source>,N-Acetylmuramyl-alanylglutamine-n-butyl ester,exact,,N-acetylmuramyl-alanylglutamine-n-butyl ester,C033575,74817-61-1,exact,,,,N-Acetylmuramyl-Alanylglutamine-N-Butyl Ester,C0067757,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000727,MeSH_PA,C033575,N-acetylmuramyl-alanylglutamine-n-butyl ester,74817-61-1,Murabutide,ChemID+,<syn per source>,,,,,,,,Murabutide,Murabutide [INN],74817-61-1,<syn per source>,N-Acetylmuramyl-alanylglutamine-n-butyl ester,exact,,N-acetylmuramyl-alanylglutamine-n-butyl ester,C033575,74817-61-1,exact,,,,N-Acetylmuramyl-Alanylglutamine-N-Butyl Ester,C0067757,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Retroviral Agents,Anti-Retroviral Agents,Y,quasi syn therclass-to-disease,retroviral infections,Retroviridae Infections,C0035369,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Retroviral Agents,Anti-Retroviral Agents,C0599685,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000728,MeSH_PA,C033575,N-acetylmuramyl-alanylglutamine-n-butyl ester,74817-61-1,Murabutide,ChemID+,<syn per source>,,,,,,,,Murabutide,Murabutide [INN],74817-61-1,<syn per source>,N-Acetylmuramyl-alanylglutamine-n-butyl ester,exact,,N-acetylmuramyl-alanylglutamine-n-butyl ester,C033575,74817-61-1,exact,,,,N-Acetylmuramyl-Alanylglutamine-N-Butyl Ester,C0067757,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000729,MeSH_PA,C033575,N-acetylmuramyl-alanylglutamine-n-butyl ester,74817-61-1,Murabutide,ChemID+,<syn per source>,,,,,,,,Murabutide,Murabutide [INN],74817-61-1,<syn per source>,N-Acetylmuramyl-alanylglutamine-n-butyl ester,exact,,N-acetylmuramyl-alanylglutamine-n-butyl ester,C033575,74817-61-1,exact,,,,N-Acetylmuramyl-Alanylglutamine-N-Butyl Ester,C0067757,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000730,MeSH_PA,C080501,1-(5-isoquinolinylsulfonyl)-3-methylpiperazine,84477-73-6,1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine,ChemID+,exact,,,,,,,,1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine,,84477-73-6,exact,,,,1-(5-isoquinolinylsulfonyl)-3-methylpiperazine,C080501,84477-73-6,exact,,,,1-(5-Isoquinolinylsulfonyl)-3-Methylpiperazine,C0214900,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000731,MeSH_PA,C080501,1-(5-isoquinolinylsulfonyl)-3-methylpiperazine,84477-73-6,1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine,ChemID+,exact,,,,,,,,1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine,,84477-73-6,exact,,,,1-(5-isoquinolinylsulfonyl)-3-methylpiperazine,C080501,84477-73-6,exact,,,,1-(5-Isoquinolinylsulfonyl)-3-Methylpiperazine,C0214900,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protein Kinase Inhibitors,Protein Kinase Inhibitors,Y,quasi syn therclass-to-function,Protein Kinase Activity,Protein Kinase Activity,C1150527,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Protein Kinase Inhibitors,Protein Kinase Inhibitors,C1449702,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,
1_000732,MeSH_PA,C090640,"1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane",356-18-3,"1,2-Dichloro-1,2,3,3,4,4-hexafluorocyclobutane",ChemID+,exact,,,,,,,,"1,2-Dichloro-1,2,3,3,4,4-hexafluorocyclobutane",,356-18-3,exact,,,,"1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane",C090640,356-18-3,exact,,,,"1,2-Dichloro-1,2,3,3,4,4-Hexafluorocyclobutane",C0291312,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Anesthetics,Anesthetics,Y,quasi syn therclass-to-function,Anesthetic Effect,Anesthetic Effect,C3179301,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Anesthetics,Anesthetics,C0002932,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000733,MeSH_PA,C090640,"1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane",356-18-3,"1,2-Dichloro-1,2,3,3,4,4-hexafluorocyclobutane",ChemID+,exact,,,,,,,,"1,2-Dichloro-1,2,3,3,4,4-hexafluorocyclobutane",,356-18-3,exact,,,,"1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane",C090640,356-18-3,exact,,,,"1,2-Dichloro-1,2,3,3,4,4-Hexafluorocyclobutane",C0291312,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000734,MeSH_PA,C090640,"1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane",356-18-3,"1,2-Dichloro-1,2,3,3,4,4-hexafluorocyclobutane",ChemID+,exact,,,,,,,,"1,2-Dichloro-1,2,3,3,4,4-hexafluorocyclobutane",,356-18-3,exact,,,,"1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane",C090640,356-18-3,exact,,,,"1,2-Dichloro-1,2,3,3,4,4-Hexafluorocyclobutane",C0291312,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000735,MeSH_PA,C061162,1-arabinofuranosylcytosine-5'-stearylphosphate,73532-83-9,Cytarabine ocfosfate,ChemID+,<syn per source>,,,,,,,,Cytarabine ocfosfate,,73532-83-9,<syn per source>,1-arabinofuranosylcytosine-5'-stearylphosphate,exact,,1-arabinofuranosylcytosine-5'-stearylphosphate,C061162,73532-83-9,exact,,,,1-Arabinofuranosylcytosine-5'-Stearylphosphate,C0089089,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000736,MeSH_PA,C011786,2-(4-(dimethylamino)styryl)-1-methylpyridinium,2156-29-8,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,ChemID+,exact,2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide,51600,2156-29-8,<syn per source>,2-(4-(dimethylamino)styryl)-1-methylpyridinium,exact,,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,,2156-29-8,exact,,,,2-(4-(dimethylamino)styryl)-1-methylpyridinium,C011786,2156-29-8,exact,,,,2-(4-(Dimethylamino)Styryl)-1-Methylpyridinium,C0045715,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,blocker,,#VALUE!,Calcium Channel Blockers,Calcium Channel Blockers,Y,quasi syn therclass-to-function,Calcium Channel Activity,Calcium Channel Activity,C1153433,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Calcium Channel Blockers,Calcium Channel Blockers,C0006684,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000737,MeSH_PA,C011786,2-(4-(dimethylamino)styryl)-1-methylpyridinium,2156-29-8,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,ChemID+,exact,2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide,51600,2156-29-8,<syn per source>,2-(4-(dimethylamino)styryl)-1-methylpyridinium,exact,,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,,2156-29-8,exact,,,,2-(4-(dimethylamino)styryl)-1-methylpyridinium,C011786,2156-29-8,exact,,,,2-(4-(Dimethylamino)Styryl)-1-Methylpyridinium,C0045715,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000738,MeSH_PA,C011786,2-(4-(dimethylamino)styryl)-1-methylpyridinium,2156-29-8,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,ChemID+,exact,2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide,51600,2156-29-8,<syn per source>,2-(4-(dimethylamino)styryl)-1-methylpyridinium,exact,,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,,2156-29-8,exact,,,,2-(4-(dimethylamino)styryl)-1-methylpyridinium,C011786,2156-29-8,exact,,,,2-(4-(Dimethylamino)Styryl)-1-Methylpyridinium,C0045715,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000739,MeSH_PA,C011786,2-(4-(dimethylamino)styryl)-1-methylpyridinium,2156-29-8,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,ChemID+,exact,2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide,51600,2156-29-8,<syn per source>,2-(4-(dimethylamino)styryl)-1-methylpyridinium,exact,,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,,2156-29-8,exact,,,,2-(4-(dimethylamino)styryl)-1-methylpyridinium,C011786,2156-29-8,exact,,,,2-(4-(Dimethylamino)Styryl)-1-Methylpyridinium,C0045715,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000740,MeSH_PA,C011786,2-(4-(dimethylamino)styryl)-1-methylpyridinium,2156-29-8,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,ChemID+,exact,2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide,51600,2156-29-8,<syn per source>,2-(4-(dimethylamino)styryl)-1-methylpyridinium,exact,,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,,2156-29-8,exact,,,,2-(4-(dimethylamino)styryl)-1-methylpyridinium,C011786,2156-29-8,exact,,,,2-(4-(Dimethylamino)Styryl)-1-Methylpyridinium,C0045715,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000741,MeSH_PA,C011786,2-(4-(dimethylamino)styryl)-1-methylpyridinium,2156-29-8,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,ChemID+,exact,2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide,51600,2156-29-8,<syn per source>,2-(4-(dimethylamino)styryl)-1-methylpyridinium,exact,,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,,2156-29-8,exact,,,,2-(4-(dimethylamino)styryl)-1-methylpyridinium,C011786,2156-29-8,exact,,,,2-(4-(Dimethylamino)Styryl)-1-Methylpyridinium,C0045715,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000742,MeSH_PA,C011786,2-(4-(dimethylamino)styryl)-1-methylpyridinium,2156-29-8,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,ChemID+,exact,2-[4-(dimethylamino)styryl]-1-methylpyridinium iodide,51600,2156-29-8,<syn per source>,2-(4-(dimethylamino)styryl)-1-methylpyridinium,exact,,2-(4-(Dimethylamino)styryl)-1-methylpyridinium,,2156-29-8,exact,,,,2-(4-(dimethylamino)styryl)-1-methylpyridinium,C011786,2156-29-8,exact,,,,2-(4-(Dimethylamino)Styryl)-1-Methylpyridinium,C0045715,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,modulator,,#VALUE!,Membrane Transport Modulators,Membrane Transport Modulators,Y,quasi syn therclass-to-function,membrane transport,Transmembrane Transport,C1519624,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Membrane Transport Modulators,Membrane Transport Modulators,C1563710,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000743,MeSH_PA,C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",60423-21-4,"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",ChemID+,exact,,,,,,,,"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",,60423-21-4,exact,,,,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,60423-21-4,exact,,,,"2-Methoxy-5-(2',3',4'-Trimethoxyphenyl)Tropone",C0046312,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,Antimitotic Agents,Antimitotic Agents,Y,quasi syn therclass-to-function,Mitosis,Mitosis,C0026255,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Antimitotic Agents,Antimitotic Agents,C0003379,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000744,MeSH_PA,C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",60423-21-4,"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",ChemID+,exact,,,,,,,,"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",,60423-21-4,exact,,,,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,60423-21-4,exact,,,,"2-Methoxy-5-(2',3',4'-Trimethoxyphenyl)Tropone",C0046312,exact,,,,A1.4.1.2.1_Organic Chemical,,,,modulator,,#VALUE!,Mitosis Modulators,Mitosis Modulators,Y,quasi syn therclass-to-function,Mitosis,Mitosis,C0026255,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Mitosis Modulators,Mitosis Modulators,C1563760,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000745,MeSH_PA,C030370,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",60423-21-4,"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",ChemID+,exact,,,,,,,,"2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",,60423-21-4,exact,,,,"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone",C030370,60423-21-4,exact,,,,"2-Methoxy-5-(2',3',4'-Trimethoxyphenyl)Tropone",C0046312,exact,,,,A1.4.1.2.1_Organic Chemical,,,,modulator,,#VALUE!,Tubulin Modulators,Tubulin Modulators,Y,quasi syn therclass-to-function,Microtubule Polymerization Process,Microtubule Polymerization Process,C1156032,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Tubulin Modulators,Tubulin Modulators,C1563757,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000746,MeSH_PA,C090937,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole,154453-18-6,3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole,ChemID+,exact,,,,,,,,3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole,,154453-18-6,exact,,,,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole,C090937,154453-18-6,exact,,,,3-(5'-Hydroxymethyl-2'-Furyl)-1-Benzylindazole,C0291978,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Enzyme Activators,Enzyme Activators,Y,exact (CUI-based),Enzyme Activators,Enzyme Activators,C0751968,P,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,,,,,,,,,,
1_000747,MeSH_PA,C090937,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole,154453-18-6,3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole,ChemID+,exact,,,,,,,,3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole,,154453-18-6,exact,,,,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole,C090937,154453-18-6,exact,,,,3-(5'-Hydroxymethyl-2'-Furyl)-1-Benzylindazole,C0291978,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000748,MeSH_PA,C090937,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole,154453-18-6,3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole,ChemID+,exact,,,,,,,,3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole,,154453-18-6,exact,,,,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole,C090937,154453-18-6,exact,,,,3-(5'-Hydroxymethyl-2'-Furyl)-1-Benzylindazole,C0291978,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000749,MeSH_PA,D012368,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,29925-17-5,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,ChemID+,exact,,,,,,,,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,,29925-17-5,exact,,,,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,D012368,29925-17-5,exact,,,,4-(3-Butoxy-4-Methoxybenzyl)-2-Imidazolidinone,C1323140,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000750,MeSH_PA,D012368,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,29925-17-5,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,ChemID+,exact,,,,,,,,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,,29925-17-5,exact,,,,4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,D012368,29925-17-5,exact,,,,4-(3-Butoxy-4-Methoxybenzyl)-2-Imidazolidinone,C1323140,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,C0031638,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000751,MeSH_PA,C051577,4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol,59578-66-4,4-(Methylnitrosoamino)-4-(3-pyridyl)-1-butanol,ChemID+,exact,,,,,,,,4-(Methylnitrosoamino)-4-(3-pyridyl)-1-butanol,,59578-66-4,exact,,,,4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol,C051577,59578-66-4,exact,,,,4-(Methylnitrosoamino)-4-(3-Pyridyl)-1-Butanol,C0047947,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000752,MeSH_PA,C051577,4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol,59578-66-4,4-(Methylnitrosoamino)-4-(3-pyridyl)-1-butanol,ChemID+,exact,,,,,,,,4-(Methylnitrosoamino)-4-(3-pyridyl)-1-butanol,,59578-66-4,exact,,,,4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol,C051577,59578-66-4,exact,,,,4-(Methylnitrosoamino)-4-(3-Pyridyl)-1-Butanol,C0047947,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000753,MeSH_PA,C024321,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,22173-64-4,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,ChemID+,exact,,,,,,,,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,,22173-64-4,exact,,,,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,C024321,22173-64-4,exact,,,,5-(2-Cyclohexylidene-Ethyl)-5-Ethylbarbiturate,C0048979,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000754,MeSH_PA,C024321,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,22173-64-4,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,ChemID+,exact,,,,,,,,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,,22173-64-4,exact,,,,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,C024321,22173-64-4,exact,,,,5-(2-Cyclohexylidene-Ethyl)-5-Ethylbarbiturate,C0048979,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000755,MeSH_PA,C024321,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,22173-64-4,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,ChemID+,exact,,,,,,,,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,,22173-64-4,exact,,,,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,C024321,22173-64-4,exact,,,,5-(2-Cyclohexylidene-Ethyl)-5-Ethylbarbiturate,C0048979,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Stimulants,Central Nervous System Stimulants,Y,quasi syn therclass-to-function,central nervous system stimulation,Central Nervous System Stimulation [Pe],C2917138,S,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Central Nervous System Stimulants,Central Nervous System Stimulants,C0002763,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000756,MeSH_PA,C024321,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,22173-64-4,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,ChemID+,exact,,,,,,,,5-(2-Cyclohexylidene-ethyl)-5-ethylbarbiturate,,22173-64-4,exact,,,,5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate,C024321,22173-64-4,exact,,,,5-(2-Cyclohexylidene-Ethyl)-5-Ethylbarbiturate,C0048979,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Convulsants,Convulsants,Y,quasi syn therclass-to-function,Convulsant Effect,Convulsant Effect,C3179492,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Convulsants,Convulsants,C0009950,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_000757,MeSH_PA,C010243,5-(3-methyl-1-triazeno)imidazole-4-carboxamide,3413-72-7,NSC 407347,ChemID+,<syn per source>,MTIC,72568,3413-72-7,<syn per source>,5-(3-methyl-1-triazeno)imidazole-4-carboxamide,exact,,NSC 407347,,3413-72-7,<syn per source>,5-(3-Methyl-1-triazeno)imidazole-4-carboxamide,exact,,5-(3-methyl-1-triazeno)imidazole-4-carboxamide,C010243,3413-72-7,exact,,,,5-(3-Methyl-1-Triazeno)Imidazole-4-Carboxamide,C0098021,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Alkylating Agents,Alkylating Agents,Y,exact (CUI-based),Alkylating Agents,Alkylating Agents,C0002073,P,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,,,,,,,,,,
1_000758,MeSH_PA,C010243,5-(3-methyl-1-triazeno)imidazole-4-carboxamide,3413-72-7,NSC 407347,ChemID+,<syn per source>,MTIC,72568,3413-72-7,<syn per source>,5-(3-methyl-1-triazeno)imidazole-4-carboxamide,exact,,NSC 407347,,3413-72-7,<syn per source>,5-(3-Methyl-1-triazeno)imidazole-4-carboxamide,exact,,5-(3-methyl-1-triazeno)imidazole-4-carboxamide,C010243,3413-72-7,exact,,,,5-(3-Methyl-1-Triazeno)Imidazole-4-Carboxamide,C0098021,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000759,MeSH_PA,C059499,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",113852-41-8,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",ChemID+,exact,,,,,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",,113852-41-8,exact,,,,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",C059499,113852-41-8,exact,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-Diaminopurine",C0050174,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000760,MeSH_PA,C059499,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",113852-41-8,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",ChemID+,exact,,,,,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",,113852-41-8,exact,,,,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",C059499,113852-41-8,exact,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-Diaminopurine",C0050174,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000761,MeSH_PA,C059499,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",113852-41-8,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",ChemID+,exact,,,,,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",,113852-41-8,exact,,,,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",C059499,113852-41-8,exact,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-Diaminopurine",C0050174,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000762,MeSH_PA,C059499,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",113852-41-8,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",ChemID+,exact,,,,,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",,113852-41-8,exact,,,,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",C059499,113852-41-8,exact,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-Diaminopurine",C0050174,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000763,MeSH_PA,C059499,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",113852-41-8,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",ChemID+,exact,,,,,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine",,113852-41-8,exact,,,,"9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",C059499,113852-41-8,exact,,,,"9-(2-Phosphonylmethoxyethyl)-2,6-Diaminopurine",C0050174,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_000764,MeSH_PA,C050127,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,92999-29-6,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,ChemID+,exact,,,,,,,,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,,92999-29-6,exact,,,,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,C050127,92999-29-6,exact,,,,9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine,C0050181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000765,MeSH_PA,C050127,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,92999-29-6,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,ChemID+,exact,,,,,,,,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,,92999-29-6,exact,,,,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,C050127,92999-29-6,exact,,,,9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine,C0050181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000766,MeSH_PA,C050127,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,92999-29-6,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,ChemID+,exact,,,,,,,,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,,92999-29-6,exact,,,,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,C050127,92999-29-6,exact,,,,9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine,C0050181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiprotozoal Agents,Antiprotozoal Agents,Y,quasi syn therclass-to-disease,Protozoan Infections,Protozoan Infections,C0033740,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiprotozoal Agents,Antiprotozoal Agents,C0003416,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000767,MeSH_PA,C050127,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,92999-29-6,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,ChemID+,exact,,,,,,,,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,,92999-29-6,exact,,,,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,C050127,92999-29-6,exact,,,,9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine,C0050181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000768,MeSH_PA,C050127,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,92999-29-6,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,ChemID+,exact,,,,,,,,9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine,,92999-29-6,exact,,,,9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,C050127,92999-29-6,exact,,,,9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine,C0050181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,cidal,,#VALUE!,Trypanocidal Agents,Trypanocidal Agents,Y,quasi syn therclass-to-disease,Trypanosomiasis,Trypanosomiasis,C0041227,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Trypanocidal Agents,Trypanocidal Agents,C0041214,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000769,MeSH_PA,C043204,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,91742-10-8,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,ChemID+,exact,,,,,,,,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,,91742-10-8,exact,,,,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,C043204,91742-10-8,exact,,,,N-(2-Guanidinoethyl)-5-Isoquinolinesulfonamide,C0130188,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,blocker,,#VALUE!,Calcium Channel Blockers,Calcium Channel Blockers,Y,quasi syn therclass-to-function,Calcium Channel Activity,Calcium Channel Activity,C1153433,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Calcium Channel Blockers,Calcium Channel Blockers,C0006684,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000770,MeSH_PA,C043204,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,91742-10-8,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,ChemID+,exact,,,,,,,,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,,91742-10-8,exact,,,,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,C043204,91742-10-8,exact,,,,N-(2-Guanidinoethyl)-5-Isoquinolinesulfonamide,C0130188,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000771,MeSH_PA,C043204,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,91742-10-8,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,ChemID+,exact,,,,,,,,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,,91742-10-8,exact,,,,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,C043204,91742-10-8,exact,,,,N-(2-Guanidinoethyl)-5-Isoquinolinesulfonamide,C0130188,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000772,MeSH_PA,C043204,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,91742-10-8,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,ChemID+,exact,,,,,,,,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,,91742-10-8,exact,,,,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,C043204,91742-10-8,exact,,,,N-(2-Guanidinoethyl)-5-Isoquinolinesulfonamide,C0130188,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulator,,#VALUE!,Membrane Transport Modulators,Membrane Transport Modulators,Y,quasi syn therclass-to-function,membrane transport,Transmembrane Transport,C1519624,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Membrane Transport Modulators,Membrane Transport Modulators,C1563710,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000773,MeSH_PA,C043204,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,91742-10-8,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,ChemID+,exact,,,,,,,,N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide,,91742-10-8,exact,,,,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide,C043204,91742-10-8,exact,,,,N-(2-Guanidinoethyl)-5-Isoquinolinesulfonamide,C0130188,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protein Kinase Inhibitors,Protein Kinase Inhibitors,Y,quasi syn therclass-to-function,Protein Kinase Activity,Protein Kinase Activity,C1150527,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Protein Kinase Inhibitors,Protein Kinase Inhibitors,C1449702,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,
1_000774,MeSH_PA,C041712,1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol,88876-88-4,1-(2-Nitro-1-imidazolyl)-3-aziridino-2-propanol,ChemID+,exact,,,,,,,,1-(2-Nitro-1-imidazolyl)-3-aziridino-2-propanol,,88876-88-4,exact,,,,1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol,C041712,88876-88-4,exact,,,,1-(2-Nitro-1-Imidazolyl)-3-Aziridino-2-Propanol,C0088718,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000775,MeSH_PA,C041712,1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol,88876-88-4,1-(2-Nitro-1-imidazolyl)-3-aziridino-2-propanol,ChemID+,exact,,,,,,,,1-(2-Nitro-1-imidazolyl)-3-aziridino-2-propanol,,88876-88-4,exact,,,,1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol,C041712,88876-88-4,exact,,,,1-(2-Nitro-1-Imidazolyl)-3-Aziridino-2-Propanol,C0088718,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,Y,quasi syn therclass-to-function,Radiation-Sensitizing Effect,Radiation-Sensitizing Effect,C3179280,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,C0034541,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000776,MeSH_PA,C097280,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,,,,,,,,,,,"1,3-Dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,C097280000,exact,,,,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",C097280,,exact,,,,"1,3-Dipropyl-8-(2-(5,6-Epoxy)Norbornyl)Xanthine",C0384984,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adenosine A1 Receptor Antagonists,Adenosine A1 Receptor Antagonists,Y,quasi syn therclass-to-function,"A1 Adenosine Receptor Activity, G-Protein Coupled","A1 Adenosine Receptor Activity, G-Protein Coupled",C1152762,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Adenosine A1 Receptor Antagonists,Adenosine A1 Receptor Antagonists,C2936569,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000777,MeSH_PA,C097280,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,,,,,,,,,,,"1,3-Dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,C097280000,exact,,,,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",C097280,,exact,,,,"1,3-Dipropyl-8-(2-(5,6-Epoxy)Norbornyl)Xanthine",C0384984,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000778,MeSH_PA,C097280,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,,,,,,,,,,,"1,3-Dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,C097280000,exact,,,,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",C097280,,exact,,,,"1,3-Dipropyl-8-(2-(5,6-Epoxy)Norbornyl)Xanthine",C0384984,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000779,MeSH_PA,C097280,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,,,,,,,,,,,"1,3-Dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,C097280000,exact,,,,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",C097280,,exact,,,,"1,3-Dipropyl-8-(2-(5,6-Epoxy)Norbornyl)Xanthine",C0384984,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000780,MeSH_PA,C097280,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,,,,,,,,,,,"1,3-Dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",,C097280000,exact,,,,"1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine",C097280,,exact,,,,"1,3-Dipropyl-8-(2-(5,6-Epoxy)Norbornyl)Xanthine",C0384984,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000781,MeSH_PA,C046379,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",85872-51-1,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",,85872-51-1,exact,,,,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",C046379,85872-51-1,exact,,,,"1,3-Dipropyl-8-(2-Amino-4-Chlorophenyl)Xanthine",C0043958,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adenosine A1 Receptor Antagonists,Adenosine A1 Receptor Antagonists,Y,quasi syn therclass-to-function,"A1 Adenosine Receptor Activity, G-Protein Coupled","A1 Adenosine Receptor Activity, G-Protein Coupled",C1152762,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Adenosine A1 Receptor Antagonists,Adenosine A1 Receptor Antagonists,C2936569,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000782,MeSH_PA,C046379,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",85872-51-1,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",,85872-51-1,exact,,,,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",C046379,85872-51-1,exact,,,,"1,3-Dipropyl-8-(2-Amino-4-Chlorophenyl)Xanthine",C0043958,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000783,MeSH_PA,C046379,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",85872-51-1,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",,85872-51-1,exact,,,,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",C046379,85872-51-1,exact,,,,"1,3-Dipropyl-8-(2-Amino-4-Chlorophenyl)Xanthine",C0043958,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000784,MeSH_PA,C046379,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",85872-51-1,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",,85872-51-1,exact,,,,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",C046379,85872-51-1,exact,,,,"1,3-Dipropyl-8-(2-Amino-4-Chlorophenyl)Xanthine",C0043958,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000785,MeSH_PA,C046379,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",85872-51-1,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",ChemID+,exact,,,,,,,,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",,85872-51-1,exact,,,,"1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine",C046379,85872-51-1,exact,,,,"1,3-Dipropyl-8-(2-Amino-4-Chlorophenyl)Xanthine",C0043958,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000786,MeSH_PA,C021248,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,70700-33-3,Pyrenelecithin,ChemID+,<syn per source>,,,,,,,,Pyrenelecithin,,70700-33-3,<syn per source>,1-Palmitoyl-2-pyrenedecanoylphosphatidylcholine,exact,,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,C021248,70700-33-3,exact,,,,1-Palmitoyl-2-Pyrenedecanoylphosphatidylcholine,C0072671,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000787,MeSH_PA,C021248,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,70700-33-3,Pyrenelecithin,ChemID+,<syn per source>,,,,,,,,Pyrenelecithin,,70700-33-3,<syn per source>,1-Palmitoyl-2-pyrenedecanoylphosphatidylcholine,exact,,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,C021248,70700-33-3,exact,,,,1-Palmitoyl-2-Pyrenedecanoylphosphatidylcholine,C0072671,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000788,MeSH_PA,C021248,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,70700-33-3,Pyrenelecithin,ChemID+,<syn per source>,,,,,,,,Pyrenelecithin,,70700-33-3,<syn per source>,1-Palmitoyl-2-pyrenedecanoylphosphatidylcholine,exact,,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,C021248,70700-33-3,exact,,,,1-Palmitoyl-2-Pyrenedecanoylphosphatidylcholine,C0072671,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000789,MeSH_PA,C021248,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,70700-33-3,Pyrenelecithin,ChemID+,<syn per source>,,,,,,,,Pyrenelecithin,,70700-33-3,<syn per source>,1-Palmitoyl-2-pyrenedecanoylphosphatidylcholine,exact,,1-palmitoyl-2-pyrenedecanoylphosphatidylcholine,C021248,70700-33-3,exact,,,,1-Palmitoyl-2-Pyrenedecanoylphosphatidylcholine,C0072671,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000790,MeSH_PA,C041369,2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin,87857-27-0,2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin,ChemID+,exact,,,,,,,,2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin,,87857-27-0,exact,,,,2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin,C041369,87857-27-0,exact,,,,2-(N-Phenethyl-N-Propyl)Amino-5-Hydroxytetralin,C0092277,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000791,MeSH_PA,C041369,2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin,87857-27-0,2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin,ChemID+,exact,,,,,,,,2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin,,87857-27-0,exact,,,,2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin,C041369,87857-27-0,exact,,,,2-(N-Phenethyl-N-Propyl)Amino-5-Hydroxytetralin,C0092277,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000792,MeSH_PA,C041369,2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin,87857-27-0,2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin,ChemID+,exact,,,,,,,,2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin,,87857-27-0,exact,,,,2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin,C041369,87857-27-0,exact,,,,2-(N-Phenethyl-N-Propyl)Amino-5-Hydroxytetralin,C0092277,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000793,MeSH_PA,C043829,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",85138-49-4,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",ChemID+,exact,,,,,,,,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",,85138-49-4,exact,,,,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",C043829,85138-49-4,exact,,,,"2',7'-Bis(Carboxyethyl)-5(6)-Carboxyfluorescein",C0045149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000794,MeSH_PA,C043829,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",85138-49-4,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",ChemID+,exact,,,,,,,,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",,85138-49-4,exact,,,,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",C043829,85138-49-4,exact,,,,"2',7'-Bis(Carboxyethyl)-5(6)-Carboxyfluorescein",C0045149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000795,MeSH_PA,C043829,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",85138-49-4,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",ChemID+,exact,,,,,,,,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",,85138-49-4,exact,,,,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",C043829,85138-49-4,exact,,,,"2',7'-Bis(Carboxyethyl)-5(6)-Carboxyfluorescein",C0045149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000796,MeSH_PA,C043829,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",85138-49-4,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",ChemID+,exact,,,,,,,,"2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein",,85138-49-4,exact,,,,"2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein",C043829,85138-49-4,exact,,,,"2',7'-Bis(Carboxyethyl)-5(6)-Carboxyfluorescein",C0045149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000797,MeSH_PA,C049584,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",105650-23-5,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",ChemID+,exact,PhIP,76290,105650-23-5,<syn per source>,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",syn no\W,,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,105650-23-5,exact,,,,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C049584,105650-23-5,exact,,,,"2-Amino-1-Methyl-6-Phenylimidazo(4,5-B)Pyridine",C0045811,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000798,MeSH_PA,C049584,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",105650-23-5,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",ChemID+,exact,PhIP,76290,105650-23-5,<syn per source>,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",syn no\W,,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,105650-23-5,exact,,,,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C049584,105650-23-5,exact,,,,"2-Amino-1-Methyl-6-Phenylimidazo(4,5-B)Pyridine",C0045811,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000799,MeSH_PA,C049584,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",105650-23-5,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",ChemID+,exact,PhIP,76290,105650-23-5,<syn per source>,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",syn no\W,,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,105650-23-5,exact,,,,"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C049584,105650-23-5,exact,,,,"2-Amino-1-Methyl-6-Phenylimidazo(4,5-B)Pyridine",C0045811,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000800,MeSH_PA,C045421,"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine",95896-78-9,"3,4,8-Trimethylimidazo(4,5-f)quinoxalin-2-amine",ChemID+,exact,,,,,,,,"3,4,8-Trimethylimidazo(4,5-f)quinoxalin-2-amine",,95896-78-9,exact,,,,"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine",C045421,95896-78-9,exact,,,,"3,4,8-Trimethylimidazo(4,5-F)Quinoxalin-2-Amine",C0046943,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000801,MeSH_PA,C045421,"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine",95896-78-9,"3,4,8-Trimethylimidazo(4,5-f)quinoxalin-2-amine",ChemID+,exact,,,,,,,,"3,4,8-Trimethylimidazo(4,5-f)quinoxalin-2-amine",,95896-78-9,exact,,,,"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine",C045421,95896-78-9,exact,,,,"3,4,8-Trimethylimidazo(4,5-F)Quinoxalin-2-Amine",C0046943,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000802,MeSH_PA,C045421,"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine",95896-78-9,"3,4,8-Trimethylimidazo(4,5-f)quinoxalin-2-amine",ChemID+,exact,,,,,,,,"3,4,8-Trimethylimidazo(4,5-f)quinoxalin-2-amine",,95896-78-9,exact,,,,"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine",C045421,95896-78-9,exact,,,,"3,4,8-Trimethylimidazo(4,5-F)Quinoxalin-2-Amine",C0046943,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000803,MeSH_PA,C046364,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",91366-65-3,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",ChemID+,exact,,,,,,,,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",,91366-65-3,exact,,,,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",C046364,91366-65-3,exact,,,,"4-(Aminosulfonyl)-7-Fluoro-2,1,3-Benzoxadiazole",C0047928,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000804,MeSH_PA,C046364,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",91366-65-3,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",ChemID+,exact,,,,,,,,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",,91366-65-3,exact,,,,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",C046364,91366-65-3,exact,,,,"4-(Aminosulfonyl)-7-Fluoro-2,1,3-Benzoxadiazole",C0047928,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000805,MeSH_PA,C046364,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",91366-65-3,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",ChemID+,exact,,,,,,,,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",,91366-65-3,exact,,,,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",C046364,91366-65-3,exact,,,,"4-(Aminosulfonyl)-7-Fluoro-2,1,3-Benzoxadiazole",C0047928,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000806,MeSH_PA,C046364,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",91366-65-3,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",ChemID+,exact,,,,,,,,"4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",,91366-65-3,exact,,,,"4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole",C046364,91366-65-3,exact,,,,"4-(Aminosulfonyl)-7-Fluoro-2,1,3-Benzoxadiazole",C0047928,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000807,MeSH_PA,C078178,6-aminoquinolyl-N-hydroxysuccinimidyl carbamate,,,,,,,,,,,,,,,,,,,6-aminoquinolyl-N-hydroxysuccinimidyl carbamate,C078178,,exact,,,,6-Aminoquinolyl-N-Hydroxysuccinimidyl Carbamate,C0210442,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000808,MeSH_PA,C025284,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",47623-98-3,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",ChemID+,exact,,,,,,,,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",,47623-98-3,exact,,,,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",C025284,47623-98-3,exact,,,,"Bis(1,3-Diethylthiobarbiturate)Trimethineoxonol",C0053679,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000809,MeSH_PA,C025284,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",47623-98-3,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",ChemID+,exact,,,,,,,,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",,47623-98-3,exact,,,,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",C025284,47623-98-3,exact,,,,"Bis(1,3-Diethylthiobarbiturate)Trimethineoxonol",C0053679,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000810,MeSH_PA,C025284,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",47623-98-3,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",ChemID+,exact,,,,,,,,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",,47623-98-3,exact,,,,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",C025284,47623-98-3,exact,,,,"Bis(1,3-Diethylthiobarbiturate)Trimethineoxonol",C0053679,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000811,MeSH_PA,C025284,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",47623-98-3,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",ChemID+,exact,,,,,,,,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",,47623-98-3,exact,,,,"bis(1,3-diethylthiobarbiturate)trimethineoxonol",C025284,47623-98-3,exact,,,,"Bis(1,3-Diethylthiobarbiturate)Trimethineoxonol",C0053679,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000812,MeSH_PA,C111914,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",,,,,,,,,,,,MRS 2179,,C111914000,<syn per source>,"N(6)-Methyl-2'-deoxyadenosine 3',5'-diphosphate",exact,,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",C111914,,exact,,,,"N(6)-Methyl-2'-Deoxyadenosine 3',5'-Diphosphate",C0754781,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000813,MeSH_PA,C111914,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",,,,,,,,,,,,MRS 2179,,C111914000,<syn per source>,"N(6)-Methyl-2'-deoxyadenosine 3',5'-diphosphate",exact,,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",C111914,,exact,,,,"N(6)-Methyl-2'-Deoxyadenosine 3',5'-Diphosphate",C0754781,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000814,MeSH_PA,C111914,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",,,,,,,,,,,,MRS 2179,,C111914000,<syn per source>,"N(6)-Methyl-2'-deoxyadenosine 3',5'-diphosphate",exact,,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",C111914,,exact,,,,"N(6)-Methyl-2'-Deoxyadenosine 3',5'-Diphosphate",C0754781,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000815,MeSH_PA,C111914,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",,,,,,,,,,,,MRS 2179,,C111914000,<syn per source>,"N(6)-Methyl-2'-deoxyadenosine 3',5'-diphosphate",exact,,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",C111914,,exact,,,,"N(6)-Methyl-2'-Deoxyadenosine 3',5'-Diphosphate",C0754781,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,antagonist,antagonist,#VALUE!,Purinergic P2 Receptor Antagonists,Purinergic P2 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P2 Receptor Antagonists,Purinergic P2 Receptor Antagonists,C2936574,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000816,MeSH_PA,C111914,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",,,,,,,,,,,,MRS 2179,,C111914000,<syn per source>,"N(6)-Methyl-2'-deoxyadenosine 3',5'-diphosphate",exact,,"N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate",C111914,,exact,,,,"N(6)-Methyl-2'-Deoxyadenosine 3',5'-Diphosphate",C0754781,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,antagonist,antagonist,#VALUE!,Purinergic P2Y Receptor Antagonists,Purinergic P2Y Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P2Y Receptor Antagonists,Purinergic P2Y Receptor Antagonists,C2936583,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000817,MeSH_PA,C019347,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,55145-14-7,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,ChemID+,exact,,,,,,,,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,,55145-14-7,exact,,,,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,C019347,55145-14-7,exact,,,,N-(7-Dimethylamino-4-Methylcoumarinyl)Maleimide,C0067561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000818,MeSH_PA,C019347,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,55145-14-7,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,ChemID+,exact,,,,,,,,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,,55145-14-7,exact,,,,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,C019347,55145-14-7,exact,,,,N-(7-Dimethylamino-4-Methylcoumarinyl)Maleimide,C0067561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000819,MeSH_PA,C019347,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,55145-14-7,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,ChemID+,exact,,,,,,,,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,,55145-14-7,exact,,,,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,C019347,55145-14-7,exact,,,,N-(7-Dimethylamino-4-Methylcoumarinyl)Maleimide,C0067561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000820,MeSH_PA,C019347,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,55145-14-7,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,ChemID+,exact,,,,,,,,N-(7-Dimethylamino-4-methylcoumarinyl)maleimide,,55145-14-7,exact,,,,N-(7-dimethylamino-4-methylcoumarinyl)maleimide,C019347,55145-14-7,exact,,,,N-(7-Dimethylamino-4-Methylcoumarinyl)Maleimide,C0067561,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000821,MeSH_PA,C042891,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,87621-00-9,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,ChemID+,exact,,,,,,,,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,,87621-00-9,exact,,,,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,C042891,87621-00-9,exact,,,,N-Alanylproline-O-(4-Nitrobenzoyl)Hydroxylamine,C0622338,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000822,MeSH_PA,C042891,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,87621-00-9,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,ChemID+,exact,,,,,,,,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,,87621-00-9,exact,,,,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,C042891,87621-00-9,exact,,,,N-Alanylproline-O-(4-Nitrobenzoyl)Hydroxylamine,C0622338,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000823,MeSH_PA,C042891,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,87621-00-9,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,ChemID+,exact,,,,,,,,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,,87621-00-9,exact,,,,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,C042891,87621-00-9,exact,,,,N-Alanylproline-O-(4-Nitrobenzoyl)Hydroxylamine,C0622338,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000824,MeSH_PA,C042891,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,87621-00-9,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,ChemID+,exact,,,,,,,,N-Alanylproline-O-(4-nitrobenzoyl)hydroxylamine,,87621-00-9,exact,,,,N-alanylproline-O-(4-nitrobenzoyl)hydroxylamine,C042891,87621-00-9,exact,,,,N-Alanylproline-O-(4-Nitrobenzoyl)Hydroxylamine,C0622338,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000825,MeSH_PA,C109154,(2-(trimethylammonium)ethyl)methanethiosulfonate,155450-08-1,(2-(Trimethylammonium)ethyl)methanethiosulfonate,ChemID+,exact,,,,,,,,(2-(Trimethylammonium)ethyl)methanethiosulfonate,,155450-08-1,exact,,,,(2-(trimethylammonium)ethyl)methanethiosulfonate,C109154,155450-08-1,exact,,,,(2-(Trimethylammonium)Ethyl)Methanethiosulfonate,C0668028,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000826,MeSH_PA,C109154,(2-(trimethylammonium)ethyl)methanethiosulfonate,155450-08-1,(2-(Trimethylammonium)ethyl)methanethiosulfonate,ChemID+,exact,,,,,,,,(2-(Trimethylammonium)ethyl)methanethiosulfonate,,155450-08-1,exact,,,,(2-(trimethylammonium)ethyl)methanethiosulfonate,C109154,155450-08-1,exact,,,,(2-(Trimethylammonium)Ethyl)Methanethiosulfonate,C0668028,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sulfhydryl Reagents,Sulfhydryl Reagents,Y,exact (CUI-based),Sulfhydryl Reagents,Sulfhydryl Reagents,C0038738,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000827,MeSH_PA,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,154447-36-6,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,ChemID+,exact,LY294002,65329,154447-36-6,<syn per source>,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,exact,,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,,154447-36-6,exact,,,,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,154447-36-6,exact,,,,2-(4-Morpholinyl)-8-Phenyl-4H-1-Benzopyran-4-One,C0950895,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000828,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Anxiety Agents,Anti-Anxiety Agents,Y,quasi syn therclass-to-disease,Anxiety,Anxiety,C0003467,P,Y,B2.2.1.1.1.1_Mental Process,,,,exact (CUI-based),Anti-Anxiety Agents,Anti-Anxiety Agents,C0040616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000829,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000830,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000831,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000832,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000833,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000834,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000835,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000836,MeSH_PA,C062865,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",118876-58-7,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",ChemID+,exact,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",31073,,exact,,,,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",,118876-58-7,exact,,,,"2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline",C062865,118876-58-7,exact,,,,"2,3-Dioxo-6-Nitro-7-Sulfamoylbenzo(F)Quinoxaline",C0045376,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Tranquilizing Agents,Tranquilizing Agents,Y,quasi syn therclass-to-function,Tranquilizing Effect,Tranquilizing Effect,C3179402,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Tranquilizing Agents,Tranquilizing Agents,C0040614,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000837,MeSH_PA,C023785,"2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole",67730-11-4,Glu-P-1,ChemID+,<syn per source> no\W,,,,,,,,Glu-P-1,,67730-11-4,<syn per source>,"2-Amino-6-methyldipyrido(1,2-a:3',2'-d)imidazole",syn no\W,,"2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole",C023785,67730-11-4,exact,,,,"2-Amino-6-Methyldipyrido(1,2-A-3',2'-D)Imidazole",C0092521,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000838,MeSH_PA,C023785,"2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole",67730-11-4,Glu-P-1,ChemID+,<syn per source> no\W,,,,,,,,Glu-P-1,,67730-11-4,<syn per source>,"2-Amino-6-methyldipyrido(1,2-a:3',2'-d)imidazole",syn no\W,,"2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole",C023785,67730-11-4,exact,,,,"2-Amino-6-Methyldipyrido(1,2-A-3',2'-D)Imidazole",C0092521,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000839,ChEBI,,3-carboxyphenyl phenylacetamidomethylphosphonate,125319-03-1,3-Carboxyphenyl phenylacetamidomethylphosphonate,ChemID+,exact,3-carboxyphenyl phenylacetamidomethylphosphonate,10586,125319-03-1,exact,,,,3-Carboxyphenyl phenylacetamidomethylphosphonate,,125319-03-1,exact,,,,3-carboxyphenyl phenylacetamidomethylphosphonate,C061729,125319-03-1,exact,,,,3-Carboxyphenyl Phenylacetamidomethylphosphonate,C0638720,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,inhibitor,inhibits, inhibitor,beta-lactamase inhibitor,beta-lactamase inhibitor,Y,quasi syn therclass-to-function,Beta-Lactamase Activity,Beta-Lactamase Activity,C0427970,P,Y,B2.2.1.1.4_Molecular Function,,,,exact 1,beta-lactamase inhibitor,Beta Lactamase Inhibitor,C2917454,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000840,MeSH_PA,C038555,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,88254-07-3,Cyanomorpholino doxorubicin,ChemID+,<syn per source>,,,,,,,,Cyanomorpholino doxorubicin,,88254-07-3,<syn per source>,3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,exact,,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,C038555,88254-07-3,exact,,,,3'-Deamino-3'-(3-Cyano-4-Morpholinyl)Doxorubicin,C0046798,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",C0003236,P,A1.4.1.1.1.1_Antibiotic,,,
1_000841,MeSH_PA,C038555,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,88254-07-3,Cyanomorpholino doxorubicin,ChemID+,<syn per source>,,,,,,,,Cyanomorpholino doxorubicin,,88254-07-3,<syn per source>,3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,exact,,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,C038555,88254-07-3,exact,,,,3'-Deamino-3'-(3-Cyano-4-Morpholinyl)Doxorubicin,C0046798,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000842,MeSH_PA,C038555,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,88254-07-3,Cyanomorpholino doxorubicin,ChemID+,<syn per source>,,,,,,,,Cyanomorpholino doxorubicin,,88254-07-3,<syn per source>,3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,exact,,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,C038555,88254-07-3,exact,,,,3'-Deamino-3'-(3-Cyano-4-Morpholinyl)Doxorubicin,C0046798,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000843,MeSH_PA,C038555,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,88254-07-3,Cyanomorpholino doxorubicin,ChemID+,<syn per source>,,,,,,,,Cyanomorpholino doxorubicin,,88254-07-3,<syn per source>,3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,exact,,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,C038555,88254-07-3,exact,,,,3'-Deamino-3'-(3-Cyano-4-Morpholinyl)Doxorubicin,C0046798,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000844,MeSH_PA,C035763,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",63741-13-9,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",ChemID+,exact,,,,,,,,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",,63741-13-9,exact,,,,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",C035763,63741-13-9,exact,,,,"5,5'-Bis(8-(Phenylamino)-1-Naphthalenesulfonate)",C0048876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000845,MeSH_PA,C035763,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",63741-13-9,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",ChemID+,exact,,,,,,,,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",,63741-13-9,exact,,,,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",C035763,63741-13-9,exact,,,,"5,5'-Bis(8-(Phenylamino)-1-Naphthalenesulfonate)",C0048876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000846,MeSH_PA,C035763,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",63741-13-9,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",ChemID+,exact,,,,,,,,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",,63741-13-9,exact,,,,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",C035763,63741-13-9,exact,,,,"5,5'-Bis(8-(Phenylamino)-1-Naphthalenesulfonate)",C0048876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000847,MeSH_PA,C035763,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",63741-13-9,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",ChemID+,exact,,,,,,,,"5,5'-Bis(8-(phenylamino)-1-naphthalenesulfonate)",,63741-13-9,exact,,,,"5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)",C035763,63741-13-9,exact,,,,"5,5'-Bis(8-(Phenylamino)-1-Naphthalenesulfonate)",C0048876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000848,MeSH_PA,C097284,manganese(III)-tetrakis(4-benzoic acid)porphyrin,,,,,,,,,,,,Manganese(III)-tetrakis(4-benzoic acid)porphyrin,,C097284000,exact,,,,manganese(III)-tetrakis(4-benzoic acid)porphyrin,C097284,,exact,,,,Manganese(Iii)-Tetrakis(4-Benzoic Acid)Porphyrin,C0384992,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Antidotes,Antidotes,Y,quasi syn therclass-to-disease,Poisoning,Poisoning,C0032343,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Antidotes,Antidotes,C0003295,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000849,MeSH_PA,C097284,manganese(III)-tetrakis(4-benzoic acid)porphyrin,,,,,,,,,,,,Manganese(III)-tetrakis(4-benzoic acid)porphyrin,,C097284000,exact,,,,manganese(III)-tetrakis(4-benzoic acid)porphyrin,C097284,,exact,,,,Manganese(Iii)-Tetrakis(4-Benzoic Acid)Porphyrin,C0384992,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000850,MeSH_PA,C097284,manganese(III)-tetrakis(4-benzoic acid)porphyrin,,,,,,,,,,,,Manganese(III)-tetrakis(4-benzoic acid)porphyrin,,C097284000,exact,,,,manganese(III)-tetrakis(4-benzoic acid)porphyrin,C097284,,exact,,,,Manganese(Iii)-Tetrakis(4-Benzoic Acid)Porphyrin,C0384992,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Free Radical Scavengers,Free Radical Scavengers,Y,quasi syn therclass-to-function,Free Radical Scavenging [Moa],Free Radical Scavenging [Moa],C1517315,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Free Radical Scavengers,Free Radical Scavengers,C0079381,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_000851,MeSH_PA,C097284,manganese(III)-tetrakis(4-benzoic acid)porphyrin,,,,,,,,,,,,Manganese(III)-tetrakis(4-benzoic acid)porphyrin,,C097284000,exact,,,,manganese(III)-tetrakis(4-benzoic acid)porphyrin,C097284,,exact,,,,Manganese(Iii)-Tetrakis(4-Benzoic Acid)Porphyrin,C0384992,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000852,MeSH_PA,C047270,"N,N-bis(trimethylsilyl)-2,2,2-trifluoroacetamide",21149-38-2,"N,N-Bis(trimethylsilyl)-2,2,2-trifluoroacetamide",ChemID+,exact,,,,,,,,"N,N-Bis(trimethylsilyl)-2,2,2-trifluoroacetamide",,21149-38-2,exact,,,,"N,N-bis(trimethylsilyl)-2,2,2-trifluoroacetamide",C047270,21149-38-2,exact,,,,"N,N-Bis(Trimethylsilyl)-2,2,2-Trifluoroacetamide",C0067333,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000853,MeSH_PA,C069894,poly-1-6-glucopyranosyl-1-3-glucopyranose glucan,152522-11-7,Zymocel,ChemID+,<syn per source> + BT of isomer,,,,,,,,Zymocel,,152522-11-7,<syn per source> + BT of isomer,Poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose polymer,syn?,,poly-1-6-glucopyranosyl-1-3-glucopyranose glucan,C069894,,exact,,,,Poly-1-6-Glucopyranosyl-1-3-Glucopyranose Glucan,C0646856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,adjuvant,adju,1,"Adjuvants, Immunologic","Adjuvants, Immunologic",Y,quasi syn therclass-to-function,Active Immunity,Active Immunity,C0020965,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),"adjuvants, immunologic",Immunologic Adjuvants,C0001551,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_000854,MeSH_PA,C069894,poly-1-6-glucopyranosyl-1-3-glucopyranose glucan,152522-11-7,Zymocel,ChemID+,<syn per source> + BT of isomer,,,,,,,,Zymocel,,152522-11-7,<syn per source> + BT of isomer,Poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose polymer,syn?,,poly-1-6-glucopyranosyl-1-3-glucopyranose glucan,C069894,,exact,,,,Poly-1-6-Glucopyranosyl-1-3-Glucopyranose Glucan,C0646856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000855,MeSH_PA,C069894,poly-1-6-glucopyranosyl-1-3-glucopyranose glucan,152522-11-7,Zymocel,ChemID+,<syn per source> + BT of isomer,,,,,,,,Zymocel,,152522-11-7,<syn per source> + BT of isomer,Poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose polymer,syn?,,poly-1-6-glucopyranosyl-1-3-glucopyranose glucan,C069894,,exact,,,,Poly-1-6-Glucopyranosyl-1-3-Glucopyranose Glucan,C0646856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_000856,MeSH_PA,C018940,(ethylenedinitrilo)-tetramethylenephosphonic acid,1429-50-1,(Ethylenedinitrilo)-tetramethylenephosphonic acid,ChemID+,exact,,,,,,,,(Ethylenedinitrilo)-tetramethylenephosphonic acid,,1429-50-1,exact,,,,(ethylenedinitrilo)-tetramethylenephosphonic acid,C018940,1429-50-1,exact,,,,(Ethylenedinitrilo)-Tetramethylenephosphonic Acid,C0043637,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000857,MeSH_PA,C061818,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,123027-56-5,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,ChemID+,exact,1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine,43060,123027-56-5,<syn per source>,1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine,syn no\W,,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,,123027-56-5,exact,,,,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,C061818,123027-56-5,exact,,,,1-((2-Hydroxyethoxy)Methyl)-6-(Phenylthio)Thymine,C0044083,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-HIV Agents,Anti-HIV Agents,Y,quasi syn therclass-to-disease,Hiv Infections,Hiv Infections,C0019693,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Hiv Agents,Anti-Hiv Agents,C0376565,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000858,MeSH_PA,C061818,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,123027-56-5,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,ChemID+,exact,1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine,43060,123027-56-5,<syn per source>,1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine,syn no\W,,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,,123027-56-5,exact,,,,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,C061818,123027-56-5,exact,,,,1-((2-Hydroxyethoxy)Methyl)-6-(Phenylthio)Thymine,C0044083,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000859,MeSH_PA,C061818,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,123027-56-5,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,ChemID+,exact,1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine,43060,123027-56-5,<syn per source>,1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine,syn no\W,,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,,123027-56-5,exact,,,,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,C061818,123027-56-5,exact,,,,1-((2-Hydroxyethoxy)Methyl)-6-(Phenylthio)Thymine,C0044083,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Anti-Retroviral Agents,Anti-Retroviral Agents,Y,quasi syn therclass-to-disease,retroviral infections,Retroviridae Infections,C0035369,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Retroviral Agents,Anti-Retroviral Agents,C0599685,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000860,MeSH_PA,C061818,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,123027-56-5,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,ChemID+,exact,1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine,43060,123027-56-5,<syn per source>,1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine,syn no\W,,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,,123027-56-5,exact,,,,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,C061818,123027-56-5,exact,,,,1-((2-Hydroxyethoxy)Methyl)-6-(Phenylthio)Thymine,C0044083,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000861,MeSH_PA,C061818,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,123027-56-5,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,ChemID+,exact,1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine,43060,123027-56-5,<syn per source>,1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine,syn no\W,,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,,123027-56-5,exact,,,,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,C061818,123027-56-5,exact,,,,1-((2-Hydroxyethoxy)Methyl)-6-(Phenylthio)Thymine,C0044083,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000862,MeSH_PA,C061818,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,123027-56-5,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,ChemID+,exact,1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine,43060,123027-56-5,<syn per source>,1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine,syn no\W,,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,,123027-56-5,exact,,,,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,C061818,123027-56-5,exact,,,,1-((2-Hydroxyethoxy)Methyl)-6-(Phenylthio)Thymine,C0044083,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,inhibitor,inhibits,Inhibitors,Nucleic Acid Synthesis Inhibitors,Nucleic Acid Synthesis Inhibitors,Y,quasi syn therclass-to-function,Nucleic Acid Biosynthesis,Nucleic Acid Biosynthesis,C0597095,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nucleic Acid Synthesis Inhibitors,Nucleic Acid Synthesis Inhibitors,C0376568,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000863,MeSH_PA,C061818,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,123027-56-5,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,ChemID+,exact,1-[(2-hydroxyethoxy)methyl]-6-(phenylsulfanyl)thymine,43060,123027-56-5,<syn per source>,1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine,syn no\W,,1-((2-Hydroxyethoxy)methyl)-6-(phenylthio)thymine,,123027-56-5,exact,,,,1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine,C061818,123027-56-5,exact,,,,1-((2-Hydroxyethoxy)Methyl)-6-(Phenylthio)Thymine,C0044083,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,inhibitor,inhibits,Inhibitors,Reverse Transcriptase Inhibitors,Reverse Transcriptase Inhibitors,Y,quasi syn therclass-to-function,Reverse Transcriptase Activity,Reverse Transcriptase Activity,C2257391,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Reverse Transcriptase Inhibitors,Reverse Transcriptase Inhibitors,C0282519,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000864,MeSH_PA,C003905,"3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione",64474-15-3,"3,6-Bis(5-chloro-2-piperidyl)-2,5-piperazinedione",ChemID+,exact,,,,,,,,"3,6-Bis(5-chloro-2-piperidyl)-2,5-piperazinedione",,64474-15-3,exact,,,,"3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione",C003905,64474-15-3,exact,,,,"3,6-Bis(5-Chloro-2-Piperidyl)-2,5-Piperazinedione",C0047061,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",C0003236,P,A1.4.1.1.1.1_Antibiotic,,,
1_000865,MeSH_PA,C003905,"3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione",64474-15-3,"3,6-Bis(5-chloro-2-piperidyl)-2,5-piperazinedione",ChemID+,exact,,,,,,,,"3,6-Bis(5-chloro-2-piperidyl)-2,5-piperazinedione",,64474-15-3,exact,,,,"3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione",C003905,64474-15-3,exact,,,,"3,6-Bis(5-Chloro-2-Piperidyl)-2,5-Piperazinedione",C0047061,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000866,MeSH_PA,C088860,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",,,,,,,,,,,,"4-((3-Bromophenyl)amino)-6,7-dimethoxyquinazoline",,C088860000,exact,,,,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",C088860,,exact,,,,"4-((3-Bromophenyl)Amino)-6,7-Dimethoxyquinazoline",C0258113,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000867,MeSH_PA,C088860,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",,,,,,,,,,,,"4-((3-Bromophenyl)amino)-6,7-dimethoxyquinazoline",,C088860000,exact,,,,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",C088860,,exact,,,,"4-((3-Bromophenyl)Amino)-6,7-Dimethoxyquinazoline",C0258113,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000868,MeSH_PA,C088860,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",,,,,,,,,,,,"4-((3-Bromophenyl)amino)-6,7-dimethoxyquinazoline",,C088860000,exact,,,,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",C088860,,exact,,,,"4-((3-Bromophenyl)Amino)-6,7-Dimethoxyquinazoline",C0258113,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000869,MeSH_PA,C088860,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",,,,,,,,,,,,"4-((3-Bromophenyl)amino)-6,7-dimethoxyquinazoline",,C088860000,exact,,,,"4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline",C088860,,exact,,,,"4-((3-Bromophenyl)Amino)-6,7-Dimethoxyquinazoline",C0258113,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Intercalating Agents,Intercalating Agents,Y,exact (CUI-based),Intercalating Agents,Intercalating Agents,C0021717,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000870,MeSH_PA,C012926,"4-(N,N-dimethylaminoazobenzene)-4'-isothiocyanate",7612-98-8,"4-(N,N-Dimethylaminoazobenzene)-4'-isothiocyanate",ChemID+,exact,,,,,,,,"4-(N,N-Dimethylaminoazobenzene)-4'-isothiocyanate",,7612-98-8,exact,,,,"4-(N,N-dimethylaminoazobenzene)-4'-isothiocyanate",C012926,7612-98-8,exact,,,,"4-(N,N-Dimethylaminoazobenzene)-4'-Isothiocyanate",C0047952,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000871,ChEBI,,"4',5'-dihydro-11,5'-dihydroxy-4'-methoxytephrosin",,,,,"4',5'-dihydro-11,5'-dihydroxy-4'-methoxytephrosin",65772,,exact,,,,,,,,,,,"4',5'-dihydro-11,5'-dihydroxy-4'-methoxytephrosin",C481560,,exact,,,,"4',5'-Dihydro-11,5'-Dihydroxy-4'-Methoxytephrosin",C1434851,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antineoplastic agent,antineoplastic agent,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact 1,antineoplastic agent,Antineoplastic Agents,C0003392,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000872,MeSH_PA,C058332,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,89459-25-6,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,ChemID+,exact,,,,,,,,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,,89459-25-6,exact,,,,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,C058332,89459-25-6,exact,,,,N-(2'-(Dimethylamino)Ethyl)Acridine-4-Carboxamide,C0130149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000873,MeSH_PA,C058332,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,89459-25-6,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,ChemID+,exact,,,,,,,,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,,89459-25-6,exact,,,,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,C058332,89459-25-6,exact,,,,N-(2'-(Dimethylamino)Ethyl)Acridine-4-Carboxamide,C0130149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000874,MeSH_PA,C058332,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,89459-25-6,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,ChemID+,exact,,,,,,,,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,,89459-25-6,exact,,,,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,C058332,89459-25-6,exact,,,,N-(2'-(Dimethylamino)Ethyl)Acridine-4-Carboxamide,C0130149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Topoisomerase II Inhibitors,Topoisomerase II Inhibitors,Y,quasi syn therclass-to-function,Dna Topoisomerase Type Ii Activity,Dna Topoisomerase Type Ii Activity,C2257146,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Topoisomerase Ii Inhibitors,Topoisomerase Ii Inhibitors,C1519554,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000875,MeSH_PA,C058332,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,89459-25-6,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,ChemID+,exact,,,,,,,,N-(2'-(Dimethylamino)ethyl)acridine-4-carboxamide,,89459-25-6,exact,,,,N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide,C058332,89459-25-6,exact,,,,N-(2'-(Dimethylamino)Ethyl)Acridine-4-Carboxamide,C0130149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Topoisomerase Inhibitors,Topoisomerase Inhibitors,Y,quasi syn therclass-to-function,Dna Topoisomerase Activity,Dna Topoisomerase Activity,C1150386,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Topoisomerase Inhibitors,Topoisomerase Inhibitors,C0598317,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000876,MeSH_PA,C043062,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",98774-23-3,Tesmilifene,ChemID+,<syn per source>,,,,,,,,Tesmilifene,Tesmilifene [INN],98774-23-3,<syn per source>,"N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",exact,,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",C043062,98774-23-3,exact,,,,"N,N-Diethyl-2-((4-Phenylmethyl)Phenoxy)Ethanamine",C0911258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000877,MeSH_PA,C043062,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",98774-23-3,Tesmilifene,ChemID+,<syn per source>,,,,,,,,Tesmilifene,Tesmilifene [INN],98774-23-3,<syn per source>,"N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",exact,,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",C043062,98774-23-3,exact,,,,"N,N-Diethyl-2-((4-Phenylmethyl)Phenoxy)Ethanamine",C0911258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Histamine Agents,Histamine Agents,Y,quasi syn therclass-to-function,Histamine Receptor Activity,Histamine Receptor Activity,C1152738,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Histamine Agents,Histamine Agents,C0242704,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000878,MeSH_PA,C043062,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",98774-23-3,Tesmilifene,ChemID+,<syn per source>,,,,,,,,Tesmilifene,Tesmilifene [INN],98774-23-3,<syn per source>,"N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",exact,,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",C043062,98774-23-3,exact,,,,"N,N-Diethyl-2-((4-Phenylmethyl)Phenoxy)Ethanamine",C0911258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Histamine Antagonists,Histamine Antagonists,Y,quasi syn therclass-to-function,Histamine Receptor Activity,Histamine Receptor Activity,C1152738,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Histamine Antagonists,Histamine Antagonists,C0019590,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000879,MeSH_PA,C043062,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",98774-23-3,Tesmilifene,ChemID+,<syn per source>,,,,,,,,Tesmilifene,Tesmilifene [INN],98774-23-3,<syn per source>,"N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",exact,,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",C043062,98774-23-3,exact,,,,"N,N-Diethyl-2-((4-Phenylmethyl)Phenoxy)Ethanamine",C0911258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000880,MeSH_PA,C043062,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",98774-23-3,Tesmilifene,ChemID+,<syn per source>,,,,,,,,Tesmilifene,Tesmilifene [INN],98774-23-3,<syn per source>,"N,N-Diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",exact,,"N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine",C043062,98774-23-3,exact,,,,"N,N-Diethyl-2-((4-Phenylmethyl)Phenoxy)Ethanamine",C0911258,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000881,MeSH_PA,C568442,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,,,,,,,,,,,,,,,,,,,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,C568442,,exact,,,,(4-Methoxyphenyl)(1-Pentyl-1H-Indol-3-Yl)Methanone,C3253091,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,22,Cannabinoid Receptor Agonists,Cannabinoid Receptor Agonists,Y,quasi syn therclass-to-function,Cannabinoid Receptor Activity,Cannabinoid Receptor Activity,C1152747,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cannabinoid Receptor Agonists,Cannabinoid Receptor Agonists,C2927148,P,B2.2.1.1.4_Molecular Function,,,
1_000882,MeSH_PA,C568442,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,,,,,,,,,,,,,,,,,,,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,C568442,,exact,,,,(4-Methoxyphenyl)(1-Pentyl-1H-Indol-3-Yl)Methanone,C3253091,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulator,,#VALUE!,Cannabinoid Receptor Modulators,Cannabinoid Receptor Modulators,Y,quasi syn therclass-to-function,Cannabinoid Receptor Activity,Cannabinoid Receptor Activity,C1152747,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cannabinoid Receptor Modulators,Cannabinoid Receptor Modulators,C3494475,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000883,MeSH_PA,C568442,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,,,,,,,,,,,,,,,,,,,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,C568442,,exact,,,,(4-Methoxyphenyl)(1-Pentyl-1H-Indol-3-Yl)Methanone,C3253091,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hormones,Hormones,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormones,Hormones,C0019932,P,A1.4.1.1.3.2_Hormone,,,
1_000884,MeSH_PA,C568442,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,,,,,,,,,,,,,,,,,,,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,C568442,,exact,,,,(4-Methoxyphenyl)(1-Pentyl-1H-Indol-3-Yl)Methanone,C3253091,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000885,MeSH_PA,C568442,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,,,,,,,,,,,,,,,,,,,(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone,C568442,,exact,,,,(4-Methoxyphenyl)(1-Pentyl-1H-Indol-3-Yl)Methanone,C3253091,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000886,MeSH_PA,C054363,2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline,85273-95-6,2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline,ChemID+,exact,,,,,,,,2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline,,85273-95-6,exact,,,,2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline,C054363,85273-95-6,exact,,,,2-((2-(Dimethylamino)Ethyl)Thio)-3-Phenylquinoline,C0091873,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000887,MeSH_PA,C054363,2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline,85273-95-6,2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline,ChemID+,exact,,,,,,,,2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline,,85273-95-6,exact,,,,2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline,C054363,85273-95-6,exact,,,,2-((2-(Dimethylamino)Ethyl)Thio)-3-Phenylquinoline,C0091873,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000888,MeSH_PA,C054363,2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline,85273-95-6,2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline,ChemID+,exact,,,,,,,,2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline,,85273-95-6,exact,,,,2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline,C054363,85273-95-6,exact,,,,2-((2-(Dimethylamino)Ethyl)Thio)-3-Phenylquinoline,C0091873,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Serotonin Antagonists,Serotonin Antagonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Antagonists,Serotonin Antagonists,C0036753,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000889,MeSH_PA,C006261,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,3039-71-2,U 18666A,ChemID+,<syn per source>,,,,,,,,U 18666A,,3039-71-2,<syn per source>,3-beta-(2-(Diethylamino)ethoxy)androst-5-en-17-one,exact,,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,C006261,3039-71-2,exact,,,,3-Beta-(2-(Diethylamino)Ethoxy)Androst-5-En-17-One,C0095225,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,anti,,#VALUE!,Anticholesteremic Agents,Anticholesteremic Agents,Y,quasi syn therclass-to-disease,Hypercholesterolemia,Hypercholesterolemia,C0020443,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anticholesteremic Agents,Anticholesteremic Agents,C0003277,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000890,MeSH_PA,C006261,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,3039-71-2,U 18666A,ChemID+,<syn per source>,,,,,,,,U 18666A,,3039-71-2,<syn per source>,3-beta-(2-(Diethylamino)ethoxy)androst-5-en-17-one,exact,,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,C006261,3039-71-2,exact,,,,3-Beta-(2-(Diethylamino)Ethoxy)Androst-5-En-17-One,C0095225,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,anti,,#VALUE!,Antimetabolites,Antimetabolites,Y,quasi syn therclass-to-function,Metabolism,Metabolism,C0025519,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Antimetabolites,Antimetabolites,C0003376,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000891,MeSH_PA,C006261,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,3039-71-2,U 18666A,ChemID+,<syn per source>,,,,,,,,U 18666A,,3039-71-2,<syn per source>,3-beta-(2-(Diethylamino)ethoxy)androst-5-en-17-one,exact,,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,C006261,3039-71-2,exact,,,,3-Beta-(2-(Diethylamino)Ethoxy)Androst-5-En-17-One,C0095225,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000892,MeSH_PA,C006261,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,3039-71-2,U 18666A,ChemID+,<syn per source>,,,,,,,,U 18666A,,3039-71-2,<syn per source>,3-beta-(2-(Diethylamino)ethoxy)androst-5-en-17-one,exact,,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,C006261,3039-71-2,exact,,,,3-Beta-(2-(Diethylamino)Ethoxy)Androst-5-En-17-One,C0095225,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,hypo,,#VALUE!,Hypolipidemic Agents,Hypolipidemic Agents,Y,quasi syn therclass-to-disease,Hyperlipidemia,Hyperlipidemia,C0020473,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypolipidemic Agents,Hypolipidemic Agents,C0086440,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000893,MeSH_PA,C006261,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,3039-71-2,U 18666A,ChemID+,<syn per source>,,,,,,,,U 18666A,,3039-71-2,<syn per source>,3-beta-(2-(Diethylamino)ethoxy)androst-5-en-17-one,exact,,3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one,C006261,3039-71-2,exact,,,,3-Beta-(2-(Diethylamino)Ethoxy)Androst-5-En-17-One,C0095225,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,regulating,,#VALUE!,Lipid Regulating Agents,Lipid Regulating Agents,Y,quasi syn therclass-to-function,Lipid Metabolism,Lipid Metabolism,C0598783,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipid Regulating Agents,Lipid Regulating Agents,C2936244,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000894,MeSH_PA,C010572,"4-N,N-dimethylaminoazobenzene-4'-sulfonyl chloride",56512-49-3,"4-N,N-Dimethylaminoazobenzene-4'-sulfonyl chloride",ChemID+,exact,,,,,,,,"4-N,N-Dimethylaminoazobenzene-4'-sulfonyl chloride",,56512-49-3,exact,,,,"4-N,N-dimethylaminoazobenzene-4'-sulfonyl chloride",C010572,56512-49-3,exact,,,,"4-N,N-Dimethylaminoazobenzene-4'-Sulfonyl Chloride",C0048536,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000895,MeSH_PA,C006014,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",57818-92-5,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",ChemID+,exact,,,,,,,,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",,57818-92-5,exact,,,,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",C006014,57818-92-5,exact,,,,"8-(N,N-Diethylamino)Octyl-3,4,5-Trimethoxybenzoate",C1812577,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,blocker,,#VALUE!,Calcium Channel Blockers,Calcium Channel Blockers,Y,quasi syn therclass-to-function,Calcium Channel Activity,Calcium Channel Activity,C1153433,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Calcium Channel Blockers,Calcium Channel Blockers,C0006684,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000896,MeSH_PA,C006014,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",57818-92-5,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",ChemID+,exact,,,,,,,,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",,57818-92-5,exact,,,,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",C006014,57818-92-5,exact,,,,"8-(N,N-Diethylamino)Octyl-3,4,5-Trimethoxybenzoate",C1812577,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000897,MeSH_PA,C006014,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",57818-92-5,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",ChemID+,exact,,,,,,,,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",,57818-92-5,exact,,,,"8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate",C006014,57818-92-5,exact,,,,"8-(N,N-Diethylamino)Octyl-3,4,5-Trimethoxybenzoate",C1812577,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulator,,#VALUE!,Membrane Transport Modulators,Membrane Transport Modulators,Y,quasi syn therclass-to-function,membrane transport,Transmembrane Transport,C1519624,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Membrane Transport Modulators,Membrane Transport Modulators,C1563710,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000898,MeSH_PA,C093260,"benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene",,,,,,,,,,,,,,,,,,,,,,,,,,"Benzyloxycarbonyl-Asp-Ch2Oc(O)-2,6-Dichlorobenzene",C0296871,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000899,MeSH_PA,C093260,"benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene",,,,,,,,,,,,,,,,,,,,,,,,,,"Benzyloxycarbonyl-Asp-Ch2Oc(O)-2,6-Dichlorobenzene",C0296871,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000900,MeSH_PA,C030824,dansylglutamyl-glycyl-arginine chloromethyl ketone,69024-84-6,Dansylglutamyl-glycyl-arginine chloromethyl ketone,ChemID+,exact,,,,,,,,Dansylglutamyl-glycyl-arginine chloromethyl ketone,,69024-84-6,exact,,,,dansylglutamyl-glycyl-arginine chloromethyl ketone,C030824,69024-84-6,exact,,,,Dansylglutamyl-Glycyl-Arginine Chloromethyl Ketone,C0057126,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000901,MeSH_PA,C030824,dansylglutamyl-glycyl-arginine chloromethyl ketone,69024-84-6,Dansylglutamyl-glycyl-arginine chloromethyl ketone,ChemID+,exact,,,,,,,,Dansylglutamyl-glycyl-arginine chloromethyl ketone,,69024-84-6,exact,,,,dansylglutamyl-glycyl-arginine chloromethyl ketone,C030824,69024-84-6,exact,,,,Dansylglutamyl-Glycyl-Arginine Chloromethyl Ketone,C0057126,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000902,MeSH_PA,C030824,dansylglutamyl-glycyl-arginine chloromethyl ketone,69024-84-6,Dansylglutamyl-glycyl-arginine chloromethyl ketone,ChemID+,exact,,,,,,,,Dansylglutamyl-glycyl-arginine chloromethyl ketone,,69024-84-6,exact,,,,dansylglutamyl-glycyl-arginine chloromethyl ketone,C030824,69024-84-6,exact,,,,Dansylglutamyl-Glycyl-Arginine Chloromethyl Ketone,C0057126,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000903,MeSH_PA,C030824,dansylglutamyl-glycyl-arginine chloromethyl ketone,69024-84-6,Dansylglutamyl-glycyl-arginine chloromethyl ketone,ChemID+,exact,,,,,,,,Dansylglutamyl-glycyl-arginine chloromethyl ketone,,69024-84-6,exact,,,,dansylglutamyl-glycyl-arginine chloromethyl ketone,C030824,69024-84-6,exact,,,,Dansylglutamyl-Glycyl-Arginine Chloromethyl Ketone,C0057126,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000904,MeSH_PA,C053177,N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide,84478-11-5,N-(2-(Methylamino)ethyl)-5-isoquinolinesulfonamide,ChemID+,exact,N-[2-(methylamino)ethyl]isoquinoline-5-sulfonamide,43561,84478-11-5,<syn per source>,N-(2-(Methylamino)ethyl)-5-isoquinolinesulfonamide,exact,,N-(2-(Methylamino)ethyl)-5-isoquinolinesulfonamide,,84478-11-5,exact,,,,N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide,C053177,84478-11-5,exact,,,,N-(2-(Methylamino)Ethyl)-5-Isoquinolinesulfonamide,C0067452,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000905,MeSH_PA,C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",16858-02-9,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",ChemID+,exact,,,,,,,,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",,16858-02-9,exact,,,,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",C044387,16858-02-9,exact,,,,"N,N,N',N'-Tetrakis(2-Pyridylmethyl)Ethylenediamine",C0067319,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000906,MeSH_PA,C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",16858-02-9,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",ChemID+,exact,,,,,,,,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",,16858-02-9,exact,,,,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",C044387,16858-02-9,exact,,,,"N,N,N',N'-Tetrakis(2-Pyridylmethyl)Ethylenediamine",C0067319,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000907,MeSH_PA,C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",16858-02-9,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",ChemID+,exact,,,,,,,,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",,16858-02-9,exact,,,,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",C044387,16858-02-9,exact,,,,"N,N,N',N'-Tetrakis(2-Pyridylmethyl)Ethylenediamine",C0067319,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Cholinesterase Inhibitors,Cholinesterase Inhibitors,Y,quasi syn therclass-to-function,Cholinesterase Activity,Cholinesterase Activity,C1149831,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cholinesterase Inhibitors,Cholinesterase Inhibitors,C0008425,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000908,MeSH_PA,C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",16858-02-9,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",ChemID+,exact,,,,,,,,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",,16858-02-9,exact,,,,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",C044387,16858-02-9,exact,,,,"N,N,N',N'-Tetrakis(2-Pyridylmethyl)Ethylenediamine",C0067319,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000909,MeSH_PA,C044387,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",16858-02-9,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",ChemID+,exact,,,,,,,,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",,16858-02-9,exact,,,,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",C044387,16858-02-9,exact,,,,"N,N,N',N'-Tetrakis(2-Pyridylmethyl)Ethylenediamine",C0067319,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000910,MeSH_PA,C060331,1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,15580-20-8,1-Cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,ChemID+,exact,N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide,59053,15580-20-8,<syn per source>,1-Cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,exact,,1-Cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,,15580-20-8,exact,,,,1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,C060331,15580-20-8,exact,,,,1-Cyclohexyl-3-(2-(4-Morpholinyl)Ethyl)Carbodiimide,C0044348,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000911,MeSH_PA,C060331,1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,15580-20-8,1-Cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,ChemID+,exact,N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide,59053,15580-20-8,<syn per source>,1-Cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,exact,,1-Cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,,15580-20-8,exact,,,,1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide,C060331,15580-20-8,exact,,,,1-Cyclohexyl-3-(2-(4-Morpholinyl)Ethyl)Carbodiimide,C0044348,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000912,MeSH_PA,C029729,2-mercaptomethyl-3-guanidinoethylthiopropionic acid,77102-28-4,2-Mercaptomethyl-3-guanidinoethylthiopropionic acid,ChemID+,exact,,,,,,,,2-Mercaptomethyl-3-guanidinoethylthiopropionic acid,,77102-28-4,exact,,,,2-mercaptomethyl-3-guanidinoethylthiopropionic acid,C029729,77102-28-4,exact,,,,2-Mercaptomethyl-3-Guanidinoethylthiopropionic Acid,C0046305,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000913,MeSH_PA,C029729,2-mercaptomethyl-3-guanidinoethylthiopropionic acid,77102-28-4,2-Mercaptomethyl-3-guanidinoethylthiopropionic acid,ChemID+,exact,,,,,,,,2-Mercaptomethyl-3-guanidinoethylthiopropionic acid,,77102-28-4,exact,,,,2-mercaptomethyl-3-guanidinoethylthiopropionic acid,C029729,77102-28-4,exact,,,,2-Mercaptomethyl-3-Guanidinoethylthiopropionic Acid,C0046305,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000914,MeSH_PA,C050592,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,100828-16-8,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,ChemID+,exact,,,,,,,,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,,100828-16-8,exact,,,,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,C050592,100828-16-8,exact,,,,3-(2-Carboxypiperazin-4-Yl)Propyl-1-Phosphonic Acid,C0047123,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000915,MeSH_PA,C050592,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,100828-16-8,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,ChemID+,exact,,,,,,,,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,,100828-16-8,exact,,,,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,C050592,100828-16-8,exact,,,,3-(2-Carboxypiperazin-4-Yl)Propyl-1-Phosphonic Acid,C0047123,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000916,MeSH_PA,C050592,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,100828-16-8,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,ChemID+,exact,,,,,,,,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,,100828-16-8,exact,,,,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,C050592,100828-16-8,exact,,,,3-(2-Carboxypiperazin-4-Yl)Propyl-1-Phosphonic Acid,C0047123,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000917,MeSH_PA,C050592,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,100828-16-8,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,ChemID+,exact,,,,,,,,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,,100828-16-8,exact,,,,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,C050592,100828-16-8,exact,,,,3-(2-Carboxypiperazin-4-Yl)Propyl-1-Phosphonic Acid,C0047123,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000918,MeSH_PA,C050592,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,100828-16-8,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,ChemID+,exact,,,,,,,,3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid,,100828-16-8,exact,,,,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,C050592,100828-16-8,exact,,,,3-(2-Carboxypiperazin-4-Yl)Propyl-1-Phosphonic Acid,C0047123,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000919,MeSH_PA,C030438,4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,38236-46-3,4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,ChemID+,exact,,,,,,,,4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,,38236-46-3,exact,,,,4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,C030438,38236-46-3,exact,,,,4-(Isopropylamino)-2-(2-Pyridyl)-2-Phenylbutyramide,C0047943,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000920,MeSH_PA,C030438,4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,38236-46-3,4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,ChemID+,exact,,,,,,,,4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,,38236-46-3,exact,,,,4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,C030438,38236-46-3,exact,,,,4-(Isopropylamino)-2-(2-Pyridyl)-2-Phenylbutyramide,C0047943,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Parasympatholytics,Parasympatholytics,Y,quasi syn therclass-to-function,Parasympatholytic Effect,Parasympatholytic Effect,C3179241,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Parasympatholytics,Parasympatholytics,C0030511,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000921,MeSH_PA,C030438,4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,38236-46-3,4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,ChemID+,exact,,,,,,,,4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,,38236-46-3,exact,,,,4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,C030438,38236-46-3,exact,,,,4-(Isopropylamino)-2-(2-Pyridyl)-2-Phenylbutyramide,C0047943,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000922,MeSH_PA,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,64091-91-4,NNK (carcinogen),ChemID+,<syn per source>,4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one,32692,64091-91-4,<syn per source>,4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,exact,,NNK (carcinogen),,64091-91-4,<syn per source>,4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,exact,,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,C016583,64091-91-4,exact,,,,4-(N-Methyl-N-Nitrosamino)-1-(3-Pyridyl)-1-Butanone,C0047964,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000923,MeSH_PA,C016583,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,64091-91-4,NNK (carcinogen),ChemID+,<syn per source>,4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one,32692,64091-91-4,<syn per source>,4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,exact,,NNK (carcinogen),,64091-91-4,<syn per source>,4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,exact,,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone,C016583,64091-91-4,exact,,,,4-(N-Methyl-N-Nitrosamino)-1-(3-Pyridyl)-1-Butanone,C0047964,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000924,ChEBI,,4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside,,,,,4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside,65741,,exact,,,,,,,,,,,4'-O-demethylknipholone-4'-O-glucopyranoside,C466223,,<syn per source>,4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside,exact,,4'-O-Demethylknipholone-4'-O-Beta-D-Glucopyranoside,C1144535,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,antiplasmodial drug,antiplasmodial drug,Y,quasi syn therclass-to-disease,plasmodium infections,Malaria,C0024530,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_000925,ChEBI,,4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside,,,,,4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside,65741,,exact,,,,,,,,,,,4'-O-demethylknipholone-4'-O-glucopyranoside,C466223,,<syn per source>,4'-O-demethylknipholone-4'-O-beta-D-glucopyranoside,exact,,4'-O-Demethylknipholone-4'-O-Beta-D-Glucopyranoside,C1144535,exact,,,,A1.4.1.2.1_Organic Chemical,,,,cidal,,#VALUE!,trypanocidal drug,trypanocidal drug,Y,quasi syn therclass-to-disease,Trypanosomiasis,Trypanosomiasis,C0041227,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,syn plural/sing,trypanocidal drugs,Trypanocidal Agents,C0041214,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000926,MeSH_PA,D013184,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",28754-68-9,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",ChemID+,exact,,,,,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",,28754-68-9,exact,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",D013184,28754-68-9,exact,,,,"5-Amino-3-((5-Nitro-2-Furyl)Vinyl)-1,2,4-Oxadiazole",C0995162,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anthelmintics,Anthelmintics,Y,quasi syn therclass-to-disease,Helminthiasis,Helminthiasis,C0018889,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anthelmintics,Anthelmintics,C0003158,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000927,MeSH_PA,D013184,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",28754-68-9,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",ChemID+,exact,,,,,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",,28754-68-9,exact,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",D013184,28754-68-9,exact,,,,"5-Amino-3-((5-Nitro-2-Furyl)Vinyl)-1,2,4-Oxadiazole",C0995162,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000928,MeSH_PA,D013184,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",28754-68-9,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",ChemID+,exact,,,,,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",,28754-68-9,exact,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",D013184,28754-68-9,exact,,,,"5-Amino-3-((5-Nitro-2-Furyl)Vinyl)-1,2,4-Oxadiazole",C0995162,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000929,MeSH_PA,D013184,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",28754-68-9,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",ChemID+,exact,,,,,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",,28754-68-9,exact,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",D013184,28754-68-9,exact,,,,"5-Amino-3-((5-Nitro-2-Furyl)Vinyl)-1,2,4-Oxadiazole",C0995162,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiplatyhelmintic Agents,Antiplatyhelmintic Agents,Y,NT + quasi syn therclass-to-disease,Helminthiasis,Helminthiasis,C0018889,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiplatyhelmintic Agents,Antiplatyhelmintic Agents,C0003414,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000930,MeSH_PA,D013184,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",28754-68-9,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",ChemID+,exact,,,,,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",,28754-68-9,exact,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",D013184,28754-68-9,exact,,,,"5-Amino-3-((5-Nitro-2-Furyl)Vinyl)-1,2,4-Oxadiazole",C0995162,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiprotozoal Agents,Antiprotozoal Agents,Y,quasi syn therclass-to-disease,Protozoan Infections,Protozoan Infections,C0033740,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiprotozoal Agents,Antiprotozoal Agents,C0003416,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000931,MeSH_PA,D013184,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",28754-68-9,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",ChemID+,exact,,,,,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",,28754-68-9,exact,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",D013184,28754-68-9,exact,,,,"5-Amino-3-((5-Nitro-2-Furyl)Vinyl)-1,2,4-Oxadiazole",C0995162,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,cide,,#VALUE!,Schistosomicides,Schistosomicides,Y,quasi syn therclass-to-disease,Schistosomiasis,Schistosomiasis,C0036323,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Schistosomicides,Schistosomicides,C0036336,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000932,MeSH_PA,D013184,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",28754-68-9,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",ChemID+,exact,,,,,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",,28754-68-9,exact,,,,"5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole",D013184,28754-68-9,exact,,,,"5-Amino-3-((5-Nitro-2-Furyl)Vinyl)-1,2,4-Oxadiazole",C0995162,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,cidal,,#VALUE!,Trypanocidal Agents,Trypanocidal Agents,Y,quasi syn therclass-to-disease,Trypanosomiasis,Trypanosomiasis,C0041227,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Trypanocidal Agents,Trypanocidal Agents,C0041214,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000933,ChEBI,,5-hydroxy-6-methoxy-2-methylchromone-7-O-rutinoside,,,,,5-hydroxy-6-methoxy-2-methylchromone-7-O-rutinoside,66370,,exact,,,,,,,,,,,5-hydroxy-6-methoxy-2-methylchromone-7-O-rutinoside,C550781,,exact,,,,5-Hydroxy-6-Methoxy-2-Methylchromone-7-O-Rutinoside,C2935310,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.8_Carbohydrate,,,anti,,#VALUE!,antineoplastic agent,antineoplastic agent,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact 1,antineoplastic agent,Antineoplastic Agents,C0003392,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000934,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000935,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000936,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000937,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000938,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000939,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000940,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000941,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000942,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,Y,quasi syn therclass-to-function,Lipoxygenase Activity,Lipoxygenase Activity,C1151586,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,C0085385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000943,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000944,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000945,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000946,MeSH_PA,C049740,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,101910-24-1,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,ChemID+,exact,,,,,,,,alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol,,101910-24-1,exact,,,,alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol,C049740,101910-24-1,exact,,,,Alpha-Pentyl-3-(2-Quinolinylmethoxy)Benzenemethanol,C0102733,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000947,MeSH_PA,C054367,"bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)",113427-19-3,"Bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)",ChemID+,exact,,,,,,,,"Bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)",,113427-19-3,exact,,,,"bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)",C054367,113427-19-3,exact,,,,"Bis-Neodecanoato-1,2-Diaminocyclohexaneplatinum(Ii)",C0053771,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_000948,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000949,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000950,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000951,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000952,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000953,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,Y,quasi syn therclass-to-function,Fatty Acid Cyclooxygenase Activity,Fatty Acid Cyclooxygenase Activity,C2261439,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,C0085387,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000954,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000955,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000956,MeSH_PA,C080955,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,123653-11-2,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,ChemID+,exact,NS-398,73458,123653-11-2,<syn per source>,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,exact,,N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide,,123653-11-2,exact,,,,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,C080955,123653-11-2,exact,,,,N-(2-Cyclohexyloxy-4-Nitrophenyl)Methanesulfonamide,C0950855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000957,MeSH_PA,C058026,polyvinylmethoxyethylene-maleic anhydride copolymer,,,,,,,,,,,,,,,,,,,polyvinylmethoxyethylene-maleic anhydride copolymer,C058026,,exact,,,,Polyvinylmethoxyethylene-Maleic Anhydride Copolymer,C0071711,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Dermatologic Agents,Dermatologic Agents,Y,quasi syn therclass-to-disease,Dermatologic Disorders,Dermatologic Disorders,C0037274,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dermatologic Agents,Dermatologic Agents,C0011625,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000958,MeSH_PA,C058026,polyvinylmethoxyethylene-maleic anhydride copolymer,,,,,,,,,,,,,,,,,,,polyvinylmethoxyethylene-maleic anhydride copolymer,C058026,,exact,,,,Polyvinylmethoxyethylene-Maleic Anhydride Copolymer,C0071711,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Surgical Fixation Devices,Surgical Fixation Devices,Y,exact (CUI-based),Surgical Fixation Devices,Surgical Fixation Devices,C1721086,P,,A1.3.1_Medical Device,,,,,,,,,,,,
1_000959,MeSH_PA,C058026,polyvinylmethoxyethylene-maleic anhydride copolymer,,,,,,,,,,,,,,,,,,,polyvinylmethoxyethylene-maleic anhydride copolymer,C058026,,exact,,,,Polyvinylmethoxyethylene-Maleic Anhydride Copolymer,C0071711,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Tissue Adhesives,Tissue Adhesives,Y,quasi syn therclass-to-disease,Tissue Damage,Tissue Damage,C0010957,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Tissue Adhesives,Tissue Adhesives,C0040277,P,A1.4.1.1.2_Biomedical or Dental Material,,,
1_000960,MeSH_PA,C001886,"2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",3576-73-6,RS 86,ChemID+,<syn per source>,,,,,,,,RS 86,,3576-73-6,<syn per source>,"2-Ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",exact,,"2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",C001886,3576-73-6,exact,,,,"2-Ethyl-8-Methyl-2,8-Diazaspiro(4,5)Decane-1,3-Dione",C1571594,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000961,MeSH_PA,C001886,"2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",3576-73-6,RS 86,ChemID+,<syn per source>,,,,,,,,RS 86,,3576-73-6,<syn per source>,"2-Ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",exact,,"2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",C001886,3576-73-6,exact,,,,"2-Ethyl-8-Methyl-2,8-Diazaspiro(4,5)Decane-1,3-Dione",C1571594,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Parasympathomimetics,Parasympathomimetics,Y,quasi syn therclass-to-function,Parasympathomimetic Effect,Parasympathomimetic Effect,C3179243,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),parasympathomimetics,Parasympathomimetic Agents,C0030512,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000962,MeSH_PA,C001886,"2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",3576-73-6,RS 86,ChemID+,<syn per source>,,,,,,,,RS 86,,3576-73-6,<syn per source>,"2-Ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",exact,,"2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione",C001886,3576-73-6,exact,,,,"2-Ethyl-8-Methyl-2,8-Diazaspiro(4,5)Decane-1,3-Dione",C1571594,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000963,MeSH_PA,C054121,3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,108-28-1,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,ChEBI,exact,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,28906,108-28-1,exact,,,,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,,77439-76-0,exact,,,,3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,C054121,77439-76-0,exact,,,,3-Chloro-4-(Dichloromethyl)-5-Hydroxy-2(5H)-Furanone,C0047292,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000964,MeSH_PA,C054121,3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,108-28-1,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,ChEBI,exact,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,28906,108-28-1,exact,,,,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,,77439-76-0,exact,,,,3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,C054121,77439-76-0,exact,,,,3-Chloro-4-(Dichloromethyl)-5-Hydroxy-2(5H)-Furanone,C0047292,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000965,MeSH_PA,C054121,3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,108-28-1,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,ChEBI,exact,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,28906,108-28-1,exact,,,,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,,77439-76-0,exact,,,,3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,C054121,77439-76-0,exact,,,,3-Chloro-4-(Dichloromethyl)-5-Hydroxy-2(5H)-Furanone,C0047292,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000966,MeSH_PA,C057059,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,114568-26-2,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,CTD,exact,,,,,,,,,,,,,,,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,C057059,114568-26-2,exact,,,,4-(2-Succinimidoethylthio)Phenyl 4-Guanidinobenzoate,C0096469,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000967,MeSH_PA,C057059,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,114568-26-2,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,CTD,exact,,,,,,,,,,,,,,,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,C057059,114568-26-2,exact,,,,4-(2-Succinimidoethylthio)Phenyl 4-Guanidinobenzoate,C0096469,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000968,MeSH_PA,C057059,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,114568-26-2,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,CTD,exact,,,,,,,,,,,,,,,4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate,C057059,114568-26-2,exact,,,,4-(2-Succinimidoethylthio)Phenyl 4-Guanidinobenzoate,C0096469,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_000969,MeSH_PA,C011813,"ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",1170-02-1,"Ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",ChemID+,exact,,,,,,,,"Ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",,1170-02-1,exact,,,,"ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",C011813,1170-02-1,exact,,,,"Ethylenediamine-N,N'-Bis(2-Hydroxyphenylacetic Acid)",C0059821,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_000970,MeSH_PA,C011813,"ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",1170-02-1,"Ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",ChemID+,exact,,,,,,,,"Ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",,1170-02-1,exact,,,,"ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid)",C011813,1170-02-1,exact,,,,"Ethylenediamine-N,N'-Bis(2-Hydroxyphenylacetic Acid)",C0059821,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Iron Chelating Agents,Iron Chelating Agents,Y,quasi syn therclass-to-function,iron chelating activity,Iron Chelating Activity [Moa],C2757050,S,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Iron Chelating Agents,Iron Chelating Agents,C0022086,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,
1_000971,MeSH_PA,C042432,"3-(2,4-dinitroanilino)-3'-amino-N-methyldipropylamine",92585-03-0,"3-(2,4-Dinitroanilino)-3'-amino-N-methyldipropylamine",ChemID+,exact,,,,,,,,"3-(2,4-Dinitroanilino)-3'-amino-N-methyldipropylamine",,92585-03-0,exact,,,,"3-(2,4-dinitroanilino)-3'-amino-N-methyldipropylamine",C042432,92585-03-0,exact,,,,"3-(2,4-Dinitroanilino)-3'-Amino-N-Methyldipropylamine",C0047117,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000972,MeSH_PA,C025145,"5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",74163-68-1,RU 24969,ChemID+,<syn per source>,,,,,,,,RU 24969,,74163-68-1,<syn per source>,"5-Methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",exact,,"5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",C025145,74163-68-1,exact,,,,"5-Methoxy 3-(1,2,3,6-Tetrahydro-4-Pyridinyl)1H Indole",C0098524,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000973,MeSH_PA,C025145,"5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",74163-68-1,RU 24969,ChemID+,<syn per source>,,,,,,,,RU 24969,,74163-68-1,<syn per source>,"5-Methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",exact,,"5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",C025145,74163-68-1,exact,,,,"5-Methoxy 3-(1,2,3,6-Tetrahydro-4-Pyridinyl)1H Indole",C0098524,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000974,MeSH_PA,C025145,"5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",74163-68-1,RU 24969,ChemID+,<syn per source>,,,,,,,,RU 24969,,74163-68-1,<syn per source>,"5-Methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",exact,,"5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole",C025145,74163-68-1,exact,,,,"5-Methoxy 3-(1,2,3,6-Tetrahydro-4-Pyridinyl)1H Indole",C0098524,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,20,Serotonin Receptor Agonists,Serotonin Receptor Agonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),serotonin receptor agonists,Serotonin Agonists,C0162757,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000975,MeSH_PA,C052464,"bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",92396-88-8,"Bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",ChemID+,exact,,,,,,,,"Bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",,92396-88-8,exact,,,,"bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",C052464,92396-88-8,exact,,,,"Bis(Tri-N-Hexylsiloxy)(2,3-Naphthalocyaninato)Silicon",C0378035,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dermatologic Agents,Dermatologic Agents,Y,quasi syn therclass-to-disease,Dermatologic Disorders,Dermatologic Disorders,C0037274,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dermatologic Agents,Dermatologic Agents,C0011625,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000976,MeSH_PA,C052464,"bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",92396-88-8,"Bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",ChemID+,exact,,,,,,,,"Bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",,92396-88-8,exact,,,,"bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",C052464,92396-88-8,exact,,,,"Bis(Tri-N-Hexylsiloxy)(2,3-Naphthalocyaninato)Silicon",C0378035,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Photosensitizing Agents,Photosensitizing Agents,Y,quasi syn therclass-to-function,Photosensitizing Effect,Photosensitizing Effect,C3179153,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Photosensitizing Agents,Photosensitizing Agents,C0162713,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000977,MeSH_PA,C052464,"bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",92396-88-8,"Bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",ChemID+,exact,,,,,,,,"Bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",,92396-88-8,exact,,,,"bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",C052464,92396-88-8,exact,,,,"Bis(Tri-N-Hexylsiloxy)(2,3-Naphthalocyaninato)Silicon",C0378035,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,Y,quasi syn therclass-to-function,Radiation-Sensitizing Effect,Radiation-Sensitizing Effect,C3179280,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,C0034541,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000978,MeSH_PA,C033628,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",71316-28-4,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",ChemID+,exact,,,,,,,,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",,71316-28-4,exact,,,,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",C033628,71316-28-4,exact,,,,"1-(4-(Trimethylamino)Phenyl)-6-Phenylhexa-1,3,5-Triene",C0044191,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000979,MeSH_PA,C033628,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",71316-28-4,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",ChemID+,exact,,,,,,,,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",,71316-28-4,exact,,,,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",C033628,71316-28-4,exact,,,,"1-(4-(Trimethylamino)Phenyl)-6-Phenylhexa-1,3,5-Triene",C0044191,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000980,MeSH_PA,C033628,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",71316-28-4,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",ChemID+,exact,,,,,,,,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",,71316-28-4,exact,,,,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",C033628,71316-28-4,exact,,,,"1-(4-(Trimethylamino)Phenyl)-6-Phenylhexa-1,3,5-Triene",C0044191,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000981,MeSH_PA,C033628,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",71316-28-4,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",ChemID+,exact,,,,,,,,"1-(4-(Trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",,71316-28-4,exact,,,,"1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene",C033628,71316-28-4,exact,,,,"1-(4-(Trimethylamino)Phenyl)-6-Phenylhexa-1,3,5-Triene",C0044191,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000982,MeSH_PA,D014013,"1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt",149-45-1,"1,2-Dihydroxybenzene-3,5-disulfonic acid disodium Salt",ChemID+,exact,,,,,,,,"1,2-Dihydroxybenzene-3,5-disulfonic acid disodium Salt",,149-45-1,exact,,,,"1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt",D014013,149-45-1,exact,,,,"1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt",C0040270,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000983,MeSH_PA,C012385,"1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril",51592-06-4,"1,3,4,6-Tetrachloro-3 alpha,6 alpha-diphenylglycoluril",ChemID+,exact,,,,,,,,"1,3,4,6-Tetrachloro-3 alpha,6 alpha-diphenylglycoluril",,51592-06-4,exact,,,,"1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril",C012385,51592-06-4,exact,,,,"1,3,4,6-Tetrachloro-3 Alpha,6 Alpha-Diphenylglycoluril",C0088222,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000984,MeSH_PA,C031563,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",73671-86-0,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",ChemID+,exact,,,,,,,,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",,73671-86-0,exact,,,,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",C031563,73671-86-0,exact,,,,"17-N,N-Diethylcarbamoyl-4-Methyl-4-Azaandrostane-3-One",C0044981,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,inhibitor,inhibits,Inhibitors,5-alpha Reductase Inhibitors,5-alpha Reductase Inhibitors,Y,quasi syn therclass-to-function,Steroid 5-Alpha Reductase Activity,Steroid 5-Alpha Reductase Activity,C2254641,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),5-Alpha Reductase Inhibitors,5-Alpha Reductase Inhibitors,C2936788,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000985,MeSH_PA,C031563,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",73671-86-0,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",ChemID+,exact,,,,,,,,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",,73671-86-0,exact,,,,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",C031563,73671-86-0,exact,,,,"17-N,N-Diethylcarbamoyl-4-Methyl-4-Azaandrostane-3-One",C0044981,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,antagonist,antagonist,#VALUE!,Androgen Antagonists,Androgen Antagonists,Y,quasi syn therclass-to-function,Androgen Receptor Activity,Androgen Receptor Activity,C1148774,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Androgen Antagonists,Androgen Antagonists,C0002842,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000986,MeSH_PA,C031563,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",73671-86-0,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",ChemID+,exact,,,,,,,,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",,73671-86-0,exact,,,,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",C031563,73671-86-0,exact,,,,"17-N,N-Diethylcarbamoyl-4-Methyl-4-Azaandrostane-3-One",C0044981,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_000987,MeSH_PA,C031563,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",73671-86-0,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",ChemID+,exact,,,,,,,,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",,73671-86-0,exact,,,,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",C031563,73671-86-0,exact,,,,"17-N,N-Diethylcarbamoyl-4-Methyl-4-Azaandrostane-3-One",C0044981,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000988,MeSH_PA,C031563,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",73671-86-0,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",ChemID+,exact,,,,,,,,"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",,73671-86-0,exact,,,,"17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",C031563,73671-86-0,exact,,,,"17-N,N-Diethylcarbamoyl-4-Methyl-4-Azaandrostane-3-One",C0044981,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000989,MeSH_PA,C002502,"2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid",28752-68-3,"2,2'-Azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid",ChemID+,exact,,,,,,,,"2,2'-Azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid",,28752-68-3,exact,,,,"2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid",C002502,28752-68-3,exact,,,,"2,2'-Azino-Di-(3-Ethylbenzothiazoline)-6-Sulfonic Acid",C0045246,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_000990,MeSH_PA,C060533,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",124489-20-9,"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",ChemID+,exact,,,,,,,,"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,124489-20-9,exact,,,,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C060533,124489-20-9,exact,,,,"2-Hydroxyamino-1-Methyl-6-Phenylimidazo(4,5-B)Pyridine",C0046181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000991,MeSH_PA,C060533,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",124489-20-9,"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",ChemID+,exact,,,,,,,,"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,124489-20-9,exact,,,,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C060533,124489-20-9,exact,,,,"2-Hydroxyamino-1-Methyl-6-Phenylimidazo(4,5-B)Pyridine",C0046181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000992,MeSH_PA,C060533,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",124489-20-9,"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",ChemID+,exact,,,,,,,,"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,124489-20-9,exact,,,,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C060533,124489-20-9,exact,,,,"2-Hydroxyamino-1-Methyl-6-Phenylimidazo(4,5-B)Pyridine",C0046181,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_000993,MeSH_PA,C079391,"2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",18390-00-6,"2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",ChemID+,exact,,,,,,,,"2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",,18390-00-6,exact,,,,"2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",C079391,18390-00-6,exact,,,,"2-Phenyl-4,4,5,5-Tetramethylimidazoline-1-Oxyl-3-Oxide",C0212815,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000994,MeSH_PA,C079391,"2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",18390-00-6,"2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",ChemID+,exact,,,,,,,,"2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",,18390-00-6,exact,,,,"2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",C079391,18390-00-6,exact,,,,"2-Phenyl-4,4,5,5-Tetramethylimidazoline-1-Oxyl-3-Oxide",C0212815,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Free Radical Scavengers,Free Radical Scavengers,Y,quasi syn therclass-to-function,Free Radical Scavenging [Moa],Free Radical Scavenging [Moa],C1517315,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Free Radical Scavengers,Free Radical Scavengers,C0079381,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_000995,MeSH_PA,C104750,3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole,81226-60-0,L 741626,ChemID+,<syn per source>,,,,,,,,L 741626,,81226-60-0,<syn per source>,3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole,exact,,3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole,C104750,81226-60-0,exact,,,,3-(4-(4-Chlorophenyl-4-Hydroxypiperidino)Methyl)Indole,C0536538,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_000996,MeSH_PA,C104750,3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole,81226-60-0,L 741626,ChemID+,<syn per source>,,,,,,,,L 741626,,81226-60-0,<syn per source>,3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole,exact,,3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole,C104750,81226-60-0,exact,,,,3-(4-(4-Chlorophenyl-4-Hydroxypiperidino)Methyl)Indole,C0536538,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_000997,MeSH_PA,C104750,3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole,81226-60-0,L 741626,ChemID+,<syn per source>,,,,,,,,L 741626,,81226-60-0,<syn per source>,3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole,exact,,3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole,C104750,81226-60-0,exact,,,,3-(4-(4-Chlorophenyl-4-Hydroxypiperidino)Methyl)Indole,C0536538,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000998,MeSH_PA,C010643,"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",53188-07-1,"6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",ChemID+,exact,,,,,,,,"6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",,53188-07-1,exact,,,,"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",C010643,56305-04-5,exact,,,,"6-Hydroxy-2,5,7,8-Tetramethylchroman-2-Carboxylic Acid",C0099224,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_000999,MeSH_PA,C010643,"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",53188-07-1,"6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",ChemID+,exact,,,,,,,,"6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",,53188-07-1,exact,,,,"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid",C010643,56305-04-5,exact,,,,"6-Hydroxy-2,5,7,8-Tetramethylchroman-2-Carboxylic Acid",C0099224,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001000,MeSH_PA,C103192,butyloxycarbonyl-O-methyl-aspartyl-fluoromethyl ketone,,,,,,,,,,,,,,,,,,,,,,,,,,Butyloxycarbonyl-O-Methyl-Aspartyl-Fluoromethyl Ketone,C0533362,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001001,MeSH_PA,C103192,butyloxycarbonyl-O-methyl-aspartyl-fluoromethyl ketone,,,,,,,,,,,,,,,,,,,,,,,,,,Butyloxycarbonyl-O-Methyl-Aspartyl-Fluoromethyl Ketone,C0533362,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001002,MeSH_PA,C103192,butyloxycarbonyl-O-methyl-aspartyl-fluoromethyl ketone,,,,,,,,,,,,,,,,,,,,,,,,,,Butyloxycarbonyl-O-Methyl-Aspartyl-Fluoromethyl Ketone,C0533362,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001003,MeSH_PA,C033891,ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate,78573-55-4,Ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate,ChemID+,exact,,,,,,,,Ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate,,78573-55-4,exact,,,,ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate,C033891,78573-55-4,exact,,,,Ethyl 2-(5-(4-Chlorophenyl)Pentyl)Oxiran-2-Carboxylate,C0059740,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001004,MeSH_PA,C037783,"1,2-dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",81851-68-5,"1,2-Dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",ChemID+,exact,,,,,,,,"1,2-Dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",,81851-68-5,exact,,,,"1,2-dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",C037783,81851-68-5,exact,,,,"1,2-Dihydroxy-Epoxy-1,2,3,4-Tetrahydro-5-Methylchrysene",C0043824,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001005,MeSH_PA,C037783,"1,2-dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",81851-68-5,"1,2-Dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",ChemID+,exact,,,,,,,,"1,2-Dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",,81851-68-5,exact,,,,"1,2-dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene",C037783,81851-68-5,exact,,,,"1,2-Dihydroxy-Epoxy-1,2,3,4-Tetrahydro-5-Methylchrysene",C0043824,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001006,MeSH_PA,C026613,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,74389-69-8,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,ChemID+,exact,1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine,75217,74389-69-8,<syn per source>,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,exact,,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,,74389-69-8,exact,,,,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,C026613,85733-91-1,exact,,,,1-0-Octadecyl 2-0-Acetyl Sn-Glycero-3-Phosphorylcholine,C0044248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001007,MeSH_PA,C026613,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,74389-69-8,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,ChemID+,exact,1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine,75217,74389-69-8,<syn per source>,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,exact,,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,,74389-69-8,exact,,,,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,C026613,85733-91-1,exact,,,,1-0-Octadecyl 2-0-Acetyl Sn-Glycero-3-Phosphorylcholine,C0044248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001008,MeSH_PA,C026613,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,74389-69-8,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,ChemID+,exact,1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine,75217,74389-69-8,<syn per source>,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,exact,,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,,74389-69-8,exact,,,,1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine,C026613,85733-91-1,exact,,,,1-0-Octadecyl 2-0-Acetyl Sn-Glycero-3-Phosphorylcholine,C0044248,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1.9_Lipid,,causes,,#VALUE!,Vasodilator Agents,Vasodilator Agents,Y,quasi syn therclass-to-function,Vasodilation,Vasodilation,C0042401,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Vasodilator Agents,Vasodilator Agents,C0042402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001009,MeSH_PA,C048977,"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",102417-86-7,"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",ChemID+,exact,,,,,,,,"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",,102417-86-7,exact,,,,"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",C048977,102417-86-7,exact,,,,"1-Methyl-4-(2'-Methylphenyl)-1,2,3,6-Tetrahydropyridine",C0044444,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001010,MeSH_PA,C048977,"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",102417-86-7,"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",ChemID+,exact,,,,,,,,"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",,102417-86-7,exact,,,,"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",C048977,102417-86-7,exact,,,,"1-Methyl-4-(2'-Methylphenyl)-1,2,3,6-Tetrahydropyridine",C0044444,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001011,MeSH_PA,C048977,"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",102417-86-7,"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",ChemID+,exact,,,,,,,,"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",,102417-86-7,exact,,,,"1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",C048977,102417-86-7,exact,,,,"1-Methyl-4-(2'-Methylphenyl)-1,2,3,6-Tetrahydropyridine",C0044444,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001012,MeSH_PA,C032289,"2,2,5,5-tetramethyl-1-pyrrolidinyloxy-3-carboxylic acid",2154-68-9,"2,2,5,5-Tetramethyl-1-pyrrolidinyloxy-3-carboxylic acid",ChemID+,exact,,,,,,,,"2,2,5,5-Tetramethyl-1-pyrrolidinyloxy-3-carboxylic acid",,2154-68-9,exact,,,,"2,2,5,5-tetramethyl-1-pyrrolidinyloxy-3-carboxylic acid",C032289,2154-68-9,exact,,,,"2,2,5,5-Tetramethyl-1-Pyrrolidinyloxy-3-Carboxylic Acid",C0045279,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,Y,quasi syn therclass-to-function,Radiation-Sensitizing Effect,Radiation-Sensitizing Effect,C3179280,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,C0034541,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001013,MeSH_PA,C030266,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",69095-83-6,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",ChemID+,exact,,,,,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",,69095-83-6,exact,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",C030266,69095-83-6,exact,,,,"3-(2-Ethylphenyl)-5-(3-Methoxyphenyl)-1H-1,2,4-Triazole",C0950498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,terminates,,#VALUE!,Abortifacient Agents,Abortifacient Agents,Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),Abortifacient Agents,Abortifacient Agents,C0000782,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001014,MeSH_PA,C030266,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",69095-83-6,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",ChemID+,exact,,,,,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",,69095-83-6,exact,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",C030266,69095-83-6,exact,,,,"3-(2-Ethylphenyl)-5-(3-Methoxyphenyl)-1H-1,2,4-Triazole",C0950498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,terminates,,#VALUE!,"Abortifacient Agents, Nonsteroidal","Abortifacient Agents, Nonsteroidal",Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),"Abortifacient Agents, Nonsteroidal","Abortifacient Agents, Nonsteroidal",C0000783,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001015,MeSH_PA,C030266,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",69095-83-6,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",ChemID+,exact,,,,,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",,69095-83-6,exact,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",C030266,69095-83-6,exact,,,,"3-(2-Ethylphenyl)-5-(3-Methoxyphenyl)-1H-1,2,4-Triazole",C0950498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001016,MeSH_PA,C030266,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",69095-83-6,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",ChemID+,exact,,,,,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",,69095-83-6,exact,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",C030266,69095-83-6,exact,,,,"3-(2-Ethylphenyl)-5-(3-Methoxyphenyl)-1H-1,2,4-Triazole",C0950498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001017,MeSH_PA,C030266,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",69095-83-6,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",ChemID+,exact,,,,,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",,69095-83-6,exact,,,,"3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole",C030266,69095-83-6,exact,,,,"3-(2-Ethylphenyl)-5-(3-Methoxyphenyl)-1H-1,2,4-Triazole",C0950498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,prevents,,#VALUE!,Reproductive Control Agents,Reproductive Control Agents,Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),Reproductive Control Agents,Reproductive Control Agents,C0035155,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001018,MeSH_PA,C112287,Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,NT salt/deriv/analog/df,,,,Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin,C112287,,exact,,,,Ac-Aspartyl-Glutamyl-Valyl-Aspartyl-Aminomethylcoumarin,C0674974,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001019,MeSH_PA,C112287,Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,NT salt/deriv/analog/df,,,,Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin,C112287,,exact,,,,Ac-Aspartyl-Glutamyl-Valyl-Aspartyl-Aminomethylcoumarin,C0674974,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001020,MeSH_PA,C112287,Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,NT salt/deriv/analog/df,,,,Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin,C112287,,exact,,,,Ac-Aspartyl-Glutamyl-Valyl-Aspartyl-Aminomethylcoumarin,C0674974,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001021,MeSH_PA,C024918,benzyloxycarbonylphenylalanylalanine diazomethyl ketone,71732-53-1,Carbobenzoxycarbonyl-L-phenylalanyl-L-alanine-D-diazomethane,ChemID+,<syn per source>,,,,,,,,Carbobenzoxycarbonyl-L-phenylalanyl-L-alanine-D-diazomethane,,71732-53-1,<syn per source>,Benzyloxycarbonylphenylalanylalanine diazomethyl ketone,exact,,benzyloxycarbonylphenylalanylalanine diazomethyl ketone,C024918,,exact,,,,Benzyloxycarbonylphenylalanylalanine Diazomethyl Ketone,C0053318,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001022,MeSH_PA,C024918,benzyloxycarbonylphenylalanylalanine diazomethyl ketone,71732-53-1,Carbobenzoxycarbonyl-L-phenylalanyl-L-alanine-D-diazomethane,ChemID+,<syn per source>,,,,,,,,Carbobenzoxycarbonyl-L-phenylalanyl-L-alanine-D-diazomethane,,71732-53-1,<syn per source>,Benzyloxycarbonylphenylalanylalanine diazomethyl ketone,exact,,benzyloxycarbonylphenylalanylalanine diazomethyl ketone,C024918,,exact,,,,Benzyloxycarbonylphenylalanylalanine Diazomethyl Ketone,C0053318,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001023,MeSH_PA,C024918,benzyloxycarbonylphenylalanylalanine diazomethyl ketone,71732-53-1,Carbobenzoxycarbonyl-L-phenylalanyl-L-alanine-D-diazomethane,ChemID+,<syn per source>,,,,,,,,Carbobenzoxycarbonyl-L-phenylalanyl-L-alanine-D-diazomethane,,71732-53-1,<syn per source>,Benzyloxycarbonylphenylalanylalanine diazomethyl ketone,exact,,benzyloxycarbonylphenylalanylalanine diazomethyl ketone,C024918,,exact,,,,Benzyloxycarbonylphenylalanylalanine Diazomethyl Ketone,C0053318,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001024,MeSH_PA,C071244,"N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine",132684-62-9,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",ChemID+,exact,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",,132684-62-9,exact,,,,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-Ylmethoxy)Carbonyl)Leucine",C0130390,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001025,MeSH_PA,C071244,"N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine",132684-62-9,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",ChemID+,exact,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",,132684-62-9,exact,,,,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-Ylmethoxy)Carbonyl)Leucine",C0130390,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001026,MeSH_PA,C071244,"N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine",132684-62-9,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",ChemID+,exact,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",,132684-62-9,exact,,,,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-Ylmethoxy)Carbonyl)Leucine",C0130390,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001027,MeSH_PA,C071244,"N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine",132684-62-9,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",ChemID+,exact,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",,132684-62-9,exact,,,,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-Ylmethoxy)Carbonyl)Leucine",C0130390,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001028,MeSH_PA,C071244,"N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine",132684-62-9,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",ChemID+,exact,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",,132684-62-9,exact,,,,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-Ylmethoxy)Carbonyl)Leucine",C0130390,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001029,MeSH_PA,C071244,"N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine",132684-62-9,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",ChemID+,exact,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",,132684-62-9,exact,,,,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-Ylmethoxy)Carbonyl)Leucine",C0130390,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001030,MeSH_PA,C071244,"N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine",132684-62-9,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",ChemID+,exact,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine",,132684-62-9,exact,,,,,,,,,,,"N-(9H-(2,7-Dimethylfluoren-9-Ylmethoxy)Carbonyl)Leucine",C0130390,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001031,MeSH_PA,C049344,S-2-(3-methylaminopropylamino)ethylphosphorothioic acid,20751-90-0,Phosphonol,ChemID+,<syn per source>,,,,,,,,Phosphonol,,20751-90-0,<syn per source>,S-2-(3-methylaminopropylamino)ethylphosphorothioic acid,exact,,S-2-(3-methylaminopropylamino)ethylphosphorothioic acid,C049344,20751-90-0,exact,,,,S-2-(3-Methylaminopropylamino)Ethylphosphorothioic Acid,C0141203,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001032,MeSH_PA,C049344,S-2-(3-methylaminopropylamino)ethylphosphorothioic acid,20751-90-0,Phosphonol,ChemID+,<syn per source>,,,,,,,,Phosphonol,,20751-90-0,<syn per source>,S-2-(3-methylaminopropylamino)ethylphosphorothioic acid,exact,,S-2-(3-methylaminopropylamino)ethylphosphorothioic acid,C049344,20751-90-0,exact,,,,S-2-(3-Methylaminopropylamino)Ethylphosphorothioic Acid,C0141203,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Protective Agents,Radiation-Protective Agents,Y,quasi syn therclass-to-function,Radiation-Protective Effect,Radiation-Protective Effect,C3179279,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Protective Agents,Radiation-Protective Agents,C0034540,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001033,MeSH_PA,C058895,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,115338-32-4,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,ChemID+,exact,NAN 190,64131,,<syn per source>,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,exact,,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,,115338-32-4,exact,,,,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,C058895,115338-32-4,exact,,,,1-(2-Methoxyphenyl)-4-(4-(2-Phthalimido)Butyl)Piperazine,C0088711,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001034,MeSH_PA,C058895,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,115338-32-4,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,ChemID+,exact,NAN 190,64131,,<syn per source>,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,exact,,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,,115338-32-4,exact,,,,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,C058895,115338-32-4,exact,,,,1-(2-Methoxyphenyl)-4-(4-(2-Phthalimido)Butyl)Piperazine,C0088711,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001035,MeSH_PA,C058895,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,115338-32-4,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,ChemID+,exact,NAN 190,64131,,<syn per source>,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,exact,,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,,115338-32-4,exact,,,,1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine,C058895,115338-32-4,exact,,,,1-(2-Methoxyphenyl)-4-(4-(2-Phthalimido)Butyl)Piperazine,C0088711,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Serotonin Antagonists,Serotonin Antagonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Antagonists,Serotonin Antagonists,C0036753,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001036,MeSH_PA,C025603,"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",85233-19-8,"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",ChemID+,exact,BAPTA,60888,85233-19-8,<syn per source>,"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",exact,,"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",,85233-19-8,exact,,,,"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",C025603,85233-19-8,exact,,,,"1,2-Bis(2-Aminophenoxy)Ethane-N,N,N',N'-Tetraacetic Acid",C0043775,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_001037,MeSH_PA,C025603,"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",85233-19-8,"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",ChemID+,exact,BAPTA,60888,85233-19-8,<syn per source>,"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",exact,,"1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",,85233-19-8,exact,,,,"1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",C025603,85233-19-8,exact,,,,"1,2-Bis(2-Aminophenoxy)Ethane-N,N,N',N'-Tetraacetic Acid",C0043775,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001038,MeSH_PA,C048193,"2-methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",102146-00-9,"2-Methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",ChemID+,exact,,,,,,,,"2-Methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",,102146-00-9,exact,,,,"2-methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",C048193,102146-00-9,exact,,,,"2-Methyl-6-Phenyl-3,7-Dihydroimidazo(1,2-A)Pyrazin-3-One",C0046352,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001039,MeSH_PA,C048193,"2-methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",102146-00-9,"2-Methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",ChemID+,exact,,,,,,,,"2-Methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",,102146-00-9,exact,,,,"2-methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one",C048193,102146-00-9,exact,,,,"2-Methyl-6-Phenyl-3,7-Dihydroimidazo(1,2-A)Pyrazin-3-One",C0046352,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001040,MeSH_PA,C086162,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",154164-30-4,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",ChemID+,exact,,,,,,,,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",,154164-30-4,exact,,,,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",C086162,154164-30-4,exact,,,,"6-(1H-Imidazol-1-Yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione",C0252498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticonvulsants,Anticonvulsants,Y,quasi syn therclass-to-disease,Convulsions,Convulsions,C0009951,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Anticonvulsants,Anticonvulsants,C0003286,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001041,MeSH_PA,C086162,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",154164-30-4,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",ChemID+,exact,,,,,,,,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",,154164-30-4,exact,,,,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",C086162,154164-30-4,exact,,,,"6-(1H-Imidazol-1-Yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione",C0252498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001042,MeSH_PA,C086162,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",154164-30-4,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",ChemID+,exact,,,,,,,,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",,154164-30-4,exact,,,,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",C086162,154164-30-4,exact,,,,"6-(1H-Imidazol-1-Yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione",C0252498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001043,MeSH_PA,C086162,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",154164-30-4,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",ChemID+,exact,,,,,,,,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",,154164-30-4,exact,,,,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",C086162,154164-30-4,exact,,,,"6-(1H-Imidazol-1-Yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione",C0252498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001044,MeSH_PA,C086162,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",154164-30-4,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",ChemID+,exact,,,,,,,,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",,154164-30-4,exact,,,,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",C086162,154164-30-4,exact,,,,"6-(1H-Imidazol-1-Yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione",C0252498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001045,MeSH_PA,C086162,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",154164-30-4,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",ChemID+,exact,,,,,,,,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",,154164-30-4,exact,,,,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",C086162,154164-30-4,exact,,,,"6-(1H-Imidazol-1-Yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione",C0252498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001046,MeSH_PA,C086162,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",154164-30-4,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",ChemID+,exact,,,,,,,,"6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",,154164-30-4,exact,,,,"6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione",C086162,154164-30-4,exact,,,,"6-(1H-Imidazol-1-Yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione",C0252498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001047,MeSH_PA,C078742,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",58109-34-5,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",ChemID+,exact,,,,,,,,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",,58109-34-5,exact,,,,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",C078742,58109-34-5,exact,,,,"Fluoromethyl 2,2-Difluoro-1-(Trifluoromethyl)Vinyl Ether",C0211574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Anesthetics,Anesthetics,Y,quasi syn therclass-to-function,Anesthetic Effect,Anesthetic Effect,C3179301,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Anesthetics,Anesthetics,C0002932,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001048,MeSH_PA,C078742,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",58109-34-5,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",ChemID+,exact,,,,,,,,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",,58109-34-5,exact,,,,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",C078742,58109-34-5,exact,,,,"Fluoromethyl 2,2-Difluoro-1-(Trifluoromethyl)Vinyl Ether",C0211574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,"Anesthetics, General","Anesthetics, General",Y,quasi syn therclass-to-function,Anesthetic Effect,Anesthetic Effect,C3179301,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),"anesthetics, general",General Anesthetic Drugs,C0017302,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001049,MeSH_PA,C078742,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",58109-34-5,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",ChemID+,exact,,,,,,,,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",,58109-34-5,exact,,,,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",C078742,58109-34-5,exact,,,,"Fluoromethyl 2,2-Difluoro-1-(Trifluoromethyl)Vinyl Ether",C0211574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,"Anesthetics, Inhalation","Anesthetics, Inhalation",Y,quasi syn therclass-to-function,Anesthetic Effect,Anesthetic Effect,C3179301,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),"Anesthetics, Inhalation","Anesthetics, Inhalation",C0242903,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001050,MeSH_PA,C078742,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",58109-34-5,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",ChemID+,exact,,,,,,,,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",,58109-34-5,exact,,,,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",C078742,58109-34-5,exact,,,,"Fluoromethyl 2,2-Difluoro-1-(Trifluoromethyl)Vinyl Ether",C0211574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001051,MeSH_PA,C078742,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",58109-34-5,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",ChemID+,exact,,,,,,,,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",,58109-34-5,exact,,,,"fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",C078742,58109-34-5,exact,,,,"Fluoromethyl 2,2-Difluoro-1-(Trifluoromethyl)Vinyl Ether",C0211574,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001052,MeSH_PA,C040364,N(2)-(4-n-butylphenyl)-2'-deoxyguanosine 5'-triphosphate,87782-05-6,N(2)-(4-n-Butylphenyl)-2'-deoxyguanosine 5'-triphosphate,ChemID+,exact,,,,,,,,N(2)-(4-n-Butylphenyl)-2'-deoxyguanosine 5'-triphosphate,,87782-05-6,exact,,,,N(2)-(4-n-butylphenyl)-2'-deoxyguanosine 5'-triphosphate,C040364,87782-05-6,exact,,,,N(2)-(4-N-Butylphenyl)-2'-Deoxyguanosine 5'-Triphosphate,C0067155,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001053,MeSH_PA,C068663,N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide,111525-11-2,N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide,CTD,exact,,,,,,,,,,,,,,,N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide,C068663,111525-11-2,exact,,,,N-Hydroxy-N-(1-(4-(Phenylmethoxy)Phenyl)Ethyl)-Acetamide,C2930498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001054,MeSH_PA,C068663,N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide,111525-11-2,N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide,CTD,exact,,,,,,,,,,,,,,,N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide,C068663,111525-11-2,exact,,,,N-Hydroxy-N-(1-(4-(Phenylmethoxy)Phenyl)Ethyl)-Acetamide,C2930498,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,Y,quasi syn therclass-to-function,Lipoxygenase Activity,Lipoxygenase Activity,C1151586,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,C0085385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001055,MeSH_PA,C046582,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,94367-21-2,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,ChemID+,exact,succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin,52770,94367-21-2,<syn per source>,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,exact,,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,,94367-21-2,exact,,,,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,C046582,94367-21-2,exact,,,,Succinyl-Leucyl-Leucyl-Valyl-Tyrosyl-Methylcoumarinamide,C0143954,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001056,MeSH_PA,C046582,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,94367-21-2,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,ChemID+,exact,succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin,52770,94367-21-2,<syn per source>,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,exact,,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,,94367-21-2,exact,,,,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,C046582,94367-21-2,exact,,,,Succinyl-Leucyl-Leucyl-Valyl-Tyrosyl-Methylcoumarinamide,C0143954,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001057,MeSH_PA,C046582,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,94367-21-2,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,ChemID+,exact,succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin,52770,94367-21-2,<syn per source>,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,exact,,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,,94367-21-2,exact,,,,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,C046582,94367-21-2,exact,,,,Succinyl-Leucyl-Leucyl-Valyl-Tyrosyl-Methylcoumarinamide,C0143954,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001058,MeSH_PA,C046582,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,94367-21-2,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,ChemID+,exact,succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin,52770,94367-21-2,<syn per source>,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,exact,,Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,,94367-21-2,exact,,,,succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide,C046582,94367-21-2,exact,,,,Succinyl-Leucyl-Leucyl-Valyl-Tyrosyl-Methylcoumarinamide,C0143954,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001059,MeSH_PA,C031517,2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid,75987-08-5,Oky 1581,ChemID+,quasi syn same CAS# <per source>,,,,,,,,Oky 1581,,75987-08-5,quasi syn same CAS# <per source>,75987-08-5,quasi syn chem name of TN/code,CAS#,2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid,C031517,75987-08-5,exact,,,,2-Methyl-3-(4-(3-Pyridinylmethyl)Phenyl)-2-Propenoic Acid,C0069393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001060,MeSH_PA,C065046,"3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",127792-75-0,"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",ChemID+,exact,,,,,,,,"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",,127792-75-0,exact,,,,"3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",C065046,127792-75-0,exact,,,,"3-(1,2,5,6-Tetrahydropyrid-4-Yl)Pyrrolo(3,2-B)Pyrid-5-One",C0094793,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001061,MeSH_PA,C065046,"3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",127792-75-0,"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",ChemID+,exact,,,,,,,,"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",,127792-75-0,exact,,,,"3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",C065046,127792-75-0,exact,,,,"3-(1,2,5,6-Tetrahydropyrid-4-Yl)Pyrrolo(3,2-B)Pyrid-5-One",C0094793,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001062,MeSH_PA,C065046,"3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",127792-75-0,"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",ChemID+,exact,,,,,,,,"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",,127792-75-0,exact,,,,"3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",C065046,127792-75-0,exact,,,,"3-(1,2,5,6-Tetrahydropyrid-4-Yl)Pyrrolo(3,2-B)Pyrid-5-One",C0094793,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,20,Serotonin Receptor Agonists,Serotonin Receptor Agonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),serotonin receptor agonists,Serotonin Agonists,C0162757,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001063,MeSH_PA,C034534,"3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid",81485-25-8,Peretinoin,ChemID+,<syn per source>,,,,,,,,Peretinoin,Peretinoin [INN],81485-25-8,<syn per source>,"3,7,11,15-Tetramethyl-2,4,6,10,14-hexadecapentaenoic acid",exact,,"3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid",C034534,81485-25-8,exact,,,,"3,7,11,15-Tetramethyl-2,4,6,10,14-Hexadecapentaenoic Acid",C0047069,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001064,MeSH_PA,C070899,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",21416-68-2,ICRF 196,ChemID+,<syn per source>,,,,,,,,ICRF 196,,21416-68-2,<syn per source>,"4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",exact,,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",C070899,21416-68-2,exact,,,,"4,4'-(1,2-Dimethyl-1,2-Ethanediyl)Bis-2,6-Piperazinedione",C2974769,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001065,MeSH_PA,C070899,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",21416-68-2,ICRF 196,ChemID+,<syn per source>,,,,,,,,ICRF 196,,21416-68-2,<syn per source>,"4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",exact,,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",C070899,21416-68-2,exact,,,,"4,4'-(1,2-Dimethyl-1,2-Ethanediyl)Bis-2,6-Piperazinedione",C2974769,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001066,MeSH_PA,C070899,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",21416-68-2,ICRF 196,ChemID+,<syn per source>,,,,,,,,ICRF 196,,21416-68-2,<syn per source>,"4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",exact,,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",C070899,21416-68-2,exact,,,,"4,4'-(1,2-Dimethyl-1,2-Ethanediyl)Bis-2,6-Piperazinedione",C2974769,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Topoisomerase II Inhibitors,Topoisomerase II Inhibitors,Y,quasi syn therclass-to-function,Dna Topoisomerase Type Ii Activity,Dna Topoisomerase Type Ii Activity,C2257146,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Topoisomerase Ii Inhibitors,Topoisomerase Ii Inhibitors,C1519554,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001067,MeSH_PA,C070899,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",21416-68-2,ICRF 196,ChemID+,<syn per source>,,,,,,,,ICRF 196,,21416-68-2,<syn per source>,"4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",exact,,"4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione",C070899,21416-68-2,exact,,,,"4,4'-(1,2-Dimethyl-1,2-Ethanediyl)Bis-2,6-Piperazinedione",C2974769,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Topoisomerase Inhibitors,Topoisomerase Inhibitors,Y,quasi syn therclass-to-function,Dna Topoisomerase Activity,Dna Topoisomerase Activity,C1150386,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Topoisomerase Inhibitors,Topoisomerase Inhibitors,C0598317,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001068,MeSH_PA,C068250,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,134448-10-5,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,ChemID+,exact,,,,,,,,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,,134448-10-5,exact,,,,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,C068250,134448-10-5,exact,,,,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,C0107942,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001069,MeSH_PA,C068250,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,134448-10-5,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,ChemID+,exact,,,,,,,,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,,134448-10-5,exact,,,,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,C068250,134448-10-5,exact,,,,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,C0107942,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001070,MeSH_PA,C068250,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,134448-10-5,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,ChemID+,exact,,,,,,,,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,,134448-10-5,exact,,,,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,C068250,134448-10-5,exact,,,,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,C0107942,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001071,MeSH_PA,C068250,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,134448-10-5,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,ChemID+,exact,,,,,,,,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,,134448-10-5,exact,,,,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,C068250,134448-10-5,exact,,,,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,C0107942,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001072,MeSH_PA,C068250,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,134448-10-5,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,ChemID+,exact,,,,,,,,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,,134448-10-5,exact,,,,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,C068250,134448-10-5,exact,,,,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,C0107942,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001073,MeSH_PA,C068250,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,134448-10-5,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,ChemID+,exact,,,,,,,,N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,,134448-10-5,exact,,,,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,C068250,134448-10-5,exact,,,,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,C0107942,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001074,MeSH_PA,C041829,1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,22572-40-3,1-Ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,ChemID+,exact,,,,,,,,1-Ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,,22572-40-3,exact,,,,1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,C041829,22572-40-3,exact,,,,1-Ethyl-3-(3-(Dimethylamino)Propyl)Carbodiimide Methiodide,C0044378,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cross-Linking Reagents,Cross-Linking Reagents,Y,exact (CUI-based),Cross-Linking Reagents,Cross-Linking Reagents,C0010360,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001075,MeSH_PA,C041829,1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,22572-40-3,1-Ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,ChemID+,exact,,,,,,,,1-Ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,,22572-40-3,exact,,,,1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide,C041829,22572-40-3,exact,,,,1-Ethyl-3-(3-(Dimethylamino)Propyl)Carbodiimide Methiodide,C0044378,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001076,MeSH_PA,C048008,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,95034-25-6,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,ChemID+,exact,,,,,,,,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,,95034-25-6,exact,,,,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,C048008,95034-25-6,exact,,,,2-(Beta-(3-Iodo-4-Hydroxyphenyl)Ethylaminomethyl)Tetralone,C0045751,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Adrenergic Agents,Adrenergic Agents,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Agents,Adrenergic Agents,C0001637,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001077,MeSH_PA,C048008,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,95034-25-6,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,ChemID+,exact,,,,,,,,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,,95034-25-6,exact,,,,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,C048008,95034-25-6,exact,,,,2-(Beta-(3-Iodo-4-Hydroxyphenyl)Ethylaminomethyl)Tetralone,C0045751,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Adrenergic alpha-Antagonists,Adrenergic alpha-Antagonists,Y,quasi syn therclass-to-function,Alpha-Adrenergic Receptor Function,Alpha-Adrenergic Receptor Function,C0544651,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Alpha-Antagonists,Adrenergic Alpha-Antagonists,C0001641,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001078,MeSH_PA,C048008,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,95034-25-6,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,ChemID+,exact,,,,,,,,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,,95034-25-6,exact,,,,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,C048008,95034-25-6,exact,,,,2-(Beta-(3-Iodo-4-Hydroxyphenyl)Ethylaminomethyl)Tetralone,C0045751,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Adrenergic Antagonists,Adrenergic Antagonists,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Antagonists,Adrenergic Antagonists,C0242889,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001079,MeSH_PA,C048008,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,95034-25-6,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,ChemID+,exact,,,,,,,,2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,,95034-25-6,exact,,,,2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone,C048008,95034-25-6,exact,,,,2-(Beta-(3-Iodo-4-Hydroxyphenyl)Ethylaminomethyl)Tetralone,C0045751,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001080,MeSH_PA,D015647,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",67287-49-4,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",CTD,exact,,,,,,,,,,,,,,,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",D015647,67287-49-4,exact,,,,"2,3,4,5-Tetrahydro-7,8-Dihydroxy-1-Phenyl-1H-3-Benzazepine",C0949470,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001081,MeSH_PA,D015647,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",67287-49-4,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",CTD,exact,,,,,,,,,,,,,,,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",D015647,67287-49-4,exact,,,,"2,3,4,5-Tetrahydro-7,8-Dihydroxy-1-Phenyl-1H-3-Benzazepine",C0949470,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001082,MeSH_PA,D015647,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",67287-49-4,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",CTD,exact,,,,,,,,,,,,,,,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",D015647,67287-49-4,exact,,,,"2,3,4,5-Tetrahydro-7,8-Dihydroxy-1-Phenyl-1H-3-Benzazepine",C0949470,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001083,MeSH_PA,C028213,3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate,75621-03-3,3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate,ChemID+,exact,,,,,,,,3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate,,75621-03-3,exact,,,,3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate,C028213,75621-03-3,exact,,,,3-((3-Cholamidopropyl)Dimethylammonium)-1-Propanesulfonate,C0047101,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,,,#VALUE!,Detergents,Detergents,Y,exact (CUI-based),Detergents,Detergents,C0011740,P,,A1.4.1.1_Chemical Viewed Functionally,,,,,,,,,,,,
1_001084,MeSH_PA,C028213,3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate,75621-03-3,3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate,ChemID+,exact,,,,,,,,3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate,,75621-03-3,exact,,,,3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate,C028213,75621-03-3,exact,,,,3-((3-Cholamidopropyl)Dimethylammonium)-1-Propanesulfonate,C0047101,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,,,#VALUE!,Surface-Active Agents,Surface-Active Agents,Y,exact (CUI-based),Surface-Active Agents,Surface-Active Agents,C0038888,P,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,,,,,,,
1_001085,MeSH_PA,C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,,,,,,,,,,,,Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,,C103712000,NT salt/deriv/analog/df,,,,,,,,,,,Benzyloxycarbonylvalyl-Alanyl-Aspartyl Fluoromethyl Ketone,C0383779,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001086,MeSH_PA,C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,,,,,,,,,,,,Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,,C103712000,NT salt/deriv/analog/df,,,,,,,,,,,Benzyloxycarbonylvalyl-Alanyl-Aspartyl Fluoromethyl Ketone,C0383779,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001087,MeSH_PA,C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,,,,,,,,,,,,Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,,C103712000,NT salt/deriv/analog/df,,,,,,,,,,,Benzyloxycarbonylvalyl-Alanyl-Aspartyl Fluoromethyl Ketone,C0383779,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001088,MeSH_PA,C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,,,,,,,,,,,,Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,,C103712000,NT salt/deriv/analog/df,,,,,,,,,,,Benzyloxycarbonylvalyl-Alanyl-Aspartyl Fluoromethyl Ketone,C0383779,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001089,MeSH_PA,C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,,,,,,,,,,,,Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,,C103712000,NT salt/deriv/analog/df,,,,,,,,,,,Benzyloxycarbonylvalyl-Alanyl-Aspartyl Fluoromethyl Ketone,C0383779,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001090,MeSH_PA,C096713,benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone,,,,,,,,,,,,Benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane,,C103712000,NT salt/deriv/analog/df,,,,,,,,,,,Benzyloxycarbonylvalyl-Alanyl-Aspartyl Fluoromethyl Ketone,C0383779,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001091,MeSH_PA,C098738,N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone,,,,,,,,,,,,,,,,,,,,,,,,,,N-Acetyl-Tyrosyl-Valyl-Alanyl-Aspartyl Chloromethyl Ketone,C0388131,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001092,MeSH_PA,C098738,N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone,,,,,,,,,,,,,,,,,,,,,,,,,,N-Acetyl-Tyrosyl-Valyl-Alanyl-Aspartyl Chloromethyl Ketone,C0388131,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001093,MeSH_PA,C098738,N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone,,,,,,,,,,,,,,,,,,,,,,,,,,N-Acetyl-Tyrosyl-Valyl-Alanyl-Aspartyl Chloromethyl Ketone,C0388131,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001094,MeSH_PA,C073896,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",60559-98-0,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",ChemID+,exact,,,,,,,,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",,60559-98-0,exact,,,,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",C073896,60559-98-0,exact,,,,"N-Cyano-N'-(1,1-Dimethylpropyl)-N''-(3-Pyridinyl)Guanidine",C0166856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001095,MeSH_PA,C073896,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",60559-98-0,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",ChemID+,exact,,,,,,,,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",,60559-98-0,exact,,,,"N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",C073896,60559-98-0,exact,,,,"N-Cyano-N'-(1,1-Dimethylpropyl)-N''-(3-Pyridinyl)Guanidine",C0166856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Vasodilator Agents,Vasodilator Agents,Y,quasi syn therclass-to-function,Vasodilation,Vasodilation,C0042401,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Vasodilator Agents,Vasodilator Agents,C0042402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001096,MeSH_PA,C044565,2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide,92891-93-5,2-((((2-Chloroethyl)nitrosoamino)carbonyl)amino)propanamide,ChemID+,exact,,,,,,,,2-((((2-Chloroethyl)nitrosoamino)carbonyl)amino)propanamide,,92891-93-5,exact,,,,2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide,C044565,92891-93-5,exact,,,,2-((((2-Chloroethyl)Nitrosoamino)Carbonyl)Amino)Propanamide,C0045644,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001097,MeSH_PA,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,127243-85-0,H 89,ChemID+,<syn per source>,N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide,47495,,<syn per source>,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,syn no\W,,H 89,,127243-85-0,<syn per source>,N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,exact,,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,127243-85-0,exact,,,,N-(2-(4-Bromocinnamylamino)Ethyl)-5-Isoquinolinesulfonamide,C0130141,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001098,MeSH_PA,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,127243-85-0,H 89,ChemID+,<syn per source>,N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide,47495,,<syn per source>,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,syn no\W,,H 89,,127243-85-0,<syn per source>,N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,exact,,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,127243-85-0,exact,,,,N-(2-(4-Bromocinnamylamino)Ethyl)-5-Isoquinolinesulfonamide,C0130141,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protein Kinase Inhibitors,Protein Kinase Inhibitors,Y,quasi syn therclass-to-function,Protein Kinase Activity,Protein Kinase Activity,C1150527,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Protein Kinase Inhibitors,Protein Kinase Inhibitors,C1449702,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,
1_001099,MeSH_PA,C030860,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,76877-33-3,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,,76877-33-3,exact,,,,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,C030860,76877-33-3,exact,,,,N-(4-(7-Diethylamino-4-Methylcoumarin-3-Yl)Phenyl)Maleimide,C0067516,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001100,MeSH_PA,C030860,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,76877-33-3,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,,76877-33-3,exact,,,,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,C030860,76877-33-3,exact,,,,N-(4-(7-Diethylamino-4-Methylcoumarin-3-Yl)Phenyl)Maleimide,C0067516,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001101,MeSH_PA,C030860,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,76877-33-3,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,,76877-33-3,exact,,,,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,C030860,76877-33-3,exact,,,,N-(4-(7-Diethylamino-4-Methylcoumarin-3-Yl)Phenyl)Maleimide,C0067516,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001102,MeSH_PA,C030860,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,76877-33-3,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,ChemID+,exact,,,,,,,,N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,,76877-33-3,exact,,,,N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide,C030860,76877-33-3,exact,,,,N-(4-(7-Diethylamino-4-Methylcoumarin-3-Yl)Phenyl)Maleimide,C0067516,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001103,MeSH_PA,D004849,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",2104-64-5,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",CTD,exact,,,,,,,,,,,,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",D004849,2104-64-5,exact,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",C0014614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001104,MeSH_PA,D004849,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",2104-64-5,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",CTD,exact,,,,,,,,,,,,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",D004849,2104-64-5,exact,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",C0014614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1.6_Organophosphorus Compound,,inhibitor,inhibits,Inhibitors,Cholinesterase Inhibitors,Cholinesterase Inhibitors,Y,quasi syn therclass-to-function,Cholinesterase Activity,Cholinesterase Activity,C1149831,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cholinesterase Inhibitors,Cholinesterase Inhibitors,C0008425,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001105,MeSH_PA,D004849,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",2104-64-5,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",CTD,exact,,,,,,,,,,,,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",D004849,2104-64-5,exact,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",C0014614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1.6_Organophosphorus Compound,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001106,MeSH_PA,D004849,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",2104-64-5,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",CTD,exact,,,,,,,,,,,,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",D004849,2104-64-5,exact,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",C0014614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1.6_Organophosphorus Compound,,cide,,#VALUE!,Insecticides,Insecticides,Y,quasi syn therclass-to-disease,Infestation By Insect,Infestation By Insect,C0277344,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Insecticides,Insecticides,C0021576,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001107,MeSH_PA,D004849,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",2104-64-5,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",CTD,exact,,,,,,,,,,,,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",D004849,2104-64-5,exact,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",C0014614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001108,MeSH_PA,D004849,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",2104-64-5,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",CTD,exact,,,,,,,,,,,,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",D004849,2104-64-5,exact,,,,"Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",C0014614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1.6_Organophosphorus Compound,,,,#VALUE!,Pesticides,Pesticides,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Pesticides,Pesticides,C0031253,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001109,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001110,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001111,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001112,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001113,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001114,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001115,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,Y,quasi syn therclass-to-function,Lipoxygenase Activity,Lipoxygenase Activity,C1151586,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,C0085385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001116,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001117,MeSH_PA,C079315,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,128253-31-6,Veliflapon,ChemID+,<syn per source>,,,,,,,,Veliflapon,Veliflapon [USAN],128253-31-6,<syn per source>,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,exact,,2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid,C079315,128253-31-6,exact,,,,2-(4-(Quinolin-2-Yl-Methoxy)Phenyl)-2-Cyclopentylacetic Acid,C0212660,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001118,ChEBI,,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",298-93-1,Thiazolyl blue,ChemID+,<syn per source>,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",53233,298-93-1,exact,,,,Thiazolyl blue,,298-93-1,<syn per source>,"3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",exact,,thiazolyl blue,C022616,298-93-1,<syn per source>,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",exact,,"3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide",C0094912,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,colorimetric reagent,colorimetric reagent,Y,NT,Colorimetry,Colorimetry,C0009407,P,,B1.3.1.1_Laboratory Procedure,,,,,,,,,,,,
1_001119,ChEBI,,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",298-93-1,Thiazolyl blue,ChemID+,<syn per source>,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",53233,298-93-1,exact,,,,Thiazolyl blue,,298-93-1,<syn per source>,"3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",exact,,thiazolyl blue,C022616,298-93-1,<syn per source>,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",exact,,"3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide",C0094912,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,dye,dye,Y,exact 1,dye,Dyes,C0013343,S,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001120,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001121,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001122,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001123,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001124,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001125,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,Y,quasi syn therclass-to-function,Fatty Acid Cyclooxygenase Activity,Fatty Acid Cyclooxygenase Activity,C2261439,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,C0085387,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001126,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001127,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,Y,quasi syn therclass-to-function,Lipoxygenase Activity,Lipoxygenase Activity,C1151586,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,C0085385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001128,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001129,MeSH_PA,D015772,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",66000-40-6,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",ChemID+,exact,,,,,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine",D015772,66000-40-6,exact,,,,"4,5-Dihydro-1-(3-(Trifluoromethyl)Phenyl)-1H-Pyrazol-3-Amine",C0949477,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001130,MeSH_PA,C038088,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,86332-16-3,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,ChemID+,exact,,,,,,,,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,,86332-16-3,exact,,,,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,C038088,86332-16-3,exact,,,,N-Cyclohexyl-N'-(4-Dimethylamino-Alpha-Naphthyl)Carbodiimide,C0067901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001131,MeSH_PA,C038088,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,86332-16-3,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,ChemID+,exact,,,,,,,,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,,86332-16-3,exact,,,,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,C038088,86332-16-3,exact,,,,N-Cyclohexyl-N'-(4-Dimethylamino-Alpha-Naphthyl)Carbodiimide,C0067901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001132,MeSH_PA,C038088,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,86332-16-3,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,ChemID+,exact,,,,,,,,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,,86332-16-3,exact,,,,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,C038088,86332-16-3,exact,,,,N-Cyclohexyl-N'-(4-Dimethylamino-Alpha-Naphthyl)Carbodiimide,C0067901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001133,MeSH_PA,C038088,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,86332-16-3,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,ChemID+,exact,,,,,,,,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,,86332-16-3,exact,,,,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,C038088,86332-16-3,exact,,,,N-Cyclohexyl-N'-(4-Dimethylamino-Alpha-Naphthyl)Carbodiimide,C0067901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001134,MeSH_PA,C038088,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,86332-16-3,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,ChemID+,exact,,,,,,,,N-Cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,,86332-16-3,exact,,,,N-cyclohexyl-N'-(4-dimethylamino-alpha-naphthyl)carbodiimide,C038088,86332-16-3,exact,,,,N-Cyclohexyl-N'-(4-Dimethylamino-Alpha-Naphthyl)Carbodiimide,C0067901,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001135,MeSH_PA,C010654,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",613-67-2,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",ChemID+,exact,"N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine",64098,,<syn per source>,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",exact,,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",,613-67-2,exact,,,,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",C010654,613-67-2,exact,,,,"(2-(2',6'-Dimethoxy)Phenoxyethylamino)Methylbenzo-1,4-Dioxane",C0087344,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Adrenergic Agents,Adrenergic Agents,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Agents,Adrenergic Agents,C0001637,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001136,MeSH_PA,C010654,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",613-67-2,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",ChemID+,exact,"N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine",64098,,<syn per source>,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",exact,,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",,613-67-2,exact,,,,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",C010654,613-67-2,exact,,,,"(2-(2',6'-Dimethoxy)Phenoxyethylamino)Methylbenzo-1,4-Dioxane",C0087344,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adrenergic alpha-Antagonists,Adrenergic alpha-Antagonists,Y,quasi syn therclass-to-function,Alpha-Adrenergic Receptor Function,Alpha-Adrenergic Receptor Function,C0544651,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Alpha-Antagonists,Adrenergic Alpha-Antagonists,C0001641,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001137,MeSH_PA,C010654,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",613-67-2,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",ChemID+,exact,"N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine",64098,,<syn per source>,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",exact,,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",,613-67-2,exact,,,,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",C010654,613-67-2,exact,,,,"(2-(2',6'-Dimethoxy)Phenoxyethylamino)Methylbenzo-1,4-Dioxane",C0087344,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adrenergic Antagonists,Adrenergic Antagonists,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Antagonists,Adrenergic Antagonists,C0242889,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001138,MeSH_PA,C010654,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",613-67-2,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",ChemID+,exact,"N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine",64098,,<syn per source>,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",exact,,"(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",,613-67-2,exact,,,,"(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane",C010654,613-67-2,exact,,,,"(2-(2',6'-Dimethoxy)Phenoxyethylamino)Methylbenzo-1,4-Dioxane",C0087344,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001139,MeSH_PA,C454816,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",,,,,,,,,,,,,,,,,,,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",C454816,,exact,,,,"1-(2'-Amino-3',3'-Dimethylbutanoyl)Pyrrolidine-2-Carbonitrile",C1122500,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001140,MeSH_PA,C454816,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",,,,,,,,,,,,,,,,,,,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",C454816,,exact,,,,"1-(2'-Amino-3',3'-Dimethylbutanoyl)Pyrrolidine-2-Carbonitrile",C1122500,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001141,MeSH_PA,C454816,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",,,,,,,,,,,,,,,,,,,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",C454816,,exact,,,,"1-(2'-Amino-3',3'-Dimethylbutanoyl)Pyrrolidine-2-Carbonitrile",C1122500,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001142,MeSH_PA,C454816,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",,,,,,,,,,,,,,,,,,,"1-(2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile",C454816,,exact,,,,"1-(2'-Amino-3',3'-Dimethylbutanoyl)Pyrrolidine-2-Carbonitrile",C1122500,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001143,MeSH_PA,C091518,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",108614-26-2,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",ChemID+,exact,,,,,,,,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",,108614-26-2,exact,,,,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",C091518,108614-26-2,exact,,,,"1-(4-Ethynylphenyl)-4-Propyl-2,6,7-Trioxabicyclo(2.2.2)Octane",C0293183,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001144,MeSH_PA,C091518,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",108614-26-2,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",ChemID+,exact,,,,,,,,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",,108614-26-2,exact,,,,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",C091518,108614-26-2,exact,,,,"1-(4-Ethynylphenyl)-4-Propyl-2,6,7-Trioxabicyclo(2.2.2)Octane",C0293183,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001145,MeSH_PA,C091518,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",108614-26-2,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",ChemID+,exact,,,,,,,,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",,108614-26-2,exact,,,,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",C091518,108614-26-2,exact,,,,"1-(4-Ethynylphenyl)-4-Propyl-2,6,7-Trioxabicyclo(2.2.2)Octane",C0293183,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,cide,,#VALUE!,Insecticides,Insecticides,Y,quasi syn therclass-to-disease,Infestation By Insect,Infestation By Insect,C0277344,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Insecticides,Insecticides,C0021576,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001146,MeSH_PA,C091518,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",108614-26-2,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",ChemID+,exact,,,,,,,,"1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",,108614-26-2,exact,,,,"1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane",C091518,108614-26-2,exact,,,,"1-(4-Ethynylphenyl)-4-Propyl-2,6,7-Trioxabicyclo(2.2.2)Octane",C0293183,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Pesticides,Pesticides,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Pesticides,Pesticides,C0031253,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001147,MeSH_PA,C006052,"2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",800-24-8,Aziridyl benzoquinone,ChemID+,<syn per source>,,,,,,,,Aziridyl benzoquinone,,800-24-8,<syn per source>,"2,5-Bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",exact,,"2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",C006052,800-24-8,exact,,,,"2,5-Bis(1-Aziridinyl)-3,6-Bis(2-Methoxyethoxy)-4-Benzoquinone",C0045542,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001148,MeSH_PA,C006052,"2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",800-24-8,Aziridyl benzoquinone,ChemID+,<syn per source>,,,,,,,,Aziridyl benzoquinone,,800-24-8,<syn per source>,"2,5-Bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",exact,,"2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",C006052,800-24-8,exact,,,,"2,5-Bis(1-Aziridinyl)-3,6-Bis(2-Methoxyethoxy)-4-Benzoquinone",C0045542,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001149,MeSH_PA,C006052,"2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",800-24-8,Aziridyl benzoquinone,ChemID+,<syn per source>,,,,,,,,Aziridyl benzoquinone,,800-24-8,<syn per source>,"2,5-Bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",exact,,"2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone",C006052,800-24-8,exact,,,,"2,5-Bis(1-Aziridinyl)-3,6-Bis(2-Methoxyethoxy)-4-Benzoquinone",C0045542,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001150,MeSH_PA,C090942,4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,152121-30-7,4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,ChemID+,exact,SB-202190,79090,152121-30-7,<syn per source>,4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,exact,,4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,,152121-30-7,exact,,,,4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,C090942,,exact,,,,4-(4-Fluorophenyl)-2-(4-Hydroxyphenyl)-5-(4-Pyridyl)Imidazole,C0380337,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001151,MeSH_PA,C082137,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,133208-93-2,Ibrolipim,ChemID+,<syn per source>,,,,,,,,Ibrolipim,Ibrolipim [USAN:INN],133208-93-2,<syn per source>,4-Diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,exact,,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,C082137,133208-93-2,exact,,,,4-Diethoxyphosphorylmethyl-N-(4-Bromo-2-Cyanophenyl)Benzamide,C0218075,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antimetabolites,Antimetabolites,Y,quasi syn therclass-to-function,Metabolism,Metabolism,C0025519,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Antimetabolites,Antimetabolites,C0003376,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001152,MeSH_PA,C082137,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,133208-93-2,Ibrolipim,ChemID+,<syn per source>,,,,,,,,Ibrolipim,Ibrolipim [USAN:INN],133208-93-2,<syn per source>,4-Diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,exact,,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,C082137,133208-93-2,exact,,,,4-Diethoxyphosphorylmethyl-N-(4-Bromo-2-Cyanophenyl)Benzamide,C0218075,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Enzyme Activators,Enzyme Activators,Y,exact (CUI-based),Enzyme Activators,Enzyme Activators,C0751968,P,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,,,,,,,,,,
1_001153,MeSH_PA,C082137,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,133208-93-2,Ibrolipim,ChemID+,<syn per source>,,,,,,,,Ibrolipim,Ibrolipim [USAN:INN],133208-93-2,<syn per source>,4-Diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,exact,,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,C082137,133208-93-2,exact,,,,4-Diethoxyphosphorylmethyl-N-(4-Bromo-2-Cyanophenyl)Benzamide,C0218075,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,hypo,,#VALUE!,Hypolipidemic Agents,Hypolipidemic Agents,Y,quasi syn therclass-to-disease,Hyperlipidemia,Hyperlipidemia,C0020473,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypolipidemic Agents,Hypolipidemic Agents,C0086440,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001154,MeSH_PA,C082137,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,133208-93-2,Ibrolipim,ChemID+,<syn per source>,,,,,,,,Ibrolipim,Ibrolipim [USAN:INN],133208-93-2,<syn per source>,4-Diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,exact,,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,C082137,133208-93-2,exact,,,,4-Diethoxyphosphorylmethyl-N-(4-Bromo-2-Cyanophenyl)Benzamide,C0218075,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,regulating,,#VALUE!,Lipid Regulating Agents,Lipid Regulating Agents,Y,quasi syn therclass-to-function,Lipid Metabolism,Lipid Metabolism,C0598783,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipid Regulating Agents,Lipid Regulating Agents,C2936244,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001155,MeSH_PA,C082137,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,133208-93-2,Ibrolipim,ChemID+,<syn per source>,,,,,,,,Ibrolipim,Ibrolipim [USAN:INN],133208-93-2,<syn per source>,4-Diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,exact,,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,C082137,133208-93-2,exact,,,,4-Diethoxyphosphorylmethyl-N-(4-Bromo-2-Cyanophenyl)Benzamide,C0218075,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,activator,,#VALUE!,Lipoprotein Lipase Activators,Lipoprotein Lipase Activators,Y,quasi syn therclass-to-function,Lipoprotein Lipase Activity,Lipoprotein Lipase Activity,C1149837,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoprotein Lipase Activators,Lipoprotein Lipase Activators,C2936534,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001156,MeSH_PA,C082137,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,133208-93-2,Ibrolipim,ChemID+,<syn per source>,,,,,,,,Ibrolipim,Ibrolipim [USAN:INN],133208-93-2,<syn per source>,4-Diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,exact,,4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide,C082137,133208-93-2,exact,,,,4-Diethoxyphosphorylmethyl-N-(4-Bromo-2-Cyanophenyl)Benzamide,C0218075,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,tropic,,#VALUE!,Lipotropic Agents,Lipotropic Agents,Y,quasi syn therclass-to-function,Lipid Metabolism,Lipid Metabolism,C0598783,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipotropic Agents,Lipotropic Agents,C0023831,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001157,MeSH_PA,C051263,N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea,79955-36-5,N'-(2-Chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea,ChemID+,exact,,,,,,,,N'-(2-Chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea,,79955-36-5,exact,,,,N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea,C051263,79955-36-5,exact,,,,N'-(2-Chloroethyl)-N-(2-(Methylsulfonyl)Ethyl)-N'-Nitrosourea,C0067099,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001158,MeSH_PA,C042077,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",64205-19-2,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",ChemID+,exact,,,,,,,,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",,64205-19-2,exact,,,,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",C042077,64205-19-2,exact,,,,"N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-Yl)Phosphatidylethanolamine",C0067563,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001159,MeSH_PA,C042077,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",64205-19-2,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",ChemID+,exact,,,,,,,,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",,64205-19-2,exact,,,,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",C042077,64205-19-2,exact,,,,"N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-Yl)Phosphatidylethanolamine",C0067563,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001160,MeSH_PA,C042077,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",64205-19-2,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",ChemID+,exact,,,,,,,,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",,64205-19-2,exact,,,,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",C042077,64205-19-2,exact,,,,"N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-Yl)Phosphatidylethanolamine",C0067563,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001161,MeSH_PA,C042077,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",64205-19-2,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",ChemID+,exact,,,,,,,,"N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",,64205-19-2,exact,,,,"N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine",C042077,64205-19-2,exact,,,,"N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-Yl)Phosphatidylethanolamine",C0067563,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001162,MeSH_PA,C023868,N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,70280-03-4,N-Acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,ChemID+,exact,,,,,,,,N-Acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,,70280-03-4,exact,,,,N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,C023868,70280-03-4,exact,,,,N-Acetyl-Beta-Glucosaminyl-N-Acetylmuramyl-Alanylisoglutamine,C0067649,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,adjuvant,adju,1,"Adjuvants, Immunologic","Adjuvants, Immunologic",Y,quasi syn therclass-to-function,Active Immunity,Active Immunity,C0020965,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),"adjuvants, immunologic",Immunologic Adjuvants,C0001551,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001163,MeSH_PA,C023868,N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,70280-03-4,N-Acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,ChemID+,exact,,,,,,,,N-Acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,,70280-03-4,exact,,,,N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine,C023868,70280-03-4,exact,,,,N-Acetyl-Beta-Glucosaminyl-N-Acetylmuramyl-Alanylisoglutamine,C0067649,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001164,MeSH_PA,C039737,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,67469-57-2,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,ChemID+,exact,,,,,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,,67469-57-2,exact,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,C039737,67469-57-2,exact,,,,1-(2-(Diphenylmethoxy)Ethyl)-4-(3-Phenyl-2-Propenyl)Piperazine,C0950602,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001165,MeSH_PA,C039737,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,67469-57-2,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,ChemID+,exact,,,,,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,,67469-57-2,exact,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,C039737,67469-57-2,exact,,,,1-(2-(Diphenylmethoxy)Ethyl)-4-(3-Phenyl-2-Propenyl)Piperazine,C0950602,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001166,MeSH_PA,C039737,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,67469-57-2,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,ChemID+,exact,,,,,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,,67469-57-2,exact,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,C039737,67469-57-2,exact,,,,1-(2-(Diphenylmethoxy)Ethyl)-4-(3-Phenyl-2-Propenyl)Piperazine,C0950602,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Dopamine Uptake Inhibitors,Dopamine Uptake Inhibitors,Y,quasi syn therclass-to-function,Dopamine Uptake,Dopamine Uptake,C1657587,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Dopamine Uptake Inhibitors,Dopamine Uptake Inhibitors,C0242980,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001167,MeSH_PA,C039737,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,67469-57-2,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,ChemID+,exact,,,,,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,,67469-57-2,exact,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,C039737,67469-57-2,exact,,,,1-(2-(Diphenylmethoxy)Ethyl)-4-(3-Phenyl-2-Propenyl)Piperazine,C0950602,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001168,MeSH_PA,C039737,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,67469-57-2,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,ChemID+,exact,,,,,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,,67469-57-2,exact,,,,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine,C039737,67469-57-2,exact,,,,1-(2-(Diphenylmethoxy)Ethyl)-4-(3-Phenyl-2-Propenyl)Piperazine,C0950602,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Neurotransmitter Uptake Inhibitors,Neurotransmitter Uptake Inhibitors,Y,quasi syn therclass-to-function,Neurotransmitter Uptake,Neurotransmitter Uptake,C0598962,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Uptake Inhibitors,Neurotransmitter Uptake Inhibitors,C0040724,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001169,MeSH_PA,C090203,"1,2-epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",111001-48-0,"1,2-Epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",ChemID+,exact,,,,,,,,"1,2-Epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",,111001-48-0,exact,,,,"1,2-epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",C090203,111001-48-0,exact,,,,"1,2-Epoxy-3,4-Dihydroxy-1,2,3,4-Tetrahydrobenzo(C)Phenanthrene",C0290327,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001170,MeSH_PA,C090203,"1,2-epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",111001-48-0,"1,2-Epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",ChemID+,exact,,,,,,,,"1,2-Epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",,111001-48-0,exact,,,,"1,2-epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",C090203,111001-48-0,exact,,,,"1,2-Epoxy-3,4-Dihydroxy-1,2,3,4-Tetrahydrobenzo(C)Phenanthrene",C0290327,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001171,MeSH_PA,C058180,"5,5'-dimethyl-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate",91416-19-2,"5,5'-Dimethyl-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate",ChemID+,exact,"5,5'-dimethyl-BAPTA",60889,91416-19-2,<syn per source>,"5,5'-Dimethyl-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate",exact,,"5,5'-Dimethyl-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate",,91416-19-2,exact,,,,"5,5'-dimethyl-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate",C058180,91416-19-2,exact,,,,"5,5'-Dimethyl-Bis(2-Aminophenoxy)Ethane-N,N,N',N'-Tetraacetate",C0048880,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_001172,MeSH_PA,C102580,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,NT salt/deriv/analog/df,,,,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,C102580,,exact,,,,Acetyl-Aspartyl-Glutamyl-Valyl-Aspartyl-Amino-4-Methylcoumarin,C0532119,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001173,MeSH_PA,C102580,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,NT salt/deriv/analog/df,,,,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,C102580,,exact,,,,Acetyl-Aspartyl-Glutamyl-Valyl-Aspartyl-Amino-4-Methylcoumarin,C0532119,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001174,MeSH_PA,C102580,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,NT salt/deriv/analog/df,,,,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,C102580,,exact,,,,Acetyl-Aspartyl-Glutamyl-Valyl-Aspartyl-Amino-4-Methylcoumarin,C0532119,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001175,MeSH_PA,C102580,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,,,,,,,,,,,,Acetyl-aspartyl-glutamyl-valyl-aspartal,,C099158000,NT salt/deriv/analog/df,,,,acetyl-aspartyl-glutamyl-valyl-aspartyl-amino-4-methylcoumarin,C102580,,exact,,,,Acetyl-Aspartyl-Glutamyl-Valyl-Aspartyl-Amino-4-Methylcoumarin,C0532119,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001176,MeSH_PA,C027236,"2-methyl-4-chlorophenoxyacetic acid, dicamba herbicide solution",94-74-6,MCPA,ChemID+,NT app + <syn per source>,,,,,,,,MCPA,MCPA [BSI:ISO],94-74-6,NT app + <syn per source>,2-methyl-4-chlorophenoxyacetic acid,NT app,,"2-methyl-4-chlorophenoxyacetic acid, dicamba herbicide solution",C027236,,exact,,,,"2-Methyl-4-Chlorophenoxyacetic Acid, Dicamba Herbicide Solution",C2930755,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.1.5_Hazardous or Poisonous Substance,,,cide,,#VALUE!,Herbicides,Herbicides,Y,quasi syn therclass-to-function,Plant Development,Plant Development,C0597252,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Herbicides,Herbicides,C0019236,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001177,MeSH_PA,C027236,"2-methyl-4-chlorophenoxyacetic acid, dicamba herbicide solution",94-74-6,MCPA,ChemID+,NT app + <syn per source>,,,,,,,,MCPA,MCPA [BSI:ISO],94-74-6,NT app + <syn per source>,2-methyl-4-chlorophenoxyacetic acid,NT app,,"2-methyl-4-chlorophenoxyacetic acid, dicamba herbicide solution",C027236,,exact,,,,"2-Methyl-4-Chlorophenoxyacetic Acid, Dicamba Herbicide Solution",C2930755,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.1.5_Hazardous or Poisonous Substance,,,,,#VALUE!,Pesticides,Pesticides,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Pesticides,Pesticides,C0031253,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001178,MeSH_PA,C068314,6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,88070-98-8,6-(Bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,ChemID+,exact,,,,,,,,6-(Bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,,88070-98-8,exact,,,,6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,C068314,88070-98-8,exact,,,,6-(Bromomethylene)Tetrahydro-3-(1-Naphthaleneyl)-2H-Pyran-2-One,C0098961,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001179,MeSH_PA,C068314,6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,88070-98-8,6-(Bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,ChemID+,exact,,,,,,,,6-(Bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,,88070-98-8,exact,,,,6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,C068314,88070-98-8,exact,,,,6-(Bromomethylene)Tetrahydro-3-(1-Naphthaleneyl)-2H-Pyran-2-One,C0098961,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,C0031638,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001180,MeSH_PA,C021159,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,65147-22-0,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,ChemID+,exact,,,,,,,,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,,65147-22-0,exact,,,,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,C021159,65147-22-0,exact,,,,Benzyloxycarbonyl-Phenylalanylarginine-4-Methylcoumaryl-7-Amide,C0054677,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001181,MeSH_PA,C021159,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,65147-22-0,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,ChemID+,exact,,,,,,,,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,,65147-22-0,exact,,,,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,C021159,65147-22-0,exact,,,,Benzyloxycarbonyl-Phenylalanylarginine-4-Methylcoumaryl-7-Amide,C0054677,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001182,MeSH_PA,C021159,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,65147-22-0,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,ChemID+,exact,,,,,,,,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,,65147-22-0,exact,,,,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,C021159,65147-22-0,exact,,,,Benzyloxycarbonyl-Phenylalanylarginine-4-Methylcoumaryl-7-Amide,C0054677,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001183,MeSH_PA,C021159,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,65147-22-0,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,ChemID+,exact,,,,,,,,Benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,,65147-22-0,exact,,,,benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide,C021159,65147-22-0,exact,,,,Benzyloxycarbonyl-Phenylalanylarginine-4-Methylcoumaryl-7-Amide,C0054677,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001184,MeSH_PA,C026704,methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,65144-34-5,Methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,ChemID+,exact,,,,,,,,Methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,,65144-34-5,exact,,,,,,,,,,,Methoxysuccinyl-Alanyl-Alanyl-Prolyl-Valine Chloromethyl Ketone,C0066167,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001185,MeSH_PA,C026704,methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,65144-34-5,Methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,ChemID+,exact,,,,,,,,Methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,,65144-34-5,exact,,,,,,,,,,,Methoxysuccinyl-Alanyl-Alanyl-Prolyl-Valine Chloromethyl Ketone,C0066167,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001186,MeSH_PA,C026704,methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,65144-34-5,Methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,ChemID+,exact,,,,,,,,Methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone,,65144-34-5,exact,,,,,,,,,,,Methoxysuccinyl-Alanyl-Alanyl-Prolyl-Valine Chloromethyl Ketone,C0066167,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001187,MeSH_PA,C049599,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",98968-92-4,Thiosultap,ChemID+,<syn per source>,thiosultap,39199,98968-92-4,<syn per source>,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",exact,,Thiosultap,Thiosultap [ISO],98968-92-4,<syn per source>,"S,S'-(2-(Dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",exact,,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",C049599,98968-92-4,exact,,,,"S,S'-(2-(Dimethylamino)-1,3-Propanediyl)Thiosulfuric Acid Ester",C0141132,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,cide,,#VALUE!,Insecticides,Insecticides,Y,quasi syn therclass-to-disease,Infestation By Insect,Infestation By Insect,C0277344,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Insecticides,Insecticides,C0021576,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001188,MeSH_PA,C049599,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",98968-92-4,Thiosultap,ChemID+,<syn per source>,thiosultap,39199,98968-92-4,<syn per source>,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",exact,,Thiosultap,Thiosultap [ISO],98968-92-4,<syn per source>,"S,S'-(2-(Dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",exact,,"S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester",C049599,98968-92-4,exact,,,,"S,S'-(2-(Dimethylamino)-1,3-Propanediyl)Thiosulfuric Acid Ester",C0141132,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Pesticides,Pesticides,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Pesticides,Pesticides,C0031253,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001189,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001190,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,tonic,,#VALUE!,Cardiotonic Agents,Cardiotonic Agents,Y,quasi syn therclass-to-disease,Heart Diseases,Heart Diseases,C0018799,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiotonic Agents,Cardiotonic Agents,C0007209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001191,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001192,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001193,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001194,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,C0031638,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001195,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001196,MeSH_PA,C049662,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",96086-67-8,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",ChemID+,exact,,,,,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",,96086-67-8,exact,,,,"1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one",C049662,96086-67-8,exact,,,,"1,5-Dihydro-7-(1-Piperidinyl)-Imidazo(2,1-B)Quinazolin-2(3H)-One",C0088459,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001197,MeSH_PA,C115239,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,146724-84-7,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,ChemID+,exact,,,,,,,,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,,146724-84-7,exact,,,,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,C115239,,exact,,,,3-(2-Hydroxy-1-Methyl-2-Nitrosohydrazino)-N-Methyl-1-Propanamine,C0759116,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001198,MeSH_PA,C115239,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,146724-84-7,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,ChemID+,exact,,,,,,,,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,,146724-84-7,exact,,,,3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine,C115239,,exact,,,,3-(2-Hydroxy-1-Methyl-2-Nitrosohydrazino)-N-Methyl-1-Propanamine,C0759116,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Nitric Oxide Donors,Nitric Oxide Donors,Y,quasi syn therclass-to-function,Nitric Oxide Metabolic Process,Nitric Oxide Metabolic Process,C1158468,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nitric Oxide Donors,Nitric Oxide Donors,C0600437,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001199,MeSH_PA,C067525,S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid,123016-21-7,WY 50295,ChemID+,<syn per source>,,,,,,,,WY 50295,,123016-21-7,<syn per source>,S(alpha)-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid,exact,,S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid,C067525,133304-99-1,exact,,,,S(Alpha)-Methyl-6-(2-Quinolinylmethoxy)-2-Naphthaleneacetic Acid,C0141130,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001200,MeSH_PA,C067525,S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid,123016-21-7,WY 50295,ChemID+,<syn per source>,,,,,,,,WY 50295,,123016-21-7,<syn per source>,S(alpha)-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid,exact,,S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid,C067525,133304-99-1,exact,,,,S(Alpha)-Methyl-6-(2-Quinolinylmethoxy)-2-Naphthaleneacetic Acid,C0141130,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,Y,quasi syn therclass-to-function,Lipoxygenase Activity,Lipoxygenase Activity,C1151586,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,C0085385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001201,MeSH_PA,C036837,"2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone",80809-81-0,docebenone,ChEBI,<syn per source>,docebenone,2340,80809-81-0,<syn per source>,"2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone",exact,,,,,,,,,"2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone",C036837,80809-81-0,exact,,,,"2,3,5-Trimethyl-6-(12-Hydroxy-5,10-Dodecadiynyl)-1,4-Benzoquinone",C0091333,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001202,MeSH_PA,C036837,"2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone",80809-81-0,docebenone,ChEBI,<syn per source>,docebenone,2340,80809-81-0,<syn per source>,"2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone",exact,,,,,,,,,"2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone",C036837,80809-81-0,exact,,,,"2,3,5-Trimethyl-6-(12-Hydroxy-5,10-Dodecadiynyl)-1,4-Benzoquinone",C0091333,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,Y,quasi syn therclass-to-function,Lipoxygenase Activity,Lipoxygenase Activity,C1151586,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipoxygenase Inhibitors,Lipoxygenase Inhibitors,C0085385,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001203,MeSH_PA,C049558,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",116780-39-3,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",ChemID+,exact,,,,,,,,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",,116780-39-3,exact,,,,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",C049558,,exact,,,,"8-Iodo-2,3,4,5-Tetrahydro-3-Methyl-5-Phenyl-1H-3-Benzazepine-7-Ol",C0100278,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001204,MeSH_PA,C049558,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",116780-39-3,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",ChemID+,exact,,,,,,,,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",,116780-39-3,exact,,,,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",C049558,,exact,,,,"8-Iodo-2,3,4,5-Tetrahydro-3-Methyl-5-Phenyl-1H-3-Benzazepine-7-Ol",C0100278,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001205,MeSH_PA,C049558,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",116780-39-3,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",ChemID+,exact,,,,,,,,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",,116780-39-3,exact,,,,"8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol",C049558,,exact,,,,"8-Iodo-2,3,4,5-Tetrahydro-3-Methyl-5-Phenyl-1H-3-Benzazepine-7-Ol",C0100278,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001206,MeSH_PA,D001371,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",366-93-8,AY-9944,ChemID+,<syn per source>,,,,,,,,AY-9944,,366-93-8,<syn per source>,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",exact,,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",D001371,366-93-8,exact,,,,"Trans-1,4-Bis(2-Chlorobenzaminomethyl)Cyclohexane Dihydrochloride",C1455833,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticholesteremic Agents,Anticholesteremic Agents,Y,quasi syn therclass-to-disease,Hypercholesterolemia,Hypercholesterolemia,C0020443,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anticholesteremic Agents,Anticholesteremic Agents,C0003277,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001207,MeSH_PA,D001371,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",366-93-8,AY-9944,ChemID+,<syn per source>,,,,,,,,AY-9944,,366-93-8,<syn per source>,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",exact,,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",D001371,366-93-8,exact,,,,"Trans-1,4-Bis(2-Chlorobenzaminomethyl)Cyclohexane Dihydrochloride",C1455833,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antimetabolites,Antimetabolites,Y,quasi syn therclass-to-function,Metabolism,Metabolism,C0025519,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Antimetabolites,Antimetabolites,C0003376,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001208,MeSH_PA,D001371,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",366-93-8,AY-9944,ChemID+,<syn per source>,,,,,,,,AY-9944,,366-93-8,<syn per source>,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",exact,,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",D001371,366-93-8,exact,,,,"Trans-1,4-Bis(2-Chlorobenzaminomethyl)Cyclohexane Dihydrochloride",C1455833,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,hypo,,#VALUE!,Hypolipidemic Agents,Hypolipidemic Agents,Y,quasi syn therclass-to-disease,Hyperlipidemia,Hyperlipidemia,C0020473,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypolipidemic Agents,Hypolipidemic Agents,C0086440,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001209,MeSH_PA,D001371,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",366-93-8,AY-9944,ChemID+,<syn per source>,,,,,,,,AY-9944,,366-93-8,<syn per source>,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",exact,,"trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride",D001371,366-93-8,exact,,,,"Trans-1,4-Bis(2-Chlorobenzaminomethyl)Cyclohexane Dihydrochloride",C1455833,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,regulating,,#VALUE!,Lipid Regulating Agents,Lipid Regulating Agents,Y,quasi syn therclass-to-function,Lipid Metabolism,Lipid Metabolism,C0598783,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Lipid Regulating Agents,Lipid Regulating Agents,C2936244,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001210,MeSH_PA,C052991,1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea,85977-49-7,Tauromustine,ChemID+,<syn per source>,,,,,,,,Tauromustine,Tauromustine [INN],85977-49-7,<syn per source>,1-(2-Chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea,exact,,1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea,C052991,85977-49-7,exact,,,,1-(2-Chloroethyl)-3-(2-(Dimethylaminosulfonyl)Ethyl)-1-Nitrosourea,C0044133,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001211,MeSH_PA,D019796,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",76898-47-0,"15-Hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid",ChemID+,syn no\W,,,,,,,,"15-Hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid",,76898-47-0,syn no\W,,,,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",D019796,76898-47-0,exact,,,,"15-Hydroxy-11 Alpha,9 Alpha-(Epoxymethano)Prosta-5,13-Dienoic Acid",C0044884,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.2_Eicosanoid,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001212,MeSH_PA,D019796,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",76898-47-0,"15-Hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid",ChemID+,syn no\W,,,,,,,,"15-Hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid",,76898-47-0,syn no\W,,,,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",D019796,76898-47-0,exact,,,,"15-Hydroxy-11 Alpha,9 Alpha-(Epoxymethano)Prosta-5,13-Dienoic Acid",C0044884,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.2_Eicosanoid,,,causes,,#VALUE!,Vasoconstrictor Agents,Vasoconstrictor Agents,Y,quasi syn therclass-to-function,vasoconstriction,Vascular Constriction (Function),C0042396,S,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Vasoconstrictor Agents,Vasoconstrictor Agents,C0042397,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001213,MeSH_PA,C117877,"2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate",,,,,,,,,,,,,,,,,,,"2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate",C117877,,exact,,,,"2-(3,5-Dimethylpiperidino)Ethyl 4-Amino-5-Chloro-2-Methoxybenzoate",C0764637,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001214,MeSH_PA,C117877,"2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate",,,,,,,,,,,,,,,,,,,"2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate",C117877,,exact,,,,"2-(3,5-Dimethylpiperidino)Ethyl 4-Amino-5-Chloro-2-Methoxybenzoate",C0764637,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001215,MeSH_PA,C117877,"2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate",,,,,,,,,,,,,,,,,,,"2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate",C117877,,exact,,,,"2-(3,5-Dimethylpiperidino)Ethyl 4-Amino-5-Chloro-2-Methoxybenzoate",C0764637,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Serotonin Antagonists,Serotonin Antagonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Antagonists,Serotonin Antagonists,C0036753,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001216,MeSH_PA,C072790,2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,137196-67-9,Sdz 205-557,ChemID+,<syn per source>,,,,,,,,Sdz 205-557,,137196-67-9,<syn per source>,2-Methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,exact,,2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,C072790,137196-67-9,exact,,,,2-Methoxy-4-Amino-5-Chlorobenzoic Acid 2-(Diethylamino)Ethyl Ester,C0093299,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001217,MeSH_PA,C072790,2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,137196-67-9,Sdz 205-557,ChemID+,<syn per source>,,,,,,,,Sdz 205-557,,137196-67-9,<syn per source>,2-Methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,exact,,2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,C072790,137196-67-9,exact,,,,2-Methoxy-4-Amino-5-Chlorobenzoic Acid 2-(Diethylamino)Ethyl Ester,C0093299,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001218,MeSH_PA,C072790,2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,137196-67-9,Sdz 205-557,ChemID+,<syn per source>,,,,,,,,Sdz 205-557,,137196-67-9,<syn per source>,2-Methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,exact,,2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester,C072790,137196-67-9,exact,,,,2-Methoxy-4-Amino-5-Chlorobenzoic Acid 2-(Diethylamino)Ethyl Ester,C0093299,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Serotonin Antagonists,Serotonin Antagonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Antagonists,Serotonin Antagonists,C0036753,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001219,MeSH_PA,C108123,"4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine",,,,,,,,,,,,"4-Amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine",,C108123000,exact,,,,"4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine",C108123,,exact,,,,"4-Amino-5-(4-Methylphenyl)-7-(Tert-Butyl)Pyrazolo(3,4-D)Pyrimidine",C0665709,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001220,MeSH_PA,C090535,benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,,,,,,,,,,,,Benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,,C090535000,exact,,,,benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,C090535,,exact,,,,Benzyloxycarbonyl-Isoleucyl-Glutamyl(O-Tert-Butyl)-Alanyl-Leucinal,C0291062,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001221,MeSH_PA,C090535,benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,,,,,,,,,,,,Benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,,C090535000,exact,,,,benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,C090535,,exact,,,,Benzyloxycarbonyl-Isoleucyl-Glutamyl(O-Tert-Butyl)-Alanyl-Leucinal,C0291062,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001222,MeSH_PA,C090535,benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,,,,,,,,,,,,Benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,,C090535000,exact,,,,benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal,C090535,,exact,,,,Benzyloxycarbonyl-Isoleucyl-Glutamyl(O-Tert-Butyl)-Alanyl-Leucinal,C0291062,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001223,MeSH_PA,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,120225-54-9,CGS 21680,ChemID+,<syn per source>,CGS-21680,73283,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,CGS 21680,,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,120225-54-9,exact,,,,2-(4-(2-Carboxyethyl)Phenethylamino)-5'-N-Ethylcarboxamidoadenosine,C0092100,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,23,Adenosine A2 Receptor Agonists,Adenosine A2 Receptor Agonists,Y,NT + quasi syn therclass-to-function,G-Protein Coupled Adenosine Receptor Activity,G-Protein Coupled Adenosine Receptor Activity,C1152761,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Adenosine A2 Receptor Agonists,Adenosine A2 Receptor Agonists,C1998062,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001224,MeSH_PA,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,120225-54-9,CGS 21680,ChemID+,<syn per source>,CGS-21680,73283,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,CGS 21680,,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,120225-54-9,exact,,,,2-(4-(2-Carboxyethyl)Phenethylamino)-5'-N-Ethylcarboxamidoadenosine,C0092100,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001225,MeSH_PA,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,120225-54-9,CGS 21680,ChemID+,<syn per source>,CGS-21680,73283,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,CGS 21680,,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,120225-54-9,exact,,,,2-(4-(2-Carboxyethyl)Phenethylamino)-5'-N-Ethylcarboxamidoadenosine,C0092100,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001226,MeSH_PA,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,120225-54-9,CGS 21680,ChemID+,<syn per source>,CGS-21680,73283,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,CGS 21680,,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,120225-54-9,exact,,,,2-(4-(2-Carboxyethyl)Phenethylamino)-5'-N-Ethylcarboxamidoadenosine,C0092100,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001227,MeSH_PA,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,120225-54-9,CGS 21680,ChemID+,<syn per source>,CGS-21680,73283,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,CGS 21680,,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,120225-54-9,exact,,,,2-(4-(2-Carboxyethyl)Phenethylamino)-5'-N-Ethylcarboxamidoadenosine,C0092100,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001228,MeSH_PA,C061282,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,120225-54-9,CGS 21680,ChemID+,<syn per source>,CGS-21680,73283,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,CGS 21680,,120225-54-9,<syn per source>,2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,exact,,2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine,C061282,120225-54-9,exact,,,,2-(4-(2-Carboxyethyl)Phenethylamino)-5'-N-Ethylcarboxamidoadenosine,C0092100,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,24,Purinergic P1 Receptor Agonists,Purinergic P1 Receptor Agonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Agonists,Purinergic P1 Receptor Agonists,C2917322,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001229,MeSH_PA,C042528,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",86798-59-6,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",ChemID+,exact,,,,,,,,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",,86798-59-6,exact,,,,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",C042528,86798-59-6,exact,,,,"4,5-Dihydro-6-(4-(Imidazol-1-Yl)Phenyl)-5-Methyl-3(2H)-Pyridazinone",C0096325,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,tonic,,#VALUE!,Cardiotonic Agents,Cardiotonic Agents,Y,quasi syn therclass-to-disease,Heart Diseases,Heart Diseases,C0018799,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiotonic Agents,Cardiotonic Agents,C0007209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001230,MeSH_PA,C042528,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",86798-59-6,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",ChemID+,exact,,,,,,,,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",,86798-59-6,exact,,,,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",C042528,86798-59-6,exact,,,,"4,5-Dihydro-6-(4-(Imidazol-1-Yl)Phenyl)-5-Methyl-3(2H)-Pyridazinone",C0096325,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001231,MeSH_PA,C042528,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",86798-59-6,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",ChemID+,exact,,,,,,,,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",,86798-59-6,exact,,,,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",C042528,86798-59-6,exact,,,,"4,5-Dihydro-6-(4-(Imidazol-1-Yl)Phenyl)-5-Methyl-3(2H)-Pyridazinone",C0096325,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001232,MeSH_PA,C042528,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",86798-59-6,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",ChemID+,exact,,,,,,,,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",,86798-59-6,exact,,,,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",C042528,86798-59-6,exact,,,,"4,5-Dihydro-6-(4-(Imidazol-1-Yl)Phenyl)-5-Methyl-3(2H)-Pyridazinone",C0096325,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001233,MeSH_PA,C042528,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",86798-59-6,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",ChemID+,exact,,,,,,,,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",,86798-59-6,exact,,,,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",C042528,86798-59-6,exact,,,,"4,5-Dihydro-6-(4-(Imidazol-1-Yl)Phenyl)-5-Methyl-3(2H)-Pyridazinone",C0096325,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,C0031638,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001234,MeSH_PA,C042528,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",86798-59-6,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",ChemID+,exact,,,,,,,,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",,86798-59-6,exact,,,,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",C042528,86798-59-6,exact,,,,"4,5-Dihydro-6-(4-(Imidazol-1-Yl)Phenyl)-5-Methyl-3(2H)-Pyridazinone",C0096325,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001235,MeSH_PA,C042528,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",86798-59-6,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",ChemID+,exact,,,,,,,,"4,5-Dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",,86798-59-6,exact,,,,"4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone",C042528,86798-59-6,exact,,,,"4,5-Dihydro-6-(4-(Imidazol-1-Yl)Phenyl)-5-Methyl-3(2H)-Pyridazinone",C0096325,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001236,MeSH_PA,C068624,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",21527-78-6,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",ChemID+,exact,"1,1',3,3'-tetraethyl-5,5',6,6'-tetrachloroimidacarbocyanine",52862,21527-78-6,<syn per source>,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",exact,,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",,21527-78-6,exact,,,,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",C068624,21527-78-6,exact,,,,"5,5',6,6'-Tetrachloro-1,1',3,3'-Tetraethylbenzimidazolocarbocyanine",C0097797,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001237,MeSH_PA,C068624,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",21527-78-6,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",ChemID+,exact,"1,1',3,3'-tetraethyl-5,5',6,6'-tetrachloroimidacarbocyanine",52862,21527-78-6,<syn per source>,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",exact,,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",,21527-78-6,exact,,,,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",C068624,21527-78-6,exact,,,,"5,5',6,6'-Tetrachloro-1,1',3,3'-Tetraethylbenzimidazolocarbocyanine",C0097797,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001238,MeSH_PA,C068624,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",21527-78-6,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",ChemID+,exact,"1,1',3,3'-tetraethyl-5,5',6,6'-tetrachloroimidacarbocyanine",52862,21527-78-6,<syn per source>,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",exact,,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",,21527-78-6,exact,,,,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",C068624,21527-78-6,exact,,,,"5,5',6,6'-Tetrachloro-1,1',3,3'-Tetraethylbenzimidazolocarbocyanine",C0097797,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001239,MeSH_PA,C068624,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",21527-78-6,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",ChemID+,exact,"1,1',3,3'-tetraethyl-5,5',6,6'-tetrachloroimidacarbocyanine",52862,21527-78-6,<syn per source>,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",exact,,"5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",,21527-78-6,exact,,,,"5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine",C068624,21527-78-6,exact,,,,"5,5',6,6'-Tetrachloro-1,1',3,3'-Tetraethylbenzimidazolocarbocyanine",C0097797,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001240,MeSH_PA,C043820,cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),84211-54-1,"Somatostatin, cyclo-(7-aminoheptanoyl-phenylalanyl-tryptophyl-lysyl-benzylthreonyl)-",ChemID+,<syn per source>,,,,,,,,"Somatostatin, cyclo-(7-aminoheptanoyl-phenylalanyl-tryptophyl-lysyl-benzylthreonyl)-",,84211-54-1,<syn per source>,Cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),exact,,cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),C043820,84211-54-1,exact,,,,Cyclo(7-Aminoheptanoylphenylalanyl-Tryptophyl-Lysyl-Benzylthreonyl),C0253503,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001241,MeSH_PA,C043820,cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),84211-54-1,"Somatostatin, cyclo-(7-aminoheptanoyl-phenylalanyl-tryptophyl-lysyl-benzylthreonyl)-",ChemID+,<syn per source>,,,,,,,,"Somatostatin, cyclo-(7-aminoheptanoyl-phenylalanyl-tryptophyl-lysyl-benzylthreonyl)-",,84211-54-1,<syn per source>,Cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),exact,,cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),C043820,84211-54-1,exact,,,,Cyclo(7-Aminoheptanoylphenylalanyl-Tryptophyl-Lysyl-Benzylthreonyl),C0253503,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001242,MeSH_PA,C040643,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",89352-67-0,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",ChemID+,exact,,,,,,,,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",,89352-67-0,exact,,,,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",C040643,89352-67-0,exact,,,,"N,N-Diallyl-Tyrosyl-Alpha-Aminoisobutyric Acid-Phenylalanyl-Leucine",C0129914,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001243,MeSH_PA,C040643,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",89352-67-0,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",ChemID+,exact,,,,,,,,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",,89352-67-0,exact,,,,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",C040643,89352-67-0,exact,,,,"N,N-Diallyl-Tyrosyl-Alpha-Aminoisobutyric Acid-Phenylalanyl-Leucine",C0129914,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,antagonist,antagonist,#VALUE!,Narcotic Antagonists,Narcotic Antagonists,Y,quasi syn therclass-to-function,Narcotic Effect,Narcotic Effect,C3179198,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Narcotic Antagonists,Narcotic Antagonists,C0027410,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001244,MeSH_PA,C040643,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",89352-67-0,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",ChemID+,exact,,,,,,,,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",,89352-67-0,exact,,,,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",C040643,89352-67-0,exact,,,,"N,N-Diallyl-Tyrosyl-Alpha-Aminoisobutyric Acid-Phenylalanyl-Leucine",C0129914,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001245,MeSH_PA,C040643,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",89352-67-0,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",ChemID+,exact,,,,,,,,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",,89352-67-0,exact,,,,"N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",C040643,89352-67-0,exact,,,,"N,N-Diallyl-Tyrosyl-Alpha-Aminoisobutyric Acid-Phenylalanyl-Leucine",C0129914,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001246,MeSH_PA,C016868,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,67383-44-2,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,ChemID+,exact,,,,,,,,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,,67383-44-2,exact,,,,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,C016868,67383-44-2,exact,,,,N-N-Propyl-N-Phenylethyl-4(3-Hydroxyphenyl)Ethylamine Hydrochloride,C0131383,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001247,MeSH_PA,C016868,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,67383-44-2,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,ChemID+,exact,,,,,,,,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,,67383-44-2,exact,,,,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,C016868,67383-44-2,exact,,,,N-N-Propyl-N-Phenylethyl-4(3-Hydroxyphenyl)Ethylamine Hydrochloride,C0131383,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001248,MeSH_PA,C016868,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,67383-44-2,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,ChemID+,exact,,,,,,,,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,,67383-44-2,exact,,,,N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride,C016868,67383-44-2,exact,,,,N-N-Propyl-N-Phenylethyl-4(3-Hydroxyphenyl)Ethylamine Hydrochloride,C0131383,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001249,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001250,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001251,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,13,Cholinergic Agonists,Cholinergic Agonists,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agonists,Cholinergic Agonists,C0242894,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001252,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Ganglionic Stimulants,Ganglionic Stimulants,Y,exact (CUI-based),Ganglionic Stimulants,Ganglionic Stimulants,C0017078,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001253,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,12,Muscarinic Agonists,Muscarinic Agonists,Y,quasi syn therclass-to-function,Muscarinic Acetylcholine Receptor Activity,Muscarinic Acetylcholine Receptor Activity,C1148664,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Muscarinic Agonists,Muscarinic Agonists,C0242947,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001254,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001255,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,11,Nicotinic Agonists,Nicotinic Agonists,Y,quasi syn therclass-to-function,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,C1148665,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nicotinic Agonists,Nicotinic Agonists,C0242948,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001256,MeSH_PA,D008455,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,55-45-8,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,ChemID+,<syn per source>,,,,,,,,4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,,55-45-8,syn no\W,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,exact,,(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride,D008455,55-45-8,exact,,,,(4-(M-Chlorophenylcarbamoyloxy)-2-Butynyl)Trimethylammonium Chloride,C1306149,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001257,MeSH_PA,C063159,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,130495-35-1,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,ChemID+,exact,,,,,,,,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,,130495-35-1,exact,,,,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,exact,,,,1-(2-(3-(4-Methoxyphenyl)Propoxy)-4-Methoxyphenylethyl)-1H-Imidazole,C0088645,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,blocker,,#VALUE!,Calcium Channel Blockers,Calcium Channel Blockers,Y,quasi syn therclass-to-function,Calcium Channel Activity,Calcium Channel Activity,C1153433,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Calcium Channel Blockers,Calcium Channel Blockers,C0006684,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001258,MeSH_PA,C063159,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,130495-35-1,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,ChemID+,exact,,,,,,,,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,,130495-35-1,exact,,,,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,exact,,,,1-(2-(3-(4-Methoxyphenyl)Propoxy)-4-Methoxyphenylethyl)-1H-Imidazole,C0088645,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001259,MeSH_PA,C063159,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,130495-35-1,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,ChemID+,exact,,,,,,,,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,,130495-35-1,exact,,,,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,exact,,,,1-(2-(3-(4-Methoxyphenyl)Propoxy)-4-Methoxyphenylethyl)-1H-Imidazole,C0088645,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001260,MeSH_PA,C063159,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,130495-35-1,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,ChemID+,exact,,,,,,,,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,,130495-35-1,exact,,,,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,exact,,,,1-(2-(3-(4-Methoxyphenyl)Propoxy)-4-Methoxyphenylethyl)-1H-Imidazole,C0088645,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulator,,#VALUE!,Membrane Transport Modulators,Membrane Transport Modulators,Y,quasi syn therclass-to-function,membrane transport,Transmembrane Transport,C1519624,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Membrane Transport Modulators,Membrane Transport Modulators,C1563710,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001261,MeSH_PA,C063159,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,130495-35-1,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,ChemID+,exact,,,,,,,,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,,130495-35-1,exact,,,,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,exact,,,,1-(2-(3-(4-Methoxyphenyl)Propoxy)-4-Methoxyphenylethyl)-1H-Imidazole,C0088645,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001262,MeSH_PA,C035573,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",67013-48-3,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",,67013-48-3,exact,,,,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",C035573,67013-48-3,exact,,,,"4-(N-(Iodoacetoxy)Ethyl-N-Methyl)Amino-7-Nitrobenz-2-Oxa-1,3-Diazole",C0047956,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001263,MeSH_PA,C035573,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",67013-48-3,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",,67013-48-3,exact,,,,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",C035573,67013-48-3,exact,,,,"4-(N-(Iodoacetoxy)Ethyl-N-Methyl)Amino-7-Nitrobenz-2-Oxa-1,3-Diazole",C0047956,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001264,MeSH_PA,C035573,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",67013-48-3,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",,67013-48-3,exact,,,,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",C035573,67013-48-3,exact,,,,"4-(N-(Iodoacetoxy)Ethyl-N-Methyl)Amino-7-Nitrobenz-2-Oxa-1,3-Diazole",C0047956,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001265,MeSH_PA,C035573,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",67013-48-3,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",ChemID+,exact,,,,,,,,"4-(N-(Iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",,67013-48-3,exact,,,,"4-(N-(iodoacetoxy)ethyl-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole",C035573,67013-48-3,exact,,,,"4-(N-(Iodoacetoxy)Ethyl-N-Methyl)Amino-7-Nitrobenz-2-Oxa-1,3-Diazole",C0047956,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001266,MeSH_PA,C054206,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",112076-76-3,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",ChemID+,exact,,,,,,,,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",,112076-76-3,exact,,,,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",C054206,112076-76-3,exact,,,,"4,7-Bis(Chlorosulfophenyl)-1,10-Phenanthroline-2,9-Dicarboxylic Acid",C0047876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001267,MeSH_PA,C054206,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",112076-76-3,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",ChemID+,exact,,,,,,,,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",,112076-76-3,exact,,,,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",C054206,112076-76-3,exact,,,,"4,7-Bis(Chlorosulfophenyl)-1,10-Phenanthroline-2,9-Dicarboxylic Acid",C0047876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001268,MeSH_PA,C054206,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",112076-76-3,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",ChemID+,exact,,,,,,,,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",,112076-76-3,exact,,,,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",C054206,112076-76-3,exact,,,,"4,7-Bis(Chlorosulfophenyl)-1,10-Phenanthroline-2,9-Dicarboxylic Acid",C0047876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001269,MeSH_PA,C054206,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",112076-76-3,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",ChemID+,exact,,,,,,,,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",,112076-76-3,exact,,,,"4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",C054206,112076-76-3,exact,,,,"4,7-Bis(Chlorosulfophenyl)-1,10-Phenanthroline-2,9-Dicarboxylic Acid",C0047876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001270,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001271,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001272,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001273,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001274,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001275,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001276,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001277,MeSH_PA,C052026,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",72873-74-6,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",ChemID+,exact,,,,,,,,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",,72873-74-6,exact,,,,"6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole",C052026,72873-74-6,exact,,,,"6-(4-Fluorophenyl)-2,3-Dihydro-5-(4-Pyridinyl)Imidazo(2,1-B)Thiazole",C0098942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001278,MeSH_PA,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,,,,,,,,,,,,Z-DEVD-FMK,,C110772000,<syn per source>,Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,exact,,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,C110772,,exact,,,,Benzoylcarbonyl-Aspartyl-Glutamyl-Valyl-Aspartyl-Fluoromethyl Ketone,C0671700,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001279,MeSH_PA,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,,,,,,,,,,,,Z-DEVD-FMK,,C110772000,<syn per source>,Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,exact,,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,C110772,,exact,,,,Benzoylcarbonyl-Aspartyl-Glutamyl-Valyl-Aspartyl-Fluoromethyl Ketone,C0671700,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001280,MeSH_PA,C110772,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,,,,,,,,,,,,Z-DEVD-FMK,,C110772000,<syn per source>,Benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,exact,,benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone,C110772,,exact,,,,Benzoylcarbonyl-Aspartyl-Glutamyl-Valyl-Aspartyl-Fluoromethyl Ketone,C0671700,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001281,MeSH_PA,C044961,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",69756-48-5,Desbutylhalofantrine,ChemID+,<syn per source>,,,,,,,,Desbutylhalofantrine,,69756-48-5,<syn per source>,"1,3-Dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",exact,,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",C044961,69756-48-5,exact,,,,"1,3-Dichloro-6-Trifluoromethyl-9-Phenanthryl-3-(N-Butyl)Aminopropanol",C0043922,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001282,MeSH_PA,C044961,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",69756-48-5,Desbutylhalofantrine,ChemID+,<syn per source>,,,,,,,,Desbutylhalofantrine,,69756-48-5,<syn per source>,"1,3-Dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",exact,,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",C044961,69756-48-5,exact,,,,"1,3-Dichloro-6-Trifluoromethyl-9-Phenanthryl-3-(N-Butyl)Aminopropanol",C0043922,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antimalarials,Antimalarials,Y,quasi syn therclass-to-disease,Malaria,Malaria,C0024530,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antimalarials,Antimalarials,C0003374,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001283,MeSH_PA,C044961,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",69756-48-5,Desbutylhalofantrine,ChemID+,<syn per source>,,,,,,,,Desbutylhalofantrine,,69756-48-5,<syn per source>,"1,3-Dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",exact,,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",C044961,69756-48-5,exact,,,,"1,3-Dichloro-6-Trifluoromethyl-9-Phenanthryl-3-(N-Butyl)Aminopropanol",C0043922,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiparasitic Agents,Antiparasitic Agents,Y,quasi syn therclass-to-disease,Parasitic Diseases,Parasitic Diseases,C0030499,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiparasitic Agents,Antiparasitic Agents,C0003404,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001284,MeSH_PA,C044961,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",69756-48-5,Desbutylhalofantrine,ChemID+,<syn per source>,,,,,,,,Desbutylhalofantrine,,69756-48-5,<syn per source>,"1,3-Dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",exact,,"1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol",C044961,69756-48-5,exact,,,,"1,3-Dichloro-6-Trifluoromethyl-9-Phenanthryl-3-(N-Butyl)Aminopropanol",C0043922,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiprotozoal Agents,Antiprotozoal Agents,Y,quasi syn therclass-to-disease,Protozoan Infections,Protozoan Infections,C0033740,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiprotozoal Agents,Antiprotozoal Agents,C0003416,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001285,MeSH_PA,C096011,"2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide",152721-37-4,EF5,ChemID+,<syn per source> no\W,,,,,,,,EF5,,152721-37-4,<syn per source>,"2-(2-Nitro-1H-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoro-propyl)acetamide",syn no\W,,"2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide",C096011,,exact,,,,"2-(2-Nitro-1H-Imidazol-1-Yl)-N-(2,2,3,3,3-Pentafluoropropyl)Acetamide",C0382334,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001286,MeSH_PA,C096011,"2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide",152721-37-4,EF5,ChemID+,<syn per source> no\W,,,,,,,,EF5,,152721-37-4,<syn per source>,"2-(2-Nitro-1H-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoro-propyl)acetamide",syn no\W,,"2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide",C096011,,exact,,,,"2-(2-Nitro-1H-Imidazol-1-Yl)-N-(2,2,3,3,3-Pentafluoropropyl)Acetamide",C0382334,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001287,MeSH_PA,C096011,"2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide",152721-37-4,EF5,ChemID+,<syn per source> no\W,,,,,,,,EF5,,152721-37-4,<syn per source>,"2-(2-Nitro-1H-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoro-propyl)acetamide",syn no\W,,"2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide",C096011,,exact,,,,"2-(2-Nitro-1H-Imidazol-1-Yl)-N-(2,2,3,3,3-Pentafluoropropyl)Acetamide",C0382334,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,Y,quasi syn therclass-to-function,Radiation-Sensitizing Effect,Radiation-Sensitizing Effect,C3179280,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,C0034541,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001288,MeSH_PA,C038708,N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,86125-48-6,N(alpha)-(2-Naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,ChemID+,exact,,,,,,,,N(alpha)-(2-Naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,,86125-48-6,exact,,,,N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,C038708,86125-48-6,exact,,,,N(Alpha)-(2-Naphthylsulfonylglycyl)-4-Amidinophenylalanine Piperidide,C0067241,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,anti,,#VALUE!,Anticoagulants,Anticoagulants,Y,quasi syn therclass-to-function,Blood Coagulation,Blood Coagulation,C0005778,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Anticoagulants,Anticoagulants,C0003280,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001289,MeSH_PA,C038708,N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,86125-48-6,N(alpha)-(2-Naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,ChemID+,exact,,,,,,,,N(alpha)-(2-Naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,,86125-48-6,exact,,,,N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide,C038708,86125-48-6,exact,,,,N(Alpha)-(2-Naphthylsulfonylglycyl)-4-Amidinophenylalanine Piperidide,C0067241,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001290,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antipsychotic Agents,Antipsychotic Agents,Y,quasi syn therclass-to-disease,Psychotic Disorders,Psychotic Disorders,C0033975,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Antipsychotic Agents,Antipsychotic Agents,C0040615,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001291,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001292,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001293,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001294,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001295,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001296,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001297,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001298,MeSH_PA,C099630,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,,,,,,,,,,,"3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",,C099630000,exact,,,,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine",C099630,,exact,,,,"3-((4-(4-Chlorophenyl)Piperazin-1-Yl)Methyl)-1H-Pyrrolo(2,3-B)Pyridine",C0389977,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Tranquilizing Agents,Tranquilizing Agents,Y,quasi syn therclass-to-function,Tranquilizing Effect,Tranquilizing Effect,C3179402,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Tranquilizing Agents,Tranquilizing Agents,C0040614,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001299,MeSH_PA,C055743,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,84226-06-2,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,ChemID+,exact,,,,,,,,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,,84226-06-2,exact,,,,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,C055743,84226-06-2,exact,,,,3-Iodo-2-Hydroxy-6-Methoxy-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)Benzamide,C0047499,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Contrast Media,Contrast Media,Y,exact (CUI-based),Contrast Media,Contrast Media,C0009924,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001300,MeSH_PA,C055743,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,84226-06-2,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,ChemID+,exact,,,,,,,,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,,84226-06-2,exact,,,,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,C055743,84226-06-2,exact,,,,3-Iodo-2-Hydroxy-6-Methoxy-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)Benzamide,C0047499,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001301,MeSH_PA,C055743,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,84226-06-2,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,ChemID+,exact,,,,,,,,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,,84226-06-2,exact,,,,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,C055743,84226-06-2,exact,,,,3-Iodo-2-Hydroxy-6-Methoxy-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)Benzamide,C0047499,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Dopamine Antagonists,Dopamine Antagonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Antagonists,Dopamine Antagonists,C0242702,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001302,MeSH_PA,C055743,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,84226-06-2,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,ChemID+,exact,,,,,,,,3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,,84226-06-2,exact,,,,3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide,C055743,84226-06-2,exact,,,,3-Iodo-2-Hydroxy-6-Methoxy-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)Benzamide,C0047499,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001303,MeSH_PA,C039877,"5,5'-difluoro-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",85233-21-2,"5,5'-Difluoro-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",ChemID+,exact,,,,,,,,"5,5'-Difluoro-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",,85233-21-2,exact,,,,"5,5'-difluoro-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid",C039877,85233-21-2,exact,,,,"5,5'-Difluoro-1,2-Bis(2-Aminophenoxy)Ethane-N,N,N',N'-Tetraacetic Acid",C0048878,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_001304,MeSH_PA,C050408,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,105565-56-8,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,ChemID+,exact,,,,,,,,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,,105565-56-8,exact,,,,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,C050408,105565-56-8,exact,,,,Alpha-(4-Fluorophenyl)-4-(5-Fluoro-2-Pyrimidinyl)-1-Piperazine Butanol,C0285351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Anxiety Agents,Anti-Anxiety Agents,Y,quasi syn therclass-to-disease,Anxiety,Anxiety,C0003467,P,Y,B2.2.1.1.1.1_Mental Process,,,,exact (CUI-based),Anti-Anxiety Agents,Anti-Anxiety Agents,C0040616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001305,MeSH_PA,C050408,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,105565-56-8,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,ChemID+,exact,,,,,,,,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,,105565-56-8,exact,,,,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,C050408,105565-56-8,exact,,,,Alpha-(4-Fluorophenyl)-4-(5-Fluoro-2-Pyrimidinyl)-1-Piperazine Butanol,C0285351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001306,MeSH_PA,C050408,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,105565-56-8,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,ChemID+,exact,,,,,,,,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,,105565-56-8,exact,,,,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,C050408,105565-56-8,exact,,,,Alpha-(4-Fluorophenyl)-4-(5-Fluoro-2-Pyrimidinyl)-1-Piperazine Butanol,C0285351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001307,MeSH_PA,C050408,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,105565-56-8,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,ChemID+,exact,,,,,,,,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,,105565-56-8,exact,,,,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,C050408,105565-56-8,exact,,,,Alpha-(4-Fluorophenyl)-4-(5-Fluoro-2-Pyrimidinyl)-1-Piperazine Butanol,C0285351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001308,MeSH_PA,C050408,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,105565-56-8,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,ChemID+,exact,,,,,,,,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,,105565-56-8,exact,,,,alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,C050408,105565-56-8,exact,,,,Alpha-(4-Fluorophenyl)-4-(5-Fluoro-2-Pyrimidinyl)-1-Piperazine Butanol,C0285351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Tranquilizing Agents,Tranquilizing Agents,Y,quasi syn therclass-to-function,Tranquilizing Effect,Tranquilizing Effect,C3179402,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Tranquilizing Agents,Tranquilizing Agents,C0040614,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001309,ChEBI,,"1,3,5-trihydroxy-2-(2',2'-dimethyl-4'-isopropenyl)cyclopentanylxanthone",,,,,"1,3,5-trihydroxy-2-(2',2'-dimethyl-4'-isopropenyl)cyclopentanylxanthone",66053,,exact,,,,,,,,,,,"1,3,5-trihydroxy-2-(2',2'-dimethyl-4'-isopropenyl)cyclopentanylxanthone",C487243,,exact,,,,"1,3,5-Trihydroxy-2-(2',2'-Dimethyl-4'-Isopropenyl)Cyclopentanylxanthone",C1452916,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antioxidant,antioxidant,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact 1,antioxidant,Antioxidants,C0003402,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001310,MeSH_PA,C063412,"2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",118877-07-9,"2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",ChemID+,exact,,,,,,,,"2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",,118877-07-9,exact,,,,"2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",C063412,118877-07-9,exact,,,,"2-Methyl-6-(4-Methoxyphenyl)-3,7-Dihydroimidazo(1,2-Alpha)Pyrazin-3-One",C0080809,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001311,MeSH_PA,C063412,"2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",118877-07-9,"2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",ChemID+,exact,,,,,,,,"2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",,118877-07-9,exact,,,,"2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one",C063412,118877-07-9,exact,,,,"2-Methyl-6-(4-Methoxyphenyl)-3,7-Dihydroimidazo(1,2-Alpha)Pyrazin-3-One",C0080809,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001312,MeSH_PA,C526690,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,,,,,,,,,,,,,,,,,,,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,C526690,,exact,,,,3-(5-Dimethylcarbamoylpent-1-Enyl)-N-(2-Hydroxy-1-Methylethyl)Benzamide,C2351523,exact,,,,A1.4.1.2.1_Organic Chemical,,,,agonist,agonist,22,Cannabinoid Receptor Agonists,Cannabinoid Receptor Agonists,Y,quasi syn therclass-to-function,Cannabinoid Receptor Activity,Cannabinoid Receptor Activity,C1152747,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cannabinoid Receptor Agonists,Cannabinoid Receptor Agonists,C2927148,P,B2.2.1.1.4_Molecular Function,,,
1_001313,MeSH_PA,C526690,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,,,,,,,,,,,,,,,,,,,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,C526690,,exact,,,,3-(5-Dimethylcarbamoylpent-1-Enyl)-N-(2-Hydroxy-1-Methylethyl)Benzamide,C2351523,exact,,,,A1.4.1.2.1_Organic Chemical,,,,modulator,,#VALUE!,Cannabinoid Receptor Modulators,Cannabinoid Receptor Modulators,Y,quasi syn therclass-to-function,Cannabinoid Receptor Activity,Cannabinoid Receptor Activity,C1152747,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cannabinoid Receptor Modulators,Cannabinoid Receptor Modulators,C3494475,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001314,MeSH_PA,C526690,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,,,,,,,,,,,,,,,,,,,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,C526690,,exact,,,,3-(5-Dimethylcarbamoylpent-1-Enyl)-N-(2-Hydroxy-1-Methylethyl)Benzamide,C2351523,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Hormones,Hormones,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormones,Hormones,C0019932,P,A1.4.1.1.3.2_Hormone,,,
1_001315,MeSH_PA,C526690,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,,,,,,,,,,,,,,,,,,,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,C526690,,exact,,,,3-(5-Dimethylcarbamoylpent-1-Enyl)-N-(2-Hydroxy-1-Methylethyl)Benzamide,C2351523,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001316,MeSH_PA,C526690,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,,,,,,,,,,,,,,,,,,,3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide,C526690,,exact,,,,3-(5-Dimethylcarbamoylpent-1-Enyl)-N-(2-Hydroxy-1-Methylethyl)Benzamide,C2351523,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001317,MeSH_PA,C085754,"5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",153042-42-3,BMS 182874,ChemID+,<syn per source>,,,,,,,,BMS 182874,,153042-42-3,<syn per source>,"5-(Dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",exact,,"5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",C085754,153042-42-3,exact,,,,"5-(Dimethylamino)-N-(3,4-Dimethyl-5-Isoxazolyl)-1-Naphthalenesulfonamide",C0251691,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001318,MeSH_PA,C085754,"5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",153042-42-3,BMS 182874,ChemID+,<syn per source>,,,,,,,,BMS 182874,,153042-42-3,<syn per source>,"5-(Dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",exact,,"5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",C085754,153042-42-3,exact,,,,"5-(Dimethylamino)-N-(3,4-Dimethyl-5-Isoxazolyl)-1-Naphthalenesulfonamide",C0251691,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001319,MeSH_PA,C103474,"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",163163-23-3,"6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",ChemID+,exact,,,,,,,,"6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",,163163-23-3,exact,,,,"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",C103474,163163-23-3,exact,,,,"6-Cyano-4-(N-Ethylsulfonyl-N-Methylamino)-3-Hydroxy-2,2-Dimethylchromane",C0533939,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001320,MeSH_PA,C103474,"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",163163-23-3,"6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",ChemID+,exact,,,,,,,,"6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",,163163-23-3,exact,,,,"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",C103474,163163-23-3,exact,,,,"6-Cyano-4-(N-Ethylsulfonyl-N-Methylamino)-3-Hydroxy-2,2-Dimethylchromane",C0533939,exact,,,,A1.4.1.2.1_Organic Chemical,,,,modulator,,#VALUE!,Membrane Transport Modulators,Membrane Transport Modulators,Y,quasi syn therclass-to-function,membrane transport,Transmembrane Transport,C1519624,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Membrane Transport Modulators,Membrane Transport Modulators,C1563710,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001321,MeSH_PA,C103474,"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",163163-23-3,"6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",ChemID+,exact,,,,,,,,"6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",,163163-23-3,exact,,,,"6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane",C103474,163163-23-3,exact,,,,"6-Cyano-4-(N-Ethylsulfonyl-N-Methylamino)-3-Hydroxy-2,2-Dimethylchromane",C0533939,exact,,,,A1.4.1.2.1_Organic Chemical,,,,blocker,,#VALUE!,Potassium Channel Blockers,Potassium Channel Blockers,Y,quasi syn therclass-to-function,Potassium Channel Activity,Potassium Channel Activity,C1153450,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Potassium Channel Blockers,Potassium Channel Blockers,C0872245,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001322,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001323,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001324,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001325,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001326,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,Y,quasi syn therclass-to-function,Fatty Acid Cyclooxygenase Activity,Fatty Acid Cyclooxygenase Activity,C2261439,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,C0085387,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001327,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001328,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001329,MeSH_PA,C090859,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,162054-19-5,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,ChemID+,exact,SC-58125,8983,162054-19-5,<syn per source>,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,exact,,1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,,162054-19-5,exact,,,,1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole,C090859,162054-19-5,exact,,,,1-((4-Methylsulfonyl)Phenyl)-3-Trifluoromethyl-5-(4-Fluorophenyl)Pyrazole,C0291812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001330,MeSH_PA,C058776,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",120551-15-7,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",ChemID+,exact,,,,,,,,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",,120551-15-7,exact,,,,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",C058776,120551-15-7,exact,,,,"2-(2-(5-Carboxy)Oxazole)-5-Hydroxy-6-Aminobenzofuran-N,N,O-Triacetic Acid",C0045669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001331,MeSH_PA,C058776,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",120551-15-7,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",ChemID+,exact,,,,,,,,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",,120551-15-7,exact,,,,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",C058776,120551-15-7,exact,,,,"2-(2-(5-Carboxy)Oxazole)-5-Hydroxy-6-Aminobenzofuran-N,N,O-Triacetic Acid",C0045669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001332,MeSH_PA,C058776,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",120551-15-7,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",ChemID+,exact,,,,,,,,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",,120551-15-7,exact,,,,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",C058776,120551-15-7,exact,,,,"2-(2-(5-Carboxy)Oxazole)-5-Hydroxy-6-Aminobenzofuran-N,N,O-Triacetic Acid",C0045669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001333,MeSH_PA,C058776,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",120551-15-7,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",ChemID+,exact,,,,,,,,"2-(2-(5-Carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",,120551-15-7,exact,,,,"2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-N,N,O-triacetic acid",C058776,120551-15-7,exact,,,,"2-(2-(5-Carboxy)Oxazole)-5-Hydroxy-6-Aminobenzofuran-N,N,O-Triacetic Acid",C0045669,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001334,MeSH_PA,C105319,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",,,,,,,,,,,,,,,,,,,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",C105319,,exact,,,,"3-(2-((Phenylamino)Carbonyl)Ethenyl)-4,6-Dichloroindole-2-Carboxylic Acid",C0537688,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001335,MeSH_PA,C105319,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",,,,,,,,,,,,,,,,,,,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",C105319,,exact,,,,"3-(2-((Phenylamino)Carbonyl)Ethenyl)-4,6-Dichloroindole-2-Carboxylic Acid",C0537688,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001336,MeSH_PA,C105319,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",,,,,,,,,,,,,,,,,,,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",C105319,,exact,,,,"3-(2-((Phenylamino)Carbonyl)Ethenyl)-4,6-Dichloroindole-2-Carboxylic Acid",C0537688,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Glycine Agents,Glycine Agents,Y,exact (CUI-based),Glycine Agents,Glycine Agents,C0242901,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001337,MeSH_PA,C105319,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",,,,,,,,,,,,,,,,,,,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid",C105319,,exact,,,,"3-(2-((Phenylamino)Carbonyl)Ethenyl)-4,6-Dichloroindole-2-Carboxylic Acid",C0537688,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001338,MeSH_PA,C110041,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",183721-15-5,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",ChemID+,exact,,,,,,,,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",,183721-15-5,exact,,,,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",C110041,,exact,,,,"9-Chloro-2-(2-Furyl)-5-Phenylacetylamino(1,2,4)Triazolo(1,5-C)Quinazoline",C0670049,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Adenosine A3 Receptor Antagonists,Adenosine A3 Receptor Antagonists,Y,quasi syn therclass-to-function,"A3 Adenosine Receptor Activity, G-Protein Coupled","A3 Adenosine Receptor Activity, G-Protein Coupled",C1152765,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Adenosine A3 Receptor Antagonists,Adenosine A3 Receptor Antagonists,C2936573,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001339,MeSH_PA,C110041,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",183721-15-5,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",ChemID+,exact,,,,,,,,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",,183721-15-5,exact,,,,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",C110041,,exact,,,,"9-Chloro-2-(2-Furyl)-5-Phenylacetylamino(1,2,4)Triazolo(1,5-C)Quinazoline",C0670049,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001340,MeSH_PA,C110041,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",183721-15-5,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",ChemID+,exact,,,,,,,,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",,183721-15-5,exact,,,,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",C110041,,exact,,,,"9-Chloro-2-(2-Furyl)-5-Phenylacetylamino(1,2,4)Triazolo(1,5-C)Quinazoline",C0670049,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001341,MeSH_PA,C110041,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",183721-15-5,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",ChemID+,exact,,,,,,,,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",,183721-15-5,exact,,,,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",C110041,,exact,,,,"9-Chloro-2-(2-Furyl)-5-Phenylacetylamino(1,2,4)Triazolo(1,5-C)Quinazoline",C0670049,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001342,MeSH_PA,C110041,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",183721-15-5,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",ChemID+,exact,,,,,,,,"9-Chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",,183721-15-5,exact,,,,"9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline",C110041,,exact,,,,"9-Chloro-2-(2-Furyl)-5-Phenylacetylamino(1,2,4)Triazolo(1,5-C)Quinazoline",C0670049,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001343,MeSH_PA,C054649,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",83003-12-7,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",ChemID+,exact,,,,,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",,83003-12-7,exact,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",C054649,83003-12-7,exact,,,,"3-(2-Hydroxy-4-(1,1-Dimethylheptyl)Phenyl)-4-(3-Hydroxypropyl)Cyclohexanol",C0094855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001344,MeSH_PA,C054649,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",83003-12-7,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",ChemID+,exact,,,,,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",,83003-12-7,exact,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",C054649,83003-12-7,exact,,,,"3-(2-Hydroxy-4-(1,1-Dimethylheptyl)Phenyl)-4-(3-Hydroxypropyl)Cyclohexanol",C0094855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001345,MeSH_PA,C054649,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",83003-12-7,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",ChemID+,exact,,,,,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",,83003-12-7,exact,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",C054649,83003-12-7,exact,,,,"3-(2-Hydroxy-4-(1,1-Dimethylheptyl)Phenyl)-4-(3-Hydroxypropyl)Cyclohexanol",C0094855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001346,MeSH_PA,C054649,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",83003-12-7,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",ChemID+,exact,,,,,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",,83003-12-7,exact,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",C054649,83003-12-7,exact,,,,"3-(2-Hydroxy-4-(1,1-Dimethylheptyl)Phenyl)-4-(3-Hydroxypropyl)Cyclohexanol",C0094855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001347,MeSH_PA,C054649,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",83003-12-7,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",ChemID+,exact,,,,,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",,83003-12-7,exact,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",C054649,83003-12-7,exact,,,,"3-(2-Hydroxy-4-(1,1-Dimethylheptyl)Phenyl)-4-(3-Hydroxypropyl)Cyclohexanol",C0094855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001348,MeSH_PA,C054649,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",83003-12-7,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",ChemID+,exact,,,,,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",,83003-12-7,exact,,,,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol",C054649,83003-12-7,exact,,,,"3-(2-Hydroxy-4-(1,1-Dimethylheptyl)Phenyl)-4-(3-Hydroxypropyl)Cyclohexanol",C0094855,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001349,MeSH_PA,C061523,"3-(2'-spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane",122341-56-4,"3-(2'-Spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane",ChemID+,exact,,,,,,,,"3-(2'-Spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane",,122341-56-4,exact,,,,"3-(2'-spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane",C061523,122341-56-4,exact,,,,"3-(2'-Spiroadamantane)-4-Methoxy-4-(3''-Phosphoryloxy)Phenyl-1,2-Dioxetane",C0047114,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001350,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,Antipsychotic Agents,Antipsychotic Agents,Y,quasi syn therclass-to-disease,Psychotic Disorders,Psychotic Disorders,C0033975,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Antipsychotic Agents,Antipsychotic Agents,C0040615,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001351,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001352,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001353,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001354,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,agonist,agonist,10,Dopamine Agonists,Dopamine Agonists,Y,quasi syn therclass-to-function,Dopamine Receptor Activity,Dopamine Receptor Activity,C1152730,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dopamine Agonists,Dopamine Agonists,C0178601,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001355,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001356,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001357,MeSH_PA,C062458,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",123594-64-9,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",ChemID+,exact,,,,,,,,"3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",,123594-64-9,exact,,,,"3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol",C062458,123594-64-9,exact,,,,"3,4,4A,10B-Tetrahydro-4-Propyl-2H,5H-(1)Benzopyrano(4,3-B)-1,4-Oxazin-9-Ol",C0378456,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Tranquilizing Agents,Tranquilizing Agents,Y,quasi syn therclass-to-function,Tranquilizing Effect,Tranquilizing Effect,C3179402,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Tranquilizing Agents,Tranquilizing Agents,C0040614,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001358,MeSH_PA,C106647,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",,,,,,,,,,,,,,,,,,,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",C106647,,exact,,,,"6-((2-(Dimethylamino)Ethyl)Amino)-3-Hydroxy-7H-Indeno(2,1-C)Quinolin-7-One",C0540351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001359,MeSH_PA,C106647,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",,,,,,,,,,,,,,,,,,,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",C106647,,exact,,,,"6-((2-(Dimethylamino)Ethyl)Amino)-3-Hydroxy-7H-Indeno(2,1-C)Quinolin-7-One",C0540351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001360,MeSH_PA,C106647,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",,,,,,,,,,,,,,,,,,,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",C106647,,exact,,,,"6-((2-(Dimethylamino)Ethyl)Amino)-3-Hydroxy-7H-Indeno(2,1-C)Quinolin-7-One",C0540351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Topoisomerase I Inhibitors,Topoisomerase I Inhibitors,Y,quasi syn therclass-to-function,Dna Topoisomerase I Activity,Dna Topoisomerase I Activity,C1150388,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Topoisomerase I Inhibitors,Topoisomerase I Inhibitors,C0594374,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001361,MeSH_PA,C106647,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",,,,,,,,,,,,,,,,,,,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",C106647,,exact,,,,"6-((2-(Dimethylamino)Ethyl)Amino)-3-Hydroxy-7H-Indeno(2,1-C)Quinolin-7-One",C0540351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Topoisomerase II Inhibitors,Topoisomerase II Inhibitors,Y,quasi syn therclass-to-function,Dna Topoisomerase Type Ii Activity,Dna Topoisomerase Type Ii Activity,C2257146,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Topoisomerase Ii Inhibitors,Topoisomerase Ii Inhibitors,C1519554,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001362,MeSH_PA,C106647,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",,,,,,,,,,,,,,,,,,,"6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one",C106647,,exact,,,,"6-((2-(Dimethylamino)Ethyl)Amino)-3-Hydroxy-7H-Indeno(2,1-C)Quinolin-7-One",C0540351,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Topoisomerase Inhibitors,Topoisomerase Inhibitors,Y,quasi syn therclass-to-function,Dna Topoisomerase Activity,Dna Topoisomerase Activity,C1150386,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Topoisomerase Inhibitors,Topoisomerase Inhibitors,C0598317,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001363,MeSH_PA,C055401,"decanedioic acid-4,4'-(1,3-propanediylbis(oxy))bis(benzoic acid) copolymer",90409-78-2,Polifeprosan 20,ChemID+,<syn per source>,,,,,,,,Polifeprosan 20,Polifeprosan 20 [USAN],90409-78-2,<syn per source>,"Decanedioic acid-4,4'-(1,3-propanediylbis(oxy))bis(benzoic acid) copolymer",exact,,"decanedioic acid-4,4'-(1,3-propanediylbis(oxy))bis(benzoic acid) copolymer",C055401,90409-78-2,exact,,,,"Decanedioic Acid-4,4'-(1,3-Propanediylbis(Oxy))Bis(Benzoic Acid) Copolymer",C0057238,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Biocompatible Materials,Biocompatible Materials,Y,exact (CUI-based),biocompatible materials,Biomaterials,C0005479,S,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,,,,,,,
1_001364,MeSH_PA,C096825,"ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",52824-61-0,PD 78416,ChemID+,<syn per source>,,,,,,,,PD 78416,,52824-61-0,<syn per source>,"Ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",exact,,"ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",C096825,,exact,,,,"Ethyl 2-Amino-3-Benzoyl-4,7-Dihydrothieno(2,3-C)Pyridine-6(5H)-Carboxylate",C0384016,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001365,MeSH_PA,C096825,"ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",52824-61-0,PD 78416,ChemID+,<syn per source>,,,,,,,,PD 78416,,52824-61-0,<syn per source>,"Ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",exact,,"ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",C096825,,exact,,,,"Ethyl 2-Amino-3-Benzoyl-4,7-Dihydrothieno(2,3-C)Pyridine-6(5H)-Carboxylate",C0384016,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001366,MeSH_PA,C096825,"ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",52824-61-0,PD 78416,ChemID+,<syn per source>,,,,,,,,PD 78416,,52824-61-0,<syn per source>,"Ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",exact,,"ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate",C096825,,exact,,,,"Ethyl 2-Amino-3-Benzoyl-4,7-Dihydrothieno(2,3-C)Pyridine-6(5H)-Carboxylate",C0384016,exact,,,,A1.4.1.2.1_Organic Chemical,,,,agonist,agonist,24,Purinergic P1 Receptor Agonists,Purinergic P1 Receptor Agonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Agonists,Purinergic P1 Receptor Agonists,C2917322,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001367,MeSH_PA,C065412,"2-N-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",129461-18-3,"2-N-(4-(1-Azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",ChemID+,exact,,,,,,,,"2-N-(4-(1-Azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",,129461-18-3,exact,,,,"2-N-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",C065412,129461-18-3,exact,,,,"2-N-(4-(1-Azitrifluoroethyl)Benzoyl)-1,3-Bis-(Mannos-4-Yloxy)-2-Propylamine",C0080812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001368,MeSH_PA,C065412,"2-N-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",129461-18-3,"2-N-(4-(1-Azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",ChemID+,exact,,,,,,,,"2-N-(4-(1-Azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",,129461-18-3,exact,,,,"2-N-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine",C065412,129461-18-3,exact,,,,"2-N-(4-(1-Azitrifluoroethyl)Benzoyl)-1,3-Bis-(Mannos-4-Yloxy)-2-Propylamine",C0080812,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001369,MeSH_PA,C012761,3'-O-(3-(N-(4-azido-2-nitrophenyl)amino)propionyl)adenosine-5'-triphosphate,58775-41-0,ANAPP3,ChemID+,<syn per source>,,,,,,,,ANAPP3,,58775-41-0,<syn per source>,3'-O-(3-(N-(4-azido-2-nitrophenyl)amino)propionyl)adenosine-5'-triphosphate,exact,,3'-O-(3-(N-(4-azido-2-nitrophenyl)amino)propionyl)adenosine-5'-triphosphate,C012761,,exact,,,,3'-O-(3-(N-(4-Azido-2-Nitrophenyl)Amino)Propionyl)Adenosine-5'-Triphosphate,C0046840,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001370,MeSH_PA,C012761,3'-O-(3-(N-(4-azido-2-nitrophenyl)amino)propionyl)adenosine-5'-triphosphate,58775-41-0,ANAPP3,ChemID+,<syn per source>,,,,,,,,ANAPP3,,58775-41-0,<syn per source>,3'-O-(3-(N-(4-azido-2-nitrophenyl)amino)propionyl)adenosine-5'-triphosphate,exact,,3'-O-(3-(N-(4-azido-2-nitrophenyl)amino)propionyl)adenosine-5'-triphosphate,C012761,,exact,,,,3'-O-(3-(N-(4-Azido-2-Nitrophenyl)Amino)Propionyl)Adenosine-5'-Triphosphate,C0046840,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001371,MeSH_PA,C044964,"6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",90829-56-4,"6,6'-Methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",ChemID+,exact,,,,,,,,"6,6'-Methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",,90829-56-4,exact,,,,"6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",C044964,90829-56-4,exact,,,,"6,6'-Methylenebis(2,2-Dimethyl-4-Methanesulfonic Acid-1,2-Dihydroquinoline)",C0049416,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001372,MeSH_PA,C044964,"6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",90829-56-4,"6,6'-Methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",ChemID+,exact,,,,,,,,"6,6'-Methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",,90829-56-4,exact,,,,"6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)",C044964,90829-56-4,exact,,,,"6,6'-Methylenebis(2,2-Dimethyl-4-Methanesulfonic Acid-1,2-Dihydroquinoline)",C0049416,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001373,MeSH_PA,C465664,2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide,,,,,,,,,,,,,,,,,,,2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide,C465664,,exact,,,,2-(1-(3-Dimethylaminopropyl)-5-Methoxyindol-3-Yl)-3-(1H-Indol-3-Yl)Maleimide,C1143661,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001374,MeSH_PA,C465664,2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide,,,,,,,,,,,,,,,,,,,2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide,C465664,,exact,,,,2-(1-(3-Dimethylaminopropyl)-5-Methoxyindol-3-Yl)-3-(1H-Indol-3-Yl)Maleimide,C1143661,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protein Kinase Inhibitors,Protein Kinase Inhibitors,Y,quasi syn therclass-to-function,Protein Kinase Activity,Protein Kinase Activity,C1150527,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Protein Kinase Inhibitors,Protein Kinase Inhibitors,C1449702,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,
1_001375,MeSH_PA,C097869,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",174689-39-5,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",ChemID+,exact,,,,,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",,174689-39-5,exact,,,,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",C097869,,exact,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-Tetrahydronaphth-1-Ylamino)-2-Propanol Oxalate",C0386263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Adrenergic Agents,Adrenergic Agents,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Agents,Adrenergic Agents,C0001637,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001376,MeSH_PA,C097869,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",174689-39-5,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",ChemID+,exact,,,,,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",,174689-39-5,exact,,,,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",C097869,,exact,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-Tetrahydronaphth-1-Ylamino)-2-Propanol Oxalate",C0386263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adrenergic Antagonists,Adrenergic Antagonists,Y,quasi syn therclass-to-function,Adrenergic Synaptic Transmission,Adrenergic Synaptic Transmission,C0234098,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Antagonists,Adrenergic Antagonists,C0242889,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001377,MeSH_PA,C097869,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",174689-39-5,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",ChemID+,exact,,,,,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",,174689-39-5,exact,,,,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",C097869,,exact,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-Tetrahydronaphth-1-Ylamino)-2-Propanol Oxalate",C0386263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adrenergic beta-3 Receptor Antagonists,Adrenergic beta-3 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Beta-Adrenergic Receptor Function,Beta-Adrenergic Receptor Function,C0544652,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Beta-3 Receptor Antagonists,Adrenergic Beta-3 Receptor Antagonists,C2936487,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001378,MeSH_PA,C097869,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",174689-39-5,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",ChemID+,exact,,,,,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",,174689-39-5,exact,,,,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",C097869,,exact,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-Tetrahydronaphth-1-Ylamino)-2-Propanol Oxalate",C0386263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adrenergic beta-Antagonists,Adrenergic beta-Antagonists,Y,quasi syn therclass-to-function,Beta-Adrenergic Receptor Function,Beta-Adrenergic Receptor Function,C0544652,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Adrenergic Beta-Antagonists,Adrenergic Beta-Antagonists,C0001645,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001379,MeSH_PA,C097869,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",174689-39-5,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",ChemID+,exact,,,,,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",,174689-39-5,exact,,,,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate",C097869,,exact,,,,"3-(2-Ethylphenoxy)-1-(1,2,3,4-Tetrahydronaphth-1-Ylamino)-2-Propanol Oxalate",C0386263,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001380,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001381,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001382,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001383,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001384,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,Y,quasi syn therclass-to-function,Fatty Acid Cyclooxygenase Activity,Fatty Acid Cyclooxygenase Activity,C2261439,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cyclooxygenase Inhibitors,Cyclooxygenase Inhibitors,C0085387,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001385,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001386,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001387,MeSH_PA,C119130,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,,,,,,,,,,,4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,,C119130000,exact,,,,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,C119130,,exact,,,,4-(5-(4-Chlorophenyl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Benzenesulfonamide,C0767380,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001388,MeSH_PA,C082263,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",146369-65-5,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",ChemID+,exact,,,,,,,,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",,146369-65-5,exact,,,,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",C082263,146369-65-5,exact,,,,"Tyrosyl-1,2,3,4-Tetrahydro-3-Isoquinolinecarbonyl-Phenylalanyl-Phenylalanine",C0218316,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001389,MeSH_PA,C082263,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",146369-65-5,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",ChemID+,exact,,,,,,,,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",,146369-65-5,exact,,,,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",C082263,146369-65-5,exact,,,,"Tyrosyl-1,2,3,4-Tetrahydro-3-Isoquinolinecarbonyl-Phenylalanyl-Phenylalanine",C0218316,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,"Analgesics, Opioid","Analgesics, Opioid",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Opioid","Analgesics, Opioid",C0002772,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001390,MeSH_PA,C082263,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",146369-65-5,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",ChemID+,exact,,,,,,,,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",,146369-65-5,exact,,,,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",C082263,146369-65-5,exact,,,,"Tyrosyl-1,2,3,4-Tetrahydro-3-Isoquinolinecarbonyl-Phenylalanyl-Phenylalanine",C0218316,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001391,MeSH_PA,C082263,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",146369-65-5,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",ChemID+,exact,,,,,,,,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",,146369-65-5,exact,,,,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",C082263,146369-65-5,exact,,,,"Tyrosyl-1,2,3,4-Tetrahydro-3-Isoquinolinecarbonyl-Phenylalanyl-Phenylalanine",C0218316,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001392,MeSH_PA,C082263,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",146369-65-5,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",ChemID+,exact,,,,,,,,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",,146369-65-5,exact,,,,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",C082263,146369-65-5,exact,,,,"Tyrosyl-1,2,3,4-Tetrahydro-3-Isoquinolinecarbonyl-Phenylalanyl-Phenylalanine",C0218316,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Narcotic Antagonists,Narcotic Antagonists,Y,quasi syn therclass-to-function,Narcotic Effect,Narcotic Effect,C3179198,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Narcotic Antagonists,Narcotic Antagonists,C0027410,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001393,MeSH_PA,C082263,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",146369-65-5,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",ChemID+,exact,,,,,,,,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",,146369-65-5,exact,,,,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",C082263,146369-65-5,exact,,,,"Tyrosyl-1,2,3,4-Tetrahydro-3-Isoquinolinecarbonyl-Phenylalanyl-Phenylalanine",C0218316,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001394,MeSH_PA,C082263,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",146369-65-5,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",ChemID+,exact,,,,,,,,"Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",,146369-65-5,exact,,,,"tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine",C082263,146369-65-5,exact,,,,"Tyrosyl-1,2,3,4-Tetrahydro-3-Isoquinolinecarbonyl-Phenylalanyl-Phenylalanine",C0218316,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001395,MeSH_PA,C511630,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",,,,,,,,,,,,,,,,,,,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",C511630,,exact,,,,"1-(((1-(Hydroxymethyl)Cyclopentyl)Amino)Acetyl)Pyrrolidine-2,5-Dicarbonitrile",C1723112,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001396,MeSH_PA,C511630,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",,,,,,,,,,,,,,,,,,,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",C511630,,exact,,,,"1-(((1-(Hydroxymethyl)Cyclopentyl)Amino)Acetyl)Pyrrolidine-2,5-Dicarbonitrile",C1723112,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001397,MeSH_PA,C511630,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",,,,,,,,,,,,,,,,,,,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",C511630,,exact,,,,"1-(((1-(Hydroxymethyl)Cyclopentyl)Amino)Acetyl)Pyrrolidine-2,5-Dicarbonitrile",C1723112,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001398,MeSH_PA,C511630,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",,,,,,,,,,,,,,,,,,,"1-(((1-(hydroxymethyl)cyclopentyl)amino)acetyl)pyrrolidine-2,5-dicarbonitrile",C511630,,exact,,,,"1-(((1-(Hydroxymethyl)Cyclopentyl)Amino)Acetyl)Pyrrolidine-2,5-Dicarbonitrile",C1723112,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001399,MeSH_PA,C060229,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",112648-68-7,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",ChemID+,exact,,,,,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",,112648-68-7,exact,,,,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",C060229,112648-68-7,exact,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-Trien-17-Yl)Amino)Hexyl)-1H-Pyrrole-2,5-Dione",C0165397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001400,MeSH_PA,C060229,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",112648-68-7,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",ChemID+,exact,,,,,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",,112648-68-7,exact,,,,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",C060229,112648-68-7,exact,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-Trien-17-Yl)Amino)Hexyl)-1H-Pyrrole-2,5-Dione",C0165397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001401,MeSH_PA,C060229,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",112648-68-7,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",ChemID+,exact,,,,,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",,112648-68-7,exact,,,,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",C060229,112648-68-7,exact,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-Trien-17-Yl)Amino)Hexyl)-1H-Pyrrole-2,5-Dione",C0165397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,inhibitor,inhibits,Inhibitors,Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,Y,quasi syn therclass-to-function,Phosphodiesterase Activity,Phosphodiesterase Activity,C1753334,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Phosphodiesterase Inhibitors,Phosphodiesterase Inhibitors,C0031638,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001402,MeSH_PA,C060229,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",112648-68-7,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",ChemID+,exact,,,,,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",,112648-68-7,exact,,,,"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",C060229,112648-68-7,exact,,,,"1-(6-((3-Methoxyestra-1,3,5(10)-Trien-17-Yl)Amino)Hexyl)-1H-Pyrrole-2,5-Dione",C0165397,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9.1_Steroid,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001403,MeSH_PA,C093354,4-(3-(3-(bis(4-isobutylphenyl)methylamino)benzoyl)-1H-indol-1-yl)butyric acid,,,,,,,,,,,,,,,,,,,4-(3-(3-(bis(4-isobutylphenyl)methylamino)benzoyl)-1H-indol-1-yl)butyric acid,C093354,,exact,,,,4-(3-(3-(Bis(4-Isobutylphenyl)Methylamino)Benzoyl)-1H-Indol-1-Yl)Butyric Acid,C0297074,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,5-alpha Reductase Inhibitors,5-alpha Reductase Inhibitors,Y,quasi syn therclass-to-function,Steroid 5-Alpha Reductase Activity,Steroid 5-Alpha Reductase Activity,C2254641,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),5-Alpha Reductase Inhibitors,5-Alpha Reductase Inhibitors,C2936788,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001404,MeSH_PA,C093354,4-(3-(3-(bis(4-isobutylphenyl)methylamino)benzoyl)-1H-indol-1-yl)butyric acid,,,,,,,,,,,,,,,,,,,4-(3-(3-(bis(4-isobutylphenyl)methylamino)benzoyl)-1H-indol-1-yl)butyric acid,C093354,,exact,,,,4-(3-(3-(Bis(4-Isobutylphenyl)Methylamino)Benzoyl)-1H-Indol-1-Yl)Butyric Acid,C0297074,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001405,MeSH_PA,C121834,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,,,,,,,,,,,,,,,,,,,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,C121834,,exact,,,,1-(((2-((5-Cyanopyridin-2-Yl)Amino)Ethyl)Amino)Acetyl)-2-Cyano-(S)-Pyrrolidine,C0909551,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001406,MeSH_PA,C121834,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,,,,,,,,,,,,,,,,,,,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,C121834,,exact,,,,1-(((2-((5-Cyanopyridin-2-Yl)Amino)Ethyl)Amino)Acetyl)-2-Cyano-(S)-Pyrrolidine,C0909551,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001407,MeSH_PA,C121834,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,,,,,,,,,,,,,,,,,,,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,C121834,,exact,,,,1-(((2-((5-Cyanopyridin-2-Yl)Amino)Ethyl)Amino)Acetyl)-2-Cyano-(S)-Pyrrolidine,C0909551,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001408,MeSH_PA,C121834,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,,,,,,,,,,,,,,,,,,,1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine,C121834,,exact,,,,1-(((2-((5-Cyanopyridin-2-Yl)Amino)Ethyl)Amino)Acetyl)-2-Cyano-(S)-Pyrrolidine,C0909551,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001409,MeSH_PA,C532179,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,,,,,,,,,,,,,,,,,,,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,C532179,,exact,,,,1-((6-Hydroxy-2-Azabicyclo(2.2.1)Hept-3-Yl)Carbonyl)-2-Pyrrolidinecarbonitrile,C2606689,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001410,MeSH_PA,C532179,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,,,,,,,,,,,,,,,,,,,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,C532179,,exact,,,,1-((6-Hydroxy-2-Azabicyclo(2.2.1)Hept-3-Yl)Carbonyl)-2-Pyrrolidinecarbonitrile,C2606689,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001411,MeSH_PA,C532179,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,,,,,,,,,,,,,,,,,,,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,C532179,,exact,,,,1-((6-Hydroxy-2-Azabicyclo(2.2.1)Hept-3-Yl)Carbonyl)-2-Pyrrolidinecarbonitrile,C2606689,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001412,MeSH_PA,C532179,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,,,,,,,,,,,,,,,,,,,1-((6-hydroxy-2-azabicyclo(2.2.1)hept-3-yl)carbonyl)-2-pyrrolidinecarbonitrile,C532179,,exact,,,,1-((6-Hydroxy-2-Azabicyclo(2.2.1)Hept-3-Yl)Carbonyl)-2-Pyrrolidinecarbonitrile,C2606689,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001413,MeSH_PA,C087205,4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,155204-23-2,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,ChemID+,exact,,,,,,,,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,,155204-23-2,exact,,,,4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,C087205,155204-23-2,exact,,,,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-Pyridinyl)-4-Iodobenzamido)Ethyl)Piperazine,C0254672,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001414,MeSH_PA,C087205,4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,155204-23-2,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,ChemID+,exact,,,,,,,,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,,155204-23-2,exact,,,,4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,C087205,155204-23-2,exact,,,,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-Pyridinyl)-4-Iodobenzamido)Ethyl)Piperazine,C0254672,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001415,MeSH_PA,C087205,4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,155204-23-2,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,ChemID+,exact,,,,,,,,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,,155204-23-2,exact,,,,4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine,C087205,155204-23-2,exact,,,,4-(2'-Methoxyphenyl)-1-(2'-(N-(2''-Pyridinyl)-4-Iodobenzamido)Ethyl)Piperazine,C0254672,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Serotonin Antagonists,Serotonin Antagonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Antagonists,Serotonin Antagonists,C0036753,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001416,MeSH_PA,C041398,"7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",73536-69-3,Bifendate,ChemID+,<syn per source>,,,,,,,,Bifendate,,73536-69-3,<syn per source>,"7,7'-Dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",exact,,"7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",C041398,73536-69-3,exact,,,,"7,7'-Dimethoxy-(4,4'-Bi-1,3-Benzodioxole)-5,5'-Dicarboxylic Acid Dimethyl Ester",C0049759,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,adjuvant,adju,1,"Adjuvants, Immunologic","Adjuvants, Immunologic",Y,quasi syn therclass-to-function,Active Immunity,Active Immunity,C0020965,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),"adjuvants, immunologic",Immunologic Adjuvants,C0001551,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001417,MeSH_PA,C041398,"7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",73536-69-3,Bifendate,ChemID+,<syn per source>,,,,,,,,Bifendate,,73536-69-3,<syn per source>,"7,7'-Dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",exact,,"7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",C041398,73536-69-3,exact,,,,"7,7'-Dimethoxy-(4,4'-Bi-1,3-Benzodioxole)-5,5'-Dicarboxylic Acid Dimethyl Ester",C0049759,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001418,MeSH_PA,C041398,"7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",73536-69-3,Bifendate,ChemID+,<syn per source>,,,,,,,,Bifendate,,73536-69-3,<syn per source>,"7,7'-Dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",exact,,"7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester",C041398,73536-69-3,exact,,,,"7,7'-Dimethoxy-(4,4'-Bi-1,3-Benzodioxole)-5,5'-Dicarboxylic Acid Dimethyl Ester",C0049759,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001419,MeSH_PA,D012531,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",19395-87-0,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",ChemID+,exact,,,,,,,,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",,19395-87-0,exact,,,,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",D012531,19395-87-0,exact,,,,"Dibenz(B,F)(1,4)Oxazepine-10(11H)-Carboxylic Acid, 8-Chloro-, 2-Acetylhydrazide",C1313990,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001420,MeSH_PA,D012531,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",19395-87-0,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",ChemID+,exact,,,,,,,,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",,19395-87-0,exact,,,,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",D012531,19395-87-0,exact,,,,"Dibenz(B,F)(1,4)Oxazepine-10(11H)-Carboxylic Acid, 8-Chloro-, 2-Acetylhydrazide",C1313990,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001421,MeSH_PA,D012531,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",19395-87-0,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",ChemID+,exact,,,,,,,,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",,19395-87-0,exact,,,,"Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide",D012531,19395-87-0,exact,,,,"Dibenz(B,F)(1,4)Oxazepine-10(11H)-Carboxylic Acid, 8-Chloro-, 2-Acetylhydrazide",C1313990,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Prostaglandin Antagonists,Prostaglandin Antagonists,Y,quasi syn therclass-to-function,Prostaglandin Receptor Activity,Prostaglandin Receptor Activity,C1152751,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Prostaglandin Antagonists,Prostaglandin Antagonists,C0033529,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001422,MeSH_PA,C083832,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",149409-57-4,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",ChemID+,exact,,,,,,,,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",,149409-57-4,exact,,,,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",C083832,149409-57-4,exact,,,,"N,N-Dipropyl-2-(4-Methoxy-3-(2-Phenylethoxy)Phenyl)Ethylamine Monohydrochloride",C0248068,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antipsychotic Agents,Antipsychotic Agents,Y,quasi syn therclass-to-disease,Psychotic Disorders,Psychotic Disorders,C0033975,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Antipsychotic Agents,Antipsychotic Agents,C0040615,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001423,MeSH_PA,C083832,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",149409-57-4,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",ChemID+,exact,,,,,,,,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",,149409-57-4,exact,,,,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",C083832,149409-57-4,exact,,,,"N,N-Dipropyl-2-(4-Methoxy-3-(2-Phenylethoxy)Phenyl)Ethylamine Monohydrochloride",C0248068,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001424,MeSH_PA,C083832,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",149409-57-4,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",ChemID+,exact,,,,,,,,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",,149409-57-4,exact,,,,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",C083832,149409-57-4,exact,,,,"N,N-Dipropyl-2-(4-Methoxy-3-(2-Phenylethoxy)Phenyl)Ethylamine Monohydrochloride",C0248068,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001425,MeSH_PA,C083832,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",149409-57-4,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",ChemID+,exact,,,,,,,,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",,149409-57-4,exact,,,,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",C083832,149409-57-4,exact,,,,"N,N-Dipropyl-2-(4-Methoxy-3-(2-Phenylethoxy)Phenyl)Ethylamine Monohydrochloride",C0248068,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Psychotropic Drugs,Psychotropic Drugs,Y,quasi syn therclass-to-disease,Mental Disorders,Mental Disorders,C0004936,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Psychotropic Drugs,Psychotropic Drugs,C0033978,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001426,MeSH_PA,C083832,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",149409-57-4,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",ChemID+,exact,,,,,,,,"N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",,149409-57-4,exact,,,,"N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride",C083832,149409-57-4,exact,,,,"N,N-Dipropyl-2-(4-Methoxy-3-(2-Phenylethoxy)Phenyl)Ethylamine Monohydrochloride",C0248068,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Tranquilizing Agents,Tranquilizing Agents,Y,quasi syn therclass-to-function,Tranquilizing Effect,Tranquilizing Effect,C3179402,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Tranquilizing Agents,Tranquilizing Agents,C0040614,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001427,MeSH_PA,C041057,"5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7H)-4,6-dione",89367-92-0,"5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7H)-4,6-dione",ChemID+,exact,,,,,,,,"5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7H)-4,6-dione",,89367-92-0,exact,,,,"5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7H)-4,6-dione",C041057,89367-92-0,exact,,,,"5(4'-Hydroxybenzylidenoimino)-3-Methylisothiazolo(5,4-D)Pyrimidine-(7H)-4,6-Dione",C0377673,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001428,MeSH_PA,C038864,"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid",71441-28-6,AGN 191183,ChemID+,<syn per source>,,,,,,,,AGN 191183,,71441-28-6,<syn per source>,"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid",exact,,"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid",C038864,71441-28-6,exact,,,,"4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)-1-Propenyl)Benzoic Acid",C0096439,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001429,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Adenosine A2 Receptor Antagonists,Adenosine A2 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,G-Protein Coupled Adenosine Receptor Activity,G-Protein Coupled Adenosine Receptor Activity,C1152761,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Adenosine A2 Receptor Antagonists,Adenosine A2 Receptor Antagonists,C2936570,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001430,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001431,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001432,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001433,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001434,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Purinergic Agents,Purinergic Agents,Y,quasi syn therclass-to-function,Purinergic Effect,Purinergic Effect,C3178749,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Purinergic Agents,Purinergic Agents,C2936549,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001435,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic Antagonists,Purinergic Antagonists,Y,quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic Antagonists,Purinergic Antagonists,C2936568,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001436,MeSH_PA,C098657,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",160098-96-4,Sch 58261,ChemID+,<syn per source> no\W,,,,,,,,Sch 58261,,160098-96-4,<syn per source>,"5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",syn no\W,,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine",C098657,,exact,,,,"5-Amino-7-(2-Phenylethyl)-2-(2-Furyl)Pyrazolo(4,3-E)-1,2,4-Triazolo(1,5-C)Pyrimidine",C0387955,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,Y,NT + quasi syn therclass-to-function,Purinergic Receptor Activity,Purinergic Receptor Activity,C3159308,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Purinergic P1 Receptor Antagonists,Purinergic P1 Receptor Antagonists,C2936829,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001437,MeSH_PA,C090413,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide,162760-96-5,WAY 100635,ChemID+,quasi syn same CAS# <per source>,,,,,,,,WAY 100635,,162760-96-5,quasi syn same CAS# <per source>,162760-96-5,quasi syn chem name of TN/code,CAS#,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide,C090413,162760-96-5,exact,,,,N-(2-(4-(2-Methoxyphenyl)-1-Piperazinyl)Ethyl)-N-(2-Pyridinyl)Cyclohexanecarboxamide,C0290798,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001438,MeSH_PA,C090413,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide,162760-96-5,WAY 100635,ChemID+,quasi syn same CAS# <per source>,,,,,,,,WAY 100635,,162760-96-5,quasi syn same CAS# <per source>,162760-96-5,quasi syn chem name of TN/code,CAS#,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide,C090413,162760-96-5,exact,,,,N-(2-(4-(2-Methoxyphenyl)-1-Piperazinyl)Ethyl)-N-(2-Pyridinyl)Cyclohexanecarboxamide,C0290798,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001439,MeSH_PA,C090413,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide,162760-96-5,WAY 100635,ChemID+,quasi syn same CAS# <per source>,,,,,,,,WAY 100635,,162760-96-5,quasi syn same CAS# <per source>,162760-96-5,quasi syn chem name of TN/code,CAS#,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide,C090413,162760-96-5,exact,,,,N-(2-(4-(2-Methoxyphenyl)-1-Piperazinyl)Ethyl)-N-(2-Pyridinyl)Cyclohexanecarboxamide,C0290798,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Serotonin Antagonists,Serotonin Antagonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Antagonists,Serotonin Antagonists,C0036753,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001440,MeSH_PA,C074617,"4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",139051-78-8,"4-trans-2-Carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",ChemID+,exact,,,,,,,,"4-trans-2-Carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",,139051-78-8,exact,,,,"4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",C074617,139051-78-8,exact,,,,"4-Trans-2-Carboxy-5,7-Dichloro-4-Phenylaminocarbonylamino-1,2,3,4-Tetrahydroquinoline",C0168264,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Agents,Excitatory Amino Acid Agents,C0242900,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001441,MeSH_PA,C074617,"4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",139051-78-8,"4-trans-2-Carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",ChemID+,exact,,,,,,,,"4-trans-2-Carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",,139051-78-8,exact,,,,"4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",C074617,139051-78-8,exact,,,,"4-Trans-2-Carboxy-5,7-Dichloro-4-Phenylaminocarbonylamino-1,2,3,4-Tetrahydroquinoline",C0168264,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,Y,NT + quasi syn therclass-to-function,Excitatory Synaptic Transmission,Excitatory Synaptic Transmission,C0234107,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Excitatory Amino Acid Antagonists,Excitatory Amino Acid Antagonists,C0242910,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001442,MeSH_PA,C074617,"4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",139051-78-8,"4-trans-2-Carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",ChemID+,exact,,,,,,,,"4-trans-2-Carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",,139051-78-8,exact,,,,"4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline",C074617,139051-78-8,exact,,,,"4-Trans-2-Carboxy-5,7-Dichloro-4-Phenylaminocarbonylamino-1,2,3,4-Tetrahydroquinoline",C0168264,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001443,MeSH_PA,C053651,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,99566-27-5,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,ChemID+,exact,,,,,,,,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,,99566-27-5,exact,,,,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,C053651,99566-27-5,exact,,,,Phenylalanyl-Leucyl-Phenylalanyl-Glutaminyl-Prolyl-Glutaminyl-Arginyl-Phenylalaninamide,C0070651,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001444,MeSH_PA,C053651,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,99566-27-5,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,ChemID+,exact,,,,,,,,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,,99566-27-5,exact,,,,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,C053651,99566-27-5,exact,,,,Phenylalanyl-Leucyl-Phenylalanyl-Glutaminyl-Prolyl-Glutaminyl-Arginyl-Phenylalaninamide,C0070651,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,antagonist,antagonist,#VALUE!,Narcotic Antagonists,Narcotic Antagonists,Y,quasi syn therclass-to-function,Narcotic Effect,Narcotic Effect,C3179198,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Narcotic Antagonists,Narcotic Antagonists,C0027410,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001445,MeSH_PA,C053651,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,99566-27-5,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,ChemID+,exact,,,,,,,,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,,99566-27-5,exact,,,,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,C053651,99566-27-5,exact,,,,Phenylalanyl-Leucyl-Phenylalanyl-Glutaminyl-Prolyl-Glutaminyl-Arginyl-Phenylalaninamide,C0070651,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001446,MeSH_PA,C053651,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,99566-27-5,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,ChemID+,exact,,,,,,,,Phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,,99566-27-5,exact,,,,phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,C053651,99566-27-5,exact,,,,Phenylalanyl-Leucyl-Phenylalanyl-Glutaminyl-Prolyl-Glutaminyl-Arginyl-Phenylalaninamide,C0070651,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001447,MeSH_PA,C044745,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",81005-34-7,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",ChemID+,exact,"1-hexadecanoyl-2-\{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl\}-sn-glycero-3-phosphocholine",59423,81005-34-7,<syn per source>,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",exact,,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",,81005-34-7,exact,,,,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",C044745,81005-34-7,exact,,,,"1-Palmitoyl-2-(6-(N-(7-Nitrobenz)-2-Oxa-1,3-Diazol-4-Yl)Aminocaproyl)Phosphatidylcholine",C0044571,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001448,MeSH_PA,C044745,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",81005-34-7,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",ChemID+,exact,"1-hexadecanoyl-2-\{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl\}-sn-glycero-3-phosphocholine",59423,81005-34-7,<syn per source>,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",exact,,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",,81005-34-7,exact,,,,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",C044745,81005-34-7,exact,,,,"1-Palmitoyl-2-(6-(N-(7-Nitrobenz)-2-Oxa-1,3-Diazol-4-Yl)Aminocaproyl)Phosphatidylcholine",C0044571,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001449,MeSH_PA,C044745,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",81005-34-7,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",ChemID+,exact,"1-hexadecanoyl-2-\{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl\}-sn-glycero-3-phosphocholine",59423,81005-34-7,<syn per source>,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",exact,,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",,81005-34-7,exact,,,,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",C044745,81005-34-7,exact,,,,"1-Palmitoyl-2-(6-(N-(7-Nitrobenz)-2-Oxa-1,3-Diazol-4-Yl)Aminocaproyl)Phosphatidylcholine",C0044571,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001450,MeSH_PA,C044745,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",81005-34-7,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",ChemID+,exact,"1-hexadecanoyl-2-\{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl\}-sn-glycero-3-phosphocholine",59423,81005-34-7,<syn per source>,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",exact,,"1-Palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",,81005-34-7,exact,,,,"1-palmitoyl-2-(6-(N-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine",C044745,81005-34-7,exact,,,,"1-Palmitoyl-2-(6-(N-(7-Nitrobenz)-2-Oxa-1,3-Diazol-4-Yl)Aminocaproyl)Phosphatidylcholine",C0044571,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.9_Lipid,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001451,MeSH_PA,D019900,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",67198-13-4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",ChemID+,exact,,,,,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",,67198-13-4,exact,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",D019900,67198-13-4,exact,,,,"3,4-Dichloro-N-Methyl-N-(2-(1-Pyrrolidinyl)-Cyclohexyl)-Benzeneacetamide, (Trans)-Isomer",C0936092,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001452,MeSH_PA,D019900,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",67198-13-4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",ChemID+,exact,,,,,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",,67198-13-4,exact,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",D019900,67198-13-4,exact,,,,"3,4-Dichloro-N-Methyl-N-(2-(1-Pyrrolidinyl)-Cyclohexyl)-Benzeneacetamide, (Trans)-Isomer",C0936092,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001453,MeSH_PA,D019900,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",67198-13-4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",ChemID+,exact,,,,,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",,67198-13-4,exact,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",D019900,67198-13-4,exact,,,,"3,4-Dichloro-N-Methyl-N-(2-(1-Pyrrolidinyl)-Cyclohexyl)-Benzeneacetamide, (Trans)-Isomer",C0936092,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001454,MeSH_PA,D019900,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",67198-13-4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",ChemID+,exact,,,,,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",,67198-13-4,exact,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",D019900,67198-13-4,exact,,,,"3,4-Dichloro-N-Methyl-N-(2-(1-Pyrrolidinyl)-Cyclohexyl)-Benzeneacetamide, (Trans)-Isomer",C0936092,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001455,MeSH_PA,D019900,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",67198-13-4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",ChemID+,exact,,,,,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",,67198-13-4,exact,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",D019900,67198-13-4,exact,,,,"3,4-Dichloro-N-Methyl-N-(2-(1-Pyrrolidinyl)-Cyclohexyl)-Benzeneacetamide, (Trans)-Isomer",C0936092,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001456,MeSH_PA,D019900,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",67198-13-4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",ChemID+,exact,,,,,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",,67198-13-4,exact,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",D019900,67198-13-4,exact,,,,"3,4-Dichloro-N-Methyl-N-(2-(1-Pyrrolidinyl)-Cyclohexyl)-Benzeneacetamide, (Trans)-Isomer",C0936092,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001457,MeSH_PA,D019900,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",67198-13-4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",ChemID+,exact,,,,,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",,67198-13-4,exact,,,,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer",D019900,67198-13-4,exact,,,,"3,4-Dichloro-N-Methyl-N-(2-(1-Pyrrolidinyl)-Cyclohexyl)-Benzeneacetamide, (Trans)-Isomer",C0936092,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001458,MeSH_PA,C057014,"1-(2-nitro-4,5-dimethoxyphenyl)-N,N,N',N'-tetrakis((oxycarbonyl)methyl)-1,2-ethanediamine",117367-86-9,"1-(2-Nitro-4,5-dimethoxyphenyl)-N,N,N',N'-tetrakis((oxycarbonyl)methyl)-1,2-ethanediamine",ChemID+,exact,,,,,,,,"1-(2-Nitro-4,5-dimethoxyphenyl)-N,N,N',N'-tetrakis((oxycarbonyl)methyl)-1,2-ethanediamine",,117367-86-9,exact,,,,"1-(2-nitro-4,5-dimethoxyphenyl)-N,N,N',N'-tetrakis((oxycarbonyl)methyl)-1,2-ethanediamine",C057014,117367-86-9,exact,,,,"1-(2-Nitro-4,5-Dimethoxyphenyl)-N,N,N',N'-Tetrakis((Oxycarbonyl)Methyl)-1,2-Ethanediamine",C0044151,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_001459,MeSH_PA,C518995,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",,,,,,,,,,,,,,,,,,,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",C518995,,exact,,,,"4-(3-Amino-4-(2,4,5-Trifluorophenyl)Butanoyl)-3-(2,2,2-Trifluoroethyl)-1,4-Diazepan-2-One",C1872983,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001460,MeSH_PA,C518995,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",,,,,,,,,,,,,,,,,,,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",C518995,,exact,,,,"4-(3-Amino-4-(2,4,5-Trifluorophenyl)Butanoyl)-3-(2,2,2-Trifluoroethyl)-1,4-Diazepan-2-One",C1872983,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001461,MeSH_PA,C518995,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",,,,,,,,,,,,,,,,,,,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",C518995,,exact,,,,"4-(3-Amino-4-(2,4,5-Trifluorophenyl)Butanoyl)-3-(2,2,2-Trifluoroethyl)-1,4-Diazepan-2-One",C1872983,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001462,MeSH_PA,C518995,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",,,,,,,,,,,,,,,,,,,"4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",C518995,,exact,,,,"4-(3-Amino-4-(2,4,5-Trifluorophenyl)Butanoyl)-3-(2,2,2-Trifluoroethyl)-1,4-Diazepan-2-One",C1872983,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001463,MeSH_PA,C034814,"ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid",71441-09-3,Arotinoid ethyl ester,ChemID+,<syn per source> no\W,,,,,,,,Arotinoid ethyl ester,,71441-09-3,<syn per source>,"Ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl benzoic acid",syn no\W,,"ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid",C034814,71441-09-3,exact,,,,"Ethyl-P-((E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthyl)-1-Propenyl)Benzoic Acid",C0377523,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001464,MeSH_PA,C059087,"2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide",117038-70-7,"2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide",ChemID+,exact,,,,,,,,"2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide",,117038-70-7,exact,,,,"2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide",C059087,117038-70-7,exact,,,,"2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-((Phenylamino)Carbonyl)-2H-Tetrazolium Hydroxide",C0045339,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001465,MeSH_PA,C541282,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",,,,,,,,,,,,,,,,,,,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",C541282,,exact,,,,"(3,3-Difluoropyrrolidin-1-Yl)-(4-(4-Pyrimidin-2-Yl-Piperazin-1-Yl)-Pyrrolidin-2-Yl)Methanone",C2716434,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001466,MeSH_PA,C541282,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",,,,,,,,,,,,,,,,,,,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",C541282,,exact,,,,"(3,3-Difluoropyrrolidin-1-Yl)-(4-(4-Pyrimidin-2-Yl-Piperazin-1-Yl)-Pyrrolidin-2-Yl)Methanone",C2716434,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001467,MeSH_PA,C541282,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",,,,,,,,,,,,,,,,,,,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",C541282,,exact,,,,"(3,3-Difluoropyrrolidin-1-Yl)-(4-(4-Pyrimidin-2-Yl-Piperazin-1-Yl)-Pyrrolidin-2-Yl)Methanone",C2716434,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001468,MeSH_PA,C541282,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",,,,,,,,,,,,,,,,,,,"(3,3-difluoropyrrolidin-1-yl)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl)methanone",C541282,,exact,,,,"(3,3-Difluoropyrrolidin-1-Yl)-(4-(4-Pyrimidin-2-Yl-Piperazin-1-Yl)-Pyrrolidin-2-Yl)Methanone",C2716434,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001469,MeSH_PA,C086910,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,,,,,,,,,,,,,,,,,,,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,C086910,,exact,,,,(2S)-2-(4-(((3S)-1-Acetimidoyl-3-Pyrrolidinyl)Oxy)Phenyl)-3-(7-Amidino-2-Naphtyl)Propanoic Acid,C3489494,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anticoagulants,Anticoagulants,Y,quasi syn therclass-to-function,Blood Coagulation,Blood Coagulation,C0005778,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Anticoagulants,Anticoagulants,C0003280,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001470,MeSH_PA,C086910,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,,,,,,,,,,,,,,,,,,,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,C086910,,exact,,,,(2S)-2-(4-(((3S)-1-Acetimidoyl-3-Pyrrolidinyl)Oxy)Phenyl)-3-(7-Amidino-2-Naphtyl)Propanoic Acid,C3489494,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001471,MeSH_PA,C086910,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,,,,,,,,,,,,,,,,,,,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,C086910,,exact,,,,(2S)-2-(4-(((3S)-1-Acetimidoyl-3-Pyrrolidinyl)Oxy)Phenyl)-3-(7-Amidino-2-Naphtyl)Propanoic Acid,C3489494,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001472,MeSH_PA,C086910,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,,,,,,,,,,,,,,,,,,,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,C086910,,exact,,,,(2S)-2-(4-(((3S)-1-Acetimidoyl-3-Pyrrolidinyl)Oxy)Phenyl)-3-(7-Amidino-2-Naphtyl)Propanoic Acid,C3489494,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,Y,quasi syn therclass-to-function,Platelet Aggregation,Platelet Aggregation,C0032176,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Platelet Aggregation Inhibitors,Platelet Aggregation Inhibitors,C0032177,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001473,MeSH_PA,C086910,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,,,,,,,,,,,,,,,,,,,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,C086910,,exact,,,,(2S)-2-(4-(((3S)-1-Acetimidoyl-3-Pyrrolidinyl)Oxy)Phenyl)-3-(7-Amidino-2-Naphtyl)Propanoic Acid,C3489494,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001474,MeSH_PA,C086910,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,,,,,,,,,,,,,,,,,,,(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid,C086910,,exact,,,,(2S)-2-(4-(((3S)-1-Acetimidoyl-3-Pyrrolidinyl)Oxy)Phenyl)-3-(7-Amidino-2-Naphtyl)Propanoic Acid,C3489494,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001475,MeSH_PA,C021279,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",50370-56-4,Win 35428,ChemID+,<syn per source> no\W,,,,,,,,Win 35428,,50370-56-4,<syn per source>,"(1R-(exo,exo))-3-(4-Fluorophenyl)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",syn no\W,,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",C021279,50370-56-4,exact,,,,"(1R-(Exo,Exo))-3-(4-Fluorophenyl)-8-Methyl-8- Azabicyclo(3.2.1)Octane-2-Carboxylic Acid, Methyl Ester",C1256547,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dopamine Agents,Dopamine Agents,Y,quasi syn therclass-to-function,Dopaminergic Synaptic Transmission,Dopaminergic Synaptic Transmission,C0234101,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),dopamine agents,Dopaminergic Agents,C0013036,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001476,MeSH_PA,C021279,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",50370-56-4,Win 35428,ChemID+,<syn per source> no\W,,,,,,,,Win 35428,,50370-56-4,<syn per source>,"(1R-(exo,exo))-3-(4-Fluorophenyl)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",syn no\W,,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",C021279,50370-56-4,exact,,,,"(1R-(Exo,Exo))-3-(4-Fluorophenyl)-8-Methyl-8- Azabicyclo(3.2.1)Octane-2-Carboxylic Acid, Methyl Ester",C1256547,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Dopamine Uptake Inhibitors,Dopamine Uptake Inhibitors,Y,quasi syn therclass-to-function,Dopamine Uptake,Dopamine Uptake,C1657587,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Dopamine Uptake Inhibitors,Dopamine Uptake Inhibitors,C0242980,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001477,MeSH_PA,C021279,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",50370-56-4,Win 35428,ChemID+,<syn per source> no\W,,,,,,,,Win 35428,,50370-56-4,<syn per source>,"(1R-(exo,exo))-3-(4-Fluorophenyl)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",syn no\W,,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",C021279,50370-56-4,exact,,,,"(1R-(Exo,Exo))-3-(4-Fluorophenyl)-8-Methyl-8- Azabicyclo(3.2.1)Octane-2-Carboxylic Acid, Methyl Ester",C1256547,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001478,MeSH_PA,C021279,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",50370-56-4,Win 35428,ChemID+,<syn per source> no\W,,,,,,,,Win 35428,,50370-56-4,<syn per source>,"(1R-(exo,exo))-3-(4-Fluorophenyl)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",syn no\W,,"(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester",C021279,50370-56-4,exact,,,,"(1R-(Exo,Exo))-3-(4-Fluorophenyl)-8-Methyl-8- Azabicyclo(3.2.1)Octane-2-Carboxylic Acid, Methyl Ester",C1256547,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Neurotransmitter Uptake Inhibitors,Neurotransmitter Uptake Inhibitors,Y,quasi syn therclass-to-function,Neurotransmitter Uptake,Neurotransmitter Uptake,C0598962,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Uptake Inhibitors,Neurotransmitter Uptake Inhibitors,C0040724,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001479,MeSH_PA,D001498,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",71145-03-4,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",ChemID+,exact,,,,,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",,71145-03-4,exact,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",D001498,71145-03-4,exact,,,,"3-Pyridinecarboxylic Acid, 1,4-Dihydro-2,6-Dimethyl-5-Nitro-4-(2-(Trifluoromethyl)Phenyl)-, Methyl Ester",C1455839,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,agonist,agonist,17,Calcium Channel Agonists,Calcium Channel Agonists,Y,quasi syn therclass-to-function,Calcium Channel Activity,Calcium Channel Activity,C1153433,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Calcium Channel Agonists,Calcium Channel Agonists,C0006683,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001480,MeSH_PA,D001498,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",71145-03-4,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",ChemID+,exact,,,,,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",,71145-03-4,exact,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",D001498,71145-03-4,exact,,,,"3-Pyridinecarboxylic Acid, 1,4-Dihydro-2,6-Dimethyl-5-Nitro-4-(2-(Trifluoromethyl)Phenyl)-, Methyl Ester",C1455839,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001481,MeSH_PA,D001498,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",71145-03-4,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",ChemID+,exact,,,,,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",,71145-03-4,exact,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",D001498,71145-03-4,exact,,,,"3-Pyridinecarboxylic Acid, 1,4-Dihydro-2,6-Dimethyl-5-Nitro-4-(2-(Trifluoromethyl)Phenyl)-, Methyl Ester",C1455839,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,modulator,,#VALUE!,Membrane Transport Modulators,Membrane Transport Modulators,Y,quasi syn therclass-to-function,membrane transport,Transmembrane Transport,C1519624,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Membrane Transport Modulators,Membrane Transport Modulators,C1563710,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001482,MeSH_PA,D001498,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",71145-03-4,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",ChemID+,exact,,,,,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",,71145-03-4,exact,,,,"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",D001498,71145-03-4,exact,,,,"3-Pyridinecarboxylic Acid, 1,4-Dihydro-2,6-Dimethyl-5-Nitro-4-(2-(Trifluoromethyl)Phenyl)-, Methyl Ester",C1455839,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Vasoconstrictor Agents,Vasoconstrictor Agents,Y,quasi syn therclass-to-function,vasoconstriction,Vascular Constriction (Function),C0042396,S,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Vasoconstrictor Agents,Vasoconstrictor Agents,C0042397,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001483,MeSH_PA,C540065,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",C540065,,exact,,,,"3-Amino-4-(2,4,5-Trifluorophenyl)-N-(4-(6-(2-Methoxyethoxy)Benzothiazol-2-Yl)Tetrahydropyran-4-Yl)Butanamide",C2715298,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001484,MeSH_PA,C540065,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",C540065,,exact,,,,"3-Amino-4-(2,4,5-Trifluorophenyl)-N-(4-(6-(2-Methoxyethoxy)Benzothiazol-2-Yl)Tetrahydropyran-4-Yl)Butanamide",C2715298,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001485,MeSH_PA,C540065,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",C540065,,exact,,,,"3-Amino-4-(2,4,5-Trifluorophenyl)-N-(4-(6-(2-Methoxyethoxy)Benzothiazol-2-Yl)Tetrahydropyran-4-Yl)Butanamide",C2715298,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001486,MeSH_PA,C540065,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(2,4,5-trifluorophenyl)-N-(4-(6-(2-methoxyethoxy)benzothiazol-2-yl)tetrahydropyran-4-yl)butanamide",C540065,,exact,,,,"3-Amino-4-(2,4,5-Trifluorophenyl)-N-(4-(6-(2-Methoxyethoxy)Benzothiazol-2-Yl)Tetrahydropyran-4-Yl)Butanamide",C2715298,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001487,MeSH_PA,C512076,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",C512076,,exact,,,,"3-Amino-4-(3,3-Difluoropyrrolidin-1-Yl)-N,N-Dimethyl-4-Oxo-2-(4-(1,2,4)Triazolo(1,5-A)Pyridin-6-Ylphenyl)Butanamide",C1723570,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001488,MeSH_PA,C512076,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",C512076,,exact,,,,"3-Amino-4-(3,3-Difluoropyrrolidin-1-Yl)-N,N-Dimethyl-4-Oxo-2-(4-(1,2,4)Triazolo(1,5-A)Pyridin-6-Ylphenyl)Butanamide",C1723570,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001489,MeSH_PA,C512076,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",C512076,,exact,,,,"3-Amino-4-(3,3-Difluoropyrrolidin-1-Yl)-N,N-Dimethyl-4-Oxo-2-(4-(1,2,4)Triazolo(1,5-A)Pyridin-6-Ylphenyl)Butanamide",C1723570,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001490,MeSH_PA,C512076,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",,,,,,,,,,,,,,,,,,,"3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-(1,2,4)triazolo(1,5-a)pyridin-6-ylphenyl)butanamide",C512076,,exact,,,,"3-Amino-4-(3,3-Difluoropyrrolidin-1-Yl)-N,N-Dimethyl-4-Oxo-2-(4-(1,2,4)Triazolo(1,5-A)Pyridin-6-Ylphenyl)Butanamide",C1723570,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001491,MeSH_PA,C475514,"2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate",,,,,,,,,,,,,,,,,,,"2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate",C475514,,exact,,,,"2-(4-((6-Amino-1,3-Dioxo-1H-Benzo(De)Isoquinolin-2(3H)-Yl)Methyl)Piperidin-1-Yl)Ethyl 4-Amino-5-Chloro-2-Methoxybenzoate",C1259546,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001492,MeSH_PA,C475514,"2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate",,,,,,,,,,,,,,,,,,,"2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate",C475514,,exact,,,,"2-(4-((6-Amino-1,3-Dioxo-1H-Benzo(De)Isoquinolin-2(3H)-Yl)Methyl)Piperidin-1-Yl)Ethyl 4-Amino-5-Chloro-2-Methoxybenzoate",C1259546,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Serotonin Agents,Serotonin Agents,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Agents,Serotonin Agents,C0242701,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.1_Neuroreactive Substance or Biogenic Amine,,
1_001493,MeSH_PA,C475514,"2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate",,,,,,,,,,,,,,,,,,,"2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate",C475514,,exact,,,,"2-(4-((6-Amino-1,3-Dioxo-1H-Benzo(De)Isoquinolin-2(3H)-Yl)Methyl)Piperidin-1-Yl)Ethyl 4-Amino-5-Chloro-2-Methoxybenzoate",C1259546,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,Serotonin Antagonists,Serotonin Antagonists,Y,quasi syn therclass-to-function,5-Ht Receptor Activity,5-Ht Receptor Activity,C1152740,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serotonin Antagonists,Serotonin Antagonists,C0036753,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001494,MeSH_PA,C075132,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",141781-17-1,Tsao-T,ChemID+,<syn per source>,,,,,,,,Tsao-T,,141781-17-1,<syn per source>,"(2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",exact,,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",C075132,141781-17-1,exact,,,,"(2',5'-Bis-O-(Tert-Butyldimethylsilyl)-Beta-Ribofuranosyl)-3'-Spiro-5''-(4''-Amino-1'',2''-Oxathiole-2'',2''-Dioxide)Thymine",C0169255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-HIV Agents,Anti-HIV Agents,Y,quasi syn therclass-to-disease,Hiv Infections,Hiv Infections,C0019693,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Hiv Agents,Anti-Hiv Agents,C0376565,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001495,MeSH_PA,C075132,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",141781-17-1,Tsao-T,ChemID+,<syn per source>,,,,,,,,Tsao-T,,141781-17-1,<syn per source>,"(2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",exact,,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",C075132,141781-17-1,exact,,,,"(2',5'-Bis-O-(Tert-Butyldimethylsilyl)-Beta-Ribofuranosyl)-3'-Spiro-5''-(4''-Amino-1'',2''-Oxathiole-2'',2''-Dioxide)Thymine",C0169255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001496,MeSH_PA,C075132,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",141781-17-1,Tsao-T,ChemID+,<syn per source>,,,,,,,,Tsao-T,,141781-17-1,<syn per source>,"(2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",exact,,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",C075132,141781-17-1,exact,,,,"(2',5'-Bis-O-(Tert-Butyldimethylsilyl)-Beta-Ribofuranosyl)-3'-Spiro-5''-(4''-Amino-1'',2''-Oxathiole-2'',2''-Dioxide)Thymine",C0169255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Anti-Retroviral Agents,Anti-Retroviral Agents,Y,quasi syn therclass-to-disease,retroviral infections,Retroviridae Infections,C0035369,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Retroviral Agents,Anti-Retroviral Agents,C0599685,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001497,MeSH_PA,C075132,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",141781-17-1,Tsao-T,ChemID+,<syn per source>,,,,,,,,Tsao-T,,141781-17-1,<syn per source>,"(2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",exact,,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",C075132,141781-17-1,exact,,,,"(2',5'-Bis-O-(Tert-Butyldimethylsilyl)-Beta-Ribofuranosyl)-3'-Spiro-5''-(4''-Amino-1'',2''-Oxathiole-2'',2''-Dioxide)Thymine",C0169255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antiviral Agents,Antiviral Agents,Y,quasi syn therclass-to-disease,Virus Diseases,Virus Diseases,C0042769,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antiviral Agents,Antiviral Agents,C0003451,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001498,MeSH_PA,C075132,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",141781-17-1,Tsao-T,ChemID+,<syn per source>,,,,,,,,Tsao-T,,141781-17-1,<syn per source>,"(2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",exact,,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",C075132,141781-17-1,exact,,,,"(2',5'-Bis-O-(Tert-Butyldimethylsilyl)-Beta-Ribofuranosyl)-3'-Spiro-5''-(4''-Amino-1'',2''-Oxathiole-2'',2''-Dioxide)Thymine",C0169255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001499,MeSH_PA,C075132,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",141781-17-1,Tsao-T,ChemID+,<syn per source>,,,,,,,,Tsao-T,,141781-17-1,<syn per source>,"(2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",exact,,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",C075132,141781-17-1,exact,,,,"(2',5'-Bis-O-(Tert-Butyldimethylsilyl)-Beta-Ribofuranosyl)-3'-Spiro-5''-(4''-Amino-1'',2''-Oxathiole-2'',2''-Dioxide)Thymine",C0169255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Nucleic Acid Synthesis Inhibitors,Nucleic Acid Synthesis Inhibitors,Y,quasi syn therclass-to-function,Nucleic Acid Biosynthesis,Nucleic Acid Biosynthesis,C0597095,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nucleic Acid Synthesis Inhibitors,Nucleic Acid Synthesis Inhibitors,C0376568,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001500,MeSH_PA,C075132,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",141781-17-1,Tsao-T,ChemID+,<syn per source>,,,,,,,,Tsao-T,,141781-17-1,<syn per source>,"(2',5'-Bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",exact,,"(2',5'-bis-O-(tert-butyldimethylsilyl)-beta-ribofuranosyl)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine",C075132,141781-17-1,exact,,,,"(2',5'-Bis-O-(Tert-Butyldimethylsilyl)-Beta-Ribofuranosyl)-3'-Spiro-5''-(4''-Amino-1'',2''-Oxathiole-2'',2''-Dioxide)Thymine",C0169255,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits,Inhibitors,Reverse Transcriptase Inhibitors,Reverse Transcriptase Inhibitors,Y,quasi syn therclass-to-function,Reverse Transcriptase Activity,Reverse Transcriptase Activity,C2257391,P,Y,B2.2.1.1.4.1_Genetic Function,,,,exact (CUI-based),Reverse Transcriptase Inhibitors,Reverse Transcriptase Inhibitors,C0282519,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001501,MeSH_PA,C075295,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",143413-84-7,TOTO 1,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,TOTO 1,,143413-84-7,BT of salt/deriv/analog/df + <syn per source>,"1,1'-(4,4,7,7-Tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium tetraiodide",BT of salt/deriv/analog/df,,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",C075295,143413-84-7,exact,,,,"1,1'-(4,4,7,7-Tetramethyl-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Thiazole)-2-Methylidene)Quinolinium",C0169568,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001502,MeSH_PA,C075295,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",143413-84-7,TOTO 1,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,TOTO 1,,143413-84-7,BT of salt/deriv/analog/df + <syn per source>,"1,1'-(4,4,7,7-Tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium tetraiodide",BT of salt/deriv/analog/df,,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",C075295,143413-84-7,exact,,,,"1,1'-(4,4,7,7-Tetramethyl-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Thiazole)-2-Methylidene)Quinolinium",C0169568,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001503,MeSH_PA,C075295,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",143413-84-7,TOTO 1,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,TOTO 1,,143413-84-7,BT of salt/deriv/analog/df + <syn per source>,"1,1'-(4,4,7,7-Tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium tetraiodide",BT of salt/deriv/analog/df,,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",C075295,143413-84-7,exact,,,,"1,1'-(4,4,7,7-Tetramethyl-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Thiazole)-2-Methylidene)Quinolinium",C0169568,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001504,MeSH_PA,C075295,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",143413-84-7,TOTO 1,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,TOTO 1,,143413-84-7,BT of salt/deriv/analog/df + <syn per source>,"1,1'-(4,4,7,7-Tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium tetraiodide",BT of salt/deriv/analog/df,,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",C075295,143413-84-7,exact,,,,"1,1'-(4,4,7,7-Tetramethyl-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Thiazole)-2-Methylidene)Quinolinium",C0169568,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Intercalating Agents,Intercalating Agents,Y,exact (CUI-based),Intercalating Agents,Intercalating Agents,C0021717,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001505,MeSH_PA,C075295,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",143413-84-7,TOTO 1,ChemID+,BT of salt/deriv/analog/df + <syn per source>,,,,,,,,TOTO 1,,143413-84-7,BT of salt/deriv/analog/df + <syn per source>,"1,1'-(4,4,7,7-Tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium tetraiodide",BT of salt/deriv/analog/df,,"1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium",C075295,143413-84-7,exact,,,,"1,1'-(4,4,7,7-Tetramethyl-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Thiazole)-2-Methylidene)Quinolinium",C0169568,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001506,MeSH_PA,C075296,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",143413-85-8,YOYO-1,ChemID+,<syn per source>,,,,,,,,YOYO-1,,143413-85-8,<syn per source>,"1,1'-((4,4,7,7-Tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",exact,,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",C075296,143413-85-8,exact,,,,"1,1'-((4,4,7,7-Tetramethyl)-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Oxazole)-2-Methylidene)Quinolinium",C0169570,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001507,MeSH_PA,C075296,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",143413-85-8,YOYO-1,ChemID+,<syn per source>,,,,,,,,YOYO-1,,143413-85-8,<syn per source>,"1,1'-((4,4,7,7-Tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",exact,,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",C075296,143413-85-8,exact,,,,"1,1'-((4,4,7,7-Tetramethyl)-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Oxazole)-2-Methylidene)Quinolinium",C0169570,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001508,MeSH_PA,C075296,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",143413-85-8,YOYO-1,ChemID+,<syn per source>,,,,,,,,YOYO-1,,143413-85-8,<syn per source>,"1,1'-((4,4,7,7-Tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",exact,,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",C075296,143413-85-8,exact,,,,"1,1'-((4,4,7,7-Tetramethyl)-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Oxazole)-2-Methylidene)Quinolinium",C0169570,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001509,MeSH_PA,C075296,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",143413-85-8,YOYO-1,ChemID+,<syn per source>,,,,,,,,YOYO-1,,143413-85-8,<syn per source>,"1,1'-((4,4,7,7-Tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",exact,,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",C075296,143413-85-8,exact,,,,"1,1'-((4,4,7,7-Tetramethyl)-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Oxazole)-2-Methylidene)Quinolinium",C0169570,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Intercalating Agents,Intercalating Agents,Y,exact (CUI-based),Intercalating Agents,Intercalating Agents,C0021717,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001510,MeSH_PA,C075296,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",143413-85-8,YOYO-1,ChemID+,<syn per source>,,,,,,,,YOYO-1,,143413-85-8,<syn per source>,"1,1'-((4,4,7,7-Tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",exact,,"1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium",C075296,143413-85-8,exact,,,,"1,1'-((4,4,7,7-Tetramethyl)-4,7-Diazaundecamethylene)Bis-4-(3-Methyl-2,3-Dihydro(Benzo-1,3-Oxazole)-2-Methylidene)Quinolinium",C0169570,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001511,MeSH_PA,C476600,"3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid",,,,,,,,,,,,,,,,,,,"3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid",C476600,,exact,,,,"3-(((2,2-Dimethyl-1-(((2-Methoxy-1-Phenylethyl)Amino)Carbonyl)Propyl)Amino)Carbonyl)-6-(3-Methyl-4-Phenylphenyl)Hexanoic Acid",C1311039,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001512,MeSH_PA,C476600,"3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid",,,,,,,,,,,,,,,,,,,"3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid",C476600,,exact,,,,"3-(((2,2-Dimethyl-1-(((2-Methoxy-1-Phenylethyl)Amino)Carbonyl)Propyl)Amino)Carbonyl)-6-(3-Methyl-4-Phenylphenyl)Hexanoic Acid",C1311039,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Matrix Metalloproteinase Inhibitors,Matrix Metalloproteinase Inhibitors,Y,quasi syn therclass-to-function,Matrix Metalloproteinase-1 Activity,Matrix Metalloproteinase-1 Activity,C2259385,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Matrix Metalloproteinase Inhibitors,Matrix Metalloproteinase Inhibitors,C1513016,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001513,MeSH_PA,C476600,"3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid",,,,,,,,,,,,,,,,,,,"3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid",C476600,,exact,,,,"3-(((2,2-Dimethyl-1-(((2-Methoxy-1-Phenylethyl)Amino)Carbonyl)Propyl)Amino)Carbonyl)-6-(3-Methyl-4-Phenylphenyl)Hexanoic Acid",C1311039,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001514,MeSH_PA,C528500,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528500,,exact,,,,"4-(8-Methyl-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353361,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001515,MeSH_PA,C528500,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528500,,exact,,,,"4-(8-Methyl-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353361,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001516,MeSH_PA,C528500,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528500,,exact,,,,"4-(8-Methyl-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353361,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001517,MeSH_PA,C528500,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-methyl-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528500,,exact,,,,"4-(8-Methyl-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353361,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001518,MeSH_PA,C528501,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528501,,exact,,,,"4-(8-(4-Fluorobenzyl)-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353362,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Dipeptidyl-Peptidase IV Inhibitors,Y,quasi syn therclass-to-function,Dipeptidyl-Peptidase Iv Activity,Dipeptidyl-Peptidase Iv Activity,C2258748,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Dipeptidyl-Peptidase Iv Inhibitors,Dipeptidyl-Peptidase Iv Inhibitors,C1827106,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001519,MeSH_PA,C528501,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528501,,exact,,,,"4-(8-(4-Fluorobenzyl)-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353362,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001520,MeSH_PA,C528501,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528501,,exact,,,,"4-(8-(4-Fluorobenzyl)-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353362,exact,,,,A1.4.1.2.1_Organic Chemical,,,,hypo,,#VALUE!,Hypoglycemic Agents,Hypoglycemic Agents,Y,quasi syn therclass-to-disease,Hyperglycemia,Hyperglycemia,C0020456,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hypoglycemic Agents,Hypoglycemic Agents,C0020616,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001521,MeSH_PA,C528501,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",,,,,,,,,,,,,,,,,,,"4-(8-(4-fluorobenzyl)-3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine",C528501,,exact,,,,"4-(8-(4-Fluorobenzyl)-3-(Trifluoromethyl)-5,6-Dihydro(1,2,4)Triazolo(4,3-A)Pyrazin-7(8H)-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)Butan-2-Amine",C2353362,exact,,,,A1.4.1.2.1_Organic Chemical,,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001522,MeSH_PA,C569050,caramel coloring,8028-89-5,Caramel,ChemID+,NT app,,,,,,,,Caramel,Caramel [NF],8028-89-5,NT app,Caramel color dye,syn,,caramel coloring,C569050,,exact,,,,Caramel Color,C0108509,syn lex var,caramel coloring,exact,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001523,MeSH_PA,C016310,cobra venom factor,,,,,,,,,,,,Cobra venom factor,,C016310000,exact,,,,cobra venom factor,C016310,,exact,,,,Cobra Venom Factor,C0056049,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,inactivating,,#VALUE!,Complement Inactivating Agents,Complement Inactivating Agents,Y,quasi syn therclass-to-function,Complement Activity,Complement Activity,C1149595,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Complement Inactivating Agents,Complement Inactivating Agents,C1564892,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001524,MeSH_PA,C016310,cobra venom factor,,,,,,,,,,,,Cobra venom factor,,C016310000,exact,,,,cobra venom factor,C016310,,exact,,,,Cobra Venom Factor,C0056049,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001525,MeSH_PA,C016310,cobra venom factor,,,,,,,,,,,,Cobra venom factor,,C016310000,exact,,,,cobra venom factor,C016310,,exact,,,,Cobra Venom Factor,C0056049,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001526,MeSH_PA,D015922,Complement C1q,80295-33-6,Complement C1q,ChemID+,exact,,,,,,,,Complement C1q,,80295-33-6,exact,,,,,,,,,,,Complement C1Q,C0009502,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001527,MeSH_PA,D050678,Complement C2a,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement C2A,C0056174,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001528,MeSH_PA,D050679,Complement C2b,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement C2B,C0056175,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001529,MeSH_PA,D051561,"Complement C3 Convertase, Alternative Pathway",9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,"Complement C3 Convertase, Alternative Pathway",C1564374,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001530,MeSH_PA,D051574,"Complement C3 Convertase, Classical Pathway",9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,"Complement C3 Convertase, Classical Pathway",C1564378,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001531,MeSH_PA,D003178,Complement C3 Nephritic Factor,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement C3 Nephritic Factor,C0009508,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inactivating,,#VALUE!,Complement Inactivating Agents,Complement Inactivating Agents,Y,quasi syn therclass-to-function,Complement Activity,Complement Activity,C1149595,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Complement Inactivating Agents,Complement Inactivating Agents,C1564892,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001532,MeSH_PA,D003178,Complement C3 Nephritic Factor,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement C3 Nephritic Factor,C0009508,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001533,MeSH_PA,D003178,Complement C3 Nephritic Factor,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement C3 Nephritic Factor,C0009508,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001534,MeSH_PA,D015926,Complement C3a,80295-42-7,Complement C3a,ChemID+,exact,,,,,,,,Complement C3a,,80295-42-7,exact,,,,,,,,,,,Complement C3A,C0009510,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001535,MeSH_PA,D003179,Complement C3b,80295-43-8,Complement C3b,ChemID+,exact,,,,,,,,Complement C3b,,80295-43-8,exact,,,,,,,,,,,Complement C3B,C0009511,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001536,MeSH_PA,D015932,Complement C3c,80295-44-9,Complement C3c,ChemID+,exact,,,,,,,,Complement C3c,,80295-44-9,exact,,,,,,,,,,,Complement C3C,C0009514,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001537,MeSH_PA,D015933,Complement C3d,80295-45-0,Complement C3d,ChemID+,exact,,,,,,,,Complement C3d,,80295-45-0,exact,,,,,,,,,,,Complement C3D,C0009515,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001538,MeSH_PA,D015935,Complement C4b,80295-50-7,Complement C4b,ChemID+,exact,,,,,,,,Complement C4b,,80295-50-7,exact,,,,,,,,,,,Complement C4B,C0009518,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001539,MeSH_PA,D051566,"Complement C5 Convertase, Alternative Pathway",9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,"Complement C5 Convertase, Alternative Pathway",C1564375,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001540,MeSH_PA,D051577,"Complement C5 Convertase, Classical Pathway",9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,"Complement C5 Convertase, Classical Pathway",C1564379,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001541,MeSH_PA,D015936,Complement C5a,80295-54-1,Complement C5a,ChemID+,exact,,,,,,,,Complement C5a,,80295-54-1,exact,,,,,,,,,,,Complement C5A,C0009521,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001542,MeSH_PA,D050776,Complement C5b,80295-55-2,Complement C5b,ChemID+,exact,,,,,,,,Complement C5b,,80295-55-2,exact,,,,,,,,,,,Complement C5B,C0056198,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001543,MeSH_PA,D011415,Complement Factor B,27792-36-5,Cobinamide dicyanide,ChemID+,<syn per source>,,,,,,,,Cobinamide dicyanide,,27792-36-5,<syn per source>,Complement Factor B,exact,,,,,,,,,Complement Factor B,C0033453,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001544,MeSH_PA,D011416,Complement Factor D,1690-72-8,"Nipecotic acid, 1-methyl-, methyl ester",ChemID+,<syn per source>,,,,,,,,"Nipecotic acid, 1-methyl-, methyl ester",,1690-72-8,<syn per source>,Complement Factor D,exact,,,,,,,,,Complement Factor D,C0033457,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001545,MeSH_PA,D017242,Complement Factor H,80295-65-4,Complement factor H,ChemID+,exact,,,,,,,,Complement factor H,,80295-65-4,exact,,,,,,,,,,,Complement Factor H,C0056207,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inactivating,,#VALUE!,Complement Inactivating Agents,Complement Inactivating Agents,Y,quasi syn therclass-to-function,Complement Activity,Complement Activity,C1149595,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Complement Inactivating Agents,Complement Inactivating Agents,C1564892,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001546,MeSH_PA,D017242,Complement Factor H,80295-65-4,Complement factor H,ChemID+,exact,,,,,,,,Complement factor H,,80295-65-4,exact,,,,,,,,,,,Complement Factor H,C0056207,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001547,MeSH_PA,D017242,Complement Factor H,80295-65-4,Complement factor H,ChemID+,exact,,,,,,,,Complement factor H,,80295-65-4,exact,,,,,,,,,,,Complement Factor H,C0056207,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001548,MeSH_PA,D017244,Complement Factor I,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement Factor I,C0110533,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,inactivating,,#VALUE!,Complement Inactivating Agents,Complement Inactivating Agents,Y,quasi syn therclass-to-function,Complement Activity,Complement Activity,C1149595,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Complement Inactivating Agents,Complement Inactivating Agents,C1564892,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001549,MeSH_PA,D017244,Complement Factor I,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement Factor I,C0110533,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001550,MeSH_PA,D017244,Complement Factor I,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement Factor I,C0110533,exact,,,,A1.4.1.1.3.3_Enzyme,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001551,MeSH_PA,D015938,Complement Membrane Attack Complex,9007-36-7,Complement System Proteins,ChemID+,NT subtype,,,,,,,,Complement System Proteins,,9007-36-7,NT subtype,,,,,,,,,,,Complement Membrane Attack Complex,C0009545,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001552,ChEBI,,enterobacterial common antigen,,,,,enterobacterial common antigen,73774,,exact,,,,,,,,,,,enterobacterial common antigen,C017286,,exact,,,,Enterobacterial Common Antigen,C0059381,exact,,,,A1.4.1.1.3.5_Immunologic Factor,A1.4.1.2.1.8_Carbohydrate,,,causes,,#VALUE!,antigen,antigen,Y,quasi syn therclass-to-function,Response To Antigens,Response To Antigens,C1314973,P,Y,A2.3.1_Clinical Attribute,,,,exact 1,antigen,Antigens,C0003320,S,A1.4.1.1.3.5_Immunologic Factor,,,
1_001553,MeSH_PA,D007127,Immunoglobulin Constant Regions,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Constant Regions,C0021008,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001554,MeSH_PA,D007141,Immunoglobulin Fc Fragments,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Fc Fragments,C0021032,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001555,MeSH_PA,D007143,Immunoglobulin Heavy Chains,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Heavy Chains,C0021034,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001556,MeSH_PA,D007133,Immunoglobulin Joining Region,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Joining Region,C0021018,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001557,MeSH_PA,D007131,Immunoglobulin Km Allotypes,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Km Allotypes,C0021016,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001558,MeSH_PA,D007147,Immunoglobulin Light Chains,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Light Chains,C0021038,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001559,MeSH_PA,D050440,Immunoglobulin Subunits,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Subunits,C1302674,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001560,MeSH_PA,D007135,Immunoglobulin Variable Region,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Variable Region,C0877857,exact,,,,A1.4.1.1.3.5_Immunologic Factor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001561,USAN_TC,,lanolin alcohols,8027-33-6,Lanolin alcohols,ChemID+,exact,,,,,,,,Lanolin alcohols,Lanolin alcohols [NF],8027-33-6,exact,,,,,,,,,,,Lanolin Alcohols,C0982245,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,pharmaceutic aid (emulsifying agent),emulsifying agent,,syn plural/sing,Emulsifying Agents,Emulsifying Agents,C0014018,P,,A1.4_Substance,,,,,,,,,,,,
1_001562,USAN_TC,,lanolin alcohols,8027-33-6,Lanolin alcohols,ChemID+,exact,,,,,,,,Lanolin alcohols,Lanolin alcohols [NF],8027-33-6,exact,,,,,,,,,,,Lanolin Alcohols,C0982245,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,pharmaceutic aid (emulsifying agent),pharmaceutic aid,,syn plural/sing,Pharmaceutic Aids,Pharmaceutic Aids,C0031318,P,,A1.4.1.1_Chemical Viewed Functionally,,,,,,,,,,,,
1_001566,NDFRT,C1375516,MEASLES VIRUS,,,,,,,,,,,,Measles Vaccine,,D008458000,quasi syn,,,,,,,,,,,Measles Virus Preparation,C1375516,quasi syn,measles virus,exact 2,,A1.1.4_Virus,,,,may_prevent,,#VALUE!,Measles,Measles,Y,exact (CUI-based),Measles,Measles,C0025007,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_001567,NDFRT,C0982273,MENINGOCOCCAL POLYSACCHARIDE,929686-52-2,Menomune A/C/Y/W 135,ChemID+,BT of subtype + <syn per source>,,,,,,,,Menomune A/C/Y/W 135,,929686-52-2,BT of subtype + <syn per source>,Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined,BT of subtype,,,,,,,,,Meningococcal Polysaccharide,C0982273,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,A1.4.1.2.1.8_Carbohydrate,,may_prevent,,#VALUE!,Meningococcal Infections,Meningococcal Infections,Y,exact (CUI-based),Meningococcal Infections,Meningococcal Infections,C0025303,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_001568,MeSH_PA,C031448,musk ketone,81-14-1,Musk ketone,ChemID+,exact,,,,,,,,Musk ketone,,81-14-1,exact,,,,musk ketone,C031448,81-14-1,exact,,,,Musk Ketone,C0066966,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001569,ChEBI,,raspberry ketone,5471-51-2,Raspberry ketone,ChemID+,exact,raspberry ketone,68656,5471-51-2,exact,,,,Raspberry ketone,,5471-51-2,exact,,,,raspberry ketone,C035522,5471-51-2,exact,,,,Raspberry Ketone,C0616813,exact,,,,A1.4.1.2.1_Organic Chemical,,,,antagonist,antagonist,#VALUE!,androgen antagonist,androgen antagonist,Y,quasi syn therclass-to-function,Androgen Receptor Activity,Androgen Receptor Activity,C1148774,P,Y,B2.2.1.1.4_Molecular Function,,,,syn sp,androgen antag,Androgen Antagonists,C0002842,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001570,ChEBI,,raspberry ketone,5471-51-2,Raspberry ketone,ChemID+,exact,raspberry ketone,68656,5471-51-2,exact,,,,Raspberry ketone,,5471-51-2,exact,,,,raspberry ketone,C035522,5471-51-2,exact,,,,Raspberry Ketone,C0616813,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,cosmetic,cosmetic,Y,exact 1,cosmetic,Cosmetics,C0010164,S,,A1.3_Manufactured Object,,,,,,,,,,,,
1_001571,ChEBI,,raspberry ketone,5471-51-2,Raspberry ketone,ChemID+,exact,raspberry ketone,68656,5471-51-2,exact,,,,Raspberry ketone,,5471-51-2,exact,,,,raspberry ketone,C035522,5471-51-2,exact,,,,Raspberry Ketone,C0616813,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,flavouring agent,flavouring agent,Y,quasi syn therclass-to-function,Flavor Perception,Flavor Perception,C0699771,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact 1,flavouring agent,Flavoring,C0475332,S,A1.4_Substance,,,
1_001572,ChEBI,,raspberry ketone,5471-51-2,Raspberry ketone,ChemID+,exact,raspberry ketone,68656,5471-51-2,exact,,,,Raspberry ketone,,5471-51-2,exact,,,,raspberry ketone,C035522,5471-51-2,exact,,,,Raspberry Ketone,C0616813,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,fragrance,fragrance,Y,exact 1,fragrance,Perfume,C0031000,S,,A1.3_Manufactured Object,,,,,,,,,,,,
1_001573,ChEBI,,raspberry ketone,5471-51-2,Raspberry ketone,ChemID+,exact,raspberry ketone,68656,5471-51-2,exact,,,,Raspberry ketone,,5471-51-2,exact,,,,raspberry ketone,C035522,5471-51-2,exact,,,,Raspberry Ketone,C0616813,exact,,,,A1.4.1.2.1_Organic Chemical,,,,protective,,#VALUE!,hepatoprotective agent,hepatoprotective agent,Y,quasi syn therclass-to-disease,Liver Damage,Liver Damage,C0151763,P,Y,B2.2.1.2_Pathologic Function,,,,exact 1,Hepatoprotective Agent,Hepatoprotective Agent,C1512412,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001574,USAN_TC,2008,spinosad factor D,131929-63-0,Spinosad factor D,ChemID+,exact,spinosyn D,9232,131929-63-0,<syn per source>,Spinosad factor D,exact,,Spinosad factor D,Spinosad factor D [USAN],131929-63-0,exact,,,,,,,,,,,Spinosad Factor D,C2827336,exact,,,,A1.4.1.1.1_Pharmacologic Substance,,,,cide,,#VALUE!,pediculicide,pediculicide,Y,quasi syn therclass-to-disease,pediculosis,Lice Infestations,C0030756,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,Pediculicide,Pediculicide,C0304599,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001575,MeSH_PA,C032263,streptococcal polysaccharide type III group B,,,,,,,,,,,,,,,,,,,streptococcal polysaccharide type III group B,C032263,,exact,,,,Streptococcal Polysaccharide Type Iii Group B,C0075296,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1.8_Carbohydrate,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001576,USAN_TC,2000-4,tulathromycin component A,217500-96-4,Tulathromycin A,ChemID+,syn,,,,,,,,Tulathromycin A,Tulathromycin A [USAN],217500-96-4,syn,,,,,,,,,,,Tulathromycin Component A,C2825635,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,1,veterinary antibacterial,veterinary antibacterial,Y,comp + quasi syn therclass-to-disease,Bacterial Infections,Bacterial Infections,C0004623,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,compound >1 term,antibacterial,Anti-Bacterial Agents,C0279516,S,A1.4.1.1.1.1_Antibiotic,,,
1_001577,USAN_TC,2000-4,tulathromycin component A,217500-96-4,Tulathromycin A,ChemID+,syn,,,,,,,,Tulathromycin A,Tulathromycin A [USAN],217500-96-4,syn,,,,,,,,,,,Tulathromycin Component A,C2825635,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,1,veterinary antibacterial,veterinary antibacterial,Y,comp + quasi syn therclass-to-disease,Animal Diseases,Animal Diseases,C0003047,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,compound >1 term,Veterinary Drugs,Veterinary Drugs,C0376438,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001578,USAN_TC,2000-4,tulathromycin component B,280755-12-6,Tulathromycin B,ChemID+,syn,,,,,,,,Tulathromycin B,Tulathromycin B [USAN],280755-12-6,syn,,,,,,,,,,,Tulathromycin Component B,C2825393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,1,veterinary antibacterial,veterinary antibacterial,Y,comp + quasi syn therclass-to-disease,Bacterial Infections,Bacterial Infections,C0004623,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,compound >1 term,antibacterial,Anti-Bacterial Agents,C0279516,S,A1.4.1.1.1.1_Antibiotic,,,
1_001579,USAN_TC,2000-4,tulathromycin component B,280755-12-6,Tulathromycin B,ChemID+,syn,,,,,,,,Tulathromycin B,Tulathromycin B [USAN],280755-12-6,syn,,,,,,,,,,,Tulathromycin Component B,C2825393,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,1,veterinary antibacterial,veterinary antibacterial,Y,comp + quasi syn therclass-to-disease,Animal Diseases,Animal Diseases,C0003047,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,compound >1 term,Veterinary Drugs,Veterinary Drugs,C0376438,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001580,MeSH_PA,C029849,Clearfil Bonding Agent,,,,,,,,,,,,,,,,,,,,,,,,,,Clearfil Bonding Agent,C0055868,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.2_Biomedical or Dental Material,,,,,#VALUE!,Dental Materials,Dental Materials,Y,quasi syn therclass-to-disease,Tooth Diseases,Tooth Diseases,C0040435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dental Materials,Dental Materials,C0011379,P,A1.4.1.1.2_Biomedical or Dental Material,,,
1_001581,MeSH_PA,C112274,Clearfil Liner Bond 2,,,,,,,,,,,,,,,,,,,Clearfil Liner Bond 2,C112274,,exact,,,,Clearfil Liner Bond 2,C0674946,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dental Materials,Dental Materials,Y,quasi syn therclass-to-disease,Tooth Diseases,Tooth Diseases,C0040435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dental Materials,Dental Materials,C0011379,P,A1.4.1.1.2_Biomedical or Dental Material,,,
1_001582,MeSH_PA,C084544,Clearfil Linerbond System,,,,,,,,,,,,,,,,,,,Clearfil Linerbond System,C084544,,exact,,,,Clearfil Linerbond System,C0249436,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Dental Materials,Dental Materials,Y,quasi syn therclass-to-disease,Tooth Diseases,Tooth Diseases,C0040435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dental Materials,Dental Materials,C0011379,P,A1.4.1.1.2_Biomedical or Dental Material,,,
1_001583,MeSH_PA,C074669,Clearfil Photo Bond,121761-81-7,Clearfil photo bond,ChemID+,exact,,,,,,,,Clearfil photo bond,,121761-81-7,exact,,,,,,,,,,,Clearfil Photo Bond,C0168373,exact,,,,A1.4.1.1.2_Biomedical or Dental Material,,,,,,#VALUE!,Dental Materials,Dental Materials,Y,quasi syn therclass-to-disease,Tooth Diseases,Tooth Diseases,C0040435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Dental Materials,Dental Materials,C0011379,P,A1.4.1.1.2_Biomedical or Dental Material,,,
1_001584,MeSH_PA,C119969,BACH 250-rGel,,,,,,,,,,,,,,,,,,,,,,,,,,Bach 250-Rgel,C0769203,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,toxin,,#VALUE!,Immunotoxins,Immunotoxins,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunotoxins,Immunotoxins,C0021084,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001585,MeSH_PA,C119969,BACH 250-rGel,,,,,,,,,,,,,,,,,,,,,,,,,,Bach 250-Rgel,C0769203,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001586,NDFRT,C0724560,"OATMEAL,COLLOIDAL",134134-86-4,"Oat, flour",ChemID+,NT salt/deriv/analog/df + <syn per source>,,,,,,,,"Oat, flour",,134134-86-4,NT salt/deriv/analog/df + <syn per source>,Oatmeal,NT salt/deriv/analog/df,,,,,,,,,Colloidal Oatmeal,C0724560,syn word order,"oatmeal,colloidal",exact,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,may_prevent&treat,,#VALUE!,Dermatitis,Dermatitis,Y,exact (CUI-based),Dermatitis,Dermatitis,C0011603,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_001587,NDFRT,C0724560,"OATMEAL,COLLOIDAL",134134-86-4,"Oat, flour",ChemID+,NT salt/deriv/analog/df + <syn per source>,,,,,,,,"Oat, flour",,134134-86-4,NT salt/deriv/analog/df + <syn per source>,Oatmeal,NT salt/deriv/analog/df,,,,,,,,,Colloidal Oatmeal,C0724560,syn word order,"oatmeal,colloidal",exact,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,may_treat,,#VALUE!,Pruritus,Pruritus,Y,exact (CUI-based),Pruritus,Pruritus,C0033774,P,Y,A2.2.2_Sign or Symptom,,,,,,,,,,,,
1_001588,MeSH_PA,D001399,Azure Stains,,,,,,,,,,,,,,,,,,,Azure Stains,D001399,,exact,,,,Azure Stains,C0004524,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001589,MeSH_PA,C017768,trichrome stain,,,,,,,,,,,,,,,,,,,trichrome stain,C017768,,exact,,,,Trichrome Stain,C0077066,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001590,MeSH_PA,C028911,cresyl violet,18472-89-4,Cresyl violet,ChemID+,exact,cresyl violet,52815,,exact,,,,Cresyl violet,,18472-89-4,exact,,,,cresyl violet,C028911,18472-89-4,exact,,,,Cresyl Violet,C0056484,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001591,MeSH_PA,C062525,atrial natriuretic factor prohormone (103-126),97793-28-7,Atrial natriuretic factor prohormone (103-126),ChemID+,exact,,,,,,,,Atrial natriuretic factor prohormone (103-126),,97793-28-7,exact,,,,atrial natriuretic factor prohormone (103-126),C062525,97793-28-7,exact,,,,Atrial Natriuretic Factor Prohormone (103-126),C0081675,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001592,MeSH_PA,C062525,atrial natriuretic factor prohormone (103-126),97793-28-7,Atrial natriuretic factor prohormone (103-126),ChemID+,exact,,,,,,,,Atrial natriuretic factor prohormone (103-126),,97793-28-7,exact,,,,atrial natriuretic factor prohormone (103-126),C062525,97793-28-7,exact,,,,Atrial Natriuretic Factor Prohormone (103-126),C0081675,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001593,MeSH_PA,C062525,atrial natriuretic factor prohormone (103-126),97793-28-7,Atrial natriuretic factor prohormone (103-126),ChemID+,exact,,,,,,,,Atrial natriuretic factor prohormone (103-126),,97793-28-7,exact,,,,atrial natriuretic factor prohormone (103-126),C062525,97793-28-7,exact,,,,Atrial Natriuretic Factor Prohormone (103-126),C0081675,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Diuretics,Diuretics,Y,quasi syn therclass-to-function,Diuresis,Diuresis,C0012797,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Diuretics,Diuretics,C0012798,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001594,MeSH_PA,C062525,atrial natriuretic factor prohormone (103-126),97793-28-7,Atrial natriuretic factor prohormone (103-126),ChemID+,exact,,,,,,,,Atrial natriuretic factor prohormone (103-126),,97793-28-7,exact,,,,atrial natriuretic factor prohormone (103-126),C062525,97793-28-7,exact,,,,Atrial Natriuretic Factor Prohormone (103-126),C0081675,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Natriuretic Agents,Natriuretic Agents,Y,quasi syn therclass-to-function,Natriuresis,Natriuresis,C0027477,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Natriuretic Agents,Natriuretic Agents,C1258001,P,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,
1_001595,MeSH_PA,C055659,atrial natriuretic factor prohormone (1-98),114101-49-4,Atrial natriuretic factor prohormone (1-98),ChemID+,exact,,,,,,,,Atrial natriuretic factor prohormone (1-98),,114101-49-4,exact,,,,atrial natriuretic factor prohormone (1-98),C055659,114101-49-4,exact,,,,Atrial Natriuretic Factor Prohormone (1-98),C0052623,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Diuretics,Diuretics,Y,quasi syn therclass-to-function,Diuresis,Diuresis,C0012797,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Diuretics,Diuretics,C0012798,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001596,MeSH_PA,C055659,atrial natriuretic factor prohormone (1-98),114101-49-4,Atrial natriuretic factor prohormone (1-98),ChemID+,exact,,,,,,,,Atrial natriuretic factor prohormone (1-98),,114101-49-4,exact,,,,atrial natriuretic factor prohormone (1-98),C055659,114101-49-4,exact,,,,Atrial Natriuretic Factor Prohormone (1-98),C0052623,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Natriuretic Agents,Natriuretic Agents,Y,quasi syn therclass-to-function,Natriuresis,Natriuresis,C0027477,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Natriuretic Agents,Natriuretic Agents,C1258001,P,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,
1_001597,MeSH_PA,C071363,"bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",138147-78-1,"Bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",ChemID+,exact,,,,,,,,"Bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",,138147-78-1,exact,,,,"bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",C071363,138147-78-1,exact,,,,"Bombesin (6-14), Tpi(6)-Leu(13)-Psi(Ch2Nh)-Leu(14)-",C0106859,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anticarcinogenic Agents,Anticarcinogenic Agents,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Anticarcinogenic Agents,Anticarcinogenic Agents,C0085169,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001598,MeSH_PA,C071363,"bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",138147-78-1,"Bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",ChemID+,exact,,,,,,,,"Bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",,138147-78-1,exact,,,,"bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",C071363,138147-78-1,exact,,,,"Bombesin (6-14), Tpi(6)-Leu(13)-Psi(Ch2Nh)-Leu(14)-",C0106859,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001599,MeSH_PA,C071363,"bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",138147-78-1,"Bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",ChemID+,exact,,,,,,,,"Bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",,138147-78-1,exact,,,,"bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-",C071363,138147-78-1,exact,,,,"Bombesin (6-14), Tpi(6)-Leu(13)-Psi(Ch2Nh)-Leu(14)-",C0106859,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001600,MeSH_PA,C058636,calcitonin gene-related peptide (8-37),119911-68-1,Calcitonin gene-related peptide (8-37),ChemID+,exact,,,,,,,,Calcitonin gene-related peptide (8-37),,119911-68-1,exact,,,,calcitonin gene-related peptide (8-37),C058636,119911-68-1,exact,,,,Calcitonin Gene-Related Peptide (8-37),C0054454,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001601,MeSH_PA,C058636,calcitonin gene-related peptide (8-37),119911-68-1,Calcitonin gene-related peptide (8-37),ChemID+,exact,,,,,,,,Calcitonin gene-related peptide (8-37),,119911-68-1,exact,,,,calcitonin gene-related peptide (8-37),C058636,119911-68-1,exact,,,,Calcitonin Gene-Related Peptide (8-37),C0054454,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Miotics,Miotics,Y,quasi syn therclass-to-function,Miotic Effect,Miotic Effect,C3179192,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Miotics,Miotics,C0026207,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001602,MeSH_PA,C058636,calcitonin gene-related peptide (8-37),119911-68-1,Calcitonin gene-related peptide (8-37),ChemID+,exact,,,,,,,,Calcitonin gene-related peptide (8-37),,119911-68-1,exact,,,,calcitonin gene-related peptide (8-37),C058636,119911-68-1,exact,,,,Calcitonin Gene-Related Peptide (8-37),C0054454,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001603,MeSH_PA,C090019,8-sulfocholecystokinin octapeptide,9011-97-6,Cecekin vitrum,ChemID+,NT salt/deriv/analog/df + <syn per source>,,,,,,,,Cecekin vitrum,,9011-97-6,NT salt/deriv/analog/df + <syn per source>,Cholecystokinin,NT salt/deriv/analog/df,,8-sulfocholecystokinin octapeptide,C090019,,exact,,,,8-Sulfocholecystokinin Octapeptide,C0289932,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001604,MeSH_PA,C090019,8-sulfocholecystokinin octapeptide,9011-97-6,Cecekin vitrum,ChemID+,NT salt/deriv/analog/df + <syn per source>,,,,,,,,Cecekin vitrum,,9011-97-6,NT salt/deriv/analog/df + <syn per source>,Cholecystokinin,NT salt/deriv/analog/df,,8-sulfocholecystokinin octapeptide,C090019,,exact,,,,8-Sulfocholecystokinin Octapeptide,C0289932,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Nootropic Agents,Nootropic Agents,Y,quasi syn therclass-to-disease,Cognitive Deficits,Cognitive Deficits,C0679466,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Nootropic Agents,Nootropic Agents,C0242913,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001605,MeSH_PA,C044758,Bolton Hunter-cholecystokinin octapeptide,117829-67-1,Bolton hunter-cholecystokinin nonapeptide,ChemID+,NT salt/deriv/analog/df,,,,,,,,Bolton hunter-cholecystokinin nonapeptide,,117829-67-1,NT salt/deriv/analog/df,,,,Bolton Hunter-cholecystokinin octapeptide,C044758,,exact,,,,Bolton Hunter-Cholecystokinin Octapeptide,C0053913,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid","A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001606,MeSH_PA,C011394,ACTH (4-10),4037-01-8,Acth (4-10),ChemID+,exact,,,,,,,,Acth (4-10),,4037-01-8,exact,,,,ACTH (4-10),C011394,4037-01-8,exact,,,,Acth (4-10),C0050611,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001607,MeSH_PA,C011394,ACTH (4-10),4037-01-8,Acth (4-10),ChemID+,exact,,,,,,,,Acth (4-10),,4037-01-8,exact,,,,ACTH (4-10),C011394,4037-01-8,exact,,,,Acth (4-10),C0050611,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,Nootropic Agents,Nootropic Agents,Y,quasi syn therclass-to-disease,Cognitive Deficits,Cognitive Deficits,C0679466,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Nootropic Agents,Nootropic Agents,C0242913,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001608,MeSH_PA,C048487,"ACTH (4-7), Pro-Gly-Pro-",80714-61-0,"ACTH (4-7), pro-gly-pro-",ChemID+,exact,,,,,,,,"ACTH (4-7), pro-gly-pro-",,80714-61-0,exact,,,,"ACTH (4-7), Pro-Gly-Pro-",C048487,80714-61-0,exact,,,,"Acth (4-7), Pro-Gly-Pro-",C0050614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001609,MeSH_PA,C048487,"ACTH (4-7), Pro-Gly-Pro-",80714-61-0,"ACTH (4-7), pro-gly-pro-",ChemID+,exact,,,,,,,,"ACTH (4-7), pro-gly-pro-",,80714-61-0,exact,,,,"ACTH (4-7), Pro-Gly-Pro-",C048487,80714-61-0,exact,,,,"Acth (4-7), Pro-Gly-Pro-",C0050614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001610,MeSH_PA,C048487,"ACTH (4-7), Pro-Gly-Pro-",80714-61-0,"ACTH (4-7), pro-gly-pro-",ChemID+,exact,,,,,,,,"ACTH (4-7), pro-gly-pro-",,80714-61-0,exact,,,,"ACTH (4-7), Pro-Gly-Pro-",C048487,80714-61-0,exact,,,,"Acth (4-7), Pro-Gly-Pro-",C0050614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Neuroprotective Agents,Neuroprotective Agents,Y,quasi syn therclass-to-function,Neuroprotective Effect,Neuroprotective Effect,C0598958,P,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neuroprotective Agents,Neuroprotective Agents,C0242912,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001611,MeSH_PA,C048487,"ACTH (4-7), Pro-Gly-Pro-",80714-61-0,"ACTH (4-7), pro-gly-pro-",ChemID+,exact,,,,,,,,"ACTH (4-7), pro-gly-pro-",,80714-61-0,exact,,,,"ACTH (4-7), Pro-Gly-Pro-",C048487,80714-61-0,exact,,,,"Acth (4-7), Pro-Gly-Pro-",C0050614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Nootropic Agents,Nootropic Agents,Y,quasi syn therclass-to-disease,Cognitive Deficits,Cognitive Deficits,C0679466,P,Y,B2.2.1.2.1.1_Mental or Behavioral Dysfunction,,,,exact (CUI-based),Nootropic Agents,Nootropic Agents,C0242913,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001612,MeSH_PA,C048487,"ACTH (4-7), Pro-Gly-Pro-",80714-61-0,"ACTH (4-7), pro-gly-pro-",ChemID+,exact,,,,,,,,"ACTH (4-7), pro-gly-pro-",,80714-61-0,exact,,,,"ACTH (4-7), Pro-Gly-Pro-",C048487,80714-61-0,exact,,,,"Acth (4-7), Pro-Gly-Pro-",C0050614,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001613,MeSH_PA,C026034,ACTH (7-38),68563-24-6,Acth (7-38),ChemID+,exact,,,,,,,,Acth (7-38),,68563-24-6,exact,,,,ACTH (7-38),C026034,68563-24-6,exact,,,,Acth (7-38),C0050621,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001614,MeSH_PA,C026034,ACTH (7-38),68563-24-6,Acth (7-38),ChemID+,exact,,,,,,,,Acth (7-38),,68563-24-6,exact,,,,ACTH (7-38),C026034,68563-24-6,exact,,,,Acth (7-38),C0050621,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001615,MeSH_PA,C045089,corticotropin releasing hormone (9-41),96118-75-1,Corticotropin releasing hormone (9-41),ChemID+,exact,,,,,,,,Corticotropin releasing hormone (9-41),,96118-75-1,exact,,,,corticotropin releasing hormone (9-41),C045089,96118-75-1,exact,,,,Corticotropin Releasing Hormone (9-41),C0056372,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001616,MeSH_PA,C045089,corticotropin releasing hormone (9-41),96118-75-1,Corticotropin releasing hormone (9-41),ChemID+,exact,,,,,,,,Corticotropin releasing hormone (9-41),,96118-75-1,exact,,,,corticotropin releasing hormone (9-41),C045089,96118-75-1,exact,,,,Corticotropin Releasing Hormone (9-41),C0056372,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001617,MeSH_PA,C026843,dynorphin (1-13),72957-38-1,Dynorphin (1-13),ChemID+,exact,,,,,,,,Dynorphin (1-13),,72957-38-1,exact,,,,dynorphin (1-13),C026843,72957-38-1,exact,,,,Dynorphin (1-13),C0058841,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001618,MeSH_PA,C026843,dynorphin (1-13),72957-38-1,Dynorphin (1-13),ChemID+,exact,,,,,,,,Dynorphin (1-13),,72957-38-1,exact,,,,dynorphin (1-13),C026843,72957-38-1,exact,,,,Dynorphin (1-13),C0058841,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,"Analgesics, Opioid","Analgesics, Opioid",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Opioid","Analgesics, Opioid",C0002772,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001619,MeSH_PA,C026843,dynorphin (1-13),72957-38-1,Dynorphin (1-13),ChemID+,exact,,,,,,,,Dynorphin (1-13),,72957-38-1,exact,,,,dynorphin (1-13),C026843,72957-38-1,exact,,,,Dynorphin (1-13),C0058841,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001620,MeSH_PA,C026843,dynorphin (1-13),72957-38-1,Dynorphin (1-13),ChemID+,exact,,,,,,,,Dynorphin (1-13),,72957-38-1,exact,,,,dynorphin (1-13),C026843,72957-38-1,exact,,,,Dynorphin (1-13),C0058841,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001621,MeSH_PA,C026843,dynorphin (1-13),72957-38-1,Dynorphin (1-13),ChemID+,exact,,,,,,,,Dynorphin (1-13),,72957-38-1,exact,,,,dynorphin (1-13),C026843,72957-38-1,exact,,,,Dynorphin (1-13),C0058841,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Narcotics,Narcotics,Y,quasi syn therclass-to-function,Narcotic Effect,Narcotic Effect,C3179198,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Narcotics,Narcotics,C0027415,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_001622,MeSH_PA,C026843,dynorphin (1-13),72957-38-1,Dynorphin (1-13),ChemID+,exact,,,,,,,,Dynorphin (1-13),,72957-38-1,exact,,,,dynorphin (1-13),C026843,72957-38-1,exact,,,,Dynorphin (1-13),C0058841,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001623,MeSH_PA,C026843,dynorphin (1-13),72957-38-1,Dynorphin (1-13),ChemID+,exact,,,,,,,,Dynorphin (1-13),,72957-38-1,exact,,,,dynorphin (1-13),C026843,72957-38-1,exact,,,,Dynorphin (1-13),C0058841,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001624,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001625,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,"Analgesics, Opioid","Analgesics, Opioid",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Opioid","Analgesics, Opioid",C0002772,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001626,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,Y,quasi syn therclass-to-disease,Cardiac Arrhythmia,Cardiac Arrhythmia,C0003811,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,C0003195,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001627,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001628,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001629,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001630,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001631,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001632,MeSH_PA,D020875,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",100929-53-1,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",ChemID+,exact,,,,,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",,100929-53-1,exact,,,,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-",D020875,100929-53-1,exact,,,,"Enkephalin, Ala(2)-Mephe(4)-Gly(5)-",C0525773,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001633,MeSH_PA,D020881,"Enkephalin, D-Penicillamine (2,5)-",88373-73-3,"Enkephalin, D-penicillamine (2,5)-",ChemID+,exact,,,,,,,,"Enkephalin, D-penicillamine (2,5)-",,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",D020881,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",C0525856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001634,MeSH_PA,D020881,"Enkephalin, D-Penicillamine (2,5)-",88373-73-3,"Enkephalin, D-penicillamine (2,5)-",ChemID+,exact,,,,,,,,"Enkephalin, D-penicillamine (2,5)-",,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",D020881,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",C0525856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,"Analgesics, Opioid","Analgesics, Opioid",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Opioid","Analgesics, Opioid",C0002772,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001635,MeSH_PA,D020881,"Enkephalin, D-Penicillamine (2,5)-",88373-73-3,"Enkephalin, D-penicillamine (2,5)-",ChemID+,exact,,,,,,,,"Enkephalin, D-penicillamine (2,5)-",,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",D020881,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",C0525856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001636,MeSH_PA,D020881,"Enkephalin, D-Penicillamine (2,5)-",88373-73-3,"Enkephalin, D-penicillamine (2,5)-",ChemID+,exact,,,,,,,,"Enkephalin, D-penicillamine (2,5)-",,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",D020881,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",C0525856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001637,MeSH_PA,D020881,"Enkephalin, D-Penicillamine (2,5)-",88373-73-3,"Enkephalin, D-penicillamine (2,5)-",ChemID+,exact,,,,,,,,"Enkephalin, D-penicillamine (2,5)-",,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",D020881,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",C0525856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001638,MeSH_PA,D020881,"Enkephalin, D-Penicillamine (2,5)-",88373-73-3,"Enkephalin, D-penicillamine (2,5)-",ChemID+,exact,,,,,,,,"Enkephalin, D-penicillamine (2,5)-",,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",D020881,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",C0525856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001639,MeSH_PA,D020881,"Enkephalin, D-Penicillamine (2,5)-",88373-73-3,"Enkephalin, D-penicillamine (2,5)-",ChemID+,exact,,,,,,,,"Enkephalin, D-penicillamine (2,5)-",,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",D020881,88373-73-3,exact,,,,"Enkephalin, D-Penicillamine (2,5)-",C0525856,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001640,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,adjuvant,adju,1,"Adjuvants, Immunologic","Adjuvants, Immunologic",Y,quasi syn therclass-to-function,Active Immunity,Active Immunity,C0020965,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),"adjuvants, immunologic",Immunologic Adjuvants,C0001551,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001641,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001642,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Non-Narcotic","Analgesics, Non-Narcotic",C0242937,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001643,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,Y,quasi syn therclass-to-disease,Cardiac Arrhythmia,Cardiac Arrhythmia,C0003811,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Arrhythmia Agents,Anti-Arrhythmia Agents,C0003195,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001644,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Inflammatory Agents,Anti-Inflammatory Agents,Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Anti-Inflammatory Agents,Anti-Inflammatory Agents,C0003209,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001645,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",Y,quasi syn therclass-to-disease,Inflammation,Inflammation,C0021368,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),"Anti-Inflammatory Agents, Non-Steroidal","Anti-Inflammatory Agents, Non-Steroidal",C0003211,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001646,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001647,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antirheumatic Agents,Antirheumatic Agents,Y,quasi syn therclass-to-disease,Rheumatism,Rheumatism,C0035435,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antirheumatic Agents,Antirheumatic Agents,C0003191,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001648,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Ulcer Agents,Anti-Ulcer Agents,Y,quasi syn therclass-to-disease,Ulcer,Ulcer,C0041582,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),anti-ulcer agents,Anti-Ulcer Agent,C0003216,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001649,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001650,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001651,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001652,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Gastrointestinal Agents,Gastrointestinal Agents,Y,quasi syn therclass-to-disease,Gastrointestinal Diseases,Gastrointestinal Diseases,C0017178,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Gastrointestinal Agents,Gastrointestinal Agents,C0017173,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001653,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001654,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001655,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001656,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001657,MeSH_PA,C040996,"enkephalin-Leu, Ala(2)-Arg(6)-",81733-79-1,Dalargin,ChemID+,<syn per source>,,,,,,,,Dalargin,,81733-79-1,<syn per source>,"Enkephalin-leu, ala(2)-arg(6)-",exact,,"enkephalin-Leu, Ala(2)-Arg(6)-",C040996,81733-79-1,exact,,,,"Enkephalin-Leu, Ala(2)-Arg(6)-",C0059306,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Sympatholytics,Sympatholytics,Y,quasi syn therclass-to-function,Sympatholytic Effect,Sympatholytic Effect,C3179395,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Sympatholytics,Sympatholytics,C0039051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001658,MeSH_PA,C053821,"enkephalin-Leu, Ala(2)-Cys(6)-",110881-59-9,"Enkephalin-leu, ala(2)-cys(6)-",ChemID+,exact,,,,,,,,"Enkephalin-leu, ala(2)-cys(6)-",,110881-59-9,exact,,,,"enkephalin-Leu, Ala(2)-Cys(6)-",C053821,110881-59-9,exact,,,,"Enkephalin-Leu, Ala(2)-Cys(6)-",C0059326,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001659,MeSH_PA,C053821,"enkephalin-Leu, Ala(2)-Cys(6)-",110881-59-9,"Enkephalin-leu, ala(2)-cys(6)-",ChemID+,exact,,,,,,,,"Enkephalin-leu, ala(2)-cys(6)-",,110881-59-9,exact,,,,"enkephalin-Leu, Ala(2)-Cys(6)-",C053821,110881-59-9,exact,,,,"Enkephalin-Leu, Ala(2)-Cys(6)-",C0059326,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001660,MeSH_PA,C013801,"enkephalin-Met, Ala(2)-",61370-87-4,"Enkephalin-met, ala(2)-",ChemID+,exact,,,,,,,,"Enkephalin-met, ala(2)-",,61370-87-4,exact,,,,"enkephalin-Met, Ala(2)-",C013801,61370-87-4,exact,,,,"Enkephalin-Met, Ala(2)-",C0059335,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001661,MeSH_PA,C013801,"enkephalin-Met, Ala(2)-",61370-87-4,"Enkephalin-met, ala(2)-",ChemID+,exact,,,,,,,,"Enkephalin-met, ala(2)-",,61370-87-4,exact,,,,"enkephalin-Met, Ala(2)-",C013801,61370-87-4,exact,,,,"Enkephalin-Met, Ala(2)-",C0059335,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,"Analgesics, Opioid","Analgesics, Opioid",Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),"Analgesics, Opioid","Analgesics, Opioid",C0002772,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001662,MeSH_PA,C013801,"enkephalin-Met, Ala(2)-",61370-87-4,"Enkephalin-met, ala(2)-",ChemID+,exact,,,,,,,,"Enkephalin-met, ala(2)-",,61370-87-4,exact,,,,"enkephalin-Met, Ala(2)-",C013801,61370-87-4,exact,,,,"Enkephalin-Met, Ala(2)-",C0059335,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001663,MeSH_PA,C013801,"enkephalin-Met, Ala(2)-",61370-87-4,"Enkephalin-met, ala(2)-",ChemID+,exact,,,,,,,,"Enkephalin-met, ala(2)-",,61370-87-4,exact,,,,"enkephalin-Met, Ala(2)-",C013801,61370-87-4,exact,,,,"Enkephalin-Met, Ala(2)-",C0059335,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001664,MeSH_PA,C013801,"enkephalin-Met, Ala(2)-",61370-87-4,"Enkephalin-met, ala(2)-",ChemID+,exact,,,,,,,,"Enkephalin-met, ala(2)-",,61370-87-4,exact,,,,"enkephalin-Met, Ala(2)-",C013801,61370-87-4,exact,,,,"Enkephalin-Met, Ala(2)-",C0059335,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001665,MeSH_PA,C013801,"enkephalin-Met, Ala(2)-",61370-87-4,"Enkephalin-met, ala(2)-",ChemID+,exact,,,,,,,,"Enkephalin-met, ala(2)-",,61370-87-4,exact,,,,"enkephalin-Met, Ala(2)-",C013801,61370-87-4,exact,,,,"Enkephalin-Met, Ala(2)-",C0059335,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001666,MeSH_PA,C036309,fibrin fragment D,9001-31-4,Fibrin,ChemID+,NT fragment,,,,,,,,Fibrin,,9001-31-4,NT fragment,,,,,,,,,,,Fibrin Fragment D,C0060323,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antifibrinolytic Agents,Antifibrinolytic Agents,Y,quasi syn therclass-to-function,Fibrinolysis,Fibrinolysis,C0016017,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Antifibrinolytic Agents,Antifibrinolytic Agents,C0003304,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001667,MeSH_PA,C036309,fibrin fragment D,9001-31-4,Fibrin,ChemID+,NT fragment,,,,,,,,Fibrin,,9001-31-4,NT fragment,,,,,,,,,,,Fibrin Fragment D,C0060323,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Coagulants,Coagulants,Y,quasi syn therclass-to-disease,Clotting Decreased,Clotting Decreased,C0549625,P,Y,A2.2_Finding,,,,exact (CUI-based),Coagulants,Coagulants,C0009117,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001668,MeSH_PA,C036309,fibrin fragment D,9001-31-4,Fibrin,ChemID+,NT fragment,,,,,,,,Fibrin,,9001-31-4,NT fragment,,,,,,,,,,,Fibrin Fragment D,C0060323,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,modulating,,#VALUE!,Fibrin Modulating Agents,Fibrin Modulating Agents,Y,quasi syn therclass-to-disease,Fibrin Deposition,Fibrin Deposition,C0333565,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Fibrin Modulating Agents,Fibrin Modulating Agents,C1563784,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001669,MeSH_PA,C036309,fibrin fragment D,9001-31-4,Fibrin,ChemID+,NT fragment,,,,,,,,Fibrin,,9001-31-4,NT fragment,,,,,,,,,,,Fibrin Fragment D,C0060323,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001670,MeSH_PA,C036309,fibrin fragment D,9001-31-4,Fibrin,ChemID+,NT fragment,,,,,,,,Fibrin,,9001-31-4,NT fragment,,,,,,,,,,,Fibrin Fragment D,C0060323,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,static,,#VALUE!,Hemostatics,Hemostatics,Y,quasi syn therclass-to-disease,Hemorrhage,Hemorrhage,C0019080,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),hemostatics,Hemostatic Agents,C0019120,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001671,MeSH_PA,C030568,fibrinogen fragment X,9001-32-5,Fibrinogen,ChemID+,NT fragment,,,,,,,,Fibrinogen,,9001-32-5,NT fragment,,,,,,,,,,,Fibrinogen Fragment X,C0060338,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anticoagulants,Anticoagulants,Y,quasi syn therclass-to-function,Blood Coagulation,Blood Coagulation,C0005778,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Anticoagulants,Anticoagulants,C0003280,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001672,MeSH_PA,C030568,fibrinogen fragment X,9001-32-5,Fibrinogen,ChemID+,NT fragment,,,,,,,,Fibrinogen,,9001-32-5,NT fragment,,,,,,,,,,,Fibrinogen Fragment X,C0060338,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Hematologic Agents,Hematologic Agents,Y,quasi syn therclass-to-disease,Hematological Disease,Hematological Disease,C0018939,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Hematologic Agents,Hematologic Agents,C0018938,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001673,MeSH_PA,C068142,glyceraldehyde 3-phosphate dehydrogenase (304-313),130349-12-1,Glyceraldehyde 3-phosphate dehydrogenase (304-313),ChemID+,exact,,,,,,,,Glyceraldehyde 3-phosphate dehydrogenase (304-313),,130349-12-1,exact,,,,,,,,,,,Glyceraldehyde 3-Phosphate Dehydrogenase (304-313),C0119659,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.3_Enzyme,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,inhibitor,inhibits,Inhibitors,Angiotensin-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Inhibitors,Y,quasi syn therclass-to-function,Angiotensin Converting Enzyme Activity,Angiotensin Converting Enzyme Activity,C2258685,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Angiotensin-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Inhibitors,C0003015,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001674,MeSH_PA,C068142,glyceraldehyde 3-phosphate dehydrogenase (304-313),130349-12-1,Glyceraldehyde 3-phosphate dehydrogenase (304-313),ChemID+,exact,,,,,,,,Glyceraldehyde 3-phosphate dehydrogenase (304-313),,130349-12-1,exact,,,,,,,,,,,Glyceraldehyde 3-Phosphate Dehydrogenase (304-313),C0119659,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.3_Enzyme,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001675,MeSH_PA,C068142,glyceraldehyde 3-phosphate dehydrogenase (304-313),130349-12-1,Glyceraldehyde 3-phosphate dehydrogenase (304-313),ChemID+,exact,,,,,,,,Glyceraldehyde 3-phosphate dehydrogenase (304-313),,130349-12-1,exact,,,,,,,,,,,Glyceraldehyde 3-Phosphate Dehydrogenase (304-313),C0119659,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.3_Enzyme,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001676,MeSH_PA,D007128,Immunoglobulin Fragments,9007-83-4,"Globulin, Immune",ChemID+,NT subtype,,,,,,,,"Globulin, Immune","Globulin, Immune [USP]",9007-83-4,NT subtype,,,,,,,,,,,Immunoglobulin Fragments,C0021009,exact,,,,A1.4.1.1.3.5_Immunologic Factor,,,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001677,MeSH_PA,C027756,"MSH, 4-Nle-7-Phe-alpha-",75921-69-6,Afamelanotide,ChemID+,<syn per source>,,,,,,,,Afamelanotide,Afamelanotide [INN],75921-69-6,<syn per source>,"Msh, 4-nle-7-phe-alpha-",exact,,"MSH, 4-Nle-7-Phe-alpha-",C027756,75921-69-6,exact,,,,"Msh, 4-Nle-7-Phe-Alpha-",C0066889,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Affinity Labels,Affinity Labels,Y,exact (CUI-based),Affinity Labels,Affinity Labels,C0001730,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001678,MeSH_PA,C027756,"MSH, 4-Nle-7-Phe-alpha-",75921-69-6,Afamelanotide,ChemID+,<syn per source>,,,,,,,,Afamelanotide,Afamelanotide [INN],75921-69-6,<syn per source>,"Msh, 4-nle-7-phe-alpha-",exact,,"MSH, 4-Nle-7-Phe-alpha-",C027756,75921-69-6,exact,,,,"Msh, 4-Nle-7-Phe-Alpha-",C0066889,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anticarcinogenic Agents,Anticarcinogenic Agents,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Anticarcinogenic Agents,Anticarcinogenic Agents,C0085169,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001679,MeSH_PA,C027756,"MSH, 4-Nle-7-Phe-alpha-",75921-69-6,Afamelanotide,ChemID+,<syn per source>,,,,,,,,Afamelanotide,Afamelanotide [INN],75921-69-6,<syn per source>,"Msh, 4-nle-7-phe-alpha-",exact,,"MSH, 4-Nle-7-Phe-alpha-",C027756,75921-69-6,exact,,,,"Msh, 4-Nle-7-Phe-Alpha-",C0066889,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001680,MeSH_PA,C027756,"MSH, 4-Nle-7-Phe-alpha-",75921-69-6,Afamelanotide,ChemID+,<syn per source>,,,,,,,,Afamelanotide,Afamelanotide [INN],75921-69-6,<syn per source>,"Msh, 4-nle-7-phe-alpha-",exact,,"MSH, 4-Nle-7-Phe-alpha-",C027756,75921-69-6,exact,,,,"Msh, 4-Nle-7-Phe-Alpha-",C0066889,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001681,MeSH_PA,C027756,"MSH, 4-Nle-7-Phe-alpha-",75921-69-6,Afamelanotide,ChemID+,<syn per source>,,,,,,,,Afamelanotide,Afamelanotide [INN],75921-69-6,<syn per source>,"Msh, 4-nle-7-phe-alpha-",exact,,"MSH, 4-Nle-7-Phe-alpha-",C027756,75921-69-6,exact,,,,"Msh, 4-Nle-7-Phe-Alpha-",C0066889,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001682,MeSH_PA,C054296,parathyroid hormone-related protein (1-34),112540-82-6,Parathyroid hormone-related protein (1-34),ChemID+,exact,,,,,,,,Parathyroid hormone-related protein (1-34),,112540-82-6,exact,,,,parathyroid hormone-related protein (1-34),C054296,112540-82-6,exact,,,,Parathyroid Hormone-Related Protein (1-34),C0135521,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antihypertensive Agents,Antihypertensive Agents,Y,quasi syn therclass-to-disease,hypertension,Hypertensive Disease,C0020538,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antihypertensive Agents,Antihypertensive Agents,C0003364,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001683,MeSH_PA,C054296,parathyroid hormone-related protein (1-34),112540-82-6,Parathyroid hormone-related protein (1-34),ChemID+,exact,,,,,,,,Parathyroid hormone-related protein (1-34),,112540-82-6,exact,,,,parathyroid hormone-related protein (1-34),C054296,112540-82-6,exact,,,,Parathyroid Hormone-Related Protein (1-34),C0135521,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Cardiovascular Agents,Cardiovascular Agents,Y,quasi syn therclass-to-disease,Cardiovascular Diseases,Cardiovascular Diseases,C0007222,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Cardiovascular Agents,Cardiovascular Agents,C0007220,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001684,MeSH_PA,C045616,"somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)-",93965-89-0,"Somatotropin releasing hormone (1-29)-amide, N-Ac-tyr(1)-phe(2)-",ChemID+,exact,,,,,,,,"Somatotropin releasing hormone (1-29)-amide, N-Ac-tyr(1)-phe(2)-",,93965-89-0,exact,,,,"somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)-",C045616,93965-89-0,exact,,,,"Somatotropin Releasing Hormone (1-29)-Amide, N-Ac-Tyr(1)-Phe(2)-",C0074876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,antagonist,antagonist,#VALUE!,Hormone Antagonists,Hormone Antagonists,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormone Antagonists,Hormone Antagonists,C0019927,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001685,MeSH_PA,C045616,"somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)-",93965-89-0,"Somatotropin releasing hormone (1-29)-amide, N-Ac-tyr(1)-phe(2)-",ChemID+,exact,,,,,,,,"Somatotropin releasing hormone (1-29)-amide, N-Ac-tyr(1)-phe(2)-",,93965-89-0,exact,,,,"somatotropin releasing hormone (1-29)-amide, N-Ac-Tyr(1)-Phe(2)-",C045616,93965-89-0,exact,,,,"Somatotropin Releasing Hormone (1-29)-Amide, N-Ac-Tyr(1)-Phe(2)-",C0074876,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001686,MeSH_PA,C032292,substance P (6-11),51165-07-2,Substance P (6-11),ChemID+,exact,,,,,,,,Substance P (6-11),,51165-07-2,exact,,,,substance P (6-11),C032292,51165-07-2,exact,,,,Substance P (6-11),C0075400,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Analgesics,Analgesics,Y,quasi syn therclass-to-disease,Pain,Pain,C0030193,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Analgesics,Analgesics,C0002771,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001687,MeSH_PA,C032292,substance P (6-11),51165-07-2,Substance P (6-11),ChemID+,exact,,,,,,,,Substance P (6-11),,51165-07-2,exact,,,,substance P (6-11),C032292,51165-07-2,exact,,,,Substance P (6-11),C0075400,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antiemetics,Antiemetics,Y,quasi syn therclass-to-disease,Nausea And Vomiting,Nausea And Vomiting,C0027498,P,Y,A2.2.2_Sign or Symptom,,,,exact (CUI-based),Antiemetics,Antiemetics,C0003297,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001688,MeSH_PA,C032292,substance P (6-11),51165-07-2,Substance P (6-11),ChemID+,exact,,,,,,,,Substance P (6-11),,51165-07-2,exact,,,,substance P (6-11),C032292,51165-07-2,exact,,,,Substance P (6-11),C0075400,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Autonomic Agents,Autonomic Agents,Y,quasi syn therclass-to-function,Autonomic Function,Autonomic Function,C0518003,P,Y,A2.2_Finding,,,,exact (CUI-based),Autonomic Agents,Autonomic Agents,C0004382,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001689,MeSH_PA,C032292,substance P (6-11),51165-07-2,Substance P (6-11),ChemID+,exact,,,,,,,,Substance P (6-11),,51165-07-2,exact,,,,substance P (6-11),C032292,51165-07-2,exact,,,,Substance P (6-11),C0075400,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001690,MeSH_PA,C032292,substance P (6-11),51165-07-2,Substance P (6-11),ChemID+,exact,,,,,,,,Substance P (6-11),,51165-07-2,exact,,,,substance P (6-11),C032292,51165-07-2,exact,,,,Substance P (6-11),C0075400,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Gastrointestinal Agents,Gastrointestinal Agents,Y,quasi syn therclass-to-disease,Gastrointestinal Diseases,Gastrointestinal Diseases,C0017178,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Gastrointestinal Agents,Gastrointestinal Agents,C0017173,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001691,MeSH_PA,C032292,substance P (6-11),51165-07-2,Substance P (6-11),ChemID+,exact,,,,,,,,Substance P (6-11),,51165-07-2,exact,,,,substance P (6-11),C032292,51165-07-2,exact,,,,Substance P (6-11),C0075400,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Peripheral Nervous System Agents,Peripheral Nervous System Agents,Y,quasi syn therclass-to-function,Pns Function,Pns Function,C0683211,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Peripheral Nervous System Agents,Peripheral Nervous System Agents,C0243049,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001692,MeSH_PA,C032292,substance P (6-11),51165-07-2,Substance P (6-11),ChemID+,exact,,,,,,,,Substance P (6-11),,51165-07-2,exact,,,,substance P (6-11),C032292,51165-07-2,exact,,,,Substance P (6-11),C0075400,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sensory System Agents,Sensory System Agents,Y,quasi syn therclass-to-disease,Sensory Disorders,Sensory Disorders,C0152027,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Sensory System Agents,Sensory System Agents,C0243058,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001693,MeSH_PA,C107489,"BIRC5 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Birc5 Protein, Human",C1571495,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Cysteine Protease Activity,Cysteine Protease Activity,C1150124,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Cysteine Proteinase Inhibitors,Cysteine Proteinase Inhibitors,C0010658,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001694,MeSH_PA,C107489,"BIRC5 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Birc5 Protein, Human",C1571495,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001695,MeSH_PA,C107489,"BIRC5 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Birc5 Protein, Human",C1571495,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001696,MeSH_PA,C084533,"CHI3L1 protein, human",,,,,,,,,,,,,,,,,,,"CHI3L1 protein, human",C084533,,exact,,,,"Chi3L1 Protein, Human",C0528649,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001697,MeSH_PA,D020740,Chimerin Proteins,,,,,,,,,,,,,,,,,,,,,,,,,,Chimerin Proteins,C0752111,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Enzyme Activators,Enzyme Activators,Y,exact (CUI-based),Enzyme Activators,Enzyme Activators,C0751968,P,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,,,,,,,,,,
1_001698,MeSH_PA,D020740,Chimerin Proteins,,,,,,,,,,,,,,,,,,,,,,,,,,Chimerin Proteins,C0752111,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,activator,,#VALUE!,GTP Phosphohydrolase Activators,GTP Phosphohydrolase Activators,Y,NT + quasi syn therclass-to-function,Nucleoside Triphosphate Phosphohydrolase Activity,Nucleoside Triphosphate Phosphohydrolase Activity,C2243553,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Gtp Phosphohydrolase Activators,Gtp Phosphohydrolase Activators,C0751976,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001699,MeSH_PA,C081787,"CHM protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Chm Protein, Human",C1664724,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Enzyme Activators,Enzyme Activators,Y,exact (CUI-based),Enzyme Activators,Enzyme Activators,C0751968,P,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,,,,,,,,,,
1_001700,MeSH_PA,C081787,"CHM protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Chm Protein, Human",C1664724,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,activator,,#VALUE!,GTP Phosphohydrolase Activators,GTP Phosphohydrolase Activators,Y,NT + quasi syn therclass-to-function,Nucleoside Triphosphate Phosphohydrolase Activity,Nucleoside Triphosphate Phosphohydrolase Activity,C2243553,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Gtp Phosphohydrolase Activators,Gtp Phosphohydrolase Activators,C0751976,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001701,MeSH_PA,C039076,"Eco protein, E coli",,,,,,,,,,,,,,,,,,,,,,,,,,"Eco Protein, E Coli",C0058933,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001702,MeSH_PA,C039076,"Eco protein, E coli",,,,,,,,,,,,,,,,,,,,,,,,,,"Eco Protein, E Coli",C0058933,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001703,MeSH_PA,C039076,"Eco protein, E coli",,,,,,,,,,,,,,,,,,,,,,,,,,"Eco Protein, E Coli",C0058933,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001704,MeSH_PA,C039076,"Eco protein, E coli",,,,,,,,,,,,,,,,,,,,,,,,,,"Eco Protein, E Coli",C0058933,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Trypsin Inhibitors,Trypsin Inhibitors,Y,quasi syn therclass-to-function,Trypsin Activity,Trypsin Activity,C1150284,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Trypsin Inhibitors,Trypsin Inhibitors,C0041242,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",
1_001705,MeSH_PA,C028656,eglin proteinase inhibitors,,,,,,,,,,,,,,,,,,,,,,,,,,Eglin Proteinase Inhibitors,C0115585,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001706,MeSH_PA,C028656,eglin proteinase inhibitors,,,,,,,,,,,,,,,,,,,,,,,,,,Eglin Proteinase Inhibitors,C0115585,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001707,MeSH_PA,C028656,eglin proteinase inhibitors,,,,,,,,,,,,,,,,,,,,,,,,,,Eglin Proteinase Inhibitors,C0115585,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001708,MeSH_PA,C082326,"FpvA protein, Pseudomonas aeruginosa",,,,,,,,,,,,,,,,,,,,,,,,,,"Fpva Protein, Pseudomonas Aeruginosa",C1447234,exact,,,,A1.4.1.1.3.6_Receptor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Chelating Agents,Chelating Agents,Y,exact (CUI-based),Chelating Agents,Chelating Agents,C0007974,P,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,
1_001709,MeSH_PA,C082326,"FpvA protein, Pseudomonas aeruginosa",,,,,,,,,,,,,,,,,,,,,,,,,,"Fpva Protein, Pseudomonas Aeruginosa",C1447234,exact,,,,A1.4.1.1.3.6_Receptor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Iron Chelating Agents,Iron Chelating Agents,Y,quasi syn therclass-to-function,iron chelating activity,Iron Chelating Activity [Moa],C2757050,S,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Iron Chelating Agents,Iron Chelating Agents,C0022086,P,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,
1_001710,MeSH_PA,C082326,"FpvA protein, Pseudomonas aeruginosa",,,,,,,,,,,,,,,,,,,,,,,,,,"Fpva Protein, Pseudomonas Aeruginosa",C1447234,exact,,,,A1.4.1.1.3.6_Receptor,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Siderophores,Siderophores,Y,quasi syn therclass-to-function,Iron Ion Binding,Iron Ion Binding,C1148613,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Siderophores,Siderophores,C0142281,P,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,
1_001711,MeSH_PA,C499483,"Gckr protein, mouse",,,,,,,,,,,,,,,,,,,,,,,,,,"Gckr Protein, Mouse",C1567822,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001712,MeSH_PA,C025674,"GEL protein, Gelonium multiflorum",75037-46-6,"GEL protein, Gelonium multiflorum",ChemID+,exact,,,,,,,,"GEL protein, Gelonium multiflorum",,75037-46-6,exact,,,,,,,,,,,"Gel Protein, Gelonium Multiflorum",C0061184,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001713,MeSH_PA,C025674,"GEL protein, Gelonium multiflorum",75037-46-6,"GEL protein, Gelonium multiflorum",ChemID+,exact,,,,,,,,"GEL protein, Gelonium multiflorum",,75037-46-6,exact,,,,,,,,,,,"Gel Protein, Gelonium Multiflorum",C0061184,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,"Antineoplastic Agents, Phytogenic","Antineoplastic Agents, Phytogenic",Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),"Antineoplastic Agents, Phytogenic","Antineoplastic Agents, Phytogenic",C0003394,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001714,MeSH_PA,C025674,"GEL protein, Gelonium multiflorum",75037-46-6,"GEL protein, Gelonium multiflorum",ChemID+,exact,,,,,,,,"GEL protein, Gelonium multiflorum",,75037-46-6,exact,,,,,,,,,,,"Gel Protein, Gelonium Multiflorum",C0061184,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001715,MeSH_PA,C025674,"GEL protein, Gelonium multiflorum",75037-46-6,"GEL protein, Gelonium multiflorum",ChemID+,exact,,,,,,,,"GEL protein, Gelonium multiflorum",,75037-46-6,exact,,,,,,,,,,,"Gel Protein, Gelonium Multiflorum",C0061184,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protein Synthesis Inhibitors,Protein Synthesis Inhibitors,Y,quasi syn therclass-to-function,Protein Biosynthesis,Protein Biosynthesis,C0597295,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Protein Synthesis Inhibitors,Protein Synthesis Inhibitors,C0033671,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001716,MeSH_PA,C102583,GKLF protein,,,,,,,,,,,,,,,,,,,,,,,,,,Gklf Protein,C0529085,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Growth Inhibitors,Growth Inhibitors,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Inhibitors,Growth Inhibitors,C0018282,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001717,MeSH_PA,C102583,GKLF protein,,,,,,,,,,,,,,,,,,,,,,,,,,Gklf Protein,C0529085,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001718,MeSH_PA,C091236,"ITIH4 protein, human",,,,,,,,,,,,,,,,,,,"ITIH4 protein, human",C091236,,exact,,,,"Itih4 Protein, Human",C0298192,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001719,MeSH_PA,C091236,"ITIH4 protein, human",,,,,,,,,,,,,,,,,,,"ITIH4 protein, human",C091236,,exact,,,,"Itih4 Protein, Human",C0298192,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001720,MeSH_PA,C091236,"ITIH4 protein, human",,,,,,,,,,,,,,,,,,,"ITIH4 protein, human",C091236,,exact,,,,"Itih4 Protein, Human",C0298192,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001721,MeSH_PA,C068675,"LECT1 protein, human",136362-10-2,"LECT1 protein, human",CTD,exact,,,,,,,,,,,,,,,"LECT1 protein, human",C068675,136362-10-2,exact,,,,"Lect1 Protein, Human",C1433426,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Angiogenesis Inhibitors,Angiogenesis Inhibitors,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Inhibitors,Angiogenesis Inhibitors,C0596087,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001722,MeSH_PA,C068675,"LECT1 protein, human",136362-10-2,"LECT1 protein, human",CTD,exact,,,,,,,,,,,,,,,"LECT1 protein, human",C068675,136362-10-2,exact,,,,"Lect1 Protein, Human",C1433426,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,modulating agent,,#VALUE!,Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,Y,quasi syn therclass-to-function,Vascularization,Vascularization,C0042382,P,A,A2.1.4_Functional Concept,,,,exact (CUI-based),Angiogenesis Modulating Agents,Angiogenesis Modulating Agents,C1257849,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001723,MeSH_PA,C068675,"LECT1 protein, human",136362-10-2,"LECT1 protein, human",CTD,exact,,,,,,,,,,,,,,,"LECT1 protein, human",C068675,136362-10-2,exact,,,,"Lect1 Protein, Human",C1433426,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001724,MeSH_PA,C068675,"LECT1 protein, human",136362-10-2,"LECT1 protein, human",CTD,exact,,,,,,,,,,,,,,,"LECT1 protein, human",C068675,136362-10-2,exact,,,,"Lect1 Protein, Human",C1433426,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Growth Inhibitors,Growth Inhibitors,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Inhibitors,Growth Inhibitors,C0018282,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001725,MeSH_PA,C068675,"LECT1 protein, human",136362-10-2,"LECT1 protein, human",CTD,exact,,,,,,,,,,,,,,,"LECT1 protein, human",C068675,136362-10-2,exact,,,,"Lect1 Protein, Human",C1433426,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001726,MeSH_PA,C036196,"MITF protein, Aspergillus restrictus",1406-72-0,"MITF protein, Aspergillus restrictus",ChemID+,exact,,,,,,,,"MITF protein, Aspergillus restrictus",,1406-72-0,exact,,,,,,,,,,,"Mitf Protein, Aspergillus Restrictus",C0073095,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.3_Enzyme,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,#VALUE!,"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),"Antibiotics, Antineoplastic","Antibiotics, Antineoplastic",C0003236,P,A1.4.1.1.1.1_Antibiotic,,,
1_001727,MeSH_PA,C036196,"MITF protein, Aspergillus restrictus",1406-72-0,"MITF protein, Aspergillus restrictus",ChemID+,exact,,,,,,,,"MITF protein, Aspergillus restrictus",,1406-72-0,exact,,,,,,,,,,,"Mitf Protein, Aspergillus Restrictus",C0073095,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.3_Enzyme,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001728,MeSH_PA,C036196,"MITF protein, Aspergillus restrictus",1406-72-0,"MITF protein, Aspergillus restrictus",ChemID+,exact,,,,,,,,"MITF protein, Aspergillus restrictus",,1406-72-0,exact,,,,,,,,,,,"Mitf Protein, Aspergillus Restrictus",C0073095,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.3_Enzyme,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001729,MeSH_PA,C036196,"MITF protein, Aspergillus restrictus",1406-72-0,"MITF protein, Aspergillus restrictus",ChemID+,exact,,,,,,,,"MITF protein, Aspergillus restrictus",,1406-72-0,exact,,,,,,,,,,,"Mitf Protein, Aspergillus Restrictus",C0073095,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.3_Enzyme,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,inhibitor,inhibits,Inhibitors,Protein Synthesis Inhibitors,Protein Synthesis Inhibitors,Y,quasi syn therclass-to-function,Protein Biosynthesis,Protein Biosynthesis,C0597295,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Protein Synthesis Inhibitors,Protein Synthesis Inhibitors,C0033671,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001730,MeSH_PA,C039582,"MMC protein, Momordica charantia",88026-31-7,"MMC protein, Momordica charantia",ChemID+,exact,,,,,,,,"MMC protein, Momordica charantia",,88026-31-7,exact,,,,,,,,,,,"Mmc Protein, Momordica Charantia",C0066701,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,terminates,,#VALUE!,Abortifacient Agents,Abortifacient Agents,Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),Abortifacient Agents,Abortifacient Agents,C0000782,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001731,MeSH_PA,C039582,"MMC protein, Momordica charantia",88026-31-7,"MMC protein, Momordica charantia",ChemID+,exact,,,,,,,,"MMC protein, Momordica charantia",,88026-31-7,exact,,,,,,,,,,,"Mmc Protein, Momordica Charantia",C0066701,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,terminates,,#VALUE!,"Abortifacient Agents, Nonsteroidal","Abortifacient Agents, Nonsteroidal",Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),"Abortifacient Agents, Nonsteroidal","Abortifacient Agents, Nonsteroidal",C0000783,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001732,MeSH_PA,C039582,"MMC protein, Momordica charantia",88026-31-7,"MMC protein, Momordica charantia",ChemID+,exact,,,,,,,,"MMC protein, Momordica charantia",,88026-31-7,exact,,,,,,,,,,,"Mmc Protein, Momordica Charantia",C0066701,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001733,MeSH_PA,C039582,"MMC protein, Momordica charantia",88026-31-7,"MMC protein, Momordica charantia",ChemID+,exact,,,,,,,,"MMC protein, Momordica charantia",,88026-31-7,exact,,,,,,,,,,,"Mmc Protein, Momordica Charantia",C0066701,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,"Antineoplastic Agents, Phytogenic","Antineoplastic Agents, Phytogenic",Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),"Antineoplastic Agents, Phytogenic","Antineoplastic Agents, Phytogenic",C0003394,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001734,MeSH_PA,C039582,"MMC protein, Momordica charantia",88026-31-7,"MMC protein, Momordica charantia",ChemID+,exact,,,,,,,,"MMC protein, Momordica charantia",,88026-31-7,exact,,,,,,,,,,,"Mmc Protein, Momordica Charantia",C0066701,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,prevents,,#VALUE!,Reproductive Control Agents,Reproductive Control Agents,Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),Reproductive Control Agents,Reproductive Control Agents,C0035155,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001735,MeSH_PA,C002541,"monellin protein, Dioscoreophyllum cumminsii",9062-83-3,Monellin,ChemID+,quasi syn,,,,,,,,Monellin,,9062-83-3,quasi syn,,,,,,,,,,,"Monellin Protein, Dioscoreophyllum Cumminsii",C0066710,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Flavoring Agents,Flavoring Agents,Y,quasi syn therclass-to-function,Flavor Perception,Flavor Perception,C0699771,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),flavoring agents,Flavoring,C0475332,S,A1.4_Substance,,,
1_001736,MeSH_PA,C002541,"monellin protein, Dioscoreophyllum cumminsii",9062-83-3,Monellin,ChemID+,quasi syn,,,,,,,,Monellin,,9062-83-3,quasi syn,,,,,,,,,,,"Monellin Protein, Dioscoreophyllum Cumminsii",C0066710,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Food Additives,Food Additives,Y,exact (CUI-based),Food Additives,Food Additives,C0016453,P,,A1.4.3_Food,,,,,,,,,,,,
1_001737,MeSH_PA,C002541,"monellin protein, Dioscoreophyllum cumminsii",9062-83-3,Monellin,ChemID+,quasi syn,,,,,,,,Monellin,,9062-83-3,quasi syn,,,,,,,,,,,"Monellin Protein, Dioscoreophyllum Cumminsii",C0066710,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Sweetening Agents,Sweetening Agents,Y,quasi syn therclass-to-function,Sweet Taste Perception,Sweet Taste Perception,C1154613,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Sweetening Agents,Sweetening Agents,C0038998,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_001738,MeSH_PA,C403669,Nogo protein,,,,,,,,,,,,,,,,,,,,,,,,,,Nogo Protein,C0911852,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Growth Inhibitors,Growth Inhibitors,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Inhibitors,Growth Inhibitors,C0018282,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001739,MeSH_PA,C403669,Nogo protein,,,,,,,,,,,,,,,,,,,,,,,,,,Nogo Protein,C0911852,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001740,MeSH_PA,C105496,"NPR1 protein, Arabidopsis",,,,,,,,,,,,,,,,,,,,,,,,,,"Npr1 Protein, Arabidopsis",C0538053,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001741,MeSH_PA,C045246,"PAEP protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Paep Protein, Human",C0071190,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,prevents,,#VALUE!,Contraceptive Agents,Contraceptive Agents,Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),Contraceptive Agents,Contraceptive Agents,C0009871,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001742,MeSH_PA,C045246,"PAEP protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Paep Protein, Human",C0071190,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Immunologic Factors,Immunologic Factors,Y,quasi syn therclass-to-function,Immunity,Immunity,C0020964,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Immunologic Factors,Immunologic Factors,C0021054,P,A1.4.1.1.3.5_Immunologic Factor,,,
1_001743,MeSH_PA,C045246,"PAEP protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Paep Protein, Human",C0071190,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,suppressive,,#VALUE!,Immunosuppressive Agents,Immunosuppressive Agents,Y,quasi syn therclass-to-function,Immune Response,Immune Response,C0301872,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Immunosuppressive Agents,Immunosuppressive Agents,C0021081,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.5_Immunologic Factor,,
1_001744,MeSH_PA,C045246,"PAEP protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Paep Protein, Human",C0071190,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,prevents,,#VALUE!,Reproductive Control Agents,Reproductive Control Agents,Y,quasi syn therclass-to-disease,Unwanted Pregnancy,Unwanted Pregnancy,C0032995,P,Y,A2.2_Finding,,,,exact (CUI-based),Reproductive Control Agents,Reproductive Control Agents,C0035155,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001745,MeSH_PA,C081479,"PGIP protein, plant",,,,,,,,,,,,,,,,,,,,,,,,,,"Pgip Protein, Plant",C0216765,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Antifungal Agents,Antifungal Agents,Y,quasi syn therclass-to-disease,fungal infections,Mycoses,C0026946,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antifungal Agents,Antifungal Agents,C0003308,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001746,MeSH_PA,C081479,"PGIP protein, plant",,,,,,,,,,,,,,,,,,,,,,,,,,"Pgip Protein, Plant",C0216765,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001747,MeSH_PA,C081479,"PGIP protein, plant",,,,,,,,,,,,,,,,,,,,,,,,,,"Pgip Protein, Plant",C0216765,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001748,MeSH_PA,D020710,RGS Proteins,,,,,,,,,,,,,,,,,,,,,,,,,,Rgs Proteins,C0633372,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,,#VALUE!,Enzyme Activators,Enzyme Activators,Y,exact (CUI-based),Enzyme Activators,Enzyme Activators,C0751968,P,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,,,,,,,,,,
1_001749,MeSH_PA,D020710,RGS Proteins,,,,,,,,,,,,,,,,,,,,,,,,,,Rgs Proteins,C0633372,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,activator,,#VALUE!,GTP Phosphohydrolase Activators,GTP Phosphohydrolase Activators,Y,NT + quasi syn therclass-to-function,Nucleoside Triphosphate Phosphohydrolase Activity,Nucleoside Triphosphate Phosphohydrolase Activity,C2243553,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Gtp Phosphohydrolase Activators,Gtp Phosphohydrolase Activators,C0751976,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001750,MeSH_PA,C473799,"SPINK7 protein, human",,,,,,,,,,,,,,,,,,,"SPINK7 protein, human",C473799,,exact,,,,"Spink7 Protein, Human",C1258118,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001751,MeSH_PA,C473799,"SPINK7 protein, human",,,,,,,,,,,,,,,,,,,"SPINK7 protein, human",C473799,,exact,,,,"Spink7 Protein, Human",C1258118,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001752,MeSH_PA,C473799,"SPINK7 protein, human",,,,,,,,,,,,,,,,,,,"SPINK7 protein, human",C473799,,exact,,,,"Spink7 Protein, Human",C1258118,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001753,MeSH_PA,C109148,"SPINT2 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Spint2 Protein, Human",C0668013,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001754,MeSH_PA,C109148,"SPINT2 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Spint2 Protein, Human",C0668013,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001755,MeSH_PA,C109148,"SPINT2 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Spint2 Protein, Human",C0668013,exact,,,,A1.4.1.1.1_Pharmacologic Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,Y,quasi syn therclass-to-function,Serine Protease Activity,Serine Protease Activity,C1150239,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Serine Proteinase Inhibitors,Serine Proteinase Inhibitors,C0036733,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001756,MeSH_PA,C560822,"TIMP1 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Timp1 Protein, Human",C1522552,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001757,MeSH_PA,C560822,"TIMP1 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Timp1 Protein, Human",C1522552,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001758,MeSH_PA,C560825,"Timp1 protein, mouse",,,,,,,,,,,,,,,,,,,,,,,,,,"Timp1 Protein, Mouse",C3178657,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001759,MeSH_PA,C560825,"Timp1 protein, mouse",,,,,,,,,,,,,,,,,,,,,,,,,,"Timp1 Protein, Mouse",C3178657,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001760,MeSH_PA,C560823,"TIMP2 protein, human",124861-55-8,Tissue inhibitor of metalloproteinase-2,ChemID+,quasi syn human,,,,,,,,Tissue inhibitor of metalloproteinase-2,,124861-55-8,quasi syn human,Timp-2,NT subtype source,,,,,,,,,"Timp2 Protein, Human",C3178655,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001761,MeSH_PA,C560823,"TIMP2 protein, human",124861-55-8,Tissue inhibitor of metalloproteinase-2,ChemID+,quasi syn human,,,,,,,,Tissue inhibitor of metalloproteinase-2,,124861-55-8,quasi syn human,Timp-2,NT subtype source,,,,,,,,,"Timp2 Protein, Human",C3178655,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001762,MeSH_PA,C088390,"TIMP3 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Timp3 Protein, Human",C1527365,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001763,MeSH_PA,C088390,"TIMP3 protein, human",,,,,,,,,,,,,,,,,,,,,,,,,,"Timp3 Protein, Human",C1527365,exact,,,,A1.4.1.1.3_Biologically Active Substance,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,inhibitor,inhibits,Inhibitors,Protease Inhibitors,Protease Inhibitors,Y,quasi syn therclass-to-function,Protease Activity,Protease Activity,C2263455,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),protease inhibitors,Protease Inhibitor,C0033607,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001764,MeSH_PA,C032300,hexaamminecobalt(II),15365-75-0,Hexaamminecobalt(II),ChemID+,exact,hexaamminecobalt(2+),30330,,<syn per source>,hexaamminecobalt(II),exact,,Hexaamminecobalt(II),,15365-75-0,exact,,,,hexaamminecobalt(II),C032300,15365-75-0,exact,,,,Hexaamminecobalt(Ii),C0062597,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.2_Inorganic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001765,MeSH_PA,C032300,hexaamminecobalt(II),15365-75-0,Hexaamminecobalt(II),ChemID+,exact,hexaamminecobalt(2+),30330,,<syn per source>,hexaamminecobalt(II),exact,,Hexaamminecobalt(II),,15365-75-0,exact,,,,hexaamminecobalt(II),C032300,15365-75-0,exact,,,,Hexaamminecobalt(Ii),C0062597,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.2_Inorganic Chemical,,,causes,,#VALUE!,Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,Y,quasi syn therclass-to-function,Radiation-Sensitizing Effect,Radiation-Sensitizing Effect,C3179280,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Radiation-Sensitizing Agents,Radiation-Sensitizing Agents,C0034541,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001766,MeSH_PA,C005056,isoascorbic acid,89-65-6,Erythorbic acid,ChemID+,<syn per source>,D-isoascorbic acid,51438,89-65-6,<syn per source>,Isoascorbic acid,exact,,Erythorbic acid,Erythorbic acid [NF],89-65-6,<syn per source>,Isoascorbic acid,exact,,isoascorbic acid,C005056,89-65-6,exact,,,,Isoascorbic Acid,C0063919,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001767,MeSH_PA,C005056,isoascorbic acid,89-65-6,Erythorbic acid,ChemID+,<syn per source>,D-isoascorbic acid,51438,89-65-6,<syn per source>,Isoascorbic acid,exact,,Erythorbic acid,Erythorbic acid [NF],89-65-6,<syn per source>,Isoascorbic acid,exact,,isoascorbic acid,C005056,89-65-6,exact,,,,Isoascorbic Acid,C0063919,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001768,MeSH_PA,D019207,beta Carotene,7235-40-7,Beta carotene,ChemID+,exact,beta-carotene,17579,7235-40-7,syn no\W,,,,Beta carotene,Beta carotene [USAN:USP],7235-40-7,exact,,,,beta Carotene,D019207,7235-40-7,exact,,,,Beta Carotene,C0053396,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Growth Substances,Growth Substances,Y,quasi syn therclass-to-function,Growth,Growth,C0018270,P,Y,B2.2.1.1.1_Organism Function,,,,exact (CUI-based),Growth Substances,Growth Substances,C1812630,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,,
1_001769,MeSH_PA,D019207,beta Carotene,7235-40-7,Beta carotene,ChemID+,exact,beta-carotene,17579,7235-40-7,syn no\W,,,,Beta carotene,Beta carotene [USAN:USP],7235-40-7,exact,,,,beta Carotene,D019207,7235-40-7,exact,,,,Beta Carotene,C0053396,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Micronutrients,Micronutrients,Y,quasi syn therclass-to-disease,Deficiency Of Micronutrients,Deficiency Of Micronutrients,C0342917,P,Y,B2.2.1.2_Pathologic Function,,,,exact (CUI-based),Micronutrients,Micronutrients,C0282575,P,A1.4.1.1.3_Biologically Active Substance,,,
1_001770,MeSH_PA,D019207,beta Carotene,7235-40-7,Beta carotene,ChemID+,exact,beta-carotene,17579,7235-40-7,syn no\W,,,,Beta carotene,Beta carotene [USAN:USP],7235-40-7,exact,,,,beta Carotene,D019207,7235-40-7,exact,,,,Beta Carotene,C0053396,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,,,#VALUE!,Vitamins,Vitamins,Y,quasi syn therclass-to-disease,Vitamin Deficiency,Vitamin Deficiency,C1510471,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Vitamins,Vitamins,C0042890,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,
1_001771,USAN_TC,1977,beta carotene,7235-40-7,Beta carotene,ChemID+,exact,beta-carotene,17579,7235-40-7,syn no\W,,,,Beta carotene,Beta carotene [USAN:USP],7235-40-7,exact,,,,beta Carotene,D019207,7235-40-7,exact,,,,Beta Carotene,C0053396,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,prevents,,#VALUE!,ultraviolet screen,ultraviolet screen,Y,quasi syn therclass-to-disease,Ultraviolet-Induced Change In Normal Skin,Ultraviolet-Induced Change In Normal Skin,C0406206,P,Y,B2.3_Injury or Poisoning,,,,,,,,,,,,
1_001772,MeSH_PA,D024321,zeta Carotene,50657-19-7,Zeacarotene,ChemID+,syn sp?,all-trans-zeta-carotene,28068,,<syn per source>,zeta-Carotene,syn no\W,,Zeacarotene,,50657-19-7,syn sp?,,,,zeta Carotene,D024321,,exact,,,,Zeta Carotene,C0043470,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antioxidants,Antioxidants,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact (CUI-based),Antioxidants,Antioxidants,C0003402,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001773,MeSH_PA,D024321,zeta Carotene,50657-19-7,Zeacarotene,ChemID+,syn sp?,all-trans-zeta-carotene,28068,,<syn per source>,zeta-Carotene,syn no\W,,Zeacarotene,,50657-19-7,syn sp?,,,,zeta Carotene,D024321,,exact,,,,Zeta Carotene,C0043470,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Protective Agents,Protective Agents,Y,quasi syn therclass-to-function,Protective Drug Effect,Protective Drug Effect,C0678771,P,Y,B2.2.1_Biologic Function,,,,exact (CUI-based),Protective Agents,Protective Agents,C0033613,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001774,ChEBI,,isocyanuric acid,108-80-5,Cyanuric acid,ChemID+,<syn per source>,isocyanuric acid,17696,108-80-5,exact,,,,Cyanuric acid,,108-80-5,NT isomer,Isocyanuric acid,exact,,isocyanuric acid,C509473,,exact,,,,Isocyanuric Acid,C1700079,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,xenobiotic,xenobiotic,Y,quasi syn therclass-to-function,Response To Xenobiotic Stimulus,Response To Xenobiotic Stimulus,C1154743,P,Y,B2.2.1.1.1_Organism Function,,,,exact 1,xenobiotic,Xenobiotics,C0043335,S,A1.4.1.1.3_Biologically Active Substance,A1.4.1.1.5_Hazardous or Poisonous Substance,,
1_001775,ChEBI,,isoferulic acid,537-73-5,Isoferulic acid,ChemID+,exact,isoferulic acid,27794,537-73-5,exact,,,,Isoferulic acid,,537-73-5,exact,,,,isoferulic acid,C008180,537-73-5,exact,,,,Isoferulic Acid,C0162986,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,antioxidant,antioxidant,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact 1,antioxidant,Antioxidants,C0003402,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001776,ChEBI,,isoferulic acid,537-73-5,Isoferulic acid,ChemID+,exact,isoferulic acid,27794,537-73-5,exact,,,,Isoferulic acid,,537-73-5,exact,,,,isoferulic acid,C008180,537-73-5,exact,,,,Isoferulic Acid,C0162986,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,biomarker,biomarker,Y,exact 1,biomarker,Biological Markers,C0005516,S,Y,A2.3.1_Clinical Attribute,,,,,,,,,,,,
1_001777,ChEBI,,2-furoic acid,88-14-2,2-Furoic acid,ChemID+,exact,2-furoic acid,30845,88-14-2,exact,,,,2-Furoic acid,,88-14-2,exact,,,,2-furoic acid,C060089,88-14-2,exact,,,,2-Furoic Acid,C0046133,exact,,,,A1.4.1.2.1_Organic Chemical,,,,isa,isa,inhibitor,inhibitor,inhibitor,Y,exact 1,Inhibitor,Inhibitor,C1999216,P,,A2.1.2_Qualitative Concept,,,,,,,,,,,,
1_001778,MeSH_PA,C031528,6-iodopenicillanic acid,74772-32-0,6-Iodopenicillanic acid,ChemID+,exact,,,,,,,,6-Iodopenicillanic acid,,74772-32-0,exact,,,,6-iodopenicillanic acid,C031528,74772-32-0,exact,,,,6-Iodopenicillanic Acid,C0049632,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,isa,isa,Inhibitors,Enzyme Inhibitors,Enzyme Inhibitors,Y,exact (CUI-based),Enzyme Inhibitors,Enzyme Inhibitors,C0014432,P,,A1.4.1.1.1_Pharmacologic Substance,,,,,,,,,,,,
1_001779,ChEBI,,10-undecenoic acid,112-38-9,Undecylenic acid,ChemID+,<syn per source>,10-undecenoic acid,35045,112-38-9,exact,,,,Undecylenic acid,Undecylenic acid [USP:JAN],112-38-9,<syn per source>,10-Undecenoic acid,exact,,undecylenic acid,C538763,,<syn per source>,10-undecenoic acid,exact,,10-Undecenoic Acid,C2714078,exact,,,,A1.4.1.2.1.9_Lipid,,,,cide,,#VALUE!,fungicide,fungicide,Y,quasi syn therclass-to-disease,fungal infections,Mycoses,C0026946,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact 1,fungicide,Industrial Fungicide,C0392419,S,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001780,NDFRT,C0982111,D-BIOTIN,58-85-5,Biotin,ChemID+,<syn per source>,biotin,15956,58-85-5,NT isomer,D-Biotin,exact,,Biotin,Biotin [USP:INN:JAN],58-85-5,NT isomer,D-Biotin,exact,,,,,,,,,D-Biotin,C0982111,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,may_treat,,#VALUE!,Alopecia,Alopecia,Y,exact (CUI-based),Alopecia,Alopecia,C0002170,P,Y,A2.2_Finding,,,,,,,,,,,,
1_001781,NDFRT,C0982111,D-BIOTIN,58-85-5,Biotin,ChemID+,<syn per source>,biotin,15956,58-85-5,NT isomer,D-Biotin,exact,,Biotin,Biotin [USP:INN:JAN],58-85-5,NT isomer,D-Biotin,exact,,,,,,,,,D-Biotin,C0982111,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,may_treat,,#VALUE!,"Metabolism, Inborn Errors","Metabolism, Inborn Errors",Y,exact (CUI-based),"metabolism, inborn errors",Inborn Errors Of Metabolism,C0025521,S,Y,A1.2.2.1_Congenital Abnormality,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,
1_001782,NDFRT,C0982111,D-BIOTIN,58-85-5,Biotin,ChemID+,<syn per source>,biotin,15956,58-85-5,NT isomer,D-Biotin,exact,,Biotin,Biotin [USP:INN:JAN],58-85-5,NT isomer,D-Biotin,exact,,,,,,,,,D-Biotin,C0982111,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,may_prevent,,#VALUE!,Nutritional and Metabolic Diseases,Nutritional and Metabolic Diseases,Y,exact (CUI-based),Nutritional And Metabolic Diseases,Nutritional And Metabolic Diseases,C0028715,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_001783,NDFRT,C0982111,D-BIOTIN,58-85-5,Biotin,ChemID+,<syn per source>,biotin,15956,58-85-5,NT isomer,D-Biotin,exact,,Biotin,Biotin [USP:INN:JAN],58-85-5,NT isomer,D-Biotin,exact,,,,,,,,,D-Biotin,C0982111,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.4_Vitamin,A1.4.1.2.1_Organic Chemical,,may_treat,,#VALUE!,Vitamin B Deficiency,Vitamin B Deficiency,Y,exact (CUI-based),Vitamin B Deficiency,Vitamin B Deficiency,C0042850,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_001784,ChEBI,,D-serine,312-84-5,D-Serine,ChemID+,exact,D-serine,16523,312-84-5,exact,,,,D-Serine,,312-84-5,exact,,,,,,,,,,,D-Serine,C1880218,exact,,,,A1.4.1.1.1_Pharmacologic Substance,,,,agonist,agonist,15,NMDA receptor agonist,NMDA receptor agonist,Y,quasi syn therclass-to-function,N-Methyl-D-Aspartate Selective Glutamate Receptor Activity,N-Methyl-D-Aspartate Selective Glutamate Receptor Activity,C1152805,P,Y,B2.2.1.1.4_Molecular Function,,,,,,,,,,,,
1_001785,MeSH_PA,C026385,n-hexane,110-54-3,n-Hexane,ChemID+,exact,hexane,29021,110-54-3,NT isomer,n-Hexane,exact,,n-Hexane,,110-54-3,exact,,,,n-hexane,C026385,110-54-3,exact,,,,N-Hexane,C0068008,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Adhesives,Adhesives,Y,exact (CUI-based),Adhesives,Adhesives,C0001516,P,,A1.3_Manufactured Object,,,,,,,,,,,,
1_001786,MeSH_PA,C036260,1-hexanol,111-27-3,1-Hexanol,ChemID+,exact,,,,,,,,1-Hexanol,,111-27-3,exact,,,,1-hexanol,C036260,111-27-3,exact,,,,1-Hexanol,C0044399,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Anesthetics,Anesthetics,Y,quasi syn therclass-to-function,Anesthetic Effect,Anesthetic Effect,C3179301,P,Y,B2.2.1.1_Physiologic Function,,,,exact (CUI-based),Anesthetics,Anesthetics,C0002932,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001787,MeSH_PA,C036260,1-hexanol,111-27-3,1-Hexanol,ChemID+,exact,,,,,,,,1-Hexanol,,111-27-3,exact,,,,1-hexanol,C036260,111-27-3,exact,,,,1-Hexanol,C0044399,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Central Nervous System Agents,Central Nervous System Agents,Y,quasi syn therclass-to-disease,Cns Disorder,Cns Disorder,C0007682,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Agents,Central Nervous System Agents,C0007680,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001788,MeSH_PA,C036260,1-hexanol,111-27-3,1-Hexanol,ChemID+,exact,,,,,,,,1-Hexanol,,111-27-3,exact,,,,1-hexanol,C036260,111-27-3,exact,,,,1-Hexanol,C0044399,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Central Nervous System Depressants,Central Nervous System Depressants,Y,quasi syn therclass-to-disease,central nervous system depression,Central Nervous System Depression (Disorder),C0151559,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Central Nervous System Depressants,Central Nervous System Depressants,C0007681,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001789,MeSH_PA,C036260,1-hexanol,111-27-3,1-Hexanol,ChemID+,exact,,,,,,,,1-Hexanol,,111-27-3,exact,,,,1-hexanol,C036260,111-27-3,exact,,,,1-Hexanol,C0044399,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Cholinergic Agents,Cholinergic Agents,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Agents,Cholinergic Agents,C0242893,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001790,MeSH_PA,C036260,1-hexanol,111-27-3,1-Hexanol,ChemID+,exact,,,,,,,,1-Hexanol,,111-27-3,exact,,,,1-hexanol,C036260,111-27-3,exact,,,,1-Hexanol,C0044399,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Cholinergic Antagonists,Cholinergic Antagonists,Y,quasi syn therclass-to-function,Cholinergic Synaptic Transmission,Cholinergic Synaptic Transmission,C0234097,P,Y,B2.2.1.1.2_Organ or Tissue Function,,,,exact (CUI-based),Cholinergic Antagonists,Cholinergic Antagonists,C0242897,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001791,MeSH_PA,C036260,1-hexanol,111-27-3,1-Hexanol,ChemID+,exact,,,,,,,,1-Hexanol,,111-27-3,exact,,,,1-hexanol,C036260,111-27-3,exact,,,,1-Hexanol,C0044399,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Neurotransmitter Agents,Neurotransmitter Agents,Y,quasi syn therclass-to-function,neurotransmission,Synaptic Transmission,C0027793,S,Y,B2.2.1.1.3_Cell Function,,,,exact (CUI-based),Neurotransmitter Agents,Neurotransmitter Agents,C0243051,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001792,MeSH_PA,C036260,1-hexanol,111-27-3,1-Hexanol,ChemID+,exact,,,,,,,,1-Hexanol,,111-27-3,exact,,,,1-hexanol,C036260,111-27-3,exact,,,,1-Hexanol,C0044399,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,antagonist,antagonist,#VALUE!,Nicotinic Antagonists,Nicotinic Antagonists,Y,quasi syn therclass-to-function,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,Nicotinic Acetylcholine-Activated Cation-Selective Channel Activity,C1148665,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Nicotinic Antagonists,Nicotinic Antagonists,C0242956,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001793,MeSH_PA,C010463,n-hexanal,66-25-1,Hexaldehyde,ChemID+,<syn per source>,,,,,,,,Hexaldehyde,,66-25-1,BT of isomer,n-Hexanal,exact,,n-hexanal,C010463,66-25-1,exact,,,,N-Hexanal,C0068007,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,Antifungal Agents,Antifungal Agents,Y,quasi syn therclass-to-disease,fungal infections,Mycoses,C0026946,S,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Antifungal Agents,Antifungal Agents,C0003308,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001794,MeSH_PA,C010463,n-hexanal,66-25-1,Hexaldehyde,ChemID+,<syn per source>,,,,,,,,Hexaldehyde,,66-25-1,BT of isomer,n-Hexanal,exact,,n-hexanal,C010463,66-25-1,exact,,,,N-Hexanal,C0068007,exact,,,,A1.4.1.2.1_Organic Chemical,,,,anti,,#VALUE!,Anti-Infective Agents,Anti-Infective Agents,Y,quasi syn therclass-to-disease,Infection,Infection,C0021311,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Anti-Infective Agents,Anti-Infective Agents,C0003204,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001795,MeSH_PA,C010463,n-hexanal,66-25-1,Hexaldehyde,ChemID+,<syn per source>,,,,,,,,Hexaldehyde,,66-25-1,BT of isomer,n-Hexanal,exact,,n-hexanal,C010463,66-25-1,exact,,,,N-Hexanal,C0068007,exact,,,,A1.4.1.2.1_Organic Chemical,,,,cide,,#VALUE!,Insecticides,Insecticides,Y,quasi syn therclass-to-disease,Infestation By Insect,Infestation By Insect,C0277344,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,exact (CUI-based),Insecticides,Insecticides,C0021576,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001796,MeSH_PA,C010463,n-hexanal,66-25-1,Hexaldehyde,ChemID+,<syn per source>,,,,,,,,Hexaldehyde,,66-25-1,BT of isomer,n-Hexanal,exact,,n-hexanal,C010463,66-25-1,exact,,,,N-Hexanal,C0068007,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,Pesticides,Pesticides,Y,quasi syn therclass-to-function,Pesticide Interaction,Pesticide Interaction,C0597202,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Pesticides,Pesticides,C0031253,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001797,MeSH_PA,C048876,"1,5-AEDANS",50402-62-5,"1,5-Aedans",ChemID+,exact,5-[(2-acetamidoethyl)amino]naphthalene-1-sulfonic acid,40594,50402-62-5,<syn per source>,"1,5-Aedans",exact,,"1,5-Aedans",,50402-62-5,exact,,,,"1,5-AEDANS",C048876,50402-62-5,exact,,,,"1,5-Aedans",C0044026,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001798,MeSH_PA,C048876,"1,5-AEDANS",50402-62-5,"1,5-Aedans",ChemID+,exact,5-[(2-acetamidoethyl)amino]naphthalene-1-sulfonic acid,40594,50402-62-5,<syn per source>,"1,5-Aedans",exact,,"1,5-Aedans",,50402-62-5,exact,,,,"1,5-AEDANS",C048876,50402-62-5,exact,,,,"1,5-Aedans",C0044026,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001799,MeSH_PA,C048876,"1,5-AEDANS",50402-62-5,"1,5-Aedans",ChemID+,exact,5-[(2-acetamidoethyl)amino]naphthalene-1-sulfonic acid,40594,50402-62-5,<syn per source>,"1,5-Aedans",exact,,"1,5-Aedans",,50402-62-5,exact,,,,"1,5-AEDANS",C048876,50402-62-5,exact,,,,"1,5-Aedans",C0044026,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001800,MeSH_PA,C048876,"1,5-AEDANS",50402-62-5,"1,5-Aedans",ChemID+,exact,5-[(2-acetamidoethyl)amino]naphthalene-1-sulfonic acid,40594,50402-62-5,<syn per source>,"1,5-Aedans",exact,,"1,5-Aedans",,50402-62-5,exact,,,,"1,5-AEDANS",C048876,50402-62-5,exact,,,,"1,5-Aedans",C0044026,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001801,ChEBI,,2-naphthol,135-19-3,Betanaphthol,ChemID+,<syn per source>,2-naphthol,10432,135-19-3,exact,,,,Betanaphthol,Betanaphthol [NF],135-19-3,<syn per source>,2-Naphthol,exact,,2-naphthol,C028405,135-19-3,exact,,,,2-Naphthol,C0046413,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,anti,,#VALUE!,antinematodal drug,antinematodal drug,Y,quasi syn therclass-to-disease,Nematode Infections,Nematode Infections,C0027583,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,syn plural/sing,antinematodal drugs,Antinematodal Agents,C0003391,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001802,ChEBI,,D-arginine,157-06-2,D-Arginine,ChemID+,exact,D-arginine,15816,157-06-2,exact,,,,D-Arginine,,157-06-2,exact,,,,,,,,,,,D-Arginine,C2699543,exact,,,,"A1.4.1.2.1.7_Amino Acid, Peptide, or Protein",,,,inhibitor,inhibits, inhibitor,arginine decarboxylase inhibitor,arginine decarboxylase inhibitor,Y,quasi syn therclass-to-function,Arginine Decarboxylase Activity,Arginine Decarboxylase Activity,C1150819,P,Y,B2.2.1.1.4_Molecular Function,,,,,,,,,,,,
1_001803,MeSH_PA,C007548,n-dodecane,112-40-3,Dodecane,ChemID+,<syn per source>,dodecane,28817,112-40-3,NT isomer,n-Dodecane,exact,,Dodecane,,112-40-3,NT isomer,n-Dodecane,exact,,n-dodecane,C007548,112-40-3,exact,,,,N-Dodecane,C0067942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001804,MeSH_PA,C007548,n-dodecane,112-40-3,Dodecane,ChemID+,<syn per source>,dodecane,28817,112-40-3,NT isomer,n-Dodecane,exact,,Dodecane,,112-40-3,NT isomer,n-Dodecane,exact,,n-dodecane,C007548,112-40-3,exact,,,,N-Dodecane,C0067942,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001805,MeSH_PA,C023622,2-toluidine,95-53-4,2-Aminotoluene,ChemID+,<syn per source>,o-toluidine,66892,95-53-4,<syn per source>,2-Toluidine,exact,,2-Aminotoluene,,95-53-4,syn,2-Toluidine,exact,,2-toluidine,C023622,95-53-4,exact,,,,2-Toluidine,C0046584,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001806,MeSH_PA,C023622,2-toluidine,95-53-4,2-Aminotoluene,ChemID+,<syn per source>,o-toluidine,66892,95-53-4,<syn per source>,2-Toluidine,exact,,2-Aminotoluene,,95-53-4,syn,2-Toluidine,exact,,2-toluidine,C023622,95-53-4,exact,,,,2-Toluidine,C0046584,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001807,MeSH_PA,C023622,2-toluidine,95-53-4,2-Aminotoluene,ChemID+,<syn per source>,o-toluidine,66892,95-53-4,<syn per source>,2-Toluidine,exact,,2-Aminotoluene,,95-53-4,syn,2-Toluidine,exact,,2-toluidine,C023622,95-53-4,exact,,,,2-Toluidine,C0046584,exact,,,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001808,MeSH_PA,C001470,4-ipomeanol,32954-58-8,Ipomeanol,ChemID+,<syn per source>,,,,,,,,Ipomeanol,,32954-58-8,NT isomer,4-Ipomeanol,exact,,4-ipomeanol,C001470,32954-58-8,exact,,,,4-Ipomeanol,C0048420,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,Antineoplastic Agents,Antineoplastic Agents,Y,quasi syn therclass-to-disease,Malignant Neoplasms,Malignant Neoplasms,C0006826,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Antineoplastic Agents,Antineoplastic Agents,C0003392,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001809,MeSH_PA,C006421,"1,5-I-AEDANS",36930-63-9,"1,5-I-Aedans",ChemID+,exact,5-\{[2-(iodoacetamido)ethyl]amino\}naphthalene-1-sulfonic acid,58984,36930-63-9,<syn per source>,"1,5-I-Aedans",exact,,"1,5-I-Aedans",,36930-63-9,exact,,,,"1,5-I-AEDANS",C006421,36930-63-9,exact,,,,"1,5-I-Aedans",C0044039,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Coloring Agents,Coloring Agents,Y,exact (CUI-based),Coloring Agents,Coloring Agents,C1566391,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001810,MeSH_PA,C006421,"1,5-I-AEDANS",36930-63-9,"1,5-I-Aedans",ChemID+,exact,5-\{[2-(iodoacetamido)ethyl]amino\}naphthalene-1-sulfonic acid,58984,36930-63-9,<syn per source>,"1,5-I-Aedans",exact,,"1,5-I-Aedans",,36930-63-9,exact,,,,"1,5-I-AEDANS",C006421,36930-63-9,exact,,,,"1,5-I-Aedans",C0044039,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Fluorescent Dyes,Fluorescent Dyes,Y,exact (CUI-based),Fluorescent Dyes,Fluorescent Dyes,C0016320,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001811,MeSH_PA,C006421,"1,5-I-AEDANS",36930-63-9,"1,5-I-Aedans",ChemID+,exact,5-\{[2-(iodoacetamido)ethyl]amino\}naphthalene-1-sulfonic acid,58984,36930-63-9,<syn per source>,"1,5-I-Aedans",exact,,"1,5-I-Aedans",,36930-63-9,exact,,,,"1,5-I-AEDANS",C006421,36930-63-9,exact,,,,"1,5-I-Aedans",C0044039,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001812,MeSH_PA,C006421,"1,5-I-AEDANS",36930-63-9,"1,5-I-Aedans",ChemID+,exact,5-\{[2-(iodoacetamido)ethyl]amino\}naphthalene-1-sulfonic acid,58984,36930-63-9,<syn per source>,"1,5-I-Aedans",exact,,"1,5-I-Aedans",,36930-63-9,exact,,,,"1,5-I-AEDANS",C006421,36930-63-9,exact,,,,"1,5-I-Aedans",C0044039,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Luminescent Agents,Luminescent Agents,Y,exact (CUI-based),Luminescent Agents,Luminescent Agents,C1450139,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001813,MeSH_PA,C006593,2-anthramine,613-13-8,2-Anthracenamine,ChemID+,<syn per source>,anthracen-2-amine,34260,613-13-8,<syn per source>,2-Anthramine,exact,,2-Anthracenamine,,613-13-8,<syn per source>,2-Anthramine,exact,,2-anthramine,C006593,613-13-8,exact,,,,2-Anthramine,C0045907,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001814,MeSH_PA,C006593,2-anthramine,613-13-8,2-Anthracenamine,ChemID+,<syn per source>,anthracen-2-amine,34260,613-13-8,<syn per source>,2-Anthramine,exact,,2-Anthracenamine,,613-13-8,<syn per source>,2-Anthramine,exact,,2-anthramine,C006593,613-13-8,exact,,,,2-Anthramine,C0045907,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001815,MeSH_PA,C006593,2-anthramine,613-13-8,2-Anthracenamine,ChemID+,<syn per source>,anthracen-2-amine,34260,613-13-8,<syn per source>,2-Anthramine,exact,,2-Anthracenamine,,613-13-8,<syn per source>,2-Anthramine,exact,,2-anthramine,C006593,613-13-8,exact,,,,2-Anthramine,C0045907,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001816,ChEBI,,5-iodouracil,696-07-1,5-Iodouracil,ChemID+,exact,5-iodouracil,43636,696-07-1,exact,,,,5-Iodouracil,,696-07-1,exact,,,,5-iodouracil,C048747,696-07-1,exact,,,,5-Iodouracil,C0049272,exact,,,,"A1.4.1.2.1.5_Nucleic Acid, Nucleoside, or Nucleotide",,,,anti,,#VALUE!,antimetabolite,antimetabolite,Y,quasi syn therclass-to-function,Metabolism,Metabolism,C0025519,P,Y,B2.2.1.1.1_Organism Function,,,,exact 1,antimetabolite,Antimetabolites,C0003376,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001817,ChEBI,,"6,6'-bieckol",88095-81-2,"6,6'-Bieckol",ChemID+,exact,"6,6'-bieckol",65496,88095-81-2,exact,,,,"6,6'-Bieckol",,88095-81-2,exact,,,,"6,6'-bieckol",C062360,88095-81-2,exact,,,,"6,6'-Bieckol",C0639377,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,anti-HIV-1 agent,anti-HIV-1 agent,Y,quasi syn therclass-to-disease,Hiv-1 Infection,Hiv-1 Infection,C2363741,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,,,,,,,,,
1_001818,ChEBI,,"6,6'-bieckol",88095-81-2,"6,6'-Bieckol",ChemID+,exact,"6,6'-bieckol",65496,88095-81-2,exact,,,,"6,6'-Bieckol",,88095-81-2,exact,,,,"6,6'-bieckol",C062360,88095-81-2,exact,,,,"6,6'-Bieckol",C0639377,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,radical scavenger,radical scavenger,Y,quasi syn therclass-to-function,Free Radical Scavenging [Moa],Free Radical Scavenging [Moa],C1517315,P,Y,B2.2.1.1.4_Molecular Function,,,,quasi syn,Free Radical Scavengers,Free Radical Scavengers,C0079381,P,A1.4.1.1_Chemical Viewed Functionally,,,
1_001819,MeSH_PA,C079142,"1,2-dioxetane",6788-84-7,"1,2-Dioxetane",ChemID+,exact,,,,,,,,"1,2-Dioxetane",,6788-84-7,exact,,,,"1,2-dioxetane",C079142,6788-84-7,exact,,,,"1,2-Dioxetane",C0212353,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Indicators and Reagents,Indicators and Reagents,Y,exact (CUI-based),Indicators And Reagents,Indicators And Reagents,C0021213,P,,"A1.4.1.1.4_Indicator, Reagent, or Diagnostic Aid",,,,,,,,,,,,
1_001820,MeSH_PA,C031763,"1,3-butadiene",106-99-0,"1,3-Butadiene",ChemID+,exact,"buta-1,3-diene",39478,106-99-0,<syn per source>,"1,3-butadiene",exact,,"1,3-Butadiene",,106-99-0,exact,,,,"1,3-butadiene",C031763,106-99-0,exact,,,,"1,3-Butadiene",C0043902,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Carcinogens,Carcinogens,Y,quasi syn therclass-to-disease,Carcinogenesis,Carcinogenesis,C0596263,P,Y,B2.2.1.2.1.2_Neoplastic Process,,,,exact (CUI-based),Carcinogens,Carcinogens,C0007090,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001821,MeSH_PA,C031763,"1,3-butadiene",106-99-0,"1,3-Butadiene",ChemID+,exact,"buta-1,3-diene",39478,106-99-0,<syn per source>,"1,3-butadiene",exact,,"1,3-Butadiene",,106-99-0,exact,,,,"1,3-butadiene",C031763,106-99-0,exact,,,,"1,3-Butadiene",C0043902,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001822,MeSH_PA,C031763,"1,3-butadiene",106-99-0,"1,3-Butadiene",ChemID+,exact,"buta-1,3-diene",39478,106-99-0,<syn per source>,"1,3-butadiene",exact,,"1,3-Butadiene",,106-99-0,exact,,,,"1,3-butadiene",C031763,106-99-0,exact,,,,"1,3-Butadiene",C0043902,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001823,MeSH_PA,C032668,1-nitropyrene,5522-43-0,1-Nitropyrene,ChemID+,exact,1-nitropyrene,34107,5522-43-0,exact,,,,1-Nitropyrene,,5522-43-0,exact,,,,1-nitropyrene,C032668,5522-43-0,exact,,,,1-Nitropyrene,C0044508,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001824,MeSH_PA,C032668,1-nitropyrene,5522-43-0,1-Nitropyrene,ChemID+,exact,1-nitropyrene,34107,5522-43-0,exact,,,,1-Nitropyrene,,5522-43-0,exact,,,,1-nitropyrene,C032668,5522-43-0,exact,,,,1-Nitropyrene,C0044508,exact,,,,A1.4.1.1.5_Hazardous or Poisonous Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001825,MeSH_PA,C026729,4-aminophenol,123-30-8,4-Aminophenol,ChemID+,exact,4-aminophenol,17602,123-30-8,exact,,,,4-Aminophenol,,123-30-8,exact,,,,4-aminophenol,C026729,123-30-8,exact,,,,4-Aminophenol,C0048047,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001826,MeSH_PA,C026729,4-aminophenol,123-30-8,4-Aminophenol,ChemID+,exact,4-aminophenol,17602,123-30-8,exact,,,,4-Aminophenol,,123-30-8,exact,,,,4-aminophenol,C026729,123-30-8,exact,,,,4-Aminophenol,C0048047,exact,,,,A1.4.1.2.1_Organic Chemical,,,,causes,,#VALUE!,Noxae,Noxae,Y,quasi syn therclass-to-disease,"Poisoning By And Exposure To Noxious Substances, Undetermined Intent","Poisoning By And Exposure To Noxious Substances, Undetermined Intent",C0480774,P,Y,B2.3_Injury or Poisoning,,,,exact (CUI-based),Noxae,Noxae,C0028470,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001827,ChEBI,,4-cyanophenol,767-00-0,4-Cyanophenol,ChemID+,exact,4-cyanophenol,38622,767-00-0,exact,,,,4-Cyanophenol,,767-00-0,exact,,,,4-cyanophenol,C007178,767-00-0,exact,,,,4-Cyanophenol,C0048218,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits, inhibitor,monoamine oxidase inhibitor,monoamine oxidase inhibitor,Y,quasi syn therclass-to-function,amine oxidase activity,Primary Amine Oxidase Activity,C1151830,S,Y,B2.2.1.1.4_Molecular Function,,,,exact 1,monoamine oxidase inhibitor,Monoamine Oxidase Inhibitors,C0026457,S,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,
1_001828,MeSH_PA,C080417,4-octylphenol,1806-26-4,4-Octylphenol,ChemID+,exact,4-octylphenol,34432,1806-26-4,exact,,,,4-Octylphenol,,1806-26-4,exact,,,,4-octylphenol,C080417,1806-26-4,exact,,,,4-Octylphenol,C0214745,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Estrogens,Estrogens,Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),Estrogens,Estrogens,C0014939,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1.9.1_Steroid,
1_001829,MeSH_PA,C080417,4-octylphenol,1806-26-4,4-Octylphenol,ChemID+,exact,4-octylphenol,34432,1806-26-4,exact,,,,4-Octylphenol,,1806-26-4,exact,,,,4-octylphenol,C080417,1806-26-4,exact,,,,4-Octylphenol,C0214745,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,"Estrogens, Non-Steroidal","Estrogens, Non-Steroidal",Y,quasi syn therclass-to-function,Estrogen Effect,Estrogen Effect,C0877035,P,Y,A2.2_Finding,,,,exact (CUI-based),"Estrogens, Non-Steroidal","Estrogens, Non-Steroidal",C0014940,P,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.1.3.2_Hormone,A1.4.1.2.1_Organic Chemical,
1_001830,MeSH_PA,C080417,4-octylphenol,1806-26-4,4-Octylphenol,ChemID+,exact,4-octylphenol,34432,1806-26-4,exact,,,,4-Octylphenol,,1806-26-4,exact,,,,4-octylphenol,C080417,1806-26-4,exact,,,,4-Octylphenol,C0214745,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,,#VALUE!,Hormones,Hormones,Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Hormones,Hormones,C0019932,P,A1.4.1.1.3.2_Hormone,,,
1_001831,MeSH_PA,C080417,4-octylphenol,1806-26-4,4-Octylphenol,ChemID+,exact,4-octylphenol,34432,1806-26-4,exact,,,,4-Octylphenol,,1806-26-4,exact,,,,4-octylphenol,C080417,1806-26-4,exact,,,,4-Octylphenol,C0214745,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,,affects,#VALUE!,"Hormones, Hormone Substitutes, and Hormone Antagonists","Hormones, Hormone Substitutes, and Hormone Antagonists",Y,quasi syn therclass-to-function,Hormone Activity,Hormone Activity,C1149475,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),"Hormones, Hormone Substitutes, And Hormone Antagonists","Hormones, Hormone Substitutes, And Hormone Antagonists",C0019934,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001832,ChEBI,,7-phloroeckol,,,,,7-phloroeckol,65790,,exact,,,,,,,,,,,7-phloroeckol,C558314,,exact,,,,7-Phloroeckol,C3181346,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,antioxidant,antioxidant,Y,quasi syn therclass-to-disease,Free Radical Oxidation Of Tissue,Free Radical Oxidation Of Tissue,C0599059,P,Y,B2.2.1.2.2_Cell or Molecular Dysfunction,,,,exact 1,antioxidant,Antioxidants,C0003402,S,A1.4.1.1.1_Pharmacologic Substance,,,
1_001833,ChEBI,,7-phloroeckol,,,,,7-phloroeckol,65790,,exact,,,,,,,,,,,7-phloroeckol,C558314,,exact,,,,7-Phloroeckol,C3181346,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits, inhibitor,triacylglycerol lipase inhibitor,triacylglycerol lipase inhibitor,Y,quasi syn therclass-to-function,triacylglycerol lipase activity,Triglyceride Lipase Activity,C2262029,S,Y,B2.2.1.1.4_Molecular Function,,,,,,,,,,,,
1_001834,ChEBI,,beta-eudesmol,473-15-4,beta-Eudesmol,ChemID+,exact,beta-eudesmol,10417,473-15-4,exact,,,,beta-Eudesmol,,473-15-4,exact,,,,beta-eudesmol,C051082,473-15-4,exact,,,,Beta-Eudesmol,C0053428,exact,,,,A1.4.1.2.1_Organic Chemical,,,,,,#VALUE!,volatile oil component,volatile oil component,Y,NT,volatile oil,"Oils, Volatile",C0028910,S,,A1.4.1.2.1_Organic Chemical,,,,,,,,,,,,
1_001835,ChEBI,,beta-sanshool,504-97-2,Sanshool,ChemID+,NT subtype,beta-sanshool,66166,,exact,,,,Sanshool,,504-97-2,NT subtype,,,,sanshool,C100574,504-97-2,NT isomer,beta-sanshool,exact,,Beta-Sanshool,C0965648,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,inhibitor,inhibits, inhibitor,acyl-CoA:cholesterol acyltransferase inhibitor,acyl-CoA:cholesterol acyltransferase inhibitor,Y,quasi syn therclass-to-function,acyl-coa:cholesterol acyltransferase activity,Cholesterol O-Acyltransferase Activity,C2612890,S,Y,B2.2.1.1.4_Molecular Function,,,,,,,,,,,,
1_001836,ChEBI,,canthin-6-one,479-43-6,Canthin-6-one,ChemID+,exact,canthin-6-one,3363,479-43-6,exact,,,,Canthin-6-one,,479-43-6,exact,,,,canthin-6-one,C453379,,exact,,,,Canthin-6-One,C1122077,exact,,,,A1.4.1.1.3_Biologically Active Substance,A1.4.1.2.1_Organic Chemical,,,anti,,#VALUE!,antimycobacterial drug,antimycobacterial drug,Y,quasi syn therclass-to-disease,Mycobacterium Infections,Mycobacterium Infections,C0026918,P,Y,B2.2.1.2.1_Disease or Syndrome,,,,quasi syn,Antimycobacterial Agent,Antimycobacterial Agent,C0360390,P,A1.4.1.1.1_Pharmacologic Substance,,,
1_001837,MeSH_PA,C103736,2-bromopropane,75-26-3,Isopropyl bromide,ChemID+,<syn per source>,,,,,,,,Isopropyl bromide,,75-26-3,syn,2-Bromopropane,exact,,2-bromopropane,C103736,75-26-3,exact,,,,2-Bromopropane,C0534492,exact,,,,A1.4.1.1.1_Pharmacologic Substance,A1.4.1.2.1_Organic Chemical,,,causes,,#VALUE!,Mutagens,Mutagens,Y,quasi syn therclass-to-function,Mutagenesis Process,Mutagenesis Process,C0079866,P,Y,B2.2.1.1.4_Molecular Function,,,,exact (CUI-based),Mutagens,Mutagens,C0026879,P,A1.4.1.1.5_Hazardous or Poisonous Substance,,,
1_001838,MeSH_PA,C103736,2-bromopropane,75-26-3,Isopropyl bromide,ChemID+,<syn per source>,,,,,,,,Isopropyl bromide,,75-26-3,syn,2-Bromopropane,exact,,2-bromopropane,C103736,75-26-3,exact,,,,2-Bromopropane,C0534492,exact,,,,A1.4.1.1